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All	  current	  chronic	  low	  back	  pain	  (LBP)	  treatments	  have	  variable	  long-­‐term	  efficacy.	  
Changes	   in	   the	  central	  nervous	  system	  pathways	  controlling	   trunk	  and	   leg	  muscles	  
(T&L)	  in	  LBP	  have	  been	  reported,	  and	  this	  thesis	  investigated	  whether	  surgery	  (n=24)	  
or	   conservative	   management	   (spinal	   injections	   [SIs;n=12]	   or	   no	   treatment	  
[NT;n=18]),	  impact	  upon	  these	  changes	  in	  the	  long	  term.	  
19	  healthy	  controls	  and	  54	  LBP	  patients	  were	  recruited.	  45	  of	  the	  LBP	  patients	  also	  
had	  leg	  pain	  distal	  to	  the	  knee	  (LBPLP),	  12	  of	  which	  had	  radicular	  pain/radiculopathy	  
at	   L5	   and	   12	   at	   S1.	   Transcranial	  magnetic	   stimulation	   (TMS)	  was	   used	   to	   evoke	   a	  
number	  of	  outcome	  measures	  in	  electromyographic	  activity.	  The	  first	  long	  term	  TMS	  
T&L	   reliability	   study	   established	   suitable	   parameters	   to	   assess	   corticomotor	  
excitability	  (CE)	  (i.e.	  motor	  evoked	  potential	  (MEP)	  threshold	  (MTh))	  and	  intracortical	  
inhibition	  (ICI:	   i.e.	  the	  cortical	  silent	  period	  (cSP))	  on	  4	  occasions,	  prior	  and	  up	  to	  1	  
year	  following	  treatment.	  
LBPLP	  patients	  had	  pain-­‐lateralised	  and	  markedly	  prolonged	   leg	  cSPs,	  which,	  unlike	  
in	   SI	   patients,	  were	   gradually	   normalised	   in	   high	   functional	   responders	   to	   surgery.	  
Significant	  reductions	  in	  leg	  MThs	  occurred	  in	  high	  functional	  responders	  to	  surgery	  
at	   6	   weeks,	   whilst	   further	   reductions	   occurred	   in	   those	   with	   excellent	   leg	   pain	  
outcome.	  Tibialis	  anterior	  was	  exclusively	   sensitive	   to	  L5	  group	   ICI&CE	  changes.	  By	  
contrast,	   back	   muscles	   in	   LBP	   had	   markedly	   elevated	   MTh	   and	   altered	   MEP	  
recruitment;	   with	   longer	   MEPs	   and	   more	   moderate	   bilaterally	   prolonged	   cSPs.	  
Patients	  who	  improved	  had	  more	  abnormal	  baseline	  CE	  and	  ICI.	  
These	   studies	   establish	   patho-­‐anatomically	   specific	   (side,	   root	   level	   and	   likely	  
pathway-­‐specific)	  cortical	  changes	  in	  leg	  pain/radiculopathy,	  which	  are	  reversible	  by	  
successful	  surgery.	  More	  significantly,	   the	  distinct	   ICI	  and	  CE	  profiles	   found	   in	  back	  
and	  leg	  muscles	  may	  eventually	  be	  useful	  in	  determining	  which	  patients	  are	  likely	  to	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Statement	  of	  Originality	  
	  
All	  of	  the	  experimental	  protocols	  in	  this	  thesis	  were	  fully	  developed	  and	  carried	  out	  
by	  myself,	  with	  invaluable	  advice	  from	  my	  supervisors.	  	  All	  experiments	  in	  this	  thesis	  
were	   carried	   out	   between	   July	   2007	   and	   September	   2010.	   As	   it	   was	   physically	  
difficult	   to	   keep	   to	   experiment	   time	   constraints,	  while	   operating	   a	   stimulating	   coil	  
and	  two	  computers,	   filling	  out	  an	  experimental	  sheet	  and	  guiding	  patients	   through	  
the	   protocols,	   I	   was	   often	   assisted	   by	   a	   colleague	   in	   the	   lab	   until	   I	   developed	   a	  
sufficiently	  confident	  capacity	  for	  multi-­‐tasking.	  In	  order	  not	  to	  compete	  for	  patient	  
inclusion	   with	   another	   study	   at	   Charing	   Cross	   Hospital,	   the	   initial	   questionnaire	  
design	  was	  altered	  to	   include	  extra	  questions	   relevant	   to	   that	  study,	   the	   format	  of	  
which	  was	  designed	  by	  Prof	  Alison	  McGregor	  (see	  Appendix).	  	  All	  patient	  recruitment	  
and	  retention,	  data	  collection,	  programming,	  data	  processing	  and	  statistical	  analyses	  
were	  also	  exclusively	  carried	  out	  by	  myself.	  
	  
Because	   of	   the	   practical	   difficulties	   in	   recording	   reliable	   cortical	   responses	   in	  
paraspinal	   muscles,	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  mean	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  mep	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micro	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MN	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MRI	   magnetic	  resonance	  imaging	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  square	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  stimulator	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MU	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N	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NC	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nMEP	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  Index	  
OE	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P	  	   paraesthesia	  	  
P2P	   mep	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PLI	   pain	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  index	  
PP	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  or	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R	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   recruitment	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  to	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  trunk	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  error	  of	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   transcranial	  magnetic	  stimulation	  
TrA	   transversus	  abdominis	  
TU	   ankle	  flexion	  
VAS	   visual	  analogue	  scales	  
W	  	   weakness	  
X50	   x-­‐axis	  midpoint	  defined	  by	  the	  fitted	  curve	  
Y50	   y-­‐axis	  midpoint	  defined	  by	  the	  fitted	  curve	  
	   	  
	   	  
	   	  
	  










	  Alterations	   in	   the	   stabilising	   musculature	   surrounding	   the	   spine	   have	   been	  
implicated	  in	  the	  development	  of	  low	  back	  pain	  by	  a	  variety	  of	  studies.	  This	  has	  been	  
reiterated	   by	   studies	   revealing	   changes	   in	   the	   brain	   pathways	   to	   some	   of	   these	  
muscles	   and	   the	   lower	   limbs	  which,	   either	   contribute	   to	   or	   represent	   an	   adaptive	  
change	  to	  low	  back	  pain	  and	  leg	  pain.	  Across	  the	  entire	  spectrum	  of	  disc	  and	  stenotic	  
pathologies,	  surgery	  to	  relieve	  symptoms	  of	  radicular	  pain	  and	  radiculopathy	  have	  so	  
far	   yielded	   highly	   variable	   long	   term	   functional	   outcomes	   and	   patient	   satisfaction.	  
Moreover,	  the	  return	  of	  symptoms	  in	  numerous	  cases	  deserves	  further	  investigation.	  
There	   is	  still	   some	  ambiguity	  as	   to	  whether	  modifications	  of	   the	  brain	  pathways	  to	  
the	  muscles	  that	  have	  been	  observed	  in	  patients	  yet	  to	  undergo	  surgery	  can	  actually	  
be	  reversed	  by	  surgery.	  This	  thesis	  has	  provided	  some	  insights	  into	  the	  time	  course	  
of	   the	   changes	  occurring	  at	   the	   level	  of	   the	   central	  nervous	   system	   in	   chronic	   low	  
back	  pain	  and	  begins	  to	  unravel	  details	  about	  which	  of	  these	  changes	  are	  mitigated	  
by	  successful	  surgery	  or	  conservative	  treatment.	  
	  
This	   is,	   to	   the	   author’s	   knowledge,	   the	   first	   longitudinal	   study	   to	   investigate	   long	  
term	  changes	  at	   the	   level	  of	   the	  central	  nervous	   system	   (CNS)	   in	   chronic	   low	  back	  
pain	   patients	   and	   also	   the	   first	   to	   look	   at	   CNS	   corticomotor	   changes	   in	   LBP	   and	  
radicular	   pain/radiculopathy	   following	   discectomy/lumbar	   decompression	   surgery.	  	  
This	  thesis	  is	  therefore	  unique	  in	  relating	  long	  term	  neuroplastic	  changes	  to	  patient	  
rated	   outcome	   of	   surgery	   and	   conservative	   treatment.	   To	   further	   characterise	  
varying	   lateralised,	   neuropathic	   and	   inflammatory	   presentations,	   a	   non-­‐treated	  
chronic	   low	  back	   pain	   group	  was	   included,	   along	  with	   a	   group	   treated	  with	   spinal	  
injections.	  	  Furthermore	  as	  the	  first	  investigation	  to	  monitor	  the	  long	  term	  reliability	  
and	   tolerances	   of	   transcranial	   magnetic	   stimulation	   (TMS)	   parameters	   of	   central	  
control	   in	   trunk	  and	   leg	  musculature,	   it	   offers	   a	   realistic	   assessment	  of	   the	   clinical	  




	    
24	  
	  
 Epidemiology of Low Back Pain 
	  
	  
Low	  back	  pain	  (LBP)	  is	  a	  growing	  musculoskeletal	  disorder	  affecting	  40%	  of	  the	  adult	  
population	   of	   the	   United	   Kingdom	   population	   (Palmer	   et	   al.,	   2000).	   Other	   studies	  
have	  indicated	  that	  50-­‐80%	  of	  adults	  will	  suffer	  from	  LBP	  at	  some	  point	  in	  their	  lives	  
while	   15-­‐30%	  of	   adults	   are	   enduring	   the	   condition	   at	   any	   time	   (Andersson,	   1998).	  
Although	   many	   recover	   within	   one	   month	   of	   its	   onset,	   most	   individuals	   will	  
experience	   recurrent	   episodes	   within	   a	   year	   (Cassidy	   et	   al.,	   2005,	   Wasiak	   et	   al.,	  
2006).	  In	  the	  western	  world,	  it	  is	  the	  leading	  cause	  of	  work	  related	  absence	  (Blyth	  et	  
al.,	  2001).	   It	   is	  also	  associated	  with	  substantial	   financial	  public	  and	  private	  burden.	  
The	   estimated	   cost	   to	   the	   NHS	   is	   £481	   million	   a	   year	   (ranging	   from	   £356	   -­‐	   649	  
million),	  with	  non	  NHS	  costs	  (private	  consultations	  and	  prescriptions	  mostly	  incurred	  
by	  individuals)	  constituting	  an	  additional	  £197	  million	  (Edwards	  et	  al.,	  1992).	  	  A	  more	  
general	   estimate	   places	   the	   direct	   health	   care	   cost	   figure	   of	   back	   pain	   at	   £1632	  
million	  based	  on	  1998	  alone,	  of	  which	  35%	  relates	  to	  services	  provided	  in	  the	  private	  
sector	   (Maniadakis	   and	  Gray,	   2000).	   One	   study	   found	   that	   roughly	   50%	   of	   people	  
suffer	  a	  recurrence	  within	  one	  year,	  60%	  within	  2	  years	  and	  70%	  within	  5	  years	  of	  an	  
episode	   of	   LBP	   (Hestbaek	   et	   al.,	   2003),	   sometimes	   leading	   to	   temporary	   disability	  
and	   surgery.	   An	   estimated	   10%	   of	   LBP	   sufferers	   are	   indefinitely	   disabled	   by	   LBP	  
(Airaksinen	   et	   al.,	   2006).	   	   The	   patients	   for	  whom	   surgery	   is	   usually	   intended,	  with	  
accompanying	   neurologic	   deficit	   or	   radicular	   pain,	   generally	   present	   with	   more	  
persistent	  and	  severe	  symptoms	  then	  other	  LBP	  patients	  and	  are	  associated	   in	   the	  
literature	   with	   prolonged	   disability	   and	   work	   absence,	   poorer	   functional	   outcome	  








Figure	   2.1:	   The	   anatomy	   of	   the	   lumbar	   vertebra.	   (from	   (Putz	   et	   al.,	   2009);	   with	  
permission)	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Clinical	  Definitions,	  Presentations	  and	  Experimentally	  Confirmed	  Physiological	  
Sources	  of	  Back	  and	  Leg	  Pain	  	  
	  
LBP,	   and	   particularly	   when	   accompanied	   with	   leg	   pain,	   may	   present	   an	  
amalgamation	   of	   stimuli	   of	   multiple	   origins	   (i.e.	   nociceptive,	   referred,	   radicular).	  
These	   have	   been	   qualified	   in	   the	   context	   of	   lumbar	   pathology	   and	   LBP	   by	   several	  
decades	   of	   formative	   experiments	   on	   normal	   volunteers	   and	   patients.	   LBP	   and	  
referred	   leg	   pain	   are	   common	   in	   primary	   care	   practice	   whereas	   radicular	   pain	   or	  
neurologic	   deficit	   (radiculopathy),	   which	   are	   indicative	   of	   nerve	   injury	   and	   may	  




Nociception	  and	  	  Lumbosacral	  Somatic	  Referred	  Pain	  
	  
Nociceptive	  LBP	   is	  evoked	  by	  noxious	  stimulation	  of	  structures	  of	  the	   lumbar	  spine	  
and	   is	   generally	   characterised	   by	   dull	   aching	   pain	   in	   the	   back	   (Bogduk,	   2009).	  	  
Probing	  under	  local	  anaesthetic,	  surgeons	  have	  shown	  that	  the	  posterior	  surface	  of	  
intervertebral	  discs	  evoke	   the	  most	   intense	   source	  of	  experimental	   LBP	   (Kuslich	  et	  
al.,	   1991,	   Falconer	   et	   al.,	   1948,	  Wiberg,	   1949).	   	   Distending	   structures	   by	   injecting	  
hypertonic	  saline,	  experimental	  nociceptive	  LBP	  arising	  from	  back	  muscles	  (Kellgren,	  
1938,	   Cornwall	   et	   al.,	   2006),	   interspinous	   ligaments	   and	   spaces	   (Kellgren,	   1939,	  
Feinstein	  et	  al.,	  1954),	  facet	  (McCall	  et	  al.,	  1979,	  Mooney	  and	  Robertson,	  1976)	  and	  
sacroiliac	  joints	  (Fortin	  et	  al.,	  1994)	  were	  also	  characterised.	  
	  
Local	  noxious	  stimulation	  of	  all	  of	  the	  above	  structures	  have	  also	  been	  reported	  to	  
be	  able	  to	  produce	  pain	  perceived	  at	  remote	  locations	  (Fortin	  et	  al.,	  1994,	  Fukui	  et	  
al.,	  1997,	  Dreyfuss	  et	  al.,	  1996,	  O'Neill	  et	  al.,	  2002,	  Cornwall	  et	  al.,	  2006,	  McCall	  et	  
al.,	  1979);	  most	  notably	  parts	  of	  the	  lower	  limbs	  innervated	  by	  the	  same	  segment.	  It	  
is	   thought	   that	   this	   somatic	   type	  of	   referred	  pain	   results	   from	   the	   convergence	  of	  
nociceptive	  afferents	  on	  second	  order	  neurons	   in	  the	  spinal	  cord,	  which	  happen	  to	  
supply	   areas	   of	   the	   lower	   limb	   (Bogduk,	   2009,	   Randy	   Jinkins,	   2004).	   	   Lumbosacral	  
somatic	   referred	   pain	   is	   mediated	   by	   central	   mechanisms	   because	   it	   can	   still	   be	  
induced,	  albeit	  with	   reduced	   intensity,	   after	  anaesthetic	  block	  of	   the	   referred	  pain	  
area	   (Laursen	   et	   al.,	   1997,	   Feinstein	   et	   al.,	   1954).	   	   Sensory	   input	   from	   the	   referral	  
area	   	  may	   thus	   have	   a	   secondary	   role,	   but	   anaesthetizing	   the	   nociceptive	   source,	  
such	   as	   facet	   joints,	   can	   certainly	   relieve	   the	   referred	   area	   (Fairbank	   et	   al.,	   1981,	  
Mooney	   and	   Robertson,	   1976,	   Schwarzer	   et	   al.,	   1994a).	   The	   size	   or	   area	   of	   the	  
referred	   pain	   correlates	   with	   the	   source	   intensity	   and	   duration	   of	   nociceptive	  
stimulation	   (Marchettini	   et	   al.,	   1996,	   Graven-­‐Nielsen	   et	   al.,	   1997),	   with	   temporal	  
summation	  of	   repeat	   painful	   stimuli	   also	   affecting	   the	  emergence	  of	   referred	  pain	  




Figure	  2.2:	  Patterns	  of	  experimental	  lumbosacral	  somatic	  referred	  pain	  induced	  by	  noxious	  stimulation	  of	  
intervertebral	  discs	  (A-­‐	  intradiscal	  electrothermal	  annuloplasty	  provoked	  pain	  and	  the	  percentage	  of	  
responders	  per	  additional	  lower	  limb	  segment.	  Adapted	  from	  O’Neill	  et	  al.,	  2002),	  interspinous	  ligaments	  
at	  L5	  and	  S1	  (B-­‐	  Adapted	  from	  Kellgren,	  1939	  and	  Bogduk,	  2009),	  multifidus	  muscle	  opposite	  L5	  (C-­‐
Adapted	  from	  Kellgren,	  1939)	  and	  the	  sacroiliac	  joint	  (D-­‐	  from	  McCall	  et	  al.,	  1979).	  
A)	  	   B)	   C)	   D)	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  L5	  




Radicular	  Pain	  and	  Radiculopathy	  
	  
Although	   often	   occurring	   together,	   radicular	   pain	   can	   occur	   in	   the	   absence	   of	   any	  
neurological	  deficit	  and	  vice	  versa.	   	  Although	  radiculopathy	  and	  radicular	  pain	  may	  
share	   the	   same	  aetiology,	   their	  mechanisms	  are	  distinct.	   	  Radiculopathy	   is	  defined	  
not	  by	  pain	  but	  by	  neurological	  deficit;	   as	  a	   loss	  of	   sensory	  and/or	  motor	   function	  
due	   to	   the	   blocked	   conduction	   in	   axons	   or	   roots	   of	   a	   spinal	   nerve	   (Merskey	   and	  
Bogduk,	   1994).	   Muscle	   weakness	   in	   a	   myotomal	   distribution	   thus	   ensues	   when	  
motor	   fibres	   are	   blocked	   and	   numbness	   when	   sensory	   fibres	   are	   blocked,	   with	  
diminished	  reflexes	  in	  either	  case	  (Bogduk,	  2009).	  	  Diagnosis	  is	  thus	  based	  on	  clinical	  
history	   and	   neurological	   examination,	   confirmed	   by	   imaging,	   and	   with	  
electrodiagnostic	   tests	   proving	   particularly	   useful	   in	   cases	   of	   negative	   imaging	  
findings	  or	  unusual	  clinical	  presentations.	  
	  
Lumbosacral	  radicular	  pain	  is	  defined	  as	  being	  perceived	  as	  arising	  in	  the	  lower	  limb	  
by	  ectopic	  activation	  of	  nociceptive	  afferents	  in	  a	  spinal	  nerve	  or	  its	  roots	  (Merskey	  
and	   Bogduk,	   1994).	   It	   is	   not	   enough	   for	   a	   nerve	   root	   to	   be	   compressed.	   Acute	  
mechanical	  compression	  result	   in	  at	  best	  brief	  momentary	  discharges	   (Howe	  et	  al.,	  
1976,	   Howe	   et	   al.,	   1977).	   Inflammation	   of	   the	   nerve	   is	   a	   critical	   part	   of	   the	  
mechanism	   of	   radicular	   pain,	   as	   will	   be	   covered	   in	   a	   subsequent	   section	   (the	  
pathophysiology	  of	  disc	  herniation).	  	  This	  has	  been	  shown	  in	  	  patients	  	  where	  sutures	  
were	  left	  around	  the	  nerve	  during	  surgery,	  to	  be	  pulled	  	  through	  the	  incision	  wound	  
the	  following	  day	  (Smyth	  and	  Wright,	  1959).	  	  Only	  in	  previously	  inflamed	  nerve	  roots	  
does	  squeezing	  or	  pulling	  result	   in	  radicular	  pain	  (Norlen,	  1944,	  Smyth	  and	  Wright,	  
1959).	   In	  animal	  studies	  only	  mechanical	   stimulation	  of	   the	  dorsal	   root	  ganglion	  or	  
inflamed	  dorsal	   roots	  evokes	  prolonged	  discharges	  of	  not	   just	  Aδ	  and	  C	   fibres,	  but	  




The	  resulting	  multiple	  discharge	  is	  described	  as	  an	  “electric”,	  shooting	  or	  lancinating	  
pain	   which	   travels	   along	   the	   lower	   limb	   in	   a	   narrow	   band	   less	   than	   50mm	   wide	  
(Smyth	   and	   Wright,	   1959,	   Merskey	   and	   Bogduk,	   1994).	   For	   a	   comparative	  
illustration,	  consult	  figure	  2.2	  and	  2.3.	  Clinically	  the	  direct	  mechanical	  compromise	  of	  	  
the	   dorsal	   root	   ganglion	   or	   of	   the	   spinal	   nerve	   and	   its	   roots	   in	   combination	   with	  
ischemia	   or	   inflammation,	   produce	   an	   episodic,	   recurrent,	   or	   paroxysmal	  
presentation	  	  (Merskey	  and	  Bogduk,	  1994).	  	  The	  required	  inflammatory	  component	  
explains	  why	  individuals	  presenting	  with	  root	  compression	  by	  disc	  herniation	  can	  be	  
asymptomatic	  or	  have	   fully	   resolved	  radicular	  pain	   (Hitselberger	  and	  Witten,	  1968,	  
Boden	  et	  al.,	  1990,	  Delauche-­‐Cavallier	  et	  al.,	  1992,	  Maigne	  et	  al.,	  1992,	  Jensen	  et	  al.,	  
1994).	  
	  
A	   common	   clinical	   precept	   reported	  en	   passant	   in	  much	   of	   the	   literature	   that	   the	  
segmental	   origin	   of	   radicular	   pain	   can	   be	   determined	   from	   its	   distribution	   is	  
generally	  not	  supported	  by	  evidence.	  	  Patients	  report	  radicular	  pain	  both	  at	  rest	  and	  
during	  diagnostic	  straight	  leg	  raises	  to	  be	  “deep”	  rather	  than	  “on	  the	  skin”	  (Bove	  et	  
al.,	   2005).	   	   It	  was	   originally	   reported	   in	   the	   40’s	   that	   L4,	   L5	   and	   S1	   patterns	  were	  
indistinguishable	   (Norlen,	  1944).	   	  A	  more	   recent	   study	   found	   that	   lumbar	   radicular	  
pain	  was	  non-­‐dermatomal	   in	  64%	  of	   cases,	  with	  only	   the	  S1	   radicular	  pain	  pattern	  
exhibiting	  specificity	  and	  sensitivity	  in	  a	  useable	  range	  (Murphy	  et	  al.,	  2009).	  Hence	  
the	   radicular	   pain	   segment	   can	   only	   be	   estimated	  when	   occurring	   in	   combination	  
with	   radiculopathy.	   	   It	   is	   thence	   the	   dermatomal	   distribution	   of	   numbness	   which	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The	   patho-­‐anatomical	   identification	   and	   treatment	   of	   inflammatory	   or	   pain	  
generating	  structures	  based	  on	  the	  patient	  clinical	  history	  and	  examination,	  clinical	  
tests	  and	  diagnostic	  blocks	  represents	  a	  core	  treatment	  model	  in	  current	  clinical	  use,	  
especially	   for	  patients	  with	   identifiable	  neurological	   signs	   (Schwarzer	  et	  al.,	   1994b,	  
Schwarzer	   et	   al.,	   1994c,	   Laslett	   and	  Williams,	   1994,	   Bogduk,	   1995,	   Bogduk,	   2004).	  	  
This	   approach,	   along	  with	   advances	   in	   spine	   research,	   have	   led	   to	   epidemiological	  
findings	   that	   the	  majority	  of	   chronic	   LBP	  originates	   from	   internal	  disruption	  of	   the	  
intervertebral	   discs	   (45%-­‐further	   on	   this	   in	   the	   following	   section),	   the	   facet	   joints	  
(20%),	  and	  the	  sacroiliac	  joint	  (15%)	  (Bogduk,	  1995).	  	  With	  this	  approach	  chronic	  low	  
back	  pain	  becomes	   “discogenic	   pain”,	   “facet	   joint	   pain”	  or	   “sacroiliac	   pain”	  with	   a	  
predefined	  diagnostic	  criteria	  and	  specific	  treatment	  target.	  	  
	  
However	  with	  the	  tendency	  of	  pathological	  conditions	  to	  coexist,	  this	  approach	  has	  
been	  difficult	  in	  general	  practice	  (Fairbank	  et	  al.,	  2011).	  European	  guidelines	  advise	  a	  
simpler	   chronic	   LBP	   patient	   management	   triage	   into	   non-­‐specific,	   specific	   and	  
radicular	   LBP	   (Airaksinen	   et	   al.,	   2006).	   Even	   these	   groups	   are	   not	   always	   easy	   to	  
differentiate.	   	   For	   example	   degenerative	   disc	   disease	   might	   be	   classified	   as	   non-­‐
specific	   (no	   clear	   aetiology)	   whereas	   a	   disc	   herniation	   may	   qualify	   as	   specific	   or	  
radicular,	  corresponding	  to	  combined	  radiographic,	  clinical	  history	  and	  examination	  
results.	  A	  close	  look	  at	  the	  large	  number	  of	  rejected	  GP	  referrals	  for	  neurosurgical	  or	  
orthopaedic	  assessment	  on	  grounds	  of	  a	  lack	  of	  neurologic	  deficit	  is	  testament	  to	  the	  
difficulties	   which	   primary	   care	   physicians	   encounter	   in	   implementing	   classification	  
guidelines.	   	   As	   the	   presence	   of	   referred	   pain	   below	   the	   knee	   is	   statistically	   less	  
common,	   this	   has	   become	   a	   simple	   yet	   useful	   diagnostic	   criteria	   to	   infer	   the	  
presence	   of	   radicular	   pain	   (Vroomen	   et	   al.,	   1999).	   	   In	   this	   thesis,	   where	  
inconsistencies	   arose	   in	   the	   clinical	   examination	   or	   the	   clinical	   diagnostic	   criteria	  
used	  to	  define	  radicular	  pain,	  this	  classification	  was	  employed.	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Finally,	   concurrent	  with	   the	  growing	  evidence	  of	   functional	   and	   structural	   changes	  
occurring	   at	   the	   level	   of	   the	   CNS	   across	   the	   LBP	   spectrum,	   classification	   systems	  
placing	  more	  emphasis	  on	  characterising	  the	  nature	  of	  CNS	  involvement	  have	  been	  
proposed.	  Central	  sensitisation	  refers	  to	  pain	  hypersensitivity	  resulting	  from	  an	  up-­‐
regulation	   of	   the	   nociceptive	   system	   throughout	   the	   CNS:	   spinal	   cord	   dorsal	   horn	  
and/or	  more	  cephalad	  centres	  including	  the	  brainstem,	  thalamus,	  limbic	  system	  and	  
cerebral	   cortex	   (Latremoliere	  and	  Woolf,	  2009,	  Woolf,	  2011).	   It	   is	   characterised	  by	  
the	   tactile	   allodynia	   (pain	   due	   to	   stimuli	   which	   do	   not	   normally	   provoke	   pain)	   or	  
secondary	  mechanical	  hyperalgesia	  or	  enhanced	  temporal	  summation	  of	  nociceptive	  
stimuli,	   more	   commonly	   associated	   with	   fibromyalgia	   and	   complex	   regional	   pain	  
syndrome,	  but	  also	  more	  sparingly	  associated	  with	  neuropathic	  pain,	  including	  post-­‐
surgical	  pain	  and	  musculoskeletal	  disorders,	  including	  chronic	  LBP	  (Latremoliere	  and	  
Woolf,	  2009,	  Woolf,	  2011,	  von	  Hehn	  et	  al.,	  2012,	  Roussel	  et	  al.,	  2013).	  A	  systematic	  
review	   concluded	   that	   central	   sensitization	   occurs	   in	   a	   subgroup	   of	   patients	   with	  
LBP,	  and	  that	  evaluation	  of	  central	   sensitization	  should	  be	   included	  as	  an	  outcome	  
parameter	  or	  classification	  criteria	  (Roussel	  et	  al.,	  2013).	  
	  
Response	  to	  Treatment	  as	  a	  Method	  Classifying	  Chronic	  LBP	  
	  
Non-­‐treatment	   based	   approaches	   have	   been	   recommended	   using	   simple	   pain	  
phenotypes	   (such	   as	   the	   presence	   of	   leg	   pain	   distal	   to	   the	   knee),	   and	   grounding	  
classifications	  of	  chronic	  LBP	  into	  sub-­‐groups	  likely	  to	  respond	  with	  better	  outcomes	  
to	   a	   given	   intervention	   (Kamper	   et	   al.,	   2010,	   Fairbank	   et	   al.,	   2011).	   A	   systematic	  
review	   of	   the	   literature	   identified	   28	   classification	   systems	   (CS)	   for	   chronic	   LBP	   in	  
current	  clinical	  use,	  of	  which	  16	  were	  diagnostic,	  7	  prognostic	  and	  5	  treatment-­‐based	  
systems	   (TBCS),	   all	   based	   on	   non-­‐operative	   management	   (Fairbank	   et	   al.,	   2011).	  	  
Reliability	   testing	   in	  4	  of	   these	  TBCSs	   found	   inter-­‐observer	   agreement,	   lying	   in	   the	  
70-­‐100%	   range,	   to	   be	   proportional	   to	   the	   level	   of	   clinician	   training	   and	   inversely	  
proportional	   to	   the	   TBCS	   complexity	   (namely	   the	   number	   of	   defined	   subgroups)	  




Only	   two	   TBCSs	   have	   undergone	   randomized	   controlled	   trial	   (RCT)	   validation	  
comparing	   treatment	   outcomes	   to	   standard	   treatment	   without	   classification	  
(Fairbank	  et	  al.,	  2011).	   	  The	  first,	   the	  McKenzie	  TBCS,	  broadly	  uses	  the	  relationship	  
between	   lumbar	   test	   movements	   and	   physical	   signs	   and	   symptom	   behaviour	   to	  
classify	   patients	   into	   the	   following	   syndromes:	  postural,	  derangement	   (with	   7	   sub-­‐
syndromes)	   and	   dysfunction	   (with	   4	   sub-­‐syndromes)	   (McKenzie,	   1981).	   Treatment	  
strategies	   are	   then	   assigned	   to	   sub-­‐syndromes.	   This	   (McKenzie)	   TBCS	   was	   not	  
demonstrated	   to	   be	   associated	   with	   a	   significantly	   higher	   reduction	   in	   pain	  
compared	  with	  unclassified	  controls	   (Petersen	  et	  al.,	  2002).	  The	  second	   is	   the	  pain	  
pattern	   oriented	   Canadian	   Back	   Institute	   TBCS,	   which	   is	   based	   on	   the	   temporal	  
characteristics	  (i.e.	  intermittent	  or	  constant)	  and	  location	  of	  dominant	  pain	  (back-­‐leg	  
pain)	   and	   their	   relationship	   to	  movement	  or	  posture	   (Hall	   et	   al.,	   2009).	   This	   TBCS,	  
has	   been	   validated	   by	   a	   reduction	   in	   pain	   and	   medication	   use	   and	   increase	   in	  
functional	  scores	  compared	  to	  unclassified	  controls	  (Hall	  et	  al.,	  2009).	  	  	  
	  
Current	  recommendations	  are	  for	  larger	  methodologically	  precise	  RCTs,	  and	  that	  no	  
single	  CS	  be	  adopted	  for	  all	  patients	  (Kamper	  et	  al.,	  2010,	  Fairbank	  et	  al.,	  2011).	  An	  
important	   finding	   highlighted	   by	   Fairbank	   (2011)	   is	   the	   lack	   of	   a	   reliable,	   easily	  
applicable	   and	   comprehensive	   TBCS	   to	   distinguish	   and	   direct	   the	   treatment	   of	  
patients	  who	  are	  likely	  or	  unlikely	  to	  benefit	  from	  surgical	  intervention.	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Disc Degeneration: Pathophysiology and Nervous System 
Response 
	  
Clinically,	   disc	   degeneration	   is	   considered	   to	   account	   for	   some	   45%	   of	   pain	  
generated	  in	  chronic	  LBP	  (Bogduk,	  1995).	  	  The	  exact	  causal	  processes	  underlying	  disc	  
degeneration	  are	  still	  not	  fully	  understood,	  but	  much	  multi-­‐disciplinary	  headway	  has	  
been	  made	   in	   the	   last	   25	   years.	   	   Certainly	   a	   reduction	   in	   the	   nutrition	   to	   the	   disc	  
provided	  by	  the	  vertebral	  end	  plates	  appears	  to	  be	  a	  pivotal	  factor	  (Moore,	  2006).	  	  A	  
thinning	  of	  the	  end	  plate	  caused	  by	  forming	  clefts,	  fractures,	  and	  fissures	  result	  in	  a	  
decline	   in	  nutrition	  and	  water	   supply	   to	   the	  nucleus	  pulposus,	  which	  consequently	  
loses	   volume,	   pressure	   and	   height.	   Throughout	   these	   developments,	   the	   annulus	  
fibrosus	  develops	  ever	  more	  clefts	  or	  fissures,	  as	  the	  inner	  annulus	  expands	  inward,	  
waning	   the	   structural	   boundary	   with	   an	   increasingly	   fibrotic	   nucleus	   (Buckwalter,	  
1995,	  Moore	  et	  al.,	  1999).	  This	  increasingly	  solidified	  structure	  starkly	  diverges	  from	  
the	   fluid	   properties	   of	   non-­‐degenerated	   discs,	   which	   are	   necessary	   for	   the	  
absorption	   of	   mechanical	   energy	   from	   surrounding	   structures	   (Niosi	   and	   Oxland,	  
2004).	  
	  
But	   indeed	   nociceptive	   stimuli	   of	   mechanical	   and	   inflammatory	   origin	   caused	   by	  
traumatic	   or	   degenerative	   events	   in	   a	   disc	   begin	   long	   before	   a	   rupture	   occurs	  
(Cavanaugh	  et	  al.,	  1997,	  Peng	  et	  al.,	  2005).	  	  	  The	  outer	  layers	  of	  the	  annulus	  fibrosis	  
of	   normal	   discs	   have	   been	   shown	   to	   be	   substantially	   innervated,	   containing	  
vasoactive	   polypeptide	   immunoreactive	   nerve	   fibres,	   substance	   P	   and	   calcitonin	  
gene-­‐related	  peptide	  (Konttinen	  et	  al.,	  1990).	   	  Disc	  deterioration,	  annular	  tears	  and	  
mechanical	  stimuli	  from	  abnormal	  loading	  due	  to	  a	  loss	  of	  weight	  bearing	  properties	  
of	   the	   annulus	   support	   the	   observation	   that	   patients	   with	   radiculopathy/radicular	  
pain	   caused	   by	   herniation	   often	   report	   low	   back	   pain	   preceding	   the	  
radiculopathy/radicular	  pain	   (Brisby,	  2003).	   	   This	   refers	   to	  discogenic	  pain	  which	   is	  
worsened	  by	  an	  ingrowth	  of	  further	  nerve	  fibres	  and	  vascular	  tissue,	  which	  has	  been	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found	  deep	   into	   the	  annulus	   (as	   far	  as	   the	  nucleus	  pulposus)	  of	  degenerated	  discs	  
(Edgar,	  2007,	  Freemont	  et	  al.,	  1997),	  and	  has	  been	  suggested	  to	  be	  characteristic	  of	  
the	   dull	   chronic	   ache	   which	   is	   experienced	   by	   LBP	   patients	   and	   exasperated	   by	  
mechanical	   loading	   of	   the	   spine	   (Brisby,	   2006).	   	   Studies	   suggest	   a	   proliferation	   of	  
mechanoreceptors	   and	   various	   nociceptors	   as	   a	   response	   to	   the	   pathology	   of	  
degeneration	   (Edgar,	   2007).	   In	   response	   to	   an	   increase	   in	   stimuli	   travelling	   up	   the	  
spinothalamic	   tract	   via	   the	   thalamus,	   the	   somatosensory	   system	  may	   increase	   its	  
sensitivity	  resulting	  in	  dysfunctionally	  amplified	  responses	  (Takebayashi	  et	  al.,	  2006).	  	  
	  
Many	   inflammatory	  and	  signalling	  chemicals	  have	  also	  been	   implicated	   in	   low	  back	  
pain.	  	  In	  particular	  nucleus	  pulposus	  tissue	  has	  been	  shown	  to	  increase	  discharge	  of	  
nerve	   fibres,	   reduce	   the	   conduction	   velocity	   at	   the	   spinal	   nerve	   root,	   provoke	  
degeneration	   of	   nerve	   fibres	   and	   increase	   intraneural	   capillary	   permeability	  
(Olmarker	  et	  al.,	  1993,	  Takahashi	  et	  al.,	  1993).	  Having	  been	  extracted	  and	  analysed	  
during	   surgery,	   this	   tissue	  has	  been	   shown	   to	   contain	  high	   levels	   proinflammatory	  
factors	   and	   mediators	   (cytokines	   such	   as	   tumour	   necrosis	   factor	   and	   interleukins	  
(Burke	   et	   al.,	   2002b,	   Burke	   et	   al.,	   2002a)).	   These	   interfere	  with	   pain	   processing	   of	  
nerve	   roots,	   sinuvertebral	   nerve	   endings	   and	   dorsal	   root	   ganglia	   and	   increase	   the	  
nociceptive	  stimuli	  in	  surrounding	  tissues	  (Kawakami	  et	  al.,	  1994).	  	  Secretion	  of	  these	  
pro-­‐inflammatory	   mediators	   have	   been	   shown	   to	   cause	   mechanically	   insensitive	  
afferents	  in	  joints	  to	  become	  active	  (Schaible	  and	  Schmidt,	  1985).	  	  
	  
Disc	  degeneration	  causing	  narrowing	  of	  the	  disc	  space	  also	  changes	  the	  mechanical	  
loading	   of	   facet	   joints.	   These	   changes	   have	   been	   linked	   to	   an	   increased	   risk	   of	  
osteoarthritis	  through	  inflammation,	  osteophyte	  formation	  and	  cartilage	  loss	  (Brisby,	  
2006).	  As	   load	  absorbing	   capabilities	  of	   a	  disc	   change	  or	  decline,	   all	   ligaments	  and	  
muscles	  which	  stabilise	   that	  motion	  segment	   (a	  vertebrae-­‐disc-­‐vertebrae	  unit)	  may	  
be	   mechanically	   stressed.	   Such	   structural	   changes	   may	   lead	   to	   spinal	   stenosis	   or	  
spondylolisthesis	  where	  a	  gradual	  nerve	  root	  compression	  may	  ensue.	  	  Much	  of	  disc	  
innervation	   passes	   through	   the	   posterior	   annulus	   and	   posterior	   longitudinal	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ligament,	   so	   that	   deterioration	   in	   the	   posterior	   aspect	   of	   the	   disc	   may	   represent	  
substantial	  nociceptive	  stimulus	  in	  the	  ligament	  (Takahashi	  et	  al.,	  1998,	  Suseki	  et	  al.,	  
1998).	   Furthermore	   experimental	   electrical	   stimulation	   to	   the	   lateral	   aspect	   of	   the	  
annulus	   in	  pigs	  have	  been	   shown	   to	  produce	  multilevel	  bilateral	  motor	  unit	   action	  
potentials	  in	  the	  lumbar	  multifidus,	  which	  can	  be	  modulated	  by	  the	  distension	  of	  the	  
adjacent	   facet	   joint	   with	   saline,	   perhaps	   by	   muscle	   spindles	   in	   the	   facet	   capsule	  
(Indahl	  et	  al.,	  1997).	  This	  discovered	  postural	  mechanism	  could	  have	  important	  pain	  
implications	   related	   to	   muscle	   spasms	   in	   LBP	   (Edgar,	   2007).	   	   Furthermore,	   this	  
mechanism	   also	   has	   a	   compound	   effect	   on	   the	   biomechanics	   of	   the	   segment	  
(confirmed	   by	   Hodges	   and	   colleagues),	   as	   rapid	   atrophy	   of	   this	   muscle	   follows	  
experimental	  disc	  or	  nerve	  root	  injury	  (Hodges	  et	  al.,	  2006).	  	  	  
	  
When	   the	   pathology	   moves	   into	   the	   realm	   of	   very	   well	   innervated	   muscles,	  
alterations	  in	  normal	  function	  may	  actually	  contribute	  further	  to	  low	  back	  pain	  (van	  
Dieen	  et	  al.,	  2003).	  Panjabi	  proposed	  that	  the	  active	  muscular	  system	  was	  normally	  
responsible	   for	   80%	   of	   cervical	   stability	   compared	   with	   the	   passive	   stability	   of	  
capsules	  and	  ligaments	  (Panjabi,	  1992).	  	  Considerable	  biomechanical	  strain	  is	  placed	  
on	   articular	   structures	   when	   muscular	   stability	   is	   compromised,	   resulting	   in	  
supplementary	  instability	  and	  pain	  stimuli.	  
	  
	  
Transcranial Magnetic Stimulation (TMS) 
	  
The	  depolarization	  of	  excitable	  tissues	  (muscles	  and	  nerves)	  by	  electrical	  stimulation	  
was	   first	   systematically	   demonstrated	   by	   Galvani	   and	   Volta	   in	   the	   late	   eighteenth	  
century.	  	  By	  the	  mid-­‐19th	  century	  interest	  steadily	  increased	  in	  the	  type	  of	  responses	  
that	   could	   be	   elicited	   by	   tissues	   of	   the	   central	   nervous	   system,	   particularly	   over	   a	  
thin	   band	   in	   the	   middle	   of	   the	   cerebral	   cortex,	   which	   produced	   reproducible	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movements	   in	  nearly	  discrete	  contralateral	  musculature.	   	  An	  English	  neurologist	  by	  
the	   name	   of	   Hughlings	   Jackson	   was	   interested	   in	   a	   type	   of	   epilepsy	   (Jacksonian	  
epilepsy)	  which	  characteristically	  began	  as	  twitching	   in	  the	  extremities	  (such	  as	  the	  
finger	   tip),	   which	   would	   move	   progressively	   medially	   until	   a	   more	   generalised	  
convulsion	  would	  ensue.	  	  He	  correctly	  deduced	  that	  these	  symptoms	  resulted	  from	  a	  
“marching”	   abnormality	   along	   this	   thin	   band	   of	   cortical	   tissue.	   The	   ordered	  
somatotopic	  motor	   representations	   of	   the	   primary	  motor	   area	  were	   subsequently	  
confirmed	  and	  accurately	  mapped	  in	  primates	  by	  Sherrington,	  and	  later	  in	  Humans,	  
during	  surgery	  to	  treat	  Jackson’s	  epilepsy,	  by	  Penfield	  and	  colleagues.	  	  
	  
Although	   very	   useful	   in	   a	   wide	   range	   of	   clinical	   neurophysiological	   investigations	  
such	  as	  measuring	  the	  conduction	  velocity	  of	  peripheral	  nerves,	  electrical	  stimulation	  
requires	  relatively	  high	  voltages	  to	  drive	  currents	  across	  the	  high	  electrical	  resistance	  
of	  the	  skin.	  	  This	  can	  be	  painful.	  	  The	  even	  higher	  electrical	  resistance	  of	  the	  skull	  can	  
also	  render	  high	  voltage	  pulse	  transcranial	  electrical	  stimulation	  (TES)	  of	  the	  cortex	  
(Merton	  and	  Morton,	  1980)	  too	  painful	  and	  impractical.	  This	  problem	  of	  high	  current	  
density	  under	  stimulating	  electrodes	  was	  solved	  by	  bypassing	  electrodes	  altogether	  
(and	  even	  largely	  bypassing	  receptors	  in	  the	  skin),	  using	  electromagnetic	  induction	  to	  
generate	   an	   electric	   field	   directly	   in	   the	   target	   neural	   tissue	   (Barker	   et	   al.,	   1985).	  
Barker	  and	  colleagues’	  device	  developed	  at	  the	  University	  of	  Sheffield	  in	  1985	  used	  a	  
capacitive	   discharge	   system	   of	   several	   kilovolts	   to	   rapidly	   rise	   a	   high	   current	   into	  
inductance	  in	  a	  low	  resistance	  copper	  stimulating	  coil.	  	  Further	  magnetic	  stimulators	  
have	   evolved	   from	   this	   original	   single	   pulse	   monophasic	   design	   (one	   full	   charge	  
discharge	  cycle	  per	  stimulus),	  notably	  bi-­‐phasic	  output	  devices.	  	  In	  this	  design	  energy	  
from	  half	  of	  the	  cycle	  is	  returned	  to	  the	  capacitor,	  greatly	  reducing	  the	  time	  required	  
to	   recharge	   and	   thus	   deliver	   subsequent	   pulses.	  Although	   this	   changes	   the	  output	  
characteristics	   (longer	   pulses	   effectively	   lower	   depolarisation	   thresholds	   in	  
stimulated	  tissue),	  it	  reduces	  power	  requirements,	  the	  minimum	  inter-­‐pulse	  interval	  
and	   allows	   for	   repetitive	   TMS	   	   (rTMS)	   applications.	   rTMS	   can	   induce	  effects	  which	  
outlast	   the	  period	  of	  stimulation,	   increasing	  or	  decreasing	  the	  excitability	  of	  neural	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tissue	   depending	   on	   the	   intensity	   of	   stimulation,	   coil	   orientation,	   and	   repetitive	  
pulse	  train	  frequency.	  	  
	  
Inherent	  to	  the	  magnetic	  flux	  output	  is	  the	  notion	  that	  neural	  tissues	  are	  coil	  shape	  
and	   coil	   orientation	   sensitive.	   	   Perhaps	   the	   most	   significant	   departure	   from	   the	  
mechanism	  of	  TES	  is	  that	  TMS	  preferentially	  depolarises	  the	  axons	  of	  neurons	  which	  
lie	   parallel	   to	   the	   coil	   surface,	   so	   that	   corticospinal	   neurons	   are	   largely	   influenced	  
transynaptically	   by	   interneurons	   connected	   to	   these	   appropriately	   oriented	   fibres.	  	  
This	  means	   that	   the	  corticomotor	  output	  can	  provide	  additional	   information	  about	  
intracortical	   facilitation	   by	   these	   cells.	   This	   factor	   is	   even	   more	   important	   than	  
stimulator	  design	  when	  interpreting	  and	  comparing	  TMS	  studies.	  	  The	  more	  focal	  the	  
field	  characteristics	  of	  the	  coil,	  the	  more	  orientation	  will	  affect	  the	  size	  the	  facilitory	  
twitch	   or	   motor	   evoked	   potential	   (MEP)	   output	   in	   the	   muscle	   electromyography	  
(EMG)	  trace.	  	  If	  the	  muscles	  is	  contracted,	  a	  larger	  facilitated	  MEP	  will	  be	  produced,	  
followed	  by	  a	  period	  of	  EMG	  silence	  referred	  to	  as	  the	  cortical	  silent	  period	  (figure	  
2.4	  bottom).	  	  	  
	  
The	  3	  most	  common	  coils	  are	  90mm	  circular,	  figure-­‐8	  	  and	  double	  cone	  coils	  (figure	  
2.4	  top).	  	  Usually	  applied	  over	  the	  vertex	  (Cz;	  deﬁned	  as	  a	  point	  midway	  between	  the	  
inion	   and	   the	   nasion	   and	   equidistant	   from	   ambilateral	   intertragal	   notches),	   the	  
circular	  coil	  provides	  a	  large	  diffuse	  field	  over	  the	  brain	  with	  preferential	  stimulation	  
of	  the	  right	  hemisphere	  with	  clockwise	  current	  flow,	  while	  counter-­‐clockwise	  current	  
flow	  (flipping	  the	  coil	  over)	  preferentially	  stimulates	  the	  left	  hemisphere	  (Hess	  et	  al.,	  
1987).	   Smaller	   figure-­‐8	   shaped	   coils	   induce	   dense	  magnetic	   field	   perpendicular	   to	  
the	  coil	  axis	  and	  allow	  more	  focal	  stimulation	  areas	  (although	  even	  there	  a	  mere	  2.5	  
cm	  ‘resolution’	  is	  possible)	  (Rosler	  et	  al.,	  1989,	  Deng	  et	  al.,	  2013).	  	  This	  is	  sufficient	  to	  
allow	   for	   the	   size	   of	   evoked	   MEPs	   over	   a	   1cm	   grid	   over	   the	   scalp	   to	   produce	  
corticomotor	   output	   maps	   (Pascual-­‐Leone	   and	   Torres,	   1993,	  Wilson	   et	   al.,	   1993c,	  
Wilson	   et	   al.,	   1993b).	   Here	   not	   simply	   current	   direction	   but	   coil	   orientation	   have	  
been	  shown	  to	  produce	   large	  variation	   in	  MEP	  sizes,	  which	  reflect	  a	  more	  detailed	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consideration	  of	  the	  underlying	  brain	  anatomy.	  	  For	  example	  to	  target	  hand	  muscles,	  
the	  optimal	  alignment	   is	  perpendicular	  to	  the	  central	  sulcus,	  while	  a	  coil	  alignment	  
perpendicular	  to	  the	  interhemispheric	  fissure	  is	  required	  for	  the	  lower	  limbs	  	  (Rosler	  
et	  al.,	  1989,	  Brasil-­‐Neto	  et	  al.,	  1992a,	  Dubach	  et	  al.,	  2004,	  Mills	  et	  al.,	  1992).	  	  Because	  
of	   the	   deeper	   anatomical	   layout	   of	   trunk	   and	   leg	   muscle	   representations	   in	   the	  
interhemispheric	   fissure,	   a	   larger	   angled	   double	   cone	   coil	   formed	   by	   two	  
perpendicular	  circular	  windings	  (figure	  2.4	  bottom)	  was	  developed	  to	  induce	  a	  more	  




There	   is	   a	   high	   inter-­‐individual	   difference	   in	   the	   minimum	   stimulator	   intensity	  
required	   to	   produce	   MEPs	   (the	   motor	   threshold	   [MTh]).	   	   The	   most	   widely	   used	  
methods	  of	  calculating	  MTh	  are	  based	  on	  the	  peak	  to	  peak	  amplitude	  (P2P)	  of	  MEPs	  
rather	  than	  their	  areas,	  	  which	  are	  more	  appropriate	  in	  quantifying	  polyphasic	  trunk	  
motor	  responses.	  	  This	  is	  because	  this	  definition	  has	  largely	  been	  developed	  for	  distal	  
muscles	   and,	   as	   discussed	   in	   chapter	   5,	   this	   has	   certain	   consequences	   when	  
interpreting	   results	   of	   studies	   involving	   trunk	   musculature,	   such	   as	   the	   erector	  
spinae	   (ES).	   	   Resting	  MTh	   is	  defined	  as	   the	   stimulator	  output	   intensity	   required	   to	  
produce	  a	  minimum	  MEP	  response	  of	  50µV	  in	  50%	  of	  delivered	  stimuli	  to	  a	  relaxed	  
muscle	   (Rossini	   et	   al.,	   1994).	   	   When	   the	   target	   muscle	   is	   contracted	   to	   a	  
predetermined	  (and	  visually	  monitored)	   level,	   this	  definition	  still	  applies	  but	  with	  a	  
minimum	  amplitude	   of	   200µV	   for	   the	   facilitated	  MEPs	   that	   are	   evoked	   (figure	   2.4	  
bottom).	   	   This	   is	   defined	   as	   the	   active	   MTh	   and	   is	   lower	   than	   the	   resting	   MTh	  
because	  this	  facilitation	  of	  corticospinal	  tract	  neurons.	  	  	  
MTh	   provides	   a	   highly	   repeatable	  measure	   of	   the	   excitability	   or	  mean	  membrane	  
potential	   of	   cortico-­‐cortical	   axons	   and	   their	   excitatory	   synapses	   with	   pyramidal	  
neurons	   (Amassian	   et	   al.,	   1987,	   Shimazu	   et	   al.,	   2004,	   Wassermann	   et	   al.,	   2008).	  
Ionotropic	  non-­‐N-­‐methyl-­‐D-­‐aspartate	  (NMDA)	  glutamate	  (GLU)	  receptors	  are	  central	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to	   this	   rapid	   excitatory	   synaptic	   cortical	   neurotransmission	   (Keller,	   1993)	   which	   is	  
regulated	  by	  voltage-­‐gated	  sodium	  channels	  (Hodgkin	  and	  Huxley,	  1952).	  This	  is	  why	  
drugs	  which	  block	   these	  channels	   increase	  MTh.	  These	   include	  anticonvulsants	   like	  
carbamazepine,	   losigamone	   (Ziemann	   et	   al.,	   1996),	   phenytoin	   (Chen	   et	   al.,	   1997,	  
Mavroudakis	  et	  al.,	  1994),	  lamotrigine	  (Ziemann	  et	  al.,	  1996,	  Tergau	  et	  al.,	  2003,	  Li	  et	  
al.,	  2004)	  and	  oxcarbazepine	  (Kimiskidis	  et	  al.,	  2005).	  
	  
As	  explained	  above,	  MTh	  varies	  between	  stimulator	  designs	  and	   (mostly	   focal)	   coil	  
orientation.	   	   Calculation	   of	   MTh	   allows	   MEPs	   to	   be	   quantified	   and	   compared	  
between	   subjects	   at	   a	   predetermined	   suprathreshold	   stimulator	   intensity,	   such	   as	  
1.2xMTh.	   	   Because	   of	   high	   neuromuscular	   inter-­‐individual	   variability,	   MEPs	   are	  
usually	   normalised	   to	   peak	   peripheral	   nerve	   responses	   (the	   maximum	   compound	  
motor	   action	   potential	   [CMAP]	   evoked	   by	   peripheral	   nerve	   electrical	   or	   magnetic	  
stimulation)	  or	  the	  peak	  voluntary	  response	  (maximum	  voluntary	  contraction	  [MVC]	  
of	   the	   target	  muscle)	   (Wassermann	   et	   al.,	   2008,	   Nicotra	   et	   al.,	   2013,	   Perez	   et	   al.,	  
2004).	  	  The	  latter	  is	  currently	  the	  only	  practical	  option	  for	  many	  trunk	  muscles.	  
	  
The Cortical Silent Period 
	  
Inhibitory	  activity	  can	  also	  be	  measured	  from	  the	  EMG	  responses	  to	  TMS	  pulses.	  The	  
cortical	  silent	  period	  (cSP)	  is	  an	  interruption	  of	  voluntary	  muscle	  contraction	  evoked	  
by	  transcranial	  stimulation	  of	  the	  contralateral	  cortex,	  which	  manifests	  as	  a	  period	  of	  
EMG	   silence	   (figure	   2.4	   bottom).	   The	   first	   group	   to	   report	   this	   period	   of	   EMG	  
suppression	  using	  transcranial	  electric	  stimulation	  (Marsden	  et	  al.,	  1983),	   reasoned	  
that	   its	   100-­‐300ms	   duration	   (above	   MTh	   intensity)	   must	   involve	   different	  
mechanisms	   than	   the	   40-­‐50ms	   spinal	   silent	   period	   (Merton,	   1951),	   evoked	   by	  
peripheral	   nerve	   stimulation	   (above	   maximum	   amplitude	   intensity).	   	   The	   cSP	   has	  
been	   described	   as	   a	   disruption	   of	   access	   of	   voluntary	  motor	   drive	   to	   the	   primary	  
motor	  cortex	  (Wassermann	  et	  al.,	  2008).	  The	  rationale	  for	  this	  lies	  in	  the	  fact	  that	  the	  
40	  
	  
difference	   between	   active	   and	   resting	   motor	   thresholds	   (often	   about	   10	   %MSO),	  
disappears	   during	   the	   cSP	   valley	   (Wassermann	   et	   al.,	   2008).	   The	   early	   50-­‐60	   ms	  
component	  of	  the	  cSP	  is	  believed	  to	  be	  caused	  by	  spinal	  mechanisms,	  including	  the	  
motor	  neuron	  after-­‐hyperpolarisation	  and	  Renshaw	  inhibition,	  whilst	  the	  subsequent	  
part	  has	  been	  confirmed	  to	  be	  of	  cortical	  origin,	  and	   is	   thought	   to	  be	  mediated	  by	  
cortical	   inhibitory	   interneurons	   that	  are	  depolarised	  by	  TMS	   (Ziemann	  et	  al.,	   1993,	  
Chen,	   2004,	   Fuhr	   et	   al.,	   1991,	   Inghilleri	   et	   al.,	   1993).	   The	   cSP	   is	   thus	   thought	   to	  
provide	  a	  measure	  of	  gamma-­‐aminobutyric	  acid	  GABAB	  receptor	  mediated	  (Werhahn	  
et	  al.,	  1999)	  cortical	  inhibitory	  activity.	  	  It	  is	  influenced	  by	  GABAergic	  drugs,	  such	  as	  
dopamine,	  carbamazepine,	  gabapentin	  and	  ethanol	  (Ziemann,	  2004,	  Ziemann	  et	  al.,	  
1996,	  Priori	  et	  al.,	  1994a,	  Ziemann	  et	  al.,	  1995).  
 
Measuring	  the	  cSP	  
	  
The	  most	  accurate	  or	  informative	  definition	  for	  the	  onset	  of	  the	  cSP	  is	  still	  debated	  
(Säisänen	  et	  al.,	  2008,	  King	  et	  al.,	  2006,	  Orth	  and	  Rothwell,	  2004,	  Daskalakis	  et	  al.,	  
2003).	  Although	  some	  authors	  measure	  the	  cSP	  from	  the	  onset	  of	   the	  MEP	  (rather	  
than	   offset)	   to	   reduce	   operator	   error	   (Säisänen	   et	   al.,	   2008),	   it	   is	   only	   useful	   in	  
suprathreshold	   comparisons,	   as	   the	   stimulator	   intensity	   at	   which	   the	   cSP	   appears	  
(the	  cSP	  threshold:	  cSPTh)	  is	  usually	  lower	  than	  the	  active	  MTh.	  Furthermore,	  as	  the	  
MEP	  and	  cSP	  are	  known	  to	  be	  largely	  independently	  mediated	  (Wilson	  et	  al.,	  1993a,	  
Taylor	  et	  al.,	  1997,	  Wu	  et	  al.,	  2002,	  Ziemann,	  2004,	  Kojima	  et	  al.,	  2013),	  the	  cSP	  can	  
be	  routinely	  measured	  from	  the	  magnetic	  stimulus	  artefact.	  	  Both	  MEPs	  and	  cSPs	  are	  
measured	  by	  creating	  an	  average	   trace	   from	  6-­‐30	  stimuli	   (shown	  overlaid	   in	   figure	  
2.4)	  and	  quantifying	  the	  area	  or	  latencies	  at	  the	  intersections	  of	  the	  horizontal	  mean	  
pre-­‐stimulus	  EMG	  line	  (representing	  the	  background	  contraction)	  and	  this	  averaged	  




Clinical	  Significance	  of	  the	  cSP	  
	  
An	   increased	   cSP	   indicates	   hyperactivity	   whereas	   decreased	   cSP	   hypoactivity	   of	  
GABAergic	   (gamma-­‐aminobutyric	   acid	   [GABA]	   B	   receptor	   [GABAB-­‐receptor]	  
mediated)	   cortical	   inhibitory	   interneurons.	   A	   comparative	   reduction	   of	   excitatory	  
interneurons	   can	  also	   result	   in	   a	  prolonged	   cSP	   (Wassermann	  et	   al.,	   2008).	   	   These	  
inhibitory	   cells	   are	   central	   to	   motor	   control	   in	   that	   they	   impact	   voluntary	   output	  
from	   the	   motor	   cortex.	   The	   effect	   of	   too	   much	   GABAB-­‐receptor	   mediated	  
intracortical	  inhibition	  would	  manifest	  as	  an	  inability	  to	  initiate	  voluntary	  movement	  
such	   as	   in	   motor	   neglect	   in	   hemiparetic	   stroke	   (Classen	   et	   al.,	   1997),	   whereas	  
pathological	   reductions	   produce	   spastic	   (Cruz	   Martinez	   et	   al.,	   1998)	   dyskinetic	   or	  
parkinsonian	  movement.	  The	  cSP	  duration	  has	  thus	  been	  found	  to	  be	  shortened	   in	  
epilepsy	  and	  in	  patients	  with	  Parkinson’s	  disease	  (Cantello	  et	  al.,	  2002,	  Berardelli	  et	  
al.,	  1996)	  and	  prolonged	  by	  increased	  thalamofugal	  firing	  as	  a	  result	  of	  dopaminergic	  
drug	  therapy,	   interventions	  to	  the	  basal	  ganglia	  and	  stimulation	  of	  the	  subthalamic	  
nucleus	   (Dauper	   et	   al.,	   2002,	   Young	   et	   al.,	   1997,	   Chen	   et	   al.,	   2001).	   Huntington’s	  
disease	  severity	  of	  chorea	  is	  also	  associated	  with	  the	  degree	  of	  prolongation	  of	  the	  
cSP	   (Modugno	  et	  al.,	  2001,	  Schippling	  et	  al.,	  2009,	  Priori	  et	  al.,	  1994b,	  Eisen	  et	  al.,	  
1989).	  
	  
Studies	   involving	   stroke	   patients	   have	   established	   that	   lesions	   outside	   the	   motor	  
cortex	  usually	  prolong	  the	  cSP,	  while	  lesions	  with	  an	  exclusive	  impact	  on	  the	  motor	  
cortex	  shorten	  or	  even	  eradicate	  the	  cSP	  (Liepert	  et	  al.,	  2005a,	  Classen	  et	  al.,	  1997).	  	  
GABAergic	   interneurons	   in	   the	  primary	  motor	   cortex	   are	   particularly	   vulnerable	   to	  
ischemic	  stress	  (Jin-­‐Hui,	  2003)	  and	  this	  can	  drastically	  shorten	  the	  cSP.	  	  In	  contrast	  its	  
lengthening	   can	   indicate	   a	   reduction	   in	   the	   afferent	   excitatory	   thalamo-­‐cortical	   or	  
cortico-­‐cortical	   input	   to	   the	   primary	   motor	   cortex,	   ensuing	   a	   swing	   of	   total	  




Changes	   in	   intracortical	   inhibitory	   drive	   to	   muscles	   have	   been	   reported	   in	  
neuropathic	   pain	   (Turgut	   and	   Altun,	   2009,	   Schwenkreis	   et	   al.,	   2010),	   fibromyalgia	  
(Salerno	   et	   al.,	   2000,	   Mhalla	   et	   al.,	   2010),	   complex	   regional	   pain	   syndrome	  
(Schwenkreis	  et	  al.,	  2005)	  and	   low	  back	  pain	   (Masse-­‐Alarie	  et	  al.,	  2012).	   	  Although	  
some	  of	   these	   refer	   to	  GABAA-­‐receptor	  mediated	   intracortical	   inhibition	  measured	  
by	  double	  pulse	  TMS	  (short	  interval	  intracortical	  inhibition	  [SICI]),	  the	  two	  measures	  
are	   inextricably	   linked	  by	  circulating	   levels	  of	  GABA.	  GABAB	  receptors	   	  are	  both	  pre	  
and	  postsynaptic	  so	  that	  the	  presynaptic	  receptors	  act	  to	  inhibit	  GABA	  release.	  As	  a	  





	   	  
Figure	  2.4:	  TMS	  Coils	  and	  representative	  EMG	  output	  in	  an	  active	  muscle	  
Top:	  Common	  TMS	  coils:	  Figure-­‐8	  (left),	  double	  cone	  (centre)	  and	  circular	  coil	  (right).	  
Reprinted	  with	  permission	  from	  Magstim	  Ltd,	  Wales,	  UK	  (2010).	  
Bottom:	  Representative	  overlaid	  EMG	  trace	  MEP	  (facilitory	  twitch)	  cSP	  (inhibitory	  
suppression	  of	  EMG)	  after	  a	  TMS	  pulse	  over	  a	  background	  graded	  contraction	  of	  30%	  of	  




MEP Recruitment Curves 
	  
Alternatively,	  a	  more	  complete	  expression	  of	  corticospinal	  excitability	  can	  be	  derived	  
by	   recruitment	   curves.	   These	   detail	   how	   MEPs	   or	   cSPs	   increase	   and	   eventually	  
plateau	  as	  the	  stimulator	  intensity	  is	  increased	  (Hess	  et	  al.,	  1986,	  Davey	  et	  al.,	  1999).	  
Recruitment	   curves	   usually	   follow	   a	   threshold-­‐saturation	   style	   distribution	   and	   so	  
both	   cSP	   and	  MEP	   recruitment	   curves	   are	   accurately	   modelled	   by	   the	   Boltzmann	  
function	  (Devanne	  et	  al.,	  1997,	  Capaday,	  1997,	  Carroll	  et	  al.,	  2001,	  Kimiskidis	  et	  al.,	  
2005,	   Cacchio	   et	   al.,	   2009).	   Recruitment	   curves	   provide	   additional	   parameters	   of	  
corticospinal	  control,	  such	  as	  the	  plateau	  (Max	  MEP	  size	  or	  longest	  cSP),	  the	  stimulus	  
intensity	   at	   the	  midpoint	   between	  Max	   and	   zero	   (X50),	   as	  well	   as	   the	   slope	   of	   the	  
curve	   at	   that	   point.	   	   These	   stimulus	   response	   curves	   provide,	   to	   a	   certain	   extent,	  
similar	  information	  to	  corticomotor	  output	  maps	  (Wassermann	  et	  al.,	  1992,	  Ridding	  
and	   Rothwell,	   1997).	   Current	   spread	   from	   a	   stationary	   stimulator	   at	   increasing	  
stimulus	  intensity	  reflects	  changes	  in	  area	  of	  cortical	  output	  maps	  over	  specific	  time	  
points.	  	  However,	  unlike	  cortical	  output	  maps	  (produced	  by	  stimulating	  many	  points	  
in	   a	   given	   area	   at	   the	   same	   intensity),	   these	   curves	   are	   blind	   to	   somatotopic	  
distribution	  of	  excitability.	  	  Furthermore,	  it	  is	  important	  to	  note	  that	  neither	  method	  
can	  strictly	  distinguish	  whether	  a	  change	   in	   these	  parameters	  over	   the	   time	  points	  
studied	   indicates	   (1)	   a	   change	   in	   cortical	   excitability	   or	   (2)	   local	   synaptic	  
reorganisation	   (Ridding	   and	   Rothwell,	   1997).	   This	   is	   because	   excitability	   can	   be	  
mediated	  by	  a	  variation	   in	  tonic	   input	  to	  the	  primary	  motor	  cortex	  from	  numerous	  
remote	   cortical	   structures.	   	   The	   term	   plasticity	   (which	   by	   definition	   includes	   both	  
synaptic	   and	   non-­‐synaptic	   plasticity)	   is	   non-­‐specifically	   employed	   in	   the	   general	  





Clinical	  significance	  of	  recruitment	  curve	  parameters	  
	  
Stimulus	   response	   curves	   (RCs)	   deliver	   information	   about	   the	   strength	   of	  
corticospinal	   projections	   (Brouwer	   and	  Ashby,	   1990,	   Boroojerdi	   et	   al.,	   2001).	   They	  
may	   be	  modulated	   by	   ischemic	   limb	   deafferentation	   (Ziemann	   et	   al.,	   1998,	   Brasil-­‐
Neto	   et	   al.,	   1992b),	   including	   amputations	   (Ridding	   and	   Rothwell,	   1997),	   and	   by	  
acquiring	  new	  motor	  skills	  (Pascual-­‐Leone	  et	  al.,	  1995a).	  	  Drug	  experiments	  have	  also	  
found	  individual	  MEP	  RC	  parameters	  to	  be	  sensitive	  to	  changes	  to	  the	  GABAergic	  and	  
monoaminergic	   systems,	   Na+	   and	   Ca2+	   channel	   properties	   and	   as	   such,	   have	   been	  
described	  as	  the	  most	  sensitive	  parameters	  of	  motor	  system	  excitability	  (Boroojerdi	  
et	  al.,	  2001).	  	  A	  single	  MN’s	  motor	  unit	  pool’s	  discharge	  probability	  increases	  linearly	  
with	  magnetic	  field	  intensity	  (Devanne	  et	  al.,	  1997).	  	  The	  sigmoid	  shape	  of	  the	  curve	  
thus	  reflects	  the	  wide	  distribution	  of	  spike	  amplitudes	  in	  the	  system	  (Devanne	  et	  al.,	  
1997),	  or	  the	  fact	  that	  stimuli	  of	  increasing	  strength	  recruit	  MNs	  of	  increasing	  motor	  
unit	   (MU)	   potentials	   (Henneman,	   1957).	   As	   Devanne	   et	   al.	   (1997)	   point	   out;	   the	  
plateau	  value	  characterises	  the	  balance	  of	  excitatory	  and	   inhibitory	  components	  of	  
the	  corticospinal	  volley	  rather	  than	  the	  maximum	  response.	  	  This	  includes	  recurrent	  
inhibition	  of	  MNs	  recruited	  late	  by	  earlier	  recruited	  MNs.	  	  The	  slope	  is	  a	  measure	  of	  
excitability	  or	  gain,	  taking	  into	  account	  augmented	  synchronisation	  of	  MU	  discharges	  
and	  multiple	   corticospinal	   volleys	   (Devanne	   et	   al.,	   1997).	   	   Because	   of	  Henneman’s	  
principle	   of	   orderly	   recruitment	   (Henneman	   and	   Olson,	   1965,	   Henneman	   et	   al.,	  
1965b,	  Henneman	  et	  al.,	  1965a,	  McPhedran	  et	  al.,	  1965a,	  McPhedran	  et	  al.,	  1965b,	  
Somjen	  et	  al.,	  1965),	  recruitment	  curves	  are	  thought	  to	  be	  repeatable	  (Cacchio	  et	  al.,	  










Clinical Outcome Measures 
	  
A	   substantial	   body	  of	   evidence	   suggests	   that	   a	   disease	   specific	   paradigm	  of	   global	  
pain	  severity	  should	  merge	  contributions	  of	  pain	  intensity	  with	  its	  interference	  with	  
daily	  activities	  (Von	  Korff	  et	  al.,	  2000).	  Methodological	  studies	  have	  shown	  that	  the	  
fundamental	   features	  of	  chronic	  pain	  can	  be	  recalled	  for	  at	   least	  a	  3-­‐month	  period	  
with	   acceptable	   levels	   of	   validity	   (Von	   Korff	   et	   al.,	   2000).	   	   The	   validation	   and	  
interpretation	   of	   the	   assessment	   tools	   of	   global	   pain	   severity	   and	   function	   in	   the	  
context	  of	  LBP	  and	  decompression	  surgery	  will	  now	  be	  discussed.	  
 
Back	  and	  Leg	  Pain	  Intensity:	  Visual	  analogue	  scale	  (VAS)	  
	  
The	   International	   Association	   for	   the	   Study	   of	   Pain	   (IASP)	   defines	   pain	   as	   an	  
unpleasant	   sensory	   and	   emotional	   experience	   associated	   with	   actual	   or	   potential	  
tissue	   damage	   (Merskey	   and	   Bogduk,	   1994).	   	   Naturally	   the	   term	   pain	   is	  
physiologically	  unspecific	  but	  not	  necessarily	  impersonal,	  in	  light	  of	  the	  wide	  array	  of	  
temporal	   and	   qualitative	   characteristics	   of	   sensations	  made	   available	   to	   a	   patient	  
chronically	  afflicted	  by	  dynamic	  inflammatory	  and	  neuropathic	  processes.	  However,	  
a	  simple	  assessment	  tool	  is	  perhaps	  more	  likely	  to	  retain	  a	  recollection	  of	  this	  global	  
personal	  experience	  over	  successive	  assessments.	  A	  VAS	  consists	  of	  a	  100-­‐mm	  long	  
uninterrupted	   line	  with	   extremities	   labelled	   as	   the	   opposite	   limits	   of	   pain.	   	   In	   the	  
studies	  carried	  out	   in	  this	   thesis,	   these	  are	   labelled	  from	  no	  pain	   to	  worse	  possible	  
pain	   (see	   Appendix	   for	   a	   surgery-­‐specific	   questionnaire).	   Patients	   label	   a	   pain	  
intensity	   score	   (0-­‐100mm)	  by	   indicating	  which	  point	   along	   the	   line	   relates	   to	   their	  
perceived	  pain	   intensity.	   	  VAS	  pain	   intensity	  scores	  have	  been	  shown	  to	  be	  reliable	  
and	  to	  correlate	  with	  other	  self-­‐reported	  measures	  of	  pain	  intensity	  (Carlsson,	  1983,	  
Revill	  et	  al.,	  1976,	  Sriwatanakul	  et	  al.,	  1983).	  Although	  VAS	  has	  been	  shown	  to	  be	  as	  
sensitive	  as	  other	  scales	  with	  fewer	  response	  levels,	  its	  101	  possible	  response	  levels	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are	  thought	  to	  be	  more	  sensitive	  when	  changes	  occur	  (Von	  Korff	  et	  al.,	  2000),	  albeit	  
with	   a	   considerable	   minimum	   score	   required	   to	   indicate	   clinically	   useful	   changes.	  	  	  
Minimum	   clinically	   important	   changes	   have	   been	   assessed	   for	   a	   few	   LBP	  
classifications.	  	  Using	  patient	  global	  perceived	  effect	  as	  the	  gold	  standard	  (Hudak	  and	  
Wright,	   2000)	   and	   a	   minimum	   period	   of	   18	   weeks,	   a	   10-­‐18mm	   cut-­‐off	   point	   was	  
found	   to	   discriminate	   non-­‐specific	   LBP	   patients	   who	   considered	   themselves	  
improved	   (Beurskens	   et	   al.,	   1996).	   	   Using	   chronic	   low	   back	   pain	   patient's	   global	  
assessment	  of	   treatment	  effect	  as	   the	  gold	  standard,	   the	  difference	   in	  mean	  score	  
changes	  of	  participants	  considering	  themselves	  unchanged	  and	  better	  was	  found	  to	  
be	  18-­‐19mm,	  compared	  to	  a	  smallest	  detectable	  change	  of	   just	  15mm	  (Hagg	  et	  al.,	  
2003).	  	  In	  acute	  low	  back	  pain	  the	  smallest	  detectable	  change	  has	  been	  found	  to	  be	  
as	  high	  as	  36.2	  mm	  (Ostelo	  et	  al.,	  2007).	   	  As	  a	  result,	  as	  a	  rule	  of	  thumb	  in	  chronic	  
low	   back	   pain,	   clinically	   significant	   change	   is	   regarded	   to	   be	   a	   minimum	   20	  mm	  
(Ostelo	  and	  de	  Vet,	  2005a).	  In	  order	  to	  address	  the	  different	  temporal	  characteristics	  
of	  nociceptive,	  referred	  and	  radicular	  pain,	  different	  VAS	  scales	  may	  be	  used	  for	  the	  
back	   and	   legs;	   for	   example	  pain	  now,	   pain	  over	   the	   last	  week	  and	  worse	  pain	   last	  




Both	   the	  Roland–Morris	  Disability	  Questionnaire	   and	   the	  Oswestry	  Disability	   Index	  
(ODI)	  have	  been	  recommended	  by	  an	  international	  expert	  panel	  on	  the	  evaluation	  of	  
the	   treatment	   of	   spinal	   disorders	   (Bombardier,	   2000).	   	   The	   ODI	   is	   a	   short	   form	  
containing	  10	  items	  referring	  to	  activities	  of	  daily	  living	  that	  may	  be	  disrupted	  by	  LBP	  
(Fairbank	   and	   Pynsent,	   2000,	   Fairbank	   et	   al.,	   1980).	   These	   include	   disruptions	   in	  
physical	   functions	   including	   standing,	   walking,	   lifting,	   sitting,	   lying	   down,	   dressing,	  
personal	  care	  and	  impacts	  on	  travel,	  sexual	  and	  social	  function.	  The	  response	  options	  
are	  6	  ranks	  of	  disability	  ranging	  from	  no	  problem	  (0	  points)	  to	  not	  possible	  (5	  points).	  
The	  ODI	  score	  is	  then	  calculated	  as	  the	  total	  scored/[50	  (total	  possible	  score)×100],	  
giving	  a	  scale	  from	  0	  (no	  disability)	  to	  100	  (maximum	  disability).	  The	  ODI’s	  construct	  
48	  
	  
validity	  and	  reproducibility	  has	  been	  assessed	  alongside	  other	  measuring	  tools	  of	  LBP	  
disability	   and	   version	   2.0	   is	   now	   generally	   recommended	   (Fairbank	   et	   al.,	   1980,	  
Roland	  and	   Fairbank,	   2000,	   Fairbank,	   2000,	  Bombardier,	   2000).	  Minimum	  clinically	  
relevant	  changes	  detectable	  with	  95%	  probability	   (based	  on	  a	  mixed	  cohort	  of	  289	  
surgical/non-­‐surgical	   patients)	   has	   been	   calculated	   to	   be	   10	   points	   (Hagg	   et	   al.,	  
2003).	  
	  
Long	  Term	  Post-­‐Surgical	  Sensitivity	  	  
	  
Further	   evidence	   for	   the	   long	   term	   sensitivity	   and	   suitable	   time	   intervals	   of	   the	  
above	  pain	  intensity-­‐disability	  construct	  was	  assessed	  within	  the	  first	  post-­‐operative	  
year	  of	  lumbar	  decompression	  surgery,	  along	  with	  validated	  psychological	  scores	  and	  
general	   health	   (of	   the	   Short	   Form	  SF-­‐36	  General	  Health	  Questionnaire)	   (McGregor	  
and	   Hughes,	   2002a).	   The	   study	   found	   that	   the	   outcome	   of	   surgery	   could	   not	   be	  
predicted	   reliably	   from	   baseline	   psychological,	   functional,	   or	   pain	   measures.	  
However,	   VAS,	   ODI	   and	   general	   health	   items	   relating	   to	   physical	   pain	   and	   social	  
function	  (SF-­‐36)	  provided	  the	  most	  sensitive	  measures	  of	  outcome,	  with	  significant	  
improvements	  occurring	  at	  6	  weeks	  and	  6	  months. 
	  
Central Neurophysiological Adaptations in Chronic LBP 
	  
From	   a	   neuromuscular	   viewpoint	   the	   development	   of	   LBP	   involves	   biomechanical	  
perturbations	   in	   the	   control	   of	   trunk	   musculature.	   Some	   of	   these	   have	   been	  
reported	  to	  be	  attributable	  to	  alterations	  in	  parameters	  such	  as	  strength	  (Hupli	  et	  al.,	  
1996,	   Lee	  et	   al.,	   1999,	  Panjabi	   et	   al.,	   1989,	  Rissanen	  et	   al.,	   1995,	  Roy	  et	   al.,	   1989,	  
Verbunt	   et	   al.,	   2005),	   activity	   (Flor	   et	   al.,	   1983,	   Hodges	   and	   Richardson,	   1996,	  
Hodges	  and	  Richardson,	  1998,	  Hodges	  and	  Richardson,	  1999,	  Holmstrom	  et	  al.,	  1992,	  
Sihvonen	   et	   al.,	   1997,	   Radebold	   et	   al.,	   2000),	   fatigability	   (Biering-­‐Sorensen,	   1984,	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Holmstrom	  et	  al.,	  1992,	   Jorgensen	  and	  Nicolaisen,	  1986,	  Mannion	  et	  al.,	  1997)	  and	  
endurance	  (Nicolaisen	  and	  Jorgensen,	  1985,	  Adams	  et	  al.,	  1999,	  Luoto	  et	  al.,	  1995).	  
Although	   the	  control	  of	   this	  musculature	   is	   central	   to	   the	  maintainance	  of	   stability	  
and	  posture	   (Radebold	   et	   al.,	   2000,	   Radebold	   et	   al.,	   2001,	   Cholewicki	   et	   al.,	   1997,	  
Cholewicki	   et	   al.,	   1996,	   Granata	   and	   Wilson,	   2001,	   Granata	   and	   Orishimo,	   2001,	  
Cholewicki	  and	  VanVliet,	  2002),	  there	  is	  currently	  no	  detailed	  understanding	  of	  how	  
this	  is	  carried	  out	  by	  the	  brain.	  
	  
Several	   studies	   have	  demonstrated	  disruptions	   to	   feed-­‐forward	   activation	  of	   trunk	  
musculature	   in	  LBP.	   	  Feedforward	  control	  occurs	  before	  movement	   is	   initiated	  and	  
throughout	  movement	   and	   is	   responsible	   for	   centre	   of	  mass	   shifting	   prior	   to	   limb	  
displacement	  and	  preparation	  of	  anticipated	  challenges	   to	  stability	   (Moseley	  et	  al.,	  
2003,	  Hodges	  et	  al.,	  2003).	  Delayed	  feedforward	  activation	  of	  deep	  abdominal	  and	  
back	  muscles	  (Hodges,	  2001,	  Hodges	  et	  al.,	  2003,	  Leinonen	  et	  al.,	  2001,	  Hodges	  and	  
Richardson,	  1996),	  have	  been	  reported	   in	  chronic	   low	  back	  pain,	  as	  well	  as	  chronic	  
neck	  pain	   (Falla	  et	  al.,	  2004)	  and	   long	  standing	  groin	  pain	   (Cowan	  et	  al.,	  2004).	  On	  
the	  other	  hand	  increased	  activity	  has	  also	  been	  reported	  in	  superficial	  muscles,	  such	  
as	  in	  paraspinal	  muscles	  during	  the	  swing	  phase	  of	  the	  gait	  cycle	  (Arendt-­‐Nielsen	  et	  
al.,	   1996)	   and	  delayed	   relaxation	  of	   obliquus	   externus	   abdominis	   (OE)	   and	   erector	  
spinae	  (ES)	  following	  sudden	  unloading	  of	  the	  trunk	  (Radebold	  et	  al.,	  2001).	  	  	  
	  
Administration	   of	   acute	   painful	   electrical	   (Urban	   et	   al.,	   2004,	   Kofler	   et	   al.,	   1998,	  
Kaneko	  et	  al.,	  1998)	  or	   laser	  (Valeriani	  et	  al.,	  2001,	  Valeriani	  et	  al.,	  1999)	  stimuli	  to	  
the	   skin	   have	   been	   shown	   to	   reduce	   corticospinal	  motor	   (MEP)	   output	   to	   painful	  
muscles.	  The	  interaction	  between	  nociceptive	  afferents	  and	  size	  and	  location	  of	  the	  
modulation	  in	  motor	  output	  are	  related	  to	  the	  type	  of	  afferent	  pathways	  activated.	  	  
So	   spinal	   rather	   than	   cortical	   inhibition	   is	   known	   to	   be	   responsible	   for	   the	   MEP	  
attenuation	   in	   electrical	   stimulation	   because	   MEP	   reduction	   occurs	   within	   the	  
(spinal)	  cutaneous	  silent	  period	  which	  has	  a	  latency	  between	  	  40-­‐100	  ms	  (Kaneko	  et	  
al.,	  1998,	  Kofler	  et	  al.,	  1998).	  Laser	  evoked	  potential	   inhibition,	  on	  the	  other	  hand,	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peaks	  at	  160ms	  when	   these	  are	  known	   to	   reach	  cortical	   interneurons	   (Valeriani	  et	  
al.,	  1999,	  Valeriani	  et	  al.,	  2001).	  The	  effects	  of	  experimentally	  induced	  acute	  pain	  on	  
corticospinal	  control	  have	  been	  studied	  in	  the	  hand	  (Le	  Pera	  et	  al.,	  2001,	  Svensson	  et	  
al.,	  2003),	  arm	  (Valeriani	  et	  al.,	  2001)	  and	  jaw	  muscles	  (Sohn	  et	  al.,	  2000,	  Svensson	  et	  
al.,	   2002).	   Injection	   of	   capsaicin	   in	   the	   masseter	   muscle	   was	   shown	   in	   the	   latter	  
studies,	  to	  reduce	  the	  firing	  rate	  of	  single	  motor	  units,	  yet	  with	  an	  increase	  in	  twitch	  
force	   to	  maintain	   output.	   	  MEP	   responses	   to	   TMS	   of	   the	  motor	   cortex	   have	   been	  
shown	  (in	  the	  former	  studies)	  to	  be	  reduced	  in	  the	  hand	  and	  arm	  in	  the	  presence	  of	  
experimentally	  induced	  pain.	  	  In	  tonic	  muscle	  pain	  by	  hypertonic	  saline	  injection	  (Le	  
Pera	  et	  al.,	  2001,	  Svensson	  et	  al.,	  2003),	  the	  inhibition	  begins	  to	  outlast	  the	  duration	  
of	   pain.	   	   Perhaps	   because	   of	   the	   afferent	   type/size	   principle	   above,	   this	   property	  
appears	   to	   be	   specific	   to	   nociceptive	   stimuli	   administered	   to	   deep	   tissues.	   The	  
maintenance	  of	  force	  output,	  despite	  a	  decrease	  in	  the	  firing	  rate	  of	  individual	  motor	  
units	   (MU)	   in	  a	  muscle	  subject	   to	  experimental	  nociceptive	  stimulation,	  has	   largely	  
been	   thought	   to	   be	   related	   the	   differential	   activity	   of	   other	   muscles.	   However,	  
synergist	  muscles	  have	  been	  shown	  to	  also	  respond	  with	  reduced	  activity	  (Hodges	  et	  
al.,	  2008).	  Recent	  work	  has	  shown	  that	  this	  maintenance	  of	  force	  output	  originates	  
from	  differential	   recruitment	   of	  MUs	  within	   the	  muscle	   itself	   (Tucker	   and	  Hodges,	  
2009,	  Tucker	  et	  al.,	  2009).	  	  In	  response	  to	  deep	  tissue	  nociception,	  a	  decrease	  in	  the	  
firing	   rate	   of	   low	   threshold	   motor	   units,	   with	   the	   simultaneous	   recruitment	   of	  
additional	  new	  units,	  is	  thought	  to	  allow	  for	  an	  increase	  in	  twitch	  force	  to	  maintain	  
output	   (Svensson	   et	   al.,	   2003,	   Svensson	   et	   al.,	   2002,	   Tucker	   and	   Hodges,	   2009,	  
Tucker	   et	   al.,	   2009).	   	   It	   is	   thus	   the	   task-­‐specific	   biomechanical	   constraints	   on	   the	  
greater	  musculoskeletal	   system,	  which	  are	   then	   though	   to	   govern	  a	   compensatory	  
strategy	  (Arendt-­‐Nielsen	  and	  Falla,	  2009).	  The	  respective	  contributions	  from	  spinal,	  
cortical	   or	   subcortical	   centres	   to	   this	   mechanism	   are	   still	   undetermined	   and	   may	  
differ	   in	   chronic	   and	   acute	   presentations.	   	   For	   example,	   an	   animal	   study	   suggests	  
increased	   cortical	   compared	   to	   spinal	   excitability	   resulting	   from	   an	   intervertebral	  




Similar	  to	  the	  mechanisms	  which	  alter	  MEP	  excitability,	  feedforward	  control	  also	  has	  
the	   property	   of	   immediately	   being	   affected,	   and	   persisting	   after	   the	   resolution	   of	  
symptoms	   (Hodges	   and	   Richardson,	   1996).	   For	   this	   reason,	   some	   authors	   have	  
suggested	   that	   this	  may	   actually	   contribute	   to	   the	   recurrence	   of	   LBP	   (Hodges	   and	  
Moseley,	   2003,	   Cholewicki	   et	   al.,	   2005).	   When	   Hodges	   and	   Moseley	   (2003)	  
attempted	  to	  reproduce	  acute	  LBP	  by	  injecting	  hypertonic	  saline	  into	  the	  longissimus	  
muscle	   at	   L4,	   transverse	   abdominis	   (TrA)	   feedforward	   activation	   was	   consistently	  
delayed.	   	   However	   cortical	   control	   of	   postural	   responses,	   and	   certainly	   afferent	  
mechanisms	   for	   altering	   these	   control	   patterns	   in	   the	  motor	   system,	   are	   still	   very	  
poorly	  understood.	  
	  
Nevertheless	  the	  motor	  cortex	   is	  critical	  to	  postural	  control	  (Deliagina	  et	  al.,	  2008).	  	  
Feedforward	   responses	   are	   faster	   than	   the	   fastest	   voluntary	  movements	   but	   have	  
longer	   latencies	  than	  spinal	  stretch	  reflexes	  (Chan	  et	  al.,	  1979).	  The	  cerebral	  cortex	  
influences	   longer	   anticipatory	   responses	   directly	   and	   indirectly	   via	   the	   brainstem	  
centres	  that	  store	  response	  synergies	  (Prochazka,	  1989).	   It	  has	  been	  proposed	  that	  
the	  premotor	  cortex	  plays	  an	   important	  role	   in	  anticipatory	  feedforward	  responses	  
in	   the	   contralateral	   arm	   loading	   during	   postural	   tasks	   (Viallet	   et	   al.,	   1992).	   Absent	  
reactions	   in	  patients	  with	   lesions	  of	   the	  corticospinal	   tract	   (hemiparesis)	   (Bennis	  et	  
al.,	   1996,	   Palmer	   et	   al.,	   1996),	   but	   not	   subcortical	   structures	   (Diedrichsen	   et	   al.,	  
2005),	  has	  provided	  evidence	  that	  these	  postural	   responses	  are	  descending	  via	  the	  
contralateral	   motor	   cortex.	   	   Furthermore	   TMS	   over	   the	   contralateral	   (and	   not	  
ipsilateral)	  M1	  delays	  or	   reduces	  postural	  mechanisms	   (Palmer	  et	  al.,	  1994,	  Taylor,	  
2005,	  Hodges	  et	  al.,	  2003).	  	  A	  reduction	  in	  short-­‐interval	  intracortical	  inhibition	  (SICI)	  
as	  been	  found	  in	  the	  soleus	  muscle	  during	  postural	  tasks	  (Soto,	  2006),	  and	  increase	  
in	  its	  excitability	  75ms	  prior	  to	  anticipated	  postural	  reactions	  (Petersen	  et	  al.,	  2009).	  	  
Naturally	   these	   mechanisms	   may	   also	   involve	   modulation	   by	   spinal	   cord	   and	  
peripheral	   nerve	   excitability	   (Le	   Pera	   et	   al.,	   2001).	   	   Nevertheless,	   as	   LBP	   patients	  
demonstrate	   acquired	   patterns	   in	  motor	   control	   deficits	  which	   outlast	   the	   stimuli,	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the	  reorganisation	  or	  changes	  in	  excitability	  of	  motor	  cortical	  areas	  become	  plausible	  
candidates.	  
	  
And	  indeed	  much	  recent	  evidence	  is	  revealing	  that	  neuropathic	  and	  musculoskeletal	  
pain	   can	   trigger	   functional	   plastic	   reorganisation	   in	   both	   the	   somatosensory	   and	  
motor	   systems	   to	   an	   extent	   previously	   thought	   to	   only	   be	   possible	   in	   early	  
development	   (Flor,	   2003,	   Flor,	   2002,	   Sanes	   and	  Donoghue,	   2000,	   Apkarian,	   2004).	  
Extensive	   motor	   cortex	   reorganisation	   has	   been	   studied	   in	   complex	   regional	   pain	  
syndrome	  (CRPS)	  (Krause	  et	  al.,	  2006,	  Maihofner	  et	  al.,	  2007)	  and	  phantom	  limb	  pain	  
(Knecht	  et	  al.,	  1995,	  Flor	  et	  al.,	  1995,	  Karl	  et	  al.,	  2001).	  In	  both	  of	  those	  conditions,	  
not	  only	  the	  amount	  of	  reorganisation	  observed	  in	  functional	  neuroimaging,	  but	  also	  
the	   duration	   of	   the	   pain	   experience	   which	   preceded	   the	   condition	   correlate	   the	  
magnitude	   of	   pain	   (Flor,	   2003).	   When	   patients	   with	   chronic	   low	   back	   pain	   are	  
stimulated	   in	   the	   painful	   sites,	   an	   expansion	   of	   representation	   of	   the	   back	   in	   the	  
primary	  somatosensory	  cortex	  becomes	  visible	  and	  again,	  the	  amount	  of	  expansion	  
increases	   with	   chronicity	   (Flor	   et	   al.,	   1997).	   Specific	   details	   of	   this	   framework	   are	  
slowly	  emerging.	  	  
	  
TMS	  Parameters	  in	  Chronic	  LBP	  with	  and	  without	  Leg	  Pain	  
	  
Changes	  in	  corticomotor	  excitability	  have	  been	  demonstrated	  in	  back	  and	  abdominal	  
muscles	  in	  chronic	  low	  back	  pain	  [LBP]	  (Tsao	  et	  al.,	  2011b,	  Tsao	  et	  al.,	  2008,	  Strutton	  
et	   al.,	   2005,	   Strutton	   et	   al.,	   2004b).	   	   LBP	   patients	   with	   accompanying	   neurologic	  
deficit	  or	  radicular	  pain	  were	  found	  to	  have	  elevated	  motor	  and	  inhibitory	  thresholds	  
to	   TMS	   in	   erector	   spinae	   (ES)	   at	   L4,	   although	   this	   has	   not	   been	   confirmed	   in	  
experimental	  or	  recurrent	  LBP	  (Tsao	  et	  al.,	  2011b,	  Tsao	  et	  al.,	  2011c).	  This	  reduced	  
corticospinal	   drive	   to	  back	  muscles	   of	   patients	  with	   chronic	   low	  back	   and	   leg	  pain	  
(Strutton	   et	   al.,	   2005)	   was	   also	   found	   in	   painful	   leg	   muscles	   in	   L4-­‐S1	   nerve	   root	  
pathology	  (Strutton	  et	  al.,	  2003b).	  	  Furthermore	  in	  both	  of	  these	  studies	  there	  was	  a	  
correlation	   between	   patient	   rated	   pain	   and	   functional	   disability	   scores	   and	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thresholds	  for	  eliciting	  TMS	  responses	  (and	  inhibitory	  and	  facilitory)	  in	  the	  back	  and	  
leg	  muscles.	  
	  
Corticomotor	   mapping	   experiments	   of	   both	   TrA	   and	   ES	   in	   recurrent	   LBP	   have	  
documented	  a	  loss	  of	  representation	  in	  anterior	  sites	  in	  the	  motor	  cortex	  (Tsao	  et	  al.,	  
2011b,	  Tsao	  et	  al.,	  2008).	  Corticomotor	  map	  coordinates	  of	  deep	  abdominal	  (TrA)	  in	  
a	   postural	   adjustment	   task	   have	   been	   found	   to	   correlate	   with	   the	   delayed	  
adjustment	  to	  rapid	  arm	  movements	   (Tsao	  et	  al.,	  2008).	  Further	  work	  by	  the	  same	  
group	  has	  confirmed	  multiple	  pathways	  to	  the	  erector	  spinae	  (ES)	  muscles	  cortically	  
accessible	   by	   TMS,	   with	   likely	   distinct	   characteristic	   latencies	   and	   somatotopic	  
organisation	   	   (Tsao	  et	  al.,	  2011b,	  O'Connell	  et	  al.,	  2007,	  Kuppuswamy	  et	  al.,	  2008).	  	  
Furthermore	   their	   differential	   activation	   is	   likely	   to	   be	   task	   specific,	   with	   some	  
postural	   tasks	  yielding	   reduced	   latencies	  and	  preferential	   somatospecific	  activation	  
(Kuppuswamy	   et	   al.,	   2008,	   Tsao	   et	   al.,	   2011a).	   Recent	   work	   facilitating	   the	   deep	  
multifidus	  muscle	  in	  an	  abdominal	  brace	  task,	  not	  only	  confirmed	  previous	  reports	  of	  
discrete	   pathways	   to	   different	   fascicles	   of	   ES,	   but	   also	   that	   these	   pathways	   are	  
differentially	  inhibited	  in	  recurrent	  LBP	  (Tsao	  et	  al.,	  2011a,	  Tsao	  et	  al.,	  2011b).	  	  The	  
dominantly	  inhibited	  pathway	  is	  thought	  to	  lie	  4cm	  anterior	  to	  the	  vertex,	  appears	  to	  
have	   faster	   latencies,	   and	   may	   originate	   from	   the	   supplementary	   motor	   area	  
(O'Connell	  et	  al.,	  2007,	  Tsao	  et	  al.,	  2011).	  	  	  
	  
Further	  alterations	  in	  intracortical	  inhibitory	  (ICI)	  activity	  have	  been	  reported	  in	  low	  
back	   pain	   (Masse-­‐Alarie	   et	   al.,	   2012),	   neuropathic	   (Turgut	   and	   Altun,	   2009,	  
Schwenkreis	  et	  al.,	  2010),	  chronic	  pain	  conditions	  such	  as	  fibromyalgia	  (Salerno	  et	  al.,	  
2000,	  Mhalla	  et	  al.,	  2010),	  and	  complex	  regional	  pain	  syndrome	  (Schwenkreis	  et	  al.,	  
2005).	  	  
	  
Although	   some	  of	   these	   central	   changes	  have	  been	   targeted	  by,	   and	   correlated	   to	  
the	   functional	   outcomes	   of,	   physical,	   manual	   and	   exogenous	   neuro-­‐stimulation	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therapies	   (Masse-­‐Alarie	   et	   al.,	   2013,	   Clark	   et	   al.,	   2011,	   Tsao	   et	   al.,	   2010a),	   little	   is	  
known	   about	   their	   expected	   profile	   and	   long	   term	   stability	   or	   disease	   progression	  
within	  the	  LBP	  patient	  spectrum.	  
	  
The	   extent	   to	   which	   these	   changes	   in	   corticomotor	   output	   and	   intracortical	  
inhibitory	  activity	  vary	  within	  the	  LBP	  classification	  spectrum,	  their	  inherent	  stability,	  
disease	   specific	   time	   course,	   and	   the	   extent	   to	   which	   they	   may	   be	   mitigated	   by	  
successful	  treatment	  still	  need	  to	  be	  determined.	  
	  
Suitable	  Muscles	  for	  Monitoring	  Corticospinal	  Excitability	  Changes	  in	  LBP	  and	  Leg	  
Pain	  
	  
Lessons	  From	  Electrodiagnostic	  Testing	  
	  
Leg	  muscles	  selected	  to	  explore	  root	   level	   specific	  changes	   in	  corticospinal	  drive	   in	  
radiculopathy/radicular	  pain	  and	  perhaps	  even	  referred	  pain,	  should	  follow	  some	  of	  
the	   same	   principles	   as	   electrodiagnostic	   testing	   for	   radiculopathies.	   	   The	   muscle	  
should	  ideally	  be	  innervated	  by	  the	  affected	  nerve	  root,	  yet	  with	  minimal	  segmental	  
overlap	  to	  other	  studied	  muscles	  and	  levels.	  Thus	  a	  sensible	  muscle	  selection	  criteria	  
might	  be	  those	  with	  different	  root	  innervation,	  as	  well	  as	  different	  peripheral	  nerve	  
innervation.	   	   This	   is	   an	   ideal	   condition	   given	   that	   there	   is	   considerable	   individual	  
variation	   in	   the	   segmental	   innervation	   of	   individual	   muscles	   (Stewart,	   1992).	  
Furthermore,	   given	   the	   anatomy	   of	   the	   region,	   there	   are	   many	   locations	   where	  
herniated	   material	   and	   compressive	   structures	   can	   act.	   	   For	   example	   the	   most	  
common	  L5	  (L5-­‐S1)	  herniation	  affects	  the	  L5	  root	   if	  posterior	   lateral,	  but	  can	  affect	  
S1-­‐S4	   as	   a	   central	   herniation	   or	   L4	   in	   the	   far-­‐lateral	   configuration.	   	   In	   the	   case	   of	  
lumbar	   central	   stenosis,	   bilateral	  multiple-­‐root	   lesions	   are	   common	  because	  nerve	  
roots	  are	  tightly	  arranged	  within	  the	  cauda	  equina	  (Wilbourn	  and	  Aminoff,	  1998).	  In	  
order	   to	   find	   those	  muscles	  which	  statistically	  have	   less	   inter-­‐subject	  variation	  and	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are	   more	   likely	   to	   be	   affected,	   Tsao	   and	   colleagues	   (2003)	   compared	   positive	  
electrodiagnostic	   results	   of	   45	   patients	   with	   positive	   MRI	   and	   surgically	   verified	  
single	  nerve	  root	  lesions.	  	  They	  found	  the	  (L4-­‐L5)	  tibialis	  anterior	  (TA)	  to	  be	  highly	  L5	  
innervated.	   Although	   commonly	   affected	   in	   L5	   radiculopathy,	   they	   found	   no	   L4	  
patients	   with	   positive	   signs	   in	   TA	   (Tsao	   et	   al.,	   2003).	   Of	   commonly	   affected	   S1	  
muscles	  with	  unlikely	  segmental	  overlap,	  as	  a	  TA	  antagonist,	  the	  (S1-­‐S2)	  soleus	  (SOL)	  
muscle,	   offers	   the	   possibility	   of	   simultaneously	   testing	  muscle	   coordination.	   Either	  
heads	   of	   the	   gastrocnemius	   muscle	   are	   equally	   suited,	   although	   isometric	  
contractions	  with	  this	  muscle	  are	  a	  little	  more	  prone	  to	  movement	  artefacts.	  
 
Trunk	  Instability	  	  
 
If	   one	   is	   hoping	   to	   retain	   chronic	   pain	   patients	   over	   several	   assessments,	   surface	  
electrodes	  may	   be	   desirable,	   given	   that	   fine	  wire	   intramuscular	   electrodes	  will	   be	  
more	   painful	   and	   require	   a	   longer	   set-­‐up	   procedure.	   As	   the	  most	   relevant	   surface	  
muscle,	   erector	   spinae	   is	   the	   first	   choice	   given	   its	   current	   confirmed	   corticomotor	  
alteration	  in	  LBP.	  The	  conclusions	  of	  a	  meta-­‐analysis	  in	  2005	  held	  that	  surface	  EMG	  
may	  potentially	  serve	  as	  a	  marker	  for	  LBP,	  with	  largest	  effect	  sizes	  found	  in	  surface	  
EMG	  hyperactivity	  in	  standing	  and	  flexion-­‐relaxation	  measures	  (Geisser	  et	  al.,	  2005).	  
LBP	   is	   associated	  with	   an	   active	   stiffness	   to	   enhance	   spinal	   stability,	   by	   increasing	  
agonist	   and	   antagonist	   co-­‐activation	   (Cholewicki	   and	   McGill,	   1996,	   Granata	   and	  
Orishimo,	  2001).	  The	  more	  multi-­‐segmental	  muscles	  exert	  larger	  and	  more	  direction-­‐
dependent	  influence	  on	  trunk	  stability	  (Kavcic	  et	  al.,	  2004).  Studying	  ES’s	  most	  direct	  
antagonist,	   rectus	   abdominis	   (RA),	   may	   thus	   provide	   insights	   into	   any	   differential	  
temporal	  or	  excitability	  changes	   in	  corticomotor	  output,	  which	  may	  be	   interpreted	  
to	   impact	   	   trunk	   stability	   or	   feed-­‐forward	   control	   in	   LBP.	   	   As	   an	   important	   hip	  
stabiliser,	  delayed	  relaxation	  of	  obliquus	  externus	  abdominis	  (OE)	  as	  well	  as	  erector	  
spinae	   (ES)	   have	   been	   reported	   in	   chronic	   LBP	   following	   sudden	   unloading	   of	   the	  
trunk	  (Radebold	  et	  al.,	  2001).	  	  A	  recent	  study	  found	  a	  delayed	  activation,	  absent	  co-­‐
activation,	  absent	  intracortical	  inhibition	  (short	  type	  [SICI])	  and	  normal	  active	  MTh	  in	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obliquus	   internus	   abdominis	   (IO)	   and	   transversus	   abdominis	   (TrA)	   (Masse-­‐Alarie	   et	  
al.,	   2012).	   Therefore	   differing	   changes	   in	   the	   cortical	   output	   to	   trunk	   muscles	  
accessible	  by	  surface	  EMG,	  may	  provide	  valuable	  information	  relating	  to	  whether	  a	  
global,	  or	  patho-­‐anatomy-­‐specific	  cortical	  contribution,	  	  may	  impact	  current	  models	  




Most	  people	  with	  chronic	  LBP	  who	  develop	  symptoms	  as	  a	  result	  of	  lumbosacral	  disc	  
herniation	  (LDH)	  or	  spinal	  stenosis	  (LSS),	  with	  or	  without	  radicular	  pain,	  improve	  with	  
conservative	  or	  no	  treatment	  (Weber,	  1983).	  Conservative	  treatment	   includes	  non-­‐
steroid	   anti-­‐inflammatory	   drugs	   (NSAIDs)	   and	   other	   analgesics,	   physical	   therapy,	  
exercise,	   and	   spinal	   steroid	   injections	   (SI).	   	   This	   section	  will	   only	   focus	   on	   SIs	   and	  
surgical	  intervention	  for	  these	  conditions.	  	  
	  
Spinal	  Steroid	  Injections	  for	  the	  Relief	  of	  LBP	  and	  Leg	  pain	  
	  
	  
Epidural	  steroid	  injections	  may	  be	  delivered	  via	  various	  routes:	  caudal	  (entailing	  less	  
risk	   of	   intradural	   injection),	   interlaminar	   (reducing	   required	   injectate	   volume)	   or	  
transforaminal	   (allowing	  close	  proximity	   to	   the	   irritated	  nerve	   root).	   	   Epidurals	  are	  
usually	  a	  three	  injection	  procedure,	  the	  third	  of	  which	  is	  conditional	  on	  the	  effect	  of	  
the	  second	  dose.	   	   If	   facet	   joint	  pain	   is	   suspected,	   facet	   joint	   injections	  may	  offer	  a	  
diagnostic	  block	  and	  significant	  pain	  relief	  from	  one	  treatment.	  
	  
Despite	  uncertainties	  regarding	  their	  efficacy	  (Manchikanti	  et	  al.,	  2010,	  McLain	  et	  al.,	  
2005,	  Staal	  et	  al.,	  2009,	  Sayegh	  et	  al.,	  2009,	  Riew	  et	  al.,	  2000)	  and	  doubts	  about	  cost	  
effectiveness	  (Price	  et	  al.,	  2005),	  spinal	  steroid	  injections	  (SI)	  are	  amongst	  the	  most	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common	  non-­‐surgical	  interventions	  for	  chronic	  low	  back	  pain	  with	  radicular	  pain.	  	  A	  
survey	  revealed	  that	  69%	  of	  spinal	  surgeons	  considered	  epidural	  steroid	  injections	  to	  
be	  the	  first	  invasive	  escalation	  in	  the	  treatment	  of	  spinal	  stenosis	  after	  conservative	  
management	   had	   failed	   to	   provide	   significant	   pain	   relief	   (Lebude	   et	   al.,	   2009).	  
However	   those	   patients	   are	   then	   associated	   with	   significantly	   less	   long	   term	  
improvement	   (at	  4	  years),	  with	  or	  without	  eventual	   surgery	   	   (Radcliff	  et	  al.,	  2013).	  
This	  escalation	  approach	  is	  not	  entirely	  misguided.	  	  	  The	  success	  (even	  temporary)	  of	  
a	   transforaminal	   steroid	   injection	   in	   reducing	   radicular	   pain	   resulting	   from	   disc	  
herniation	   or	   lateral	   bony	   stenosis,	   has	   been	   reported	   to	   predict	   the	   subsequent	  
success	   of	   surgery,	   with	   an	   agreement	   of	   95%	   for	   treatment	   failure	   (Lutz	   et	   al.,	  
1998).	  	  
	  
SIs	   are	   often	   perceived	   as	   a	   hit	   or	   miss	   procedure,	   	   with	   the	   duration	   of	   effects	  
reported	   to	  be	  highly	  unpredictable.	   	   Carette	  et	   al.	   for	   example	   reported	  a	   loss	  of	  
treatment	  effect	  2-­‐3	  months	  post	  epidural	  (Carette	  et	  al.,	  1997).	  In	  a	  follow	  up	  of	  212	  
patients,	   another	   study	   found	   that	   although	   only	   half	   of	   patients	   significantly	  
improved	  by	  2	  weeks,	  those	  responders	  went	  on	  to	  further	  improve	  by	  the	  6	  month	  
and	   1	   year	   follow	   up	   (Hopwood	   and	   Abram,	   1993).	   	   Despite	   the	   anatomical	  
uncertainty	   of	   adequate	   injectate	   delivery,	   even	   with	   fluoroscopy	   guidance,	  
uncertainty	   regarding	   the	   existence	   of	   an	   effective	   pain	   generating	   target	   beyond	  
the	  ventral	  epidural	  space	  is	  always	  a	  factor	  for	  first	  procedures.	  	  
	  
The	  diagnostic	  utility	  of	   lumbar	   facet	   joint	   injections	  with	   single	  blocks	  means	   that	  
false-­‐positives	   are	   frequent,	   ranging	   between	   17%-­‐47%	   (Revel	   et	   al.,	   1998,	  
Manchikanti	  et	  al.,	  2003,	  Manchikanti	  et	  al.,	  2004).	  	  The	  duration	  of	  effects	  have	  also	  
been	  reported	  to	  be	  highly	  unpredictable,	  1–4	  week	  duration	  of	  pain	  relief	  has	  been	  
reported	  anywhere	  between	  42	  to	  92	  %	  of	  patients	  (Lynch	  and	  Taylor,	  1986,	  Carette	  
et	   al.,	   1991).	   	   On	   the	   other	   hand,	   reports	   of	   relief	   for	   up	   to	   three	  months	   range	  





Nonetheless	  SI’s	  have	  obvious	  advantages	  over	  oral	  NSAIDs,	   including	  much	  higher	  
targeted	   dosage	   compared	   to	   systemic	   delivery.	   	   Furthermore	   glucocorticoids	   act	  
higher	  up	  in	  the	  inflammatory	  cascade	  and	  inhibit	  the	  arachidonic	  acid	  pathway	  that	  
serves	   as	   a	   precursors	   for	   2	   inflammatory	   cascades	   (cyclooxygenase	   and	  
lipoxygenase	   synthesis),	   whereas	   NSAIDs	   only	   inhibit	   1	   of	   these	   (cyclooxygenase),	  
leading	   to	   inhibited	   prostaglandin	   and	   thromboxane	   production	   (McLain	   et	   al.,	  
2004).	   	   Glucocorticoids	   inhibit	   the	   synthesis	   or	   release	   of	   several	   inflammatory	  
substances	  (phospholipase	  A2,	  tumour	  necrosis	  factor	  α,	  interleukin-­‐1,	  prostaglandin	  
E2,	   arachidonic	   acid)(McLain	   et	   al.,	   2004)	   and	   endothelial	   membrane	   damage	   by	  
leukocytes	   (which	   lead	   to	   oedema)	   (Varani	   et	   al.,	   1989,	   Cronstein	   et	   al.,	   1992).	   In	  
radiculopathy	   glucocorticoids	   have	   the	   potential	   for	   improving	   early	   (oedema	   by	  
capillary	  dilatation,	  phagocytosis,	   fibrin	  and	   leukocyte	  aggregation)	  and	   late	  effects	  
(proliferation	   of	   fibroblast	   and	   cicatrisation)(McLain	   et	   al.,	   2004).	   	   Back	   pain	  
reduction	  mechanisms	  are	  more	  elusive,	  and	  prominent	  referred	  leg	  pain	   is	  usually	  
indicated.	   	  Nevertheless	  a	   reduction	   in	   the	   inflammation	   in	   the	  posterior	   ligament,	  
annulus	  and	  facet	  joint	  may	  reduce	  referred	  symptoms	  in	  patients	  with	  degenerative	  
disc	  disease	  or	  facet	  joint	  pain.	  
	  
Factors	   predicting	   failure	   have	   included	   numerous	   previous	   treatments,	   	   chronic	  
symptoms	   (>6	   months),	   a	   greater	   dependence	   on	   drugs,	   and	   non-­‐radicular	   pain	  
(Jamison	  et	  al.,	  1991,	  Hopwood	  and	  Abram,	  1993).	  Patient	  selectivity	  is	  an	  important	  
factor.	   It	   is	   not	   known	   whether	   aspects	   of	   a	   patient’s	   central	   neurophysiological	  
profile,	   or	   short	   term	   effect	   of	   SIs	   on	   central	   neurophysiology,	   may	   predispose	   a	  
patient	  to	  better	  long	  term	  outcome.	  	  Nevertheless	  structural	  changes	  in	  grey	  matter	  
organisation	  and	  altered	  cognitive	  function	  associated	  with	  chronic	  pain	  were	  found	  
to	   be	   reduced	   by	   successful	   facet	   joint	   injections	   (and	   surgery)	   at	   6	  months	   post-­‐
procedure	  (Seminowicz	  et	  al.,	  2011).	   	  The	  study	  found	  an	   increase	  thickness	  of	   the	  
primary	   motor	   cortex	   to	   be	   associated	   with	   reduced	   disability.	   Motor	   cortex	  




Surgery	  to	  Relieve	  Radicular	  Pain	  and	  Improve	  Function	  
	  
Surgery	  is	  reserved	  for	  a	  subset	  of	  cases	  of	  LBP	  with	  both	  degenerative	  (as	  in	  stenosis	  
or	   degenerative	   disc	   disease)	   and	   traumatic	   damage	   (as	   in	   disc	   prolapse),	   where	  
neurologic	   deficit	   is	   present	   and	   where	   conservative	   treatments	   have	   proven	  
ineffective	  beyond	  a	  minimum	  of	  6	  weeks.	  	  Surgical	  treatment	  accounts	  for	  one	  third	  
of	   health	   care	   costs	   for	   spinal	   disorders	   but	   scientific	   evidence	   of	   efficacy	   is	   still	  
lacking	   for	  most	   procedures	   (Gibson	   et	   al.,	   2000).	   Spinal	   stenosis	   is	   now	   the	  most	  
common	  and	   fastest	   growing	   reason	   for	   spinal	   surgery	   in	   adults	   over	   65	   years	   old	  
(Ciol	  et	  al.,	  1996),	  but	  the	  diagnostic	  criteria	  has	  still	  not	  been	  clearly	  established	  and	  
the	   natural	   disease	   progression	   is	   not	   clearly	   understood	   (Gibson	   and	   Waddell,	  
2007).	  
	  
In	   the	   case	   of	   disc	   prolapse,	   the	   most	   common	   type	   of	   procedure	   is	   microscopic	  
discectomy,	   in	   which	   surgical	   removal	   of	   part	   of	   the	   disc	   is	   performed	   using	   an	  
operating	  microscope.	  Although	  the	  use	  of	  tubular	  muscle	  splitting	  retractors	  is	  also	  
used.	   	   A	   recent	   systematic	   review	   has	   not	   found	   any	   significant	   differences	   in	  
outcomes	   associated	   with	   these	   different	   discectomy	   procedures	   (Jacobs	   et	   al.,	  
2012).	  	  	  
	  
There	  is	  still	  no	  decisive	  evidence	  as	  to	  whether	  surgery	  can	  benefit	  patients	  without	  
clear	   and	   significant	   neurologic	   deficit	   (Gibson	   and	   Waddell,	   2007,	   Gibson	   and	  
Waddell,	  2005).	   	   In	  the	  case	  disc	  herniation,	  consensus	   is	   inching	  towards	  a	  careful	  
patient	   selection	   criteria	   including	  neurologic	  deficit	   and	   radiological	   evidence	  of	   a	  
prolapse	  presenting	  as	  a	  suitable	  surgical	  target	  (Gibson	  and	  Waddell,	  2007,	  Gregory	  
et	  al.,	  2008,	  Gotfryd	  and	  Avanzi,	  2009).	  	  A	  Cochrane	  review	  concluded	  that	  in	  those	  
carefully	   selected	   patients	   with	   radicular	   pain	   due	   to	   disc	   prolapse,	   surgical	  
discectomy	   provides	   faster	   relief	   than	   conservative	   management,	   although	   any	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effects	  on	  the	  lifetime	  of	  the	  underlying	  disc	  disease	  are	  still	  unknown	  (Gibson	  and	  
Waddell,	   2007).	   A	   recent	   systematic	   review	   concluded	   that	   although	   this	   recovery	  
was	   faster	   compared	   to	   conservative	   care,	   there	   is	   no	   significant	   difference	   in	   the	  
long	  term	  (1	  year)	  outcome	  (Jacobs	  et	  al.,	  2011).	   	  The	  picture	   for	  spinal	   stenosis	   is	  
less	   clear.	   	   Based	   mostly	   on	   retrospective	   cases,	   meta-­‐analyses	   suggest	   that,	   on	  
average,	  64%	  of	  patients	  will	  obtain	  a	  satisfactory	  outcome	  from	  surgery	   for	  spinal	  
stenosis	   (Turner	   et	   al.,	   1992),	   while	   decompression	   without	   fusion	   results	   in	   69%	  
satisfactory	  outcome	  (Mardjetko	  et	  al.,	  1994).	  	  
	  
Clear	   indications	   for	   surgery	   and	   neither	   the	   clinical	   profile	   nor	   patient	  
characteristics	   associated	   with	   favourable	   outcome	   have	   been	   clearly	   established	  
(Gibson	  and	  Waddell,	  2005,	  Gibson	  and	  Waddell,	  2007).	   	  This	  may	  explain	  some	  of	  
the	   variation	   in	   outcome	   and	   generally	   limited	   satisfaction	   and	   limited	  
improvements	   in	   pain	   and	   function	   (McGregor	   and	  Hughes,	   2002b,	  McGregor	   and	  
Hughes,	  2002a).	  	  Furthermore	  the	  return	  of	  symptoms	  in	  many	  cases	  and	  reduction	  
in	  improvements	  in	  the	  long	  term	  (Malmivaara	  et	  al.,	  2007,	  Anjarwalla	  et	  al.,	  2007)	  
deserve	  further	  investigation.	  
	  
It	   is	  necessary	   to	  establish	  whether	   surgery	  aimed	  at	   reducing	   leg	  pain	   reverses	  or	  
affects	   the	   changes	   observed	   in	   corticospinal	   control	   of	   trunk	   and	   leg	   muscles	  
(Strutton	   et	   al.,	   2003b,	   Strutton	   et	   al.,	   2005).	   If	   surgery	   does	   not	   actually	   reverse	  
these	   cortical	   changes	   induced	   by	   chronic	   pain	   or	   altered	   afferent	   drive	   to	   the	  
cortex,	  then	  this	  might	  explain	  the	  poor	  long	  term	  prognosis	  and	  functional	  outcome	  








Corticospinal	   drive	   to	   trunk	   and	   leg	   muscles	   is	   altered	   by	   chronic	   low	   back	   pain,	  
lumbosacral	  neurologic	  deficit,	  or	  radicular	  pain,	  and	  either	  successful	  conservative	  
treatment	   or	   surgery	   to	   relieve	   symptoms	   of	   back	   and	   leg	   pain	   reverses	   these	  
changes.	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  THESIS	  	  OBJECTIVES	  
	  
	  
! To	   analyse	   the	   long	   term	   reliability	   of	   parameters	   of	   corticospinal	  
excitability	   in	   trunk	   and	   leg	  muscles	   in	   a	   healthy	   population	   and	   deduce	  
their	   suitability	   in	   longitudinal	   analyses,	   group	   comparisons	   and	   clinical	  
analyses.	  	  
! To	  make	  a	  longitudinal	  comparison	  of	  the	  cortical	  drive	  to	  back	  muscles	  in	  a	  
healthy	  population	  and	  in	  two	  chronic	  LBP	  classifications:	  patients	  with	  and	  
without	  leg	  pain	  distal	  to	  the	  knee.	  
! To	   establish	   whether	   surgery	   to	   relieve	   radicular	   pain	   and	   mitigate	  
neurological	  deficits	  induces	  any	  changes	  in	  the	  corticospinal	  control	  of	  leg	  
muscles	  innervated	  by	  affected	  nerve	  roots.	  
! To	  examine	  whether	  longitudinal	  changes	  in	  the	  cortical	  drive	  to	  trunk	  and	  
leg	   muscles	   are	   impacted	   by	   lumbosacral	   caudal	   epidural	   or	   facet	   joint	  
injections.	  
! To	   compare	   both	   baseline	   and	   longitudinal	   changes	   in	   presenting	  












Patients	  presenting	  with	  either	  chronic	   low	  back	  pain	  or	   leg	  pain	  of	  radicular	  origin	  
(with	   or	   without	   neurologic	   deficit)	   associated	   with	   radiological	   evidence	   of	   disc	  
prolapse	  or	   lateral	  nerve	  root	  stenosis	   (caused	  by	  narrowing	  of	  the	  spinal	  canal)	  at	  
were	   suitable	   for	   inclusion.	   	   	   Once	   recruited	   patients	   were	   subdivided	   into	   the	  
following	  groups:	  
	  
• Radicular	   pain/neurological	   deficit	   at	   L5:	   This	   group	   comprised	   of	   patients	  
with	   radicular	   pain	   and/or	   neurological	   deficit	   attributable	   to	   an	   L5	   nerve	  
root	   compression	   as	   a	   result	   of	   disc	   prolapse	   or	   stenotic	   changes	   in	   the	  
lumbar	  spine	  (as	  confirmed	  by	  a	  recent	  magnetic	  resonance	  imaging	  scan	  [<5	  
months]).	   	   All	   patients	   in	   this	   group	   were	   on	   the	   waiting	   list	   for	   lumbar	  
laminectomy,	   microdiscectomy,	   discectomy,	   foraminotomy	   or	   lateral	   root	  
canal	  decompression	  surgery	  at	  Charing	  Cross	  Hospital	  when	  recruited.	  	  This	  
group	  was	   studied	   prior	   to,	   and	   at	   a	   6	  week,	   6	  month	   and	   1	   year	   interval	  
following	  neurosurgical	  intervention.	  
	  
• Radicular	   pain/neurological	   deficit	   at	   S1:	   This	   group	   comprises	   of	   patients	  
with	  radicular	  pain	  and/or	  neurologic	  deficit	  attributable	  to	  an	  S1	  nerve	  root	  
compression	   as	   a	   result	   of	   disc	   prolapse	   or	   stenotic	   changes	   in	   the	   lumbar	  
spine	   (as	   confirmed	   by	   a	   recent	   magnetic	   resonance	   imaging	   scan	   [<5	  
months]).	   	   All	   patients	   in	   this	   group	   were	   on	   the	   waiting	   list	   for	   lumbar	  
laminectomy,	   microdiscectomy,	   discectomy,	   foraminotomy	   or	   lateral	   root	  
canal	  decompression	  surgery	  at	  Charing	  Cross	  Hospital	  when	  recruited.	  	  This	  
group	  was	   studied	   prior	   to,	   and	   at	   a	   6	  week,	   6	  month	   and	   1	   year	   interval	  




• Chronic	  LBP	  without	  leg	  pain:	  This	  group	  consisted	  of	  volunteers	  with	  chronic	  
LBP	   (duration	   greater	   than	   3	   months)	   without	   leg	   pain.	   	   Subjects	   for	   this	  
group	  were	  recruited	  from	  a	  spinal	  clinic	  at	  Charing	  Cross	  Hospital	  and	  a	  local	  
GP	  practice.	  	  This	  group	  was	  studied	  on	  4	  visits,	  including	  a	  6	  week,	  6	  month	  
and	  1	  year	  interval	  following	  baseline.	  	  	  
	  
• Chronic	   LBP	  with	   leg	   pain:	  This	   group	   consisted	  of	   volunteers	  with	   chronic	  
LBP	   and	   leg	   pain	   radiating	   below	   the	   knee.	   	   Subjects	   for	   this	   group	   were	  
recruited	   from	   the	   spinal	   clinics	   at	   Charing	   Cross	   Hospital,	   and	   a	   local	   GP	  
practice.	  	  This	  group	  was	  studied	  on	  4	  visits,	  including	  a	  6	  week,	  6	  month	  and	  
1	  year	  interval	  following	  baseline.	  	  	  
	  
• Epidural	   Injection	   Group:	   This	   group	   comprised	   patients	   with	   chronic	   LBP	  
with	   leg	   pain	   radiating	   below	   the	   knee	   attributable	   to	   a	   nerve	   root	  
compression	   as	   a	   result	   of	   disc	   prolapse	   or	   stenotic	   changes	   in	   the	   lumbar	  
spine	  (as	  confirmed	  by	  a	  magnetic	  resonance	  imaging	  scan	  [<12	  months]).	  	  All	  
patients	   in	   this	   group	   were	   on	   the	   waiting	   list	   for	   a	   spinal	   injection	  
intervention	  for	  pain	  relief	  such	  a	  caudal	  epidural	  or	  facet	  joint	  injection.	  	  This	  
group	  was	   studied	   on	   4	   visits,	   including	   a	   1	   week,	   a	   6	   week	   and	   6	  month	  
interval	  following	  intervention.	  	  	  
	  
• Control	  Group:	  This	  group	  consisted	  of	  healthy	  volunteers	  recruited	  from	  the	  
student	   and	   staff	   population	  of	   Charing	   London	  Cross	  Hospital.	   	   They	  were	  









Participants	  who	  had	  not	   reached	  skeletal	  maturity	   (i.e.	  under	  18	  years)	  and	   those	  
who	   were	   pregnant	   were	   excluded	   from	   the	   study.	   Current	   treatment	   with	  
antidepressants	   or	   other	   neuromodulatory	   drugs	   (Ziemann	   2003;	   2004)	   also	  
constituted	   an	  exclusion	   criterion.	   	   	   Furthermore	   the	  use	  of	   TMS	  has	   a	   number	  of	  
contra	  indications	  including	  artificial	  cardiac	  pacemakers,	  metal	  implants,	  a	  personal	  
or	  family	  history	  of	  epilepsy	  or	  seizures,	  a	  history	  of	  brain	  damage	  (or	  neurosurgical	  
intervention),	  neurological	  or	  psychiatric	  disorders.	  	  	  	  The	  following	  general	  exclusion	  
criteria	  were	   also	   applied:	   fracture,	   infection,	  malignancy,	   cauda	   equina	   syndrome	  
and	   a	   history	   of	   any	   serious	   cardiovascular	   or	   respiratory	   conditions	   which	   might	  
prevent	  the	  subject	  from	  safely	  carrying	  out	  maximum	  and	  moderate	  isometric	  trunk	  
contractions.	   	  Subjects	  were	  also	   required	   to	  be	  sufficiently	  proficient	   in	  English	   to	  
understand	   all	   instructions,	   forms	   and	   questionnaires.	   	   A	   short	   verbal	   interview	  
followed	   by	   a	   signed	   consent	   form,	   confirmed	   that	   prospective	   participants	  
understood	   the	   patient	   information	   sheet	   and	   that	   none	   of	   the	   above	   conditions	  
applied	   to	   them.	   The	   exclusion	   conditions	   were	   also	   included	   on	   the	   patient	  
information	  sheet	  included	  in	  Appendix	  B.	  
	  
	  
Electromyography (EMG) Recordings 
	  
	  
Alcohol	   wipes	   were	   used	   to	   clean	   the	   surface	   of	   the	   skin	   prior	   to	   electrode	  
placement.	   Bipolar	   surface	   electrodes	   (Ag/AgCl,	   ARBO	   blue/kiddy,	   2-­‐cm	   diameter)	  
were	  placed	  on	  the	  skin	  overlying	   trunk	  and	   leg	  muscles,	  2.5	  cm	  apart	  and	  aligned	  
with	  the	  presumed	  muscle	  fibres.	  The	  EMG	  signals	  were	  bandpass	  filtered	  (-­‐3	  db	  at	  
10	  Hz	  and	  2	  kHz)	  and	  amplified	  (usually	  at	  ×1000	  but	  occasionally	  ×10,000;	  Iso-­‐DAM,	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WPI,	  UK)	  before	  being	  sampled	  at	  4	  kHz	  by	  a	  data	  acquisition	  interface	  (Power	  1401	  
Plus	  and	  Signal	  software	  Version	  3.1;	  Cambridge	  Electronic	  Design,	  UK)	  connected	  to	  
a	   personal	   computer.	   Subjects	   were	   recorded	   relaxed	   and	   then	   producing	  
contractions	  up	  to	  maximum	  voluntary	  contraction	  (MVC)	  of	  the	  erector	  spinae	  (ES),	  
lower	   rectus	   abdominis	   (RA),	   obliquus	   externus	   abdominis	   (OE),	   soleus	   (Sol)	   and	  
tibialis	  anterior	  (TA)	  muscles.	  
	  
Trunk	  Muscle	  EMG	  	  
	  
Positioned	  prone	  on	   a	   couch,	  with	   EMG	  electrodes	  on	   either	   side	  of	   the	   vertebral	  
column	  over	   the	  palpable	  bulge	  of	   the	  erector	   spinae	  muscle	   (≈3cm	  bilateral	   to	   the	  
midline)	   both	   at	   the	   twelfth	   thoracic	   and	   fourth	   lumbar	   levels	   (Vink	   et	   al.,	   1989,	  
Nowicky	   et	   al.,	   2001),	   the	   volunteer	   was	   instructed	   to	   produce	   bilateral	   trunk	  
extensions	   (BTEs)	   while	   TMS	   was	   delivered.	   	   A	   ground	   reference	   electrode	   was	  
placed	  on	  the	  iliac	  crest	  of	  the	  pelvis.	  
	  
Then	   two	   further	   electrode	   pairs	   were	   affixed	   over	   the	   lower	   rectus	   abdominis	  
muscles,	   the	  more	   superior	   electrode	   placed	   1.5	   cm	   inferior	   to	   the	   umbilicus	   and	  
approximately	  2.5-­‐3	  cm	  bilateral	   from	  the	  midline	   (Tunstill	  et	  al.,	  2001).	  Electrodes	  
were	  then	  placed	  over	  the	  OE,	  the	  superior	  electrode	  directly	  below	  the	  most	  inferior	  
point	  of	  costal	  margin	  and	  the	  inferior	  electrode	  on	  the	  line	  to	  opposite	  pubic	  tubercle	  
(Anders	  et	  al.,	  2008).	  A	  ground	  reference	  electrode	  was	  placed	  on	  the	  iliac	  crest	  of	  the	  
pelvis.	  
	  
Leg	  Muscle	  EMG	  	  
	  
Electrodes	  were	  positioned	  bilaterally	  in	  the	  midline	  of	  the	  soleus	  belly,	  the	  superior	  
electrode	   about	   2.5	   cm	   inferior	   to	   the	   inferior	   border	   of	   the	   medial	   head	   of	   the	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gastrocnemius	  muscle,	  and	  parallel	  to	  the	  longitudinal	  axis	  of	  the	  leg	  to	  approximate	  
the	   direction	   of	   the	   muscle	   fibres	   (Winter	   and	   Yack,	   1987).	   The	   tibialis	   anterior	  
electrodes	   were	   placed	   and	   aligned	   at	   a	   third	   of	   the	   distance	   from	   the	   fibial	   to	  
medial	  malleolus	   heads	   (Hermens	   et	   al.,	   2000),	  with	   a	   ground	   reference	   electrode	  
positioned	  on	  the	  left	  fibular	  head.	  
	  
Transcranial Magnetic Stimulation (TMS)  
	  
A	  single-­‐pulse	  Magstim	  stimulator	   (Magstim	  2002,	  Magstim	  Co.	  Ltd.,	  UK)	  was	  used,	  
powering	  a	  9cm	  angled	  double-­‐cone	  coil,	  positioned	  symmetrically	  over	   the	  vertex	  
and	  polarised	  to	  induce	  posterior-­‐to-­‐anterior	  current	  flow	  in	  the	  motor	  cortex.	  	  The	  
vertex	  was	  identified	  using	  the	  International	  10/20	  system;	  defined	  as	  the	  midpoint	  
between	   the	   inion	   and	   the	   nasion	   and	   equidistant	   from	   the	   left	   and	   right	  
intratracheal	  notches	  (Kanai	  et	  al.,	  2008).	   	  This	  point	  was	  labelled	  and	  the	  contours	  
of	  the	  double-­‐cone	  coil	  were	  traced,	  perhaps	  inconsiderately,	  with	  a	  marker	  on	  the	  





Figure	  3.2:	  	  A	  single	  trace	  of	  a	  motor	  evoked	  potential	  (MEP).	  	  A	  magnetic	  stimulus	  to	  the	  motor	  cortex	  
(at	  t=0),	  is	  followed	  by	  a	  MEP	  in	  TA,	  followed	  by	  a	  period	  of	  suppression	  of	  EMG	  activity	  known	  as	  the	  
cortical	  silent	  period	  (cSP)	  
	  
As	  can	  be	  seen	   in	   figure	  3.2,	  a	  TMS	  response	   is	  characterised	  by	  a	   facilitory	   twitch	  
(MEP)	  followed	  by	  an	  inhibitory	  period	  of	  suppression	  of	  EMG	  activity	  known	  as	  the	  
cortical	  silent	  period	  (cSP).	  	  In	  order	  to	  construct	  useful,	  complete	  and	  independent	  
representation	   of	   both	   of	   those	   measures	   at	   a	   range	   of	   stimulator	   intensities,	  
recruitment	  curves	  are	  recommended	  (Kimiskidis	  et	  al.,	  2005,	  Devanne	  et	  al.,	  1997).	  
These	   are	   plots	   of	  MEP	   and	   cSP	   values	   at	   magnetic	   stimulator	   intensities	   ranging	  
from	   the	   intensity	   at	   which	   the	   cSP	   appears	   (the	   cSP	   threshold,	   cSPTh),	   to	   an	  
intensity	  equivalent	  to	  at	  least	  1.5x	  the	  motor	  threshold	  (MTh).	  	  
	  
The	   motor	   threshold	   was	   assessed	   as	   the	   lowest	   intensity	   of	   TMS	   that	   produced	  
MEPs	  of	  200uV	  on	  at	   least	  50%	  of	  stimulus	  presentations	  (Rossini	  et	  al.,	  1994);	  this	  
ranged	   from	   35	   to	   62%	   of	   the	   maximum	   stimulator	   output	   (%MSO).	   Consistent	  




































contraction	  levels	  of	  a	  set	  percentage	  of	  MVC	  were	  used	  to	  facilitate	  the	  MEPs	  while	  
bilateral	   responses	   to	   transcranial	  magnetic	   stimulation	   of	   the	  motor	   cortex	  were	  
recorded	  in	  the	  muscle	  of	  interest.	  These	  levels	  were	  set	  to	  20%	  of	  MVC	  for	  the	  legs	  
as	  this	  level	  has	  been	  found	  to	  be	  reliable	  (van	  Hedel	  et	  al.,	  2007).	  Trunk	  extension	  
(ES)	  contraction	  levels	  were	  set	  to	  40%	  of	  MVC	  while	  rotations	  (EO)	  and	  flexions	  (RA)	  
were	   carried	   out	   to	   30%	   of	  MVC.	   These	   higher	   levels	   of	   contraction	  were	   chosen	  
because	   the	   relation	   between	   force	   and	   facilitation	   is	   a	   little	  more	   linear	   in	   these	  
muscles	   (Kischka	   et	   al.,	   1993,	   Buhler	   et	   al.,	   2001).	   Furthermore	   pilot	   studies	   had	  
confirmed	   	   that	   the	   trunk	   cSP	  offsets	  were	  more	  prominent	   and	   thus	   reliable	   in	   a	  
variety	   of	   subjects	   at	   30%	   MVC	   (Damron	   et	   al.,	   2008).	   	   	   Using	   online	   full	   wave	  
rectified	   average	   responses	   as	   a	   guide	   to	   the	   whereabouts	   of	   inhibition	   and	  
facilitation	  thresholds,	  a	  recruitment	  curve	  of	  TMS	  pulse	  intensities,	  delivered	  in	  sets	  
of	  6	  to	  30	  pulses	  at	  least	  3	  seconds	  apart	  (Rothwell	  et	  al.,	  1999),	  at	  intervals	  of	  5%	  of	  
maximum	  stimulator	  output	  (MSO),	  from	  one	  intensity	  below	  cSPTh	  to	  150%	  of	  MTh,	  
was	  then	  delivered	  in	  a	  randomised	  sequence.	  	  If	  participants	  found	  higher	  stimulus	  





In	  order	  to	  examine,	  where	  necessary,	  whether	  any	  of	  the	  parameters	  studied	  were	  
affected	  or	   related	   to	  handedness,	  all	   subjects	  were	  asked	  on	   their	   first	   visit	   to	   fill	  
out	   an	   Edinburgh	  Handedness	   Inventory	   questionnaire	   (Oldfield,	   1971).	   	   Based	   on	  
everyday	   activities,	   this	   simple	   questionnaire	   (included	   in	   Appendix	   2)	   produces	   a	  
score	   of	   -­‐100%	   for	   a	   left	   hander	   with	   almost	   no	   right	   hand	   dexterity,	   0%	   for	   a	  




Pain, Function  and Secondary Outcome Measures 
	  
Questionnaires	   were	   specifically	   assembled	   for	   each	   of	   the	   four	   visits	   for	   all	   four	  
participant	   groups.	   Appendix	   2	   contains	   the	   baseline	   version	   of	   the	   surgery	   group	  
questionnaire.	   	   At	   every	   visit,	   Surgery,	   Chronic	   and	   Epidural	   group	   patients	   were	  
given	  a	  questionnaire	  comprising	  the	  following	  outcome	  measures:	  
• Oswestry	  Disability	  Index	  (ODI)	  questionnaire1	  (Version	  2.1a;	  user	  agreement	  
240):	   a	  disease	   specific	  disability	  questionnaire	  used	   in	   the	  management	  of	  
spinal	  disorders	  (Fairbank,	  2000,	  Fairbank	  and	  Pynsent,	  2000,	  Fairbank	  et	  al.,	  
1980).	  	  
• 10cm	  Visual	  Analogue	  Scales	  (VAS)	  of	  Leg	  and	  Back	  Pain	  (Wewers	  and	  Lowe,	  
1990).	   In	   order	   to	   address	   the	   different	   temporal	   characteristics	   of	  
nociceptive,	   referred	   and	   radicular	   pain,	   3	   different	   VAS	   scales	   were	   used,	  
including	  a	  scale	   for	  “pain	  now”	  or	  current	   levels	  of	  pain	  at	   the	  time	  of	   the	  
assessment,	  “average”	  and	  “worst”	  pain	   levels	  over	  the	  week	  preceding	  the	  
assessment	  for	  both	  the	  back	  and	  legs.	  	  
• Physical	  activity	  scale	  section	  of	  the	  Fear	  and	  Avoidance	  Beliefs	  Questionnaire	  
(FABQ):	   	   providing	   measures	   of	   fear	   of	   pain	   on	   movement	   which	   affects	  
evident	   disability	   and	   responsiveness	   to	   a	   single	   treatment	   (Waddell	   et	   al.,	  
1993).	  Scores	  above	  15	  are	  considered	  to	  be	   in	   the	  high	   range	   (Williamson,	  
2006).	  




1	   For	   information	   and	   permission	   to use	   ODI	   contact	   Mapi	   Research	   Trust,	   Lyon,	   France.	   E-­‐mail:	  
PROinformation@mapi-­‐trust.org;	  Internet:	  www.proqolid.org	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• EuroQol	   EQ-­‐5D	   health	   quality	   of	   life	   questionnaire	   (EuroQol	   Group,	   1990):	  
providing	   an	   outcome	  measure	   of	   health	   status	   (0-­‐100)	   and	   quality	   of	   life	  
adjusted	  for	  different	  nations	  (resulting	  in	  a	  UK	  specific	  QOL	  index	  0-­‐1).	  
• Hospital	   Anxiety	   and	   Depression	   Scale	   (HADS)	   questionnaire	   (Zigmond	   and	  
Snaith,	   1983):	   	   allowing	  pre-­‐operative	  psychological	   status	   to	  be	   taken	  as	   a	  
factor	  potentially	  affecting	  outcome	  of	  surgery.	  A	  score	  of	  11	  (maximum	  21)	  
or	   higher	   indicates	   the	   probable	   presence	   of	   a	   mood	   disorder.	   HADS	   is	  
divided	   into	   four	   ranges:	   normal	   (0-­‐7),	   mild	   (8-­‐10),	   moderate	   (11-­‐15)	   and	  
severe	  (16-­‐21).	  
• Global	   perceived	   effect	   (Hudak	   and	  Wright,	   2000).	   	   7	   point	   scales	   detailing	  
global	  satisfaction	  with	  treatment	  outcome.	  
• Specific	  drug	   intake	  and	  details	  of	  other	  treatments	   (such	  as	  physiotherapy,	  
osteopathy,	   chiropracy,	   over-­‐the-­‐counter	   pain	   killers).	   	   Every	   post-­‐baseline	  
questionnaire	  also	  contained	  a	  Drug	  Diary	  (please	  refer	  to	  the	  final	  2	  pages	  of	  
Appendix	  2)	  to	  account	  for	  these	  in	  pain	  rating	  and	  to	  further	  screen	  for	  any	  
neuromodulatory	  drugs.	  	  	  
• Information	  on	  the	  type	  of	  main	  activity	  and	  return	  to	  work	  
In	   addition,	   surgery	   and	   epidural	   patients	   filled	   out	   a	   section	   with	   10	   cm	   visual	  
analogue	   scales	   relating	   to	   expectations	   from	   treatment	   and	   (in	   post	   intervention	  
questionnaires)	  satisfaction	  with	  the	  procedure.	  	  Control	  subjects	  only	  provided	  their	  
body	   mass	   index,	   their	   main	   type	   of	   activity,	   details	   of	   any	   drug	   intake	   and	   any	  
previous	  history	  of	  acute	  LBP.	  
	  
The	   questionnaires	   provided	   a	   wealth	   of	   information	   on	   any	   patient-­‐specific	   or	  
external	   factors	   which	   may	   have	   influenced	   neurophysiological	   results	   or	   indeed	  
other	   outcome	   measures.	   	   The	   pain	   and	   functional	   disability	   scores	   and	   their	  
variations	  over	   visits	  were	   correlated	  with	   changes	   in	  neurophysiological	   variables.	  	  







Leg	  Muscle	  Assessment	  
	  
With	   all	   electrodes	   affixed,	   forms	   and	   questionnaires	   completed,	   subjects	   were	  
seated	  on	  a	  45	  cm	  high	  chair,	  with	  feet	  strapped	  flat	  to	  a	  board	  on	  the	  floor	  and	  the	  
ankle	  in	  line	  with	  the	  vertical	  projection	  of	  the	  knee	  joint.	  	  The	  straps	  restrained	  the	  
dorsal	   and	   frontal	   aspects	   of	   the	   ankle	   as	  well	   as	   the	   toes.	   	   A	   bilateral	  maximum	  
voluntary	  contraction	  (MVC)	  of	  tibialis	  anterior	  by	  dorsiflexion	  of	  the	  feet	  was	  then	  
recorded,	  whilst	  also	  calibrating	  an	  EMG	  visual	  feedback	  program.	  	  This	  EMG	  visual	  
feedback	   program	   then	   facilitated	   the	  maintenance	   of	   subsequent	   contractions	   at	  
consistent	   levels	  of	  20%	  of	  MVC,	  while	  bilateral	  responses	  to	  transcranial	  magnetic	  
stimulation	  of	  the	  motor	  cortex	  were	  recorded	  in	  the	  TA.	  	  A	  full	  recruitment	  curve	  of	  
TMS	  pulse	  intensities,	  delivered	  in	  sets	  of	  6	  to	  30	  pulses	  (more	  pulses	  are	  necessary	  
at	   low	   stimulator	   intensities),	   at	   intervals	   of	   5%	   of	   maximum	   stimulator	   output	  
(%MSO),	   from	   the	   threshold	   for	   the	   cortical	   silent	   period	   to	   150%	   of	   motor	  
threshold,	   was	   then	   delivered	   in	   a	   randomised	   sequence.	   	   Finally,	   30	   seconds	   of	  
relaxed	   EMG	   activity	   was	   also	   recorded	   (where	   the	   subject	   was	   asked	   to	   breathe	  
normally	   and	   quietly).	   Throughout	   all	   recordings,	   silence	   was	   observed	   and	  
participants	  were	  asked	  to	  maintain	  all	  other	  muscles	  relaxed	  and	  immobile,	  whilst	  
resting	  their	  forearms	  and	  hands	  on	  the	  arm	  rest	  provided,	  and	  looking	  at	  the	  eye-­‐
level	   visual	   feedback	   program.	   	   This	   was	   to	   minimise	   transient	   facilitation	   or	  
inhibition	   from	   remote	  muscle	   contractions	   (Andersen	   et	   al.,	   1999,	   Pereon	   et	   al.,	  
1995,	  Hess	  et	  al.,	  1986),	  tendon	  and	  muscle	  afferents	  (Claus	  et	  al.,	  1988,	  Kossev	  et	  
al.,	  1999,	  Siggelkow	  et	  al.,	  1999)	  or	  cognitive	   inputs	  (Izumi	  et	  al.,	  1995,	  Kiers	  et	  al.,	  
1997,	  Pascual-­‐Leone	  et	  al.,	  1994).	  This	  protocol	  was	  then	  repeated	  for	  the	  bilateral	  




Abdominal	  Muscle	  Assessment	  
	  
Next	   positioned	   supine,	   with	   the	   aid	   of	   an	   inclinometer,	   the	   couch	   backrest	   was	  
inclined	   at	   45°	   and	   wedge	   cushions	   and	   Velcro	   straps	   were	   used	   to	   maintain	   the	  
subjects’	  knees	  flexed	  at	  90°	  and	  ankles	  at	  90°	  to	  minimise	  activation	  of	  thigh	  flexors.	  
The	  above	  TMS	  protocol	  was	  again	  repeated	  with	  participants	  first	  producing	  a	  set	  of	  
bilateral	  trunk	  flexions	  (BTF),	  followed	  by	  a	  set	  of	  left	  to	  right	  rotations	  (L-­‐RTR),	  and	  
finally	   a	   set	   of	   right	   to	   left	   trunk	   rotations	   (R-­‐LTR);	   all	   to	   a	   level	   of	   30%	   of	  MVC.	  	  
Participants	  were	  instructed	  to	  hold	  their	  breath	  for	  all	  exercises	  in	  order	  to	  maintain	  
equal	  abdominal	  muscle	  breathing	  cycle	  modulation.	  	  For	  the	  rotations,	  participants	  
were	  asked	  move	  one	  shoulder	  towards	  the	  contralateral	  knee.	  	  	  
Figure	  3.3:	  Bilateral	  Trunk	  Flexion:	  Control	  participant	  strapped	  down	  (at	  hip	  and	  ankle	  
joints)	  onto	  a	  couch	  inclined	  up	  to	  45º,	  performing	  a	  30%	  bilateral	  trunk	  flexion	  guided	  by	  
the	  EMG	  visual	  feedback	  computer	  (not	  shown),	  while	  receiving	  stimuli	  administered	  
through	  a	  70mm	  double	  cone	  coil	  on	  the	  vertex	  of	  the	  primary	  motor	  cortex.	  Wedge	  





Back	  Muscle	  Assessment	  
	  
Lying	  prone	  on	  a	  flat	  horizontal	  couch	  with	  large	  Velcro	  bands	  restraining	  ankles	  and	  
scapulae,	   the	   protocol	   was	   repeated	   for	   erector	   spinae	   with	   bilateral	   extensions	  
(BTE)	  of	  the	  trunk	  to	  40%	  of	  MVC.	  Participants	  were	  asked	  	  to	  hold	  their	  breaths	  and	  
rigidly	  extend	  their	  trunks,	   imagining	  an	   inflexible	   lever	  along	  their	  spine	  extending	  
from	   the	   sacrum.	   	   In	   order	   to	  minimise	   fatigue	   and	   discomfort,	   only	   three	   stimuli	  
were	  delivered	  between	  rests	  at	  higher	  (<40%MSO)	  intensities.	  
	  




The	   outcome	   measures,	   MEP	   and	   cSP	   parameters	   of	   the	   participant	   groups	   and	  
controls	   were	   statistically	   analysed	   for	   reliability	   using	   SPSS	   Statistics	   (version	   19,	  
IBM	  Corp)	  and	  for	  changes,	  interactions	  and	  correlations	  with	  Sigmaplot	  (version	  11,	  
Systat	   Software,	   Inc).	   	   Individual	   participant	   non-­‐linear	   regression	   fitting	   of	  
facilitation	   or	   inhibition	   recruitment	   (stimulus	   input	   to	   parameter	   output)	   profiles	  
were	  carried	  out	  by	  a	  custom	  program	  (see	  Appendix)	  written	  in	  CED	  Signal	  scripting	  
language	   (version	   3.13,	   Cambridge	   Electronic	   Design),	   the	   result	   of	   which	   were	  
statistically	   analysed	   with	   Sigmaplot.	   	   Recruitment	   curves	   were	   also	   constructed	  
using	  all	  of	  the	  data	  points	  for	  entire	  participant	  groups	  at	  each	  time	  point	  and	  both	  
non-­‐linear	   regression	   curve	   fitting	   and	   the	   statistical	   analysis	   of	   these	   curves	   was	  
conducted	  using	  Prism	  (version	  5,	  Graphpad	  Software,	  Inc).	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As	  can	  be	  examined	  in	  the	  average	  rectified	  EMG	  trace	  of	  figure	  3.4,	  the	  posterior	  to	  
anterior	   current	   induced	   by	   a	   TMS	   pulse	   elicits	   motor	   evoked	   responses	   (MEPs)	  
above	   a	   certain	   threshold	   intensity	   of	   stimulus	   (in	   this	   case	   52%	   of	   MSO)	   for	   a	  
specific	   subject	   and	   muscle	   (here	   the	   right	   soleus)	   whilst	   maintaining	   a	   20%	  
contraction.	  	  A	  horizontal	  cursor	  located	  at	  the	  pre-­‐stimulus	  mean	  background	  EMG	  
level	  (figure	  3.4)	  provide	  a	  cue	  for	  visually	  identifying	  the	  MEP	  boundaries,	  providing	  
measurements	  of	  latency	  (a),	  duration	  (b-­‐a)	  and	  size	  (the	  curve	  area	  above	  the	  mean	  
and	   between	   a	   and	   b).	   These	   areas,	   latencies	   and	   amplitudes	   were	   calculated	   by	  
Figure	  3.4:	  Averaged	  rectified	  motor	  evoked	  potentials	  (MEPS)	  in	  the	  right	  soleus	  muscles	  at	  0.5	  
to	  1.2	  x	  Motor	  Threshold.	  	  The	  horizontal	  dashed	  line	  indicate	  the	  background	  mean	  level	  of	  EMG	  
in	  the	  pre-­‐stimulus	  period.	  Cursors	  are	  manually	  positioned	  in	  order	  for	  the	  MEP	  curve	  area	  




programs	  written	   in	  Signal	  3	  scripting	   language	  (Cambridge	  Electronic	  Design,	  UK)	   ,	  
based	  on	  the	  manually	  positioned	  vertical	  cursors	  of	  figure	  3.4.	  Valuable	  information	  
on	  corticospinal	  control	  could	  also	  then	  be	  provided	  by	  stimulus	  response	  curves	  (as	  
for	  the	  tibialis	  anterior	  in	  figure	  3.5),	  demonstrating	  how	  MEPs	  vary	  as	  the	  stimulus	  
intensity	   is	  altered,	  and	   facilitation	  curves	   revealing	  how	   increasing	  voluntary	  drive	  
alters	  MEP	  characteristics	  (Hess	  et	  al.,	  1986;	  Davey	  et	  al.,	  1999).	  These	  give	  insights	  
into	   patterns	   of	   corticospinal	   control.	   	   During	   contraction,	   a	   period	   of	   actively	  
suppressed	  EMG	  activity	  known	  as	  the	  cortical	  silent	  period	  (cSP)	  (Davey	  et	  al.,	  1994)	  
also	   immediately	   follows	   the	   MEP	   boundary	   (figure	   3.4).	   This	   (almost	   entirely)	  
intracortical	  inhibition	  was	  recorded	  with	  measurements	  of	  the	  stimulus	  threshold	  at	  
which	   it	  begins	   to	  appear	   (cSP	  Thresold:	   cSPTh),	   its	   latency	   (b),	   duration	   (c-­‐b),	   size	  
(curve	   area	   between	   points	  b	   and	   c	   below	   the	  mean	   line)	   and	   recruitment	   profile	  
(curve	   in	  figure	  3.6).	   	  Motor	  thresholds	  were	  also	  recorded.	   	  However,	   there	   is	  still	  
some	  controversy	  in	  the	  literature	  as	  to	  the	  most	  accurate	  or	  informative	  definition	  
for	  the	  onset	  of	  the	  cSP	  (Daskalakis	  et	  al.,	  2003,	  Orth	  and	  Rothwell	  2004,	  King	  et	  al.,	  
2006,	  Säisänen	  et	  al.,	  2008).	  	  Although	  the	  cSP	  full	  duration	  (c-­‐a),	  which	  includes	  the	  
MEP,	  has	  been	  reported	  to	  be	  more	  stable	  and	  reduce	  operator	  error	   (Säisänen	  et	  
al.,	   2008),	   it	   is	   only	   useful	   in	   suprathreshold	   comparisons,	   and	   not	   in	   recruitment	  
curves	  displayed	  below	   (figure	  3.6),	  due	   to	   the	  absence	  of	  MEPs	  at	   low	   stimulator	  
intensities	  (SI)	  (in	  the	  x-­‐axis	  of	  figure	  3.5,	  MEPs	  do	  not	  appear	  until	  35%MSO	  whilst	  
cSPs	  begin	  at	  25%).	  As	  a	  result,	  although	  all	  three	  definitions	  of	  cSP	  were	  measured,	  
there	  was	   a	   preference	   for	   the	   definition	  which	   defines	   the	   stimulus	   as	   the	   onset	  
(hence	  the	  cSP	  is	  equal	  to	  [c])	  for	  accuracy	  and	  repeatability.	  	  The	  cSP	  end	  or	  offset	  
was	   always	   defined	   as	  absolute,	   that	   is,	   when	   the	   pre-­‐stimulus	  mean	   EMG	   line	   is	  
intersected	  at	  c.	  	  Therefore	  this	  thesis	  always	  refers	  to	  the	  cSP	  as	  the	  duration	  from	  
stimulus	   to	   cSP	   offset	   (c).	   	   However	   the	   cSP	   area,	   which	   was	   investigated	   in	   the	  
reliability	   analysis	   of	   mathematically	   derived	   version	   of	   the	   cSPTh,	   was	   always	  






MEP	  and	  cSP	  Recruitment	  Curves	  
	  
Recruitment	  curves	  provided	  additional	  parameters	  of	  corticospinal	  control,	  such	  as	  
the	  maximum	   (of	  MEPs	   and	   cSP),	   the	   stimulus	   intensity	   at	   the	  midpoint	   between	  
those	  two	  values	  (X50),	  as	  well	  as	  the	  slope	  (m	  or	   its	   inverse	  k)	  of	  the	  curve	  at	  that	  
point.	   	   These	   stimulus	   response	   curves	   provide,	   to	   a	   certain	   extent,	   similar	  
information	  to	  cortical	  output	  maps	  (Wassermann	  et	  al.,	  1992,	  Ridding	  et	  al.,	  1997).	  	  
Current	  spread	  from	  a	  stationary	  stimulator	  at	   increasing	  stimulus	  intensity	  reflects	  
changes	   in	  area	  of	  cortical	  output	  maps	  over	  specific	  time	  points.	   	  However,	  unlike	  
cortical	   output	  maps	   (produced	   by	   stimulating	  many	   points	   in	   a	   given	   area	   at	   the	  
same	   intensity),	   these	   curves	   are	   blind	   to	   somatotopic	   distribution	   of	   excitability.	  	  
Furthermore,	   it	   is	   important	   to	   note	   that	   neither	   method	   can	   strictly	   distinguish	  
whether	  a	  change	   in	   these	  parameters	  over	   the	  time	  points	  studied	   indicates	   (1)	  a	  
change	   in	   cortical	   excitability	   or	   (2)	   local	   synaptic	   reorganisation	   (Ridding	   et	   al.,	  
1997).	   	  This	   is	  because	  excitability	  can	  be	  mediated	  by	  a	  variation	   in	   tonic	   input	  to	  
the	  primary	  motor	  cortex	  from	  numerous	  remote	  cortical	  structures.	  
	  
The	   curves	   in	   figures	   3.5	   and	   3.6	  were	   fitted	  with	   a	   second	   order	   polynomial	   but	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more	  physiologically	  accurate	  (Devanne	  et.	  al	  1997),	  regardless	  of	  the	  amount	  data	  
points	   available.	   	   Both	   cSP	   and	   MEP	   (area	   and	   P2P	   amplitude)	   recruitment	   are	  
accurately	  modelled	  by	  the	  Boltzmann	  function	  (Devanne	  et.	  al	  1997,	  Capaday	  1997,	  
Carroll	   et	   al.,	   2001,	   Kimiskidis	   et	   al.,	   2005,	   Cacchio	   et	   al.,	   2009).	   A	  more	   intuitive	  
version	  presented	  by	  Carroll	  et	  al.	  was	  modified	  so	  that	  a	  change	  in	  the	  slope	  m	  [the	  
inverse	  of	  Boltzmann’s	  k	  slope	  parameter]	  sensibly	  corresponds	  to	  a	  larger	  change	  in	  
the	   cortical	   parameter	   plotted.	   	   However	   in	   order	   to	   standardise	   between	   the	  
different	   strategies	   investigated	   in	   this	   thesis	   to	   fit	   both	   individual	   and	  group	  data	  
(and	  therefore	  software	  packages	  with	  built-­‐in	  Boltzmann	  functions),	  all	  parameters	  
P	  (cSP	  or	  MEP)	  were	  defined	  per	  unit	  TMS	  intensity	  P(s)	  as:	  
	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Where	   Max	   is	   the	   maximum	   parameter	   value	   (such	   as	   the	   largest	   MEP	   area	   or	  
longest	  cSP)	  defined	  by	  the	  function.	  Min	  is	  the	  minimum	  parameter	  value	  and	  X50	  is	  
the	  middle	  intensity	  in	  %MSO	  at	  the	  midpoint	  between	  Max	  and	  Min.	  
	  
Two-­‐sample	   (homoscedastic)	   Student's	   t-­‐tests	   were	   used	   to	   compare	   all	   variables	  
between	   left	   and	   right	   muscles.	   	   Symmetry	   (AI)	   and	   lateralisation	   indices	   (LI)	  
(between	   IPSI	   and	   CONTRA	   radic	   sides)	   were	   calculated	   for	   MEP	   latency	   and	   for	  
parameters	   (P)	   displaying	   side	   differences.	   This	   was	   given	   by	   LI(P)=(PIPSI-­‐
PCONTRA)/(PIPSI+PCONTRA),	   where	   AI=|LI|.	   	   One-­‐way	   repeated	   measures	   analyses	   of	  
variance	  (ANOVAs)	  were	  used	  to	  measure	  individual	  group	  parameter	  reliability	  and	  
variations	  over	  the	  four	  visits	  	  while	  Two-­‐way	  ANOVAs	  were	  used	  to	  compare	  clinical	  
groups	  and	  controls.	  	  Two	  way-­‐repeated	  measures	  ANOVAs	  factorised	  for	  were	  used	  




Finally	   Pearson	   Product	   Moment	   Correlation	   and	   linear	   regression	   analysis	   were	  
used	  to	  infer	  whether	  a	  relationship	  existed	  between	  changes	  in	  outcome	  measures	  
(such	  as	  VAS	  pain	  and	  disability	  scores)	  and	  changes	  in	  MEP	  or	  cSP	  parameters.	  
	  
	  




Because	   of	   the	   number	   of	   subjects	   involved	   and	  muscles	   studied,	   traditional	   TMS	  
emg	  data	  processing	  techniques	  presented	  several	  problems.	  	  As	  thresholds,	  onsets	  
and	   offsets	   of	   MEPs	   and	   silent	   periods	   are	   visually	   guided	   and	   rated,	   the	   main	  
obstacles	   are	   usually	   consistency	   (both	   single	   and	   inter-­‐rater),	   reproducibility,	  
accountability,	   and	   of	   course	   the	   monumental	   processing	   time	   involved.	   	   The	  
interface	   also	   had	   to	   cope	  with	  measures	   derived	   from	   individual	   frames	   (such	   as	  
P2P	  amplitudes),	  average	  frames	  (such	  as	  all	  latencies,	  areas,	  offsets	  and	  offsets)	  and	  
multiple	  files	  (such	  as	  recruitment	  curves	  fitted	  from	  all	  stimulator	  intensities).	  	  Using	  
the	   CED	   programming	   language,	   a	   modular	   group	   of	   programmes	   was	   written	   to	  
address	   these	   issues	   by	   progressively	   storing	   processing	   information	   within	   the	  
sampled	   file	   extensions,	   such	   as	   thresholds,	   cursor	   positions	   and	   normalising	   data	  
(maximum	  contractions),	  and	  outputting	  graphic	   files	  and	  data	  tables	  at	  every	  step	  
of	   the	  way.	   	  This	  allowed	   for	  a	  maximum	  amount	  of	   flexibility,	  as	   the	  programmes	  
could	   “talk”	   to	   one	   another	   and	   retrieved	   previously	   processed	   information	   and	  
every	  step	  could	  be	  quickly	  checked	  and	  edited	  if	  necessary.	  	  A	  year	  after	  the	  end	  of	  
the	  study,	  not	  only	  could	  an	  unfamiliar	  scientist	   	  view	  exactly	  how	  the	  MTh	  or	  cSP	  
was	  rated	  and	  add	  to	  or	  edit	  any	  part	  of	  the	  processing,	  but	  one	  click	  would	  instantly	  




The	  framework	  is	  essentially	  a	  6	  programme	  system	  which	  can	  be	  used	  in	  any	  type	  of	  
single	  or	  paired	  pulse	  TMS	  experiment	  (In	  the	  case	  of	  paired	  pulse	  experiments,	  an	  
additional	  programme	  is	  supplied	  replacing	  step	  5).	  	  
	  
	  
1. STIMINT	  :	  «	  De-­‐randomisation	  »	  and	  Automated	  MVC	  Calculation	  
	  
	  
Appendix	   A	   contains	   the	   code	   for	   the	   StimINT	   program.	   	   	   The	   purpose	   of	   this	  
program	  is	  to	  reorganise	  the	  files	  (de-­‐randomise)	  and	  write	  stimulator	  intensities	  and	  
MVCs	  to	  the	  cfs	  file	  extensions	  (also	  known	  as	  frame	  variables).	   	  Once	  the	  program	  
has	  been	  guided	  to	  appropriate	  experimental	  folder	  it	  will	  detect	  (or	  allow	  the	  user	  
to	   enter)	   the	   stimulator	   intensities	   for	   each	   file	   in	   the	   folder,	   and	   regroup	   and	  
rename	  files	  based	  on	  experiment	  sections	  by	  querying	  the	  user	  for	  a	  contraction	  tag	  
(such	  as	  BE	  for	  Abdominal	  extension).	  The	  stimulator	  intensities	  are	  either	  picked	  up	  
from	   the	  Magstim	  Stimulator	   specific	   file	   extension,	   the	   file	   comment	  or	   the	  user,	  
which	  always	   confirms	  by	   clicking	   “Set”	   (figure	  3.7).	   	   Every	   time	   the	   file	   for	   a	  new	  
contraction	  is	  reached	  the	  user	  can	  click	  on	  “New	  MVC”	  and	  will	  be	  asked	  to	  point	  to	  
the	   file	   containing	   the	   MVC	   for	   that	   contraction.	   	   Maxima	   and	   minima	   are	  
automatically	  calculated	  by	  breaking	  up	  the	  entire	  MVC	  file	  into	  200	  msec	  frames	  for	  
each	  channel	  and	  selecting	   the	  highest	  and	   lowest	   three	  means.	   	  The	   lowest	   three	  
and	  highest	  three	  are	  then	  averaged	  to	  yield	  the	  MVC	  and	  “Silent	  breathing”	  relaxed	  
EMG	   levels.	   	   The	   user	   is	   then	   prompted	   to	   scroll	   through	   the	   “MVC	   report”	   and	  
confirm	   that	   no	   abnormally	   large	   frames	   have	   been	   recorded	   due	   to	   electrode	  
artefacts.	   	  The	  MVC	  calculation	  subroutine	  also	  exists	  as	  a	  stand-­‐alone	  programme	  





Figure	  3.7:	  Automatic	  MVC	  calculation	  and	  “De-­‐randomisation”	  with	  stimulator	  intensity	  information	  
	  
The	   result	   are	   an	   experiment	   broken	   up	   in	   section	   folders	   (named	   say	   “BE”)	  
containing	   files	   with	   names	   detailing	   the	   contraction	   and	   intensity,	   and	   frame	  
variables	  containing	  the	  same	  information	  along	  with	  MVC	  and	  Quiet	  Breathing	  EMG	  
levels.	  
	  
Step	   2	   &	   3.	   AUTOMEP:	   Automated	   MEP	   identification	   and	   Threshold	   Calculation	  
(Appendix	  B).	  
	  
Calculating	   the	   motor	   threshold	   quickly	   and	   accurately	   depends	   on	   a	   stimulator	  
intensity’s	  ability	  to	  evoke	  responses	  (MEPs)	  of	  a	  specific	  latency	  and	  amplitude	  50%	  
of	  the	  time	  relative	  to	  the	  pre-­‐stimulus	  EMG	  activity.	  	  Although	  simple	  to	  implement	  
mathematically,	  this	  process	  is	  almost	  never	  automated	  because	  not	  only	  will	  these	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  different	  muscles	  produce	  different	  types	  of	  responses	  (trunk	  muscle	  MEPs	  tend	  to	  
be	   shorter	   polyphasic),	   but	   short	   latency	   EMG	   responses	   are	   routinely	   affected	  by	  
stimulus	   and	   movement	   artefacts.	   	   The	   aim	   was	   hence	   to	   develop	   an	   algorithm	  
which	  would	   cater	   for	  different	  muscles	   in	  both	   resting	  and	  active	   conditions	  with	  
constants	  that	  could	  be	  adapted	  to	  each	  muscle.	  	  A	  further	  program	  (MANUALMEP)	  
would	   then	   take	   the	   rater	   to	   the	   threshold	   intensity	   to	   confirm	   the	   automated	  
choice,	  saving	  hundreds	  of	  hours	  of	  processing	  time	  in	  multiple	  channel	  experiments.	  
	  
The	  program	  will	  open	  every	  file	  in	  the	  folder	  and	  if	  it	  contains	  a	  stimulus	  intensity	  it	  
measures	   the	  pre-­‐stimulus	   and	  MEP	  period	  RMS	   (root	  mean	   square)	   and	   absolute	  
maximum	  amplitudes	  (PreStimMax,	  PrestimRMS,	  MEPmax	  and	  MEPrms	  below).	   	  By	  
default	  the	  MEP	  period	  is	  20-­‐40ms	  but	  the	  software	  will	  also	  recognise	  muscles	  from	  
the	   file	   and	   channel	   names	   for	   a	   more	   accurate	   MEP	   periods.	   	   Likewise	   the	  
programme	   will	   automatically	   determine	   whether	   the	   muscle	   is	   active	   or	   resting	  
either	  from	  the	  pre-­‐stimulus	  EMG	  activity	  or	  from	  the	  contraction	  tag	  (such	  as	  BE).	  	  
Figure	  3.8:	  Automated	  MEP	  identification	  and	  threshold	  calculation	  Results	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Frames	  satisfying	  active	  MEP	  conditions,	   for	  example,	  will	  be	  flagged	   if	   they	  satisfy	  
the	  following	  conditions:	  
	  
MEPMax	  >	  (aPC*PreStimRMS+(aMC*MEPDef))	  
MEPMax	  >	  PreStimMax	  
MEPrms	  >	  PreStimRMS	  
	  
Where	   aPC	   and	   aMC	  are	   active	   prestim	   and	  MEP	   constants	   specific	   to	   the	  muscle	  
detected	  (or	  default	  value	  if	  the	  muscle	  is	  not	  recognised)	  and	  MEPDef	  is	  0.2	  Volts.	  	  	  
	  
The	  3	  constants	  also	  have	  a	  different	  value	  in	  resting	  conditions	  (where	  the	  MEPDef	  
becomes	   0.05).	   	   The	  program	  will	   then	  display	   the	   results	   for	   all	   files	   (intensities),	  
including	  muscle	  names,	  number	  of	  MEPs	  and	  active	  or	  resting	  state	  (figure	  3.8).	  	  	  
	  
A	   subroutine	   called	   ThreshCALC	   (also	   available	   as	   a	   standalone	   program)	   then	  






Where	   INTBelowMth	   is	   the	   stimulus	   intensity	   just	   below	   the	   50%	  MEPs	   condition	  
and	  pcThBelowMth	  is	  the	  percentage	  of	  MEPs	  at	  that	  intensity.	  	  Many	  conditions	  are	  
established	  to	  guarantee	  that	  this	  number	  makes	  sense	  regardless	  of	  the	  distribution	  
of	  intensities	  available	  in	  the	  folder	  of	  interest	  (see	  code	  in	  Appendix	  B).	  	  Threshold	  
values	  are	  then	  displayed	  for	  up	  to	  16	  channels	  (figure	  3.8)	  and	  all	  values	  are	  entered	  






Step	  3:	  Visual	  indentification	  of	  cSP,	  inspection	  and	  correction	  at	  motor	  threshold	  	  
	  
MANUALMEP	   (Apendix	   C)	   provides	   a	   convenient	   interface	   to	   determine	   the	   silent	  
period	   threshold	   (SPTh)	   and	   to	   double	   check	   and	   edit	   the	   tagged	   frames	   at	   the	  
automatically	   determined	   Mth	   intensity.	   	   The	   program	   optimises	   the	   display	   for	  
judging	  MEPs	  and	  also	  munitions	  the	  rater	  with	  the	  rectified	  and	  average	  MEP,	  and	  
prestimulus	   mean	   (with	   2xSD),	   mep	   onset	   and	   mep	   offset	   cursors.	   	   A	   series	   of	  
buttons	   on	   the	   top	   right	   corner	   (figure	   3.9)	   enable	   the	   rater	   to	   tag	   the	   SPTh	   file,	  
change	   the	  MEP	   flag	   of	   any	   frame	   or	  manually	   enter	   thresholds.	   	   	   The	   Threshcalc	  
program	   then	   allows	   all	   new	   and	   corrected	   values,	   with	   a	   new	  Mth	   calculation	   if	  
necessary,	  to	  be	  displayed	  and	  then	  written	  to	  all	  files	  in	  the	  folder.	  	  	  
	  
Figure	  3.9:	  Manually	  checking	  MEPs	  and	  determining	  the	  SPTh	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Step	   4.	   CURSORS:	   frame	   by	   frame	   and	   average	   waveform	   calculations	   at	   each	  
stimulator	  intensity	  
	  
The	  CURSORS	  program	  (APPENDIX	  D)	  cycles	  through	  all	  files	  in	  the	  folder	  and	  allows	  
the	  user	  to	  position	  MEP	  onset,	  MEP	  offset	  and	  cSP	  offset	  cursors	  on	  an	  average	  of	  
all	  the	  frames.	  	  Having	  retrieved	  all	  MEP,	  MTh,	  MVC,	  cSPTh	  and	  Minima	  information	  
from	  each	   file,	   the	   program	   calculates	   the	   pre-­‐stimulus	  mean,	  MEP	   and	   cSP	   areas	  
from	  the	  average	  frame	  and	  the	  P2P	  amplitudes	  are	  averaged	  MEP	  amplitudes	  from	  
all	  of	  the	  original	  frames.	  	  For	  each	  channel	  (or	  muscle),	  a	  new	  mean	  waveform	  file	  is	  
created	  with	  cursor	  positions	  and	  all	  data	  recorded	  to	  its	  frame	  variable.	  	  Although	  a	  
table	   containing	  all	   raw	  and	  normalised	  values	   is	   created,	   this	   can	  be	  discarded	  as	  
the	  final	  program	  will	  reconstruct	  it	  from	  these	  new	  files.	  	  A	  variant	  of	  this	  program,	  
PAIREDPULSE	  (APPENDIX	  E),	  was	  also	  created	  for	  paired	  pulse	  experiments,	  and	  will	  
automatically	   organise	   all	   of	   the	   output	   data	   in	   frame	   states	   designated	   for	   each	  
paired	  interval	  used.	  	  
	  




Step	  5.	  ALLCURVES:	  recruitment	  curve	  fitting	  
	  
The	   final	   program	   (APPENDIX	   F)	   has	   two	   functions.	   	   The	   first	   is	   to	   instantly	  
reconstruct	  all	  of	  the	  data	  and	  calculations	  based	  on	  the	  mean	  files	  for	  each	  muscle	  
(it	  has	  a	  record	  of	   the	  P2P	  measure	  and	  previously	  calculated	  data	   from	  the	  frame	  
variables	   of	   the	   new	   files).	   	   The	   second	   is	   to	   construct	   a	   recruitment	   curve	   for	  
normalised	  and	  raw	  MEPs	  and	  cSPs	  for	  each	  muscle	  of	  a	  single	  subject	  based	  on	  all	  
files	   (stimulus	   intensities).	   	   This	  makes	   the	  whole	   system	  highly	   flexible.	   	  CURSORS	  
can	  be	  used	  to	  go	  back	  and	  correct	  cursor	  positions	  for	  any	  intensity	  or	  even	  delete	  a	  
file	  with	  an	  artefact.	  	  Pressing	  the	  ALLCURVES	  button	  will	  then	  instantly	  reconstruct	  
the	   output	   data	   table	   (formatted	   with	   even	   spacing	   regardless	   of	   the	   number	   of	  
intensities)	  with	  all	  curve	  fitting	  data	  included.	  	  For	  each	  muscle,	  up	  to	  seven	  curves	  
(cSP	  [offset],	  cSP	  area,	  cSP	  duration,	  P2P	  and	  MEP	  Area	  [raw	  and	  normalised]),	  are	  
also	   momentarily	   displayed	   (figure	   3.11)	   for	   the	   user	   to	   inspect	   and	   output	   as	  
graphics	  files.	  	  The	  example	  in	  figure	  3.11	  is	  for	  a	  right	  erector	  spinae	  muscle	  and	  the	  
poor	  curve	  result	  at	  the	  bottom	  right	  is	  an	  illustration	  of	  how	  cSP	  area	  is	  unreliable	  in	  
trunk	  muscles	  (compared	  to	  cSP	  [offset]	  on	  the	  bottom	  left).	  
The	  program	  fits	  a	  single	  Boltzmann	  sigmoid	  by	  an	   iterative	  method.	  The	  data	  was	  
once	  again	  fitted	  to	  the	  equation:	  
	  
y	  =	  Min	  +	  (Max	  -­‐	  Min)/(1	  +	  exp((X50	  –	  x)/	  k)	  
	  
where	  Min	   and	  Max	   are	   the	   low	   and	   high	   fitting	   limits,	   X50	   is	   curve	  midpoint	   at	  
which	  the	  steepest	  slope	  k	  is	  measured.	  	  For	  all	  variables	  that	  tend	  to	  zero,	  the	  fitting	  
Min	   limit	  was	   set	   to	   zero.	   	   If	   individual	   curves	   had	   a	   good	   enough	   fit	   and	   enough	  
points	  covering	  the	  sigmoid	  minimum	  and	  maximum	  plateaux,	  then	  there	  would	  be	  
the	  attractive	  option	  of	  deriving	  all	  thresholds	  free	  from	  observer	  error	  directly	  from	  
the	  curve.	  	  To	  explore	  this	  possibility	  in	  these	  muscles	  the	  RC	  derived	  threshold	  was	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defined	  as	  the	  x-­‐intercept	  of	  a	  line	  with	  slope	  k	  intercepting	  point	  (X50,	  Y50),	  where	  
Y50	  is	  derived	  from	  the	  Boltzmann	  formula:	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  X-­‐INT=-­‐Y50+(k*X50)/k	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Reliability	  and	  Long	  Term	  Stability	  of	  TMS	  Measures	  	  
	  
Long	   term	   test-­‐retest	   reliability	   and	   stability	   was	   measured	   using	   intraclass	  
correlation	   coefficients	   (ICC(A,k0))	   and	   their	   95%	   confidence	   limits,	   using	   a	   two-­‐way	  
random	   effects	   model	   indexed	   for	   absolute	   agreement.	   	   This	   is	   the	   most	   robust	  
measure	  of	  reliability	  and	  can	  identify	  the	  suitability	  of	  physiological	  measurements	  	  
in	  clinical	  applications.	  	  This	  analysis	  of	  central	  motor	  control	  parameters	  has	  never	  
been	  carried	  out	  over	  such	  a	  long	  period	  (>1	  year)	  and	  computing	  4	  repeats	  into	  the	  
ICC.	  
A	  one	  way	  RM	  ANOVA	  was	  also	  used	  to	  calculate	  the	  standard	  error	  of	  measurement	  
(SEM).	  It	  is	  derived	  from	  the	  ANOVA	  mean	  square	  error	  (MSE)	  term	  and	  is	  a	  measure	  
of	  the	  within-­‐subject	  absolute	  reliability	  of	  the	  data:	   
SEM= 	  
An	  important	  distinction	  between	  the	  ICC	  and	  SEM	  is	  that	  the	  SEM	  is	  comparatively	  
sample	   independent,	   while	   the	   ICC	   also	   accounts	   for	   the	   total	   variation	   in	   the	  
population	  analysed.	  
	  The	   smallest	   real	   difference	   (SRD;	   also	   in	   the	   same	   units)	   was	   also	   calculated	  
(Beckerman	  et	  al.,	  2001).	   It	   indicates	  the	  smallest	  difference	  required	  to	  produce	  a	  






Group	  Recruitment	  Curves	  
	  
Group	  recruitment	  curves	  were	  constructed	  to	  assess	  back	  muscle	  corticospinal	  excitability	  
in	   chronic	   LBP	   and	   controls.	   This	   method	   did	   not	   allow	   for	   RC	   curve	   parameters	   to	   be	  
assessed	   on	   an	   individual	   basis.	   It	   was	   however,	   more	   robust	   to	   outliers	   and	   to	   the	  
constraints	  imposed	  by	  the	  low	  tolerability	  of	  cone	  coil	  TMS	  at	  high	  stimulator	  intensities,	  by	  
drawing	   	   on	   the	   group	   mean	   for	   curve	   plateau	   values.	   	   This	   offered	   the	   possibility	   of	   a	  
“normal”	  profile	  and	  variability	  range	  to	  compare	  to	  patient	  groups.	  
Mean	   MEP	   area	   recruitment	   curves	   were	   constructed	   using	   all	   values	   for	   MEP	   area	  
(normalised	   to	  MVC)	   plotted	   against	   stimulator	   intensity	   (normalised	   to	  motor	   threshold).	  
Normaly	   distributed	   data	   (confirmed	   by	   d’Agostino-­‐Pearson	   normality	   tests)	   was	   fit	   using	  
standard	   least-­‐squares	   nonlinear	   regression.	   	   For	   non-­‐normally	   distributed	   data,	   a	  
Marquardt	  regression	  algorithm	  adapted	  to	  a	  Lorentzian	  distribution	  of	   residuals	  was	  used	  
(Motulsky	   and	   Brown,	   2006).	   	   In	   order	   to	   see	   if	   the	   best-­‐fit	   parameters	   differed	   between	  
various	  data	  sets	  (time	  points	  for	  example),	  a	  sum-­‐of-­‐squares	  F-­‐test	  was	  used	  to	  select	  the	  
simpler	  model	  unless	  P<0.05.	  	  This	  allowed	  contralateral	  limb	  or	  time	  point	  MEP	  area	  data	  in	  
individual	  groups	  to	  be	  pooled	  (when	  P>0.05)	  and	  the	  patient	  group	  curves	  to	  be	  statistically	  
compared	  to	  controls.	  
Mean±SEM	  left	  and	  right	  MEP	  Area	  RC	  parameter	  data	   for	  SOL	  at	  4	   time	  points	   in	  healthy	  
controls	   are	   displayed	   in	   	   figure	   3.12.	   	   As	   none	  of	   the	   fit	   parameters	   significantly	   differed	  
over	  the	  4	  assessments,	  a	  global	  curve	  was	  fitted	  for	  soleus	  MEP	  Area	  on	  the	  left	  side	  of	  the	  
body	  (blue;	  with	  slope	  =	  1.23±0.03	  and	  R2=0.663)	  and	  the	  right	  (red;	  with	  slope	  =	  1.26±0.03	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   B	   R1	   R2	   R3	   Shared	  
	  
L	   R	   L	   R	   L	   R	   L	   R	   L	   R	  
SOL	  Normalised	  MEP	  Area	  
Max	   38.7±4.72	   29.67±4.76	   35.43±5.51	   37.45±7.32	   40.45±6.01	   33.1±5.94	   35.56±5.28	   44.19±9.71	   37.54±2.66	   35.06±3.25	  
X50	   1.242±0.04	   1.225±0.06	   1.241±0.06	   1.279±0.06	   1.23±0.05	   1.214±0.06	   1.225±0.06	   1.33±0.07	   1.234±0.03	   1.26±0.03	  
k	   0.15±0.01	   0.159±0.01	   0.156±0.01	   0.156±0.01	   0.152±0.01	   0.153±0.02	   0.161±0.01	   0.17±0.01	   0.155±0.01	   0.16±0.01	  
R²	   0.6624	   0.6326	   0.6362	   0.7079	   0.7162	   0.577	   0.5797	   0.6621	   0.6631	   0.6355	  
Figure	  3.12:	  (Top)	  Representative	  left	  (L;	  blue)	  and	  right	  (R;	  red)	  soleus	  recruitment	  curves	  produced	  
from	  4	  assessments	  (bottom	  table:	  B	  to	  R3	  columns)	  statistically	  compared	  (F-­‐test)	  and	  pooled	  	  with	  
the	  common	  non-­‐linear	  regression	  fit	  results	  (Mean±SEM	  Max,	  X50,	  k	  and	  R2	  values	  in	  “Shared”	  
column).	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4.	  The	  Reliability	  of	  Measures	  of	  Corticospinal	  Excitability	  in	  the	  Trunk	  and	  Legs	  for	  Long	  Term	  Treatment	  Outcome	  Studies	  
	  
	  





Non-­‐invasive	   stimulation	   of	   the	   motor	   cortex	   is	   increasingly	   used	   to	   assess	  
intracortical	  and	  corticomotor	  pathways	  over	  the	  course	  of	  therapeutic	  intervention.	  
Transcranial	  magnetic	  stimulation	  (TMS)	  can	  be	  used	  to	  localise	  lesions	  and	  disease	  
processes	  affecting	  the	  central	  and	  peripheral	  nervous	  systems	  (CNS	  and	  PNS),	  and	  
monitor	   plastic	   adaptations	   resulting	   from	   rehabilitation,	   surgery,	   pharmaceutical	  
treatment,	  or	  exogenous	  neurostimulation	  therapies.	  In	  myelopathy,	  spinal	  stenosis	  
and	   radiculopathy,	   for	   example,	   changes	   in	   evoked	   facilitory	   responses	   (motor	  
evoked	  potentials	  [MEPs]),	  their	  thresholds	  (MTh)	  or	  stimulus-­‐response	  profiles,	  and	  
latencies	   (deriving	   the	   central	  motor	   conduction	   time	   [CMCT]),	   are	   quantifiable	   in	  
the	   electromyogram	   (EMG)	   of	   paravertebral	   or	   leg	   muscles	   innervated	   by	   the	  
affected	  nerve	  root(s)	  (Lo,	  2007,	  Kaneko	  et	  al.,	  2001,	  Nicotra	  et	  al.,	  2013,	  Saadeh	  et	  
al.,	  1994,	  Simo	  et	  al.,	  2004,	  Linden	  and	  Berlit,	  1995,	  Mochizuki	  et	  al.,	  1999,	  Strutton	  
et	   al.,	   2003b).	   These	   parameters	   can	   be	   re-­‐evaluated	   alongside	   surgical	   outcome	  
(Nicotra	   et	   al.,	   2013)	   several	   weeks	   or	   months	   later.	   	   Alterations	   in	   intracortical	  
inhibition	   (ICI)	   have	   been	   reported	   in	   neuropathic	   pain	   (Turgut	   and	   Altun,	   2009,	  
Schwenkreis	  et	  al.,	  2010),	  and	  chronic	  pain	  conditions	  such	  as	  fibromyalgia	  (Salerno	  
et	   al.,	   2000,	  Mhalla	  et	   al.,	   2010),	   complex	   regional	  pain	   syndrome	   (Schwenkreis	  et	  
al.,	  2005)	  and	  low	  back	  pain	  (Masse-­‐Alarie	  et	  al.,	  2012).	  	  In	  the	  case	  of	  fibromyalgia,	  
outcomes	   resulting	   from	   repetitive	   motor	   cortex	   stimulation	   therapy	   have	   been	  
monitored	  and	  correlated	  to	  ICI	  for	  up	  to	  one	  year (Mhalla	  et	  al.,	  2011,	  Baudic	  et	  al.,	  
2013).	   	   Some	   of	   the	   changes	   in	   corticospinal	   excitability	   in	   back	   and	   abdominal	  
muscles	  associated	  with	  chronic	  low	  back	  pain	  (Tsao	  et	  al.,	  2011b,	  Tsao	  et	  al.,	  2008,	  
Strutton	  et	  al.,	  2005,	  Strutton	  et	  al.,	  2004b)	  have	  been	  targeted	  by,	  and	  correlated	  to	  
the	  functional	  outcome	  of,	  physical,	  manual	  and	  electrotherapy	  (Masse-­‐Alarie	  et	  al.,	  
2013,	   Clark	   et	   al.,	   2011,	   Tsao	   et	   al.,	   2010a).	   Finally,	   in	   stroke	   rehabilitation,	   a	  
relationship	  between	  parameters	  of	  intracortical,	  interhemispheric	  and	  corticomotor	  
excitability	   and	   long	   term	   recovery	   of	   motor	   function	   has	   long	   been	   established	  
(Turton	   et	   al.,	   1996,	   Traversa	   et	   al.,	   1998,	   Liepert	   et	   al.,	   2001,	   Platz	   et	   al.,	   2005,	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Wittenberg	   et	   al.,	   2003,	   Harris-­‐Love	   et	   al.,	   2011,	   Marconi	   et	   al.,	   2011,	   Butefisch,	  
2006,	  Butefisch	  et	  al.,	  2003).	   	  
	  
As	   the	   vast	   majority	   of	   reliability	   studies	   for	   TMS	   parameters	   are	   based	   on	   one	  
repeat	  experiment,	  and	  as	  few	  as	  two	  studies	  have	  assessed	  reliability	  in	  active	  TMS	  
parameters	   over	   a	   time	   span	   as	   long	   as	   4	   weeks	   or	   more	   (Ngomo	   et	   al.,	   2012,	  
Cacchio	  et	  al.,	  2009),	  there	  exists	  some	  disparity	  between	  interventional	  longitudinal	  
studies	   and	   knowledge	   of	   the	   variability	   of	   TMS	   parameters	   over	   useful	   outcome	  
periods.	   	   In	   resting	   conditions	   these	   have	   all	   used	   figure-­‐8	   coils	   to	   assess	   hand	  
muscle	   resting	   MTh	   or	   cortical	   mapping	   techniques	   using	   one	   reassessment	   at	   a	  
random	   interval	   (Mortifee	   et	   al.,	   1994,	   Weiss	   et	   al.,	   2012,	   Corneal	   et	   al.,	   2005,	  
Ngomo	   et	   al.,	   2012,	   Mills	   and	   Nithi,	   1997).	   The	   exception	   and	   only	   repeatability	  
study	   extending	   past	   the	   median	   4	   month	   mark	   (5.5	   years),	   found	   resting	   MTh	  
reliability	   to	   be	   higher	   at	   fixed	   stimulation	   sites	   and	   independent	   of	   age	   or	   retest	  
interval	  (Kimiskidis	  et	  al.,	  2004).	  	  Ngomo	  et	  al.,	  (2012)	  found	  no	  differences	  between	  
active	  MTh	   and	   resting	   ICI	   (short	   interval	   type	   [SICI])	   in	   the	   short	   (4	   days)	   or	   long	  
term	   (median	   88	   days).	   	   With	   regards	   to	   short	   term	   variability,	   there	   have	   been	  
mixed	   reports	   regarding	   circadian	   variations	   in	   ICI	   (measured	  by	   the	   cortical	   silent	  
period	  [cSP])	  (Lang	  et	  al.,	  2011,	  Strutton	  et	  al.,	  2003a).	  On	  the	  other	  hand,	  long	  term	  
activity	  dependent,	  developmental	  and	  lifelong	  changes	  in	  ICI,	  active	  MTh	  and	  other	  
MEP	   derived	   parameters	   have	   been	   reported	   (Heise	   et	   al.,	   2013,	   Davidson	   and	  
Tremblay,	   2013,	   Selvanayagam	   et	   al.,	   2011,	   McGregor	   et	   al.,	   2011,	   Wassermann,	  
2002,	   Kozel	   et	   al.,	   2000,	  Matsunaga	   et	   al.,	   1998,	   Nezu	   et	   al.,	   1997,	   Rossini	   et	   al.,	  
1992,	  Pascual-­‐Leone	  et	  al.,	  1995b).	  
	  
Despite	   their	   widespread	   adoption	   in	   neurophysiological	   investigations,	   the	   intra-­‐
subject	   and	   trial	   to	   trial	   variability	   of	   TMS	   parameters	   such	   as	   MEP	   amplitudes	  
remains	   considerable	   (Ellaway	   et	   al.,	   1998,	   Truccolo	   et	   al.,	   2002).	   Reliability	   and	  
repeatability	   are	   also	   strongly	   influenced	   by	   the	   coil	   type	   and	   methodological	  
technique	  used,	  muscle	   type	  and	  the	   level	  of	  background	  activation	   (Kamen,	  2004,	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Fleming	  et	  al.,	  2012,	  Bastani	  and	  Jaberzadeh,	  2012,	  Malcolm	  et	  al.,	  2006,	  McDonnell	  
et	  al.,	  2004).	  Despite	  these	  reports,	  most	  reliability	  studies	  have	  continually	  assessed	  
the	   less	   reliable	   and	   most	   time	   consuming	   methodologies:	   MEPs	   at	   rest	   using	   a	  
mobile	   and	   freely	   rotatable	   focal	   figure-­‐8	   coil.	   Although	   this	   technique	   is	   useful	   in	  
assessing	   changes	   in	   discrete	   resting	   somatotopic	   distribution	   of	   excitability	  
(particularly	   in	  hand	  muscles),	   this	   study	  aimed	  to	  standardise	  a	   fixed	  coil	  protocol	  
for	   the	   clinical	   setting,	   and	   assess	   the	   suitability	   of	   TMS	  parameters	   in	  monitoring	  
long	  term	  (1	  year)	  treatment	  outcomes.	  
	  
Indeed,	   although	   TMS	  MEP	   derived	   parameters	   and	   the	   cSPs	   (the	   period	   of	   EMG	  
suppression	  following	  a	  stimulus	  in	  a	  voluntary	  activated	  muscle)	  have	  been	  shown	  
to	  be	  reliable	  measures	  of	  corticospinal	  and	  intracortical	  excitability	  in	  hand	  muscles	  
(De	  Gennaro	  et	  al.,	  2003,	  Carson	  et	  al.,	  2013,	  Corneal	  et	  al.,	  2005,	  Orth	  and	  Rothwell,	  
2004,	  Wassermann,	   2002,	   Christie	   et	   al.,	   2007,	   Malcolm	   et	   al.,	   2006,	  Wolf	   et	   al.,	  
2004,	  McDonnell	   et	   al.,	   2004,	   Kamen,	   2004,	   Carroll	   et	   al.,	   2001,	   Fritz	   et	   al.,	   1997,	  
Mortifee	  et	  al.,	  1994),	   	   few	  studies	  have	   investigated	  reliability	  and	  repeatability	   in	  
lower	  limb	  muscles	  (Tallent	  et	  al.,	  2012,	  Cacchio	  et	  al.,	  2011,	  van	  Hedel	  et	  al.,	  2007,	  
Cacchio	   et	   al.,	   2009),	   only	   one	   recent	   study	   has	   investigated	   the	   reliability	   of	  
paraspinal	  MEPs	  at	  rest	  over	  a	  single	  session	  (Goss	  et	  al.,	  2011)	  and	  none	  to	  date	  has	  
investigated	   abdominal	   muscles.	   Furthermore,	   only	   one	   of	   these	   studies	   has	  
assessed	   the	   reliability	  of	   fitted	   stimulus-­‐response	   curve	  parameters	   (Carroll	   et	   al.,	  
2001,	  Cacchio	  et	   al.,	   2009).	   This	   study	   found	   these	   to	  be	   reliable	   in	  hand	  muscles.	  	  
The	   vast	   majority	   of	   these	   studies	   have	   also	   used	   the	   coefficient	   of	   variation	  
(CV=session	   SD/session	   mean×100)	   and	   only	   a	   handful	   have	   calculated	   the	   more	  
robust	   statistical	   test	   for	   reliability	   and	   repeatability;	   the	   intra-­‐class	   correlation	  
coefficient	  (Portney	  and	  Watkins,	  2000).	  The	  advantage	  of	  the	  current	  protocol	  is	  the	  
inclusion	   of	   4	   repeat	   experiments	   at	   fixed	   and	   successively	   longer	   intervals,	   with	  
sufficient	  power	  to	  assess	  the	  suitability	  of	  the	  full	  range	  of	  both	  recruitment	  curve	  




The	  purpose	  of	  this	  study	  is	  thus	  to	  assess	  the	  long	  term	  reliability	  of	  all	  single	  pulse	  
TMS	   parameters	   in	   trunk	   and	   leg	   muscles	   and	   thus	   their	   suitability	   for	   assessing	  








With	   local	   ethical	   approval	   and	   informed	   consent,	   19	   participants,	   comprising	   14	  
males	   and	   5	   females	   (32.39±7.29	   [SD]	   years	   of	   age	   with	   a	   body	   mass	   index	   of	  
23.46±3.0	   [SD])	   were	   recruited.	   Exclusion	   criteria	   included	   current	   treatment	   with	  
antidepressants/neuromodulatory	  drugs	   (Ziemann,	  2004,	  Ziemann,	  2003),	  a	  history	  
of	  chronic	  pain	  or	  spinal	  disorders,	  as	  well	  as	  the	  general	  TMS	  exclusions	  outlined	  in	  
chapter	  3.	  	  
	  
Corticospinal	   excitability	   of	   the	   trunk	   (erector	   spinae	   [ES],	   obliquus	   externus	  
abdominis	  [OE]	  and	  rectus	  abdominis	  [RA])	  and	  lower	  leg	  muscles	  (soleus	  and	  tibialis	  
anterior	   [TA])	  was	  assessed	   (B),	   and	   then	   reassessed	  after	  6	  weeks	   (R1),	  6	  months	  
(R2)	   and	   1	   year	   (R3).	   	  With	   19	   participants	   and	   4	   assessments,	   this	   study	   ranked	  
amongst	  the	  	  highest	  powered	  reliability	  studies	  of	  TMS	  parameters	  ever	  conducted	  
using	  ICCs,	  and	  a	  sufficient	  combination	  to	  assess	  the	  most	  variable	  TMS	  parameters	  




Bipolar	   surface	   electrodes	   (Ag/AgCl,	   ARBO	   blue,	   2-­‐cm	   diameter)	   were	   positioned	  
over	  the	  following	  muscles:	  	  
• ES:	   on	   either	   side	   of	   the	   vertebral	   column	   over	   the	   palpable	   bulge	   of	   the	  
erector	   spinae	   muscle	   (≈3cm	   bilateral	   to	   the	   midline),	   both	   at	   the	   twelfth	  
thoracic	  and	  fourth	  lumbar	  levels	  (Vink	  et	  al.,	  1989,	  Nowicky	  et	  al.,	  2001).	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• RA:	  on	  the	   lower	  rectus	  abdominis,	  the	  more	  superior	  electrode	  was	  placed	  
1.5	   cm	   inferior	   to	   the	   umbilicus	   and	   approximately	   2.5-­‐3	   cm	  bilateral	   from	  
the	  midline	  (Tunstill	  et	  al.,	  2001).	  	  
• OE:	   the	   superior	   electrode	   directly	   below	   the	   most	   inferior	   point	   of	   costal	  
margin	  and	  the	  inferior	  electrode	  on	  the	  line	  to	  opposite	  pubic	  tubercle	  (Anders	  
et	  al.,	  2008).	  	  
• Soleus:	  bilaterally	  over	  the	  midline	  of	  the	  soleus	  belly,	  the	  superior	  electrode	  
about	   2.5	   cm	   inferior	   to	   the	   inferior	   border	   of	   the	   medial	   head	   of	   the	  
gastrocnemius	   muscle,	   and	   parallel	   to	   the	   longitudinal	   axis	   of	   the	   leg	   to	  
approximate	  the	  direction	  of	  the	  muscle	  fibres.	  	  
• TA:	   over	   the	  most	   longitudinally	   prominent	   aspect	   of	   the	  muscle	   belly,	   the	  
superior	  electrode	  approximately	  one	  quarter	  of	  the	  distance	  from	  the	  tibial	  
plateau	  to	  the	  medial	  malleolus,	  immediately	  lateral	  to	  the	  crest	  of	  the	  tibia.	  	  
	  
A	  ground	  reference	  electrode	  was	  placed	  on	  the	  iliac	  crest	  of	  the	  pelvis	  and	  on	  the	  
left	  fibular	  head.	  The	  EMG	  signals	  were	  bandpass	  filtered	  (-­‐3	  db	  at	  10	  Hz	  and	  2	  kHz)	  
and	  amplified	   (×1000;	   Iso-­‐DAM,	  WPI,	  UK)	  before	  being	  sampled	  at	  4	  kHz	  by	  a	  data	  
acquisition	  interface	  (Power	  1401	  Plus	  and	  Signal	  software	  Version	  3.13;	  Cambridge	  
Electronic	   Design,	   UK).	   Participants	   were	   given	   visual	   feedback	   of	   the	   integrated	  






Participants	  were	  asked	  not	   to	   consume	  caffeinated	  or	   alcoholic	  drinks	   and	  where	  
possible,	   were	   studied	   during	   the	   same	   time	   slot	   of	   the	   day	   between	   visits	   to	  
minimise	  to	  minimise	  any	  circadian	  effects	  on	  the	  cSP	  (Lang	  et	  al.,	  2011).	  They	  first	  
filled	  out	   a	   short	  questionnaire,	   providing	   their	   body	  mass	   index,	   handedness	   (see	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chapter	   3),	   their	   main	   type	   of	   recent	   activity,	   details	   of	   any	   drug	   intake	   and	   any	  
previous	   history	   of	   acute	   LBP	   or	   other	   musculoskeletal	   pathologies.	   Positioned	  
supine,	  with	   the	   couch	   backrest	   inclined	   at	   45°,	  wedge	   cushions	   and	  Velcro	   straps	  
were	  used	  to	  maintain	  the	  subjects’	  knees	  flexed	  at	  90°	  and	  ankles	  at	  90°	  to	  minimise	  
activation	  of	   thigh	   flexors.	  Participants	  used	  visual	   feedback	   to	  maintain	  consistent	  
isometric	   abdominal	   contractions.	   All	   trunk	   contractions	   were	   carried	   out	   while	  
breath-­‐holding	   in	   order	   to	   maintain	   equal	   abdominal	   muscle	   breathing	   cycle	  
modulation.	  	  A	  set	  of	  bilateral	  trunk	  flexions	  (BTF),	  followed	  by	  a	  set	  of	  left	  to	  right	  
rotations	   (L-­‐RTR),	   	   and	   finally	   a	   set	   of	   right	   to	   left	   trunk	   rotations	   (R-­‐LTR)	   were	  
performed,	   	   while	   bilateral	   responses	   to	   transcranial	   magnetic	   stimulation	   of	   the	  
motor	  cortex	  were	  recorded.	  	  For	  the	  rotations,	  participants	  were	  asked	  to	  move	  one	  
shoulder	  towards	  the	  contralateral	  knee.	  	  Lying	  prone	  on	  a	  flat	  horizontal	  couch	  with	  
large	   Velcro	   bands	   restraining	   ankles	   and	   scapulae,	   the	   protocol	  was	   repeated	   for	  
erector	   spinae	   with	   bilateral	   extensions	   (BTE)	   of	   the	   trunk	   to	   40%	   of	   MVC.	  
Participants	   were	   asked	   	   to	   hold	   their	   breaths	   and	   rigidly	   extend	   their	   trunks,	  
imagining	  an	  inflexible	  lever	  along	  their	  spine	  extending	  from	  the	  sacrum.	  	   In	  order	  
to	  minimise	  fatigue	  and	  discomfort,	  only	  three	  stimuli	  were	  delivered	  between	  rests	  
at	   higher	   (<40%MSO)	   intensities.	   Then	   participants	   were	   seated	   on	   a	   45	   cm	   high	  
chair	  with	  restrained	  ankles	  in	  line	  with	  the	  vertical	  projection	  of	  the	  knee	  joint;	  feet	  
strapped	  flat	  to	  a	  board	  on	  the	  floor.	  	  The	  contraction	  of	  TA	  was	  achieved	  by	  graded	  
dorsiflexion	  of	  the	  ankle	  whereas	  soleus	  responses	  were	  facilitated	  by	  plantarflexion.	  
TMS	  was	  delivered	  using	  a	  9cm	  angled	  double-­‐cone	  coil	  	  powered	  by	  a	  Magstim	  2002	  
stimulator	   (Magstim	   Co.	   Ltd.,	   UK),	   positioned	   symmetrically	   over	   the	   vertex	   and	  
polarised	   to	   induce	   posterior-­‐to-­‐anterior	   current	   flow	   in	   the	  motor	   cortex.	   	   A	   full	  
recruitment	   curve	   of	   TMS	   pulse	   intensities,	   delivered	   in	   sets	   of	   6	   to	   30	   pulses,	   at	  
intervals	  of	  5%	  of	  maximum	  stimulator	  output	   (%MSO),	   from	  the	  threshold	   for	   the	  
cortical	  silent	  period	  (cSPTh)	  to	  150%	  of	  motor	  threshold	  (MTh),	  was	  delivered	  in	  a	  




Data	  and	  Statistical	  Analyses	  
	  
The	  cSPTh	  was	  defined	  as	  the	  intensity	  of	  the	  lowest	  appearance	  of	  the	  cSP	  valley	  in	  
20-­‐30	   averaged	   rectified	   PSTHs.	   The	  MTh	  was	   assessed	   as	   the	   lowest	   intensity	   of	  
TMS	  that	  produced	   identifiable	  MEPs	  of	  at	   least	  200uV	  on	  at	   least	  50%	  of	  stimulus	  
presentations.	   All	   MEP	   and	   cSP	   onsets	   and	   offsets	   were	   visually	   identified	   and	  
defined	   by	   intersection	   of	   the	   average	   rectified	   EMG	   trace	   and	   the	   mean	   pre-­‐
stimulus	  EMG	  line.	  MEPs	  were	  quantified	  as	  the	  area	  above	  this	  line	  whereas	  the	  cSP	  
was	  defined	  as	  the	  offset.	  	  MEPs	  and	  cSPs	  were	  quantified	  at	  120%	  of	  MTh	  (1.2MTh).	  	  
MEP	  areas	   (MArea),	  peak	   to	  peak	  amplitudes	   (P2P),	   cSP	  offset	   (cSP)	  at	  all	   stimulus	  
intensities	  were	  also	  fitted	  to	  a	  Boltzmann	  function	  (Devanne	  et	  al.,	  1997)	  given	  by:	  P	  
(%MSO)	  =	  Max	  /(1	  +	  exp	  [X50-­‐P/k]),	  where	  P	  is	  the	  TMS	  parameter	  of	  interest,	  Max	  is	  
the	   recruitment	  curve	   (RC)	  plateau	  parameter	  value,	  k	   is	   the	  slope	  parameter,	  and	  
X50	   is	   the	  curve	  midpoint	   intensity	  as	  a	  percentage	  of	  MSO.	   	  EMG	  data	  processing	  
and	  non-­‐linear	   regression	  analysis	  was	   carried	  out	  using	   the	   set	  of	   custom	  written	  
programs	  (detailed	  in	  chapter	  3	  and	  included	  in	  the	  Appendices	  3-­‐8),	  written	  in	  CED	  




Parameters	   of	   corticospinal	   excitability	   (MTh,	  MArea,	   P2P,	   RC	  Max,	   RC	   k,	   RC	   X50,	  
cSP,	  cSPTh,	  MEP	   latency)	   for	   left	  and	  right	  muscles	  over	   the	   four	   time	  points	  were	  
analysed	   separately	   using	   one-­‐way	   repeated	   measures	   (RM)	   analysis	   of	   variance	  
(ANOVA)	  factorised	  for	  time	  (B,	  R1,	  R2,	  R3).	  Paired	  t-­‐tests	  were	  used	  to	  compare	  left	  
and	  right	  muscles.	  	  Statistical	  analyses	  were	  carried	  out	  using	  Sigmastat	  (version	  3.5,	  
Systat	   Software,	   Inc).	   	   Long	   term	   test-­‐retest	   reliability	   and	   stability	  was	  measured	  
using	   intraclass	   correlation	   coefficients	   (ICC(A,k0))	   and	   their	   95%	   confidence	   limits,	  
using	  a	  two-­‐way	  random	  effects	  model	  indexed	  for	  absolute	  agreement.	  	  This	  is	  the	  
most	   robust	   measure	   of	   reliability	   and	   can	   identify	   the	   suitability	   of	   physiological	  
measurements	   for	   clinical	   applications.	   	   This	   analysis	   of	   central	   motor	   control	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parameters	   has	   never	   been	   carried	   out	   over	   such	   a	   long	   period	   (1	   year)	   and	  
computing	  4	  repeats	  into	  the	  ICC.	  A	  one	  way	  RM	  ANOVA	  was	  used	  to	  calculate	  the	  
standard	  error	  of	  measurement	   (SEM).	   It	   is	  derived	   from	  the	  ANOVA	  mean	  square	  
error	   (MSE)	   term	  and	   is	   a	  measure	  of	   the	  within-­‐subject	   absolute	   reliability	  of	   the	  
data.	   It	   is	  given	  by:	  SEM= .	  SEM	   is	  different	   to	   ICC	   in	   that	   it	   is	   comparatively	  
sample	   independent,	   while	   the	   ICC	   also	   accounts	   for	   the	   total	   variation	   of	   the	  
population	   analysed.	   The	   smallest	   real	   difference	   (SRD;	   also	   in	   the	   same	   units)	  
(Beckerman	   et	   al.,	   2001)	   indicates	   the	   smallest	   difference	   required	   to	   produce	   a	  
statistically	   significant	   change	   in	   one	   subject	   given	   the	   current	   sample	   and	  
measurement	   error:	   SRD= .	   	   spinal	   Excitability	   of	   the	   Trunk	   and	  





Of	   the	  19	  healthy	   control	  participants,	  2	   subjects	  dropped	  out	  of	   the	   study	  before	  
completing	  all	  four	  sessions	  and	  1	  subject’s	  data	  post	  baseline	  was	  disregarded	  from	  
the	   analysis	   due	   to	   his	   development	   of	   chronic	   (16	  week	   duration)	   back	   pain	   at	   5	  
weeks.	   	   Two	   further	   subjects	   also	   reported	   details	   of	   acute	   self-­‐limiting	   muscular	  
back	  pain	  of	  a	  few	  days	  duration	  which	  had	  fully	  resolved	  at	   least	  3	  weeks	  prior	  to	  
their	   next	   EMG	   assessment.	   	   Generally	   6	   of	   the	   18	   controls	   reported	   having	  








Leg Muscles  
	  
Graded and Maximum Voluntary Contractions 
	  
Subjects	   managed	   to	   consistently	   produce	   graded	   contractions	   between	   20%	   and	  
30%	  of	  their	  maximum	  recorded	  voluntary	  contraction	  (MVC)	  with	  both	  SOL	  and	  TA.	  	  
Soleus	   graded	   contractions	   at	   1.2MTh	  were	   consistently	   less	   precise	   and	   deviated	  
roughly	  twice	  as	  much	  from	  the	  mean	  percentage	  (of	  MVC)	  as	  TA	  contractions.	  	  	  
Subjects	   produced	   higher	   MVC’s	   with	   the	   left	   Soleus	   and	   right	   TA	   and	   this	   was	  
significant	   in	   TA	   at	   baseline	   and	   R1.	   	   Consistency	   analysis	   over	   four	   time	   points	  
showed	  no	  time	  effects	  in	  either	  muscles	  ([F-­‐test,	  P]	  in	  Table	  4.2).	  	  Although	  within-­‐
subject	   test	   retest	   reliability	   was	   fair	   to	   good	   (as	   in	   left	   soleus)	   with	   wide	   CI,	   the	  
magnitude	   of	   the	   error	   of	  measurement	   (SEM)	  was	   less	   than	   0.01	   V	   (ignoring	   the	  
group	  mean	  component	  present	  in	  ICC	  measurements).	  
	  
Table	  4.2:	  Long	  Term	  Consistency	  of	  Leg	  Maximum	  Voluntary	  Contractions	  
	  
P	   ICC	   95%CI	   SEM	  (V)	  
L	   R	   L	   R	   L	   R	   L	   R	  
Soleus	   0.5	   0.61	   0.69	   0.48	   0.47:0.86	   0.23:0.74	   0.002	   0.003	  
TA	   0.86	   0.64	   0.47	   0.46	   0.22:0.73	   0.21:0.72	   0.002	   0.008	  










Side	   L	   R	   L	   R	   L	   R	   L	   R	  
Sol	  
MVC	  (V)	   0.21±0.02	   0.22±0.02	   0.21±0.03	   0.22±0.03	   0.2±0.02	   0.21±0.02	   0.22±0.03	   0.19±0.02	  
GC	  %	   25.67±1.51	   24.08±1.32	   27.95±1.67	   25.74±1.74	   26.06±1.38	   24.53±1.43	   25.02±1.72	   24.29±1.65	  
TA	  
MVC	  (V)	   0.33±0.02	   0.38±0.04	   0.32±0.03	   0.4±0.04	   0.32±0.03	   0.33±0.02	   0.34±0.03	   0.38±0.04	  




Motor Evoked Potentials 
	  
Figure	  4.1	  and	  Table	  4.3	  display	  consistent	  motor	  thresholds	  in	  Soleus	  and	  TA.	   	  Active	  MTh	  




A	  bar	  graph	  of	  MEP	  areas	  (Figure	  4.2)	  and	  P2P	  Amplitudes	  (Figure	  4.3)	  	  normalised	  to	  MVCs	  
at	  1.2MTh	   further	   reflects	   this	   threshold	  asymmetry	  with	   larger	   (yet	  not	   significant)	  mean	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Figure	  4.1:	  Leg	  Motor	  Thresholds	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Table	  4.3	  reports	  the	  mean	  values	  of	  these	  MEP	  sizes	  and	  latencies	  at	  1.2MTh.	  	  As	  stimulator	  
intensities	   increased	  by	  a	  nominal	  5%	  this	  was	  as	  close	  to	  1.2MTh	  as	  possible	  [%MTh],	  and	  
generally	   between	  1.18	   and	  1.24.	   	   Latencies	   remained	   a	   steady	   average	  of	   30.45±0.22	  ms	  
throughout	  the	  4	  sessions	  with	  no	  side	  differences.	  	  	  
Recruitment	  curves	  constructed	  for	  each	   individual	  such	  as	  the	  Soleus	  MEP	  Area	  (nMArea)	  
curve	  in	  figure	  4.4	  displayed	  a	  sigmoidal	  shape	  and	  mean	  boltzmann	  fit	  parameters	  such	  as	  
the	  maximum	  MEP	  value	  defined	  by	  the	  function	  (Max),	  the	  midpoint	  of	  the	  curve	  (X50)	  in	  
%MSO,	  the	  slope	  a	  this	  steepest	  point,	  and	  the	  x-­‐intercept	  of	  a	  straight	  line	  with	  this	  slope	  
from	  X50.	  	  
	  
	  
	  	  Figure	  4.4:	  Soleus	  nMEP	  Area	  RC	  for	  a	  single	  Subject	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L	   R	   L	   R	   L	   R	   L	   R	  
%MTh	   1.22±0.02	   1.2±0.02	   1.22±0.02	   1.2±0.02	   1.22±0.02	   1.23±0.01	   1.21±0.01	   1.21±0.01	  
MTh	  (%MSO)	  	   37.97±2.07	   40.5±2.07	   37.44±1.96	   42.52±2.32*	   38.19±2.01	   41.25±2.2	   38.67±2.34	   43.32±2.8*	  
Latency(ms)	   30.82±0.53	   30.76±0.71	   30.98±0.52	   30.89±0.57	   30.65±0.56	   30.41±0.59	   30.58±0.66	   29.94±0.66	  
nMArea	  	   17.9±2.16	   14.67±1.98	   17.58±1.92	   15.81±1.76	   19.34±2.61	   16.89±2.38	   17.95±2.64	   17.86±2.25	  
RC	  R2	   0.56±0.06	   0.63±0.08	   0.58±0.05	   0.57±0.07	   0.65±0.06	   0.60±0.07	   0.55±0.05	   0.68±0.06	  
RC	  Slope	   2.55±0.28	   3.4±0.85	   4.36±1.76	   4.19±1.2	   4.98±1.88	   6.32±2.75	   4.79±2.12	   4.53±1.6	  
RC	  Max	   37.79±4.36	   57.55±16.55	   35.49±5.06	   52.45±18.84	   29.46±3.71	   59.79±21.43	   37.44±8.57	   51.94±9.52	  
X50(%MSO)	   44.89±2.06	   51.14±3.06	   43.63±2.21	   48.94±3.57*	   43.39±1.85	   51.82±3.27*	   44.83±2.4	   56.33±5.38*	  
X-­‐INT(%MSO)	   36.56±2.18	   42.4±2.67*	   36.31±2.11	   40.74±2.87*	   35.84±2.1	   42.17±2.93	   37.43±1.98	   44.58±3.63	  
nP2P	  	   6.24±0.48	   5.06±0.55	   6.31±0.55	   5.84±0.65	   6.85±0.68	   6.01±0.63	   6.66±0.88	   6.14±0.76	  
RC	  R2	   0.63±0.05	   0.58±0.07	   0.65±0.05	   0.6±0.06	   0.68±0.06	   0.65±0.07	   0.51±0.06	   0.65±0.06	  
RC	  Slope	   2.22±1.24	   1.2±0.32	   3.09±2.09	   1.31±0.44	   1.29±0.52	   1.24±0.44	   1.76±0.8	   1.46±0.59	  
RC	  Max	   17.6±5.34	   42.49±12.11*	   19.75±6.57	   27.27±9.01	   28.74±18.58	   41.06±13.17*	   9.06±0.93	   24.11±8.3	  
X50(%MSO)	   44.32±3.77	   57.6±6.19*	   44.03±4.45	   50.46±4.91	   44.26±4.14	   55.22±8.98	   40.26±2.07	   61.05±8.38	  
X-­‐INT(%MSO)	   32.47±2.85	   40.16±4.34*	   32.67±3.32	   37.46±3.78	   32.57±3.34	   39.74±6.32	   30.6±2.07	   37.33±5.2	  
Left	  to	  Right	  Asymmetry	  *P<0.05,**P<0.01	  
In	  table	  4.3,	  these	  are	  accompanied	  by	  nP2P	  curve	  results.	  	  Some	  of	  this	  MTh	  asymmetry	  has	  
carried	  over	  to	  some	  MTh	  dependent	  variables	  such	  as	  X50	  (significantly	  larger	  on	  the	  right	  
at	  R1,	  R2	  &	  R3	  in	  Area	  and	  B	  in	  P2P)	  and	  X-­‐
INT	  (significantly	  larger	  on	  the	  right	  at	  B	  and	  
R1	  in	  Area	  and	  B	   in	  P2P).	   	  Max	  values	  were	  
highly	  variable,	  as	  were	  slope	  and	  	  intercept	  
values.	  	  This	  was	  reduced	  in	  MEP	  Area	  (both	  
raw	   and	   normalised).	   X-­‐Intercept	   displayed	  
a	   better	   correlation	   with	   MTh	   by	   visual	  
inspection	   with	   a	   pearson’s	   correlation	  
coefficient	   of	   r=0.784	   compared	   to	   P2P	  
(r=0.453).	  
	  
TA	   had	   lower	  mean	  MTh	   (table	   4.4)	   and	  more	   individual	   curves,	   such	   as	   the	   sample	  MEP	  
Area	  RC	  of	  figure	  4.5,	  had	  visible	  plateaux	  regions.	  	  Significantly	  higher	  right	  thresholds	  and	  




matching	   significant	   asymmetries	   in	   some	   X50	   and	   X-­‐INT	   values	   were	   not	   found	   at	   every	  
time	  point.	  
	  
Table	  4.4:	  Tibialis	  Anterior	  1.2MTh	  Mean	  	  MEP	  	  and	  Individual	  Curve	  Fit	  Parameters	  














L	   R	   L	   R	   L	   R	   L	   R	  
%MTh	   1.23±0.01	   1.23±0.02	   1.22±0.02	   1.22±0.02	   1.24±0.01	   1.23±0.01	   1.23±0.01	   1.24±0.01	  
MTh	  (%MSO)	  	   34.93±1.32	   37.87±1.79*	   33.77±1.45	   37.29±2.06*	   33.73±1.65	   36.72±2.09*	   34.91±1.49	   37.7±1.98*	  
Latency(ms)	   28.57±0.56	   28.19±0.52	   27.83±0.62	   27.96±0.63	   28.2±0.59	   27.56±0.65	   28.01±0.55	   28.25±0.69	  
nMArea	  	   15.09±1.94	   12.83±1.64	   15.43±1.37	   14.65±1.44	   13.37±1.53	   14.64±1.8	   16.56±1.95	   15.05±1.82	  
RC	  R2	   0.69±0.05	   0.68±0.05	   0.73±0.05	   0.7±0.06	   0.73±0.04	   0.74±0.04	   0.7±0.05	   0.61±0.06	  
RC	  Slope	   1.96±0.19	   2.03±0.4	   2.19±0.38	   2.93±1.02	   1.87±0.27	   2.59±0.84	   2.26±0.3	   3.27±1.34	  
RC	  Max	   36.44±5.15	   39.25±13.47	   38.32±5.25	   35.14±4.21	   38.71±5	   44.34±8.74	   32.4±3.11	   39.98±8.34	  
X50	  (%MSO)	   44.39±1.76	   50.52±3.9	   42.14±1.97	   47.42±3.28**	   44.24±2.63	   47.07±2.33	   42.09±1.76	   51.25±3.99	  
X-­‐INT	  (%MSO)	   34.55±1.7	   38.84±3.02	   31.28±2	   37.1±2.62**	   33.95±2.11	   36.22±2.17*	   33.92±1.65	   38.59±2.08*	  
nP2P	  	   5.15±0.49	   4.03±0.42*	   5.2±0.24	   4.75±0.28	   4.66±0.31	   4.41±0.33	   5.04±0.38	   4.59±0.35	  
RC	  R2	   0.77±0.03	   0.6±0.08	   0.73±0.04	   0.66±0.04	   0.78±0.03	   0.67±0.05	   0.63±0.06	   0.66±0.07	  
RC	  Slope	   0.38±0.05	   0.55±0.2	   0.41±0.05	   0.42±0.06	   0.37±0.04	   1.3±0.54	   0.37±0.03	   0.33±0.03	  
RC	  Max	   8.27±0.66	   16.54±6.11	   10.34±1.7	   13.88±3.75	   8.63±0.75	   14.69±3.29	   7.89±0.42	   10.32±2.04	  
X50	  (%MSO)	   40.39±1.95	   52.15±5.67*	   35.65±3.58	   48.98±4.21*	   39.7±2.1	   46.17±5.96	   39.55±1.79	   47.84±4.21*	  
X-­‐INT	  (%MSO)	   27.19±1.56	   34.55±4.03	   25.36±2.28	   32.67±2.79**	   27.99±1.72	   32.89±3.4	   27.89±1.5	   32.03±2.73	  
Left	  to	  Right	  Asymmetry	  *P<0.05,**P<0.01	  
Mean	  X-­‐INT	  values	  closely	  matched	  mean	  MTh	  (by	  visual	  inspection)	  and	  3	  out	  of	  4	  sessions	  
matching	   the	   significant	   MTh	   asymmetry.	   	   Individual	   X-­‐INT	   values	   correlated	   with	   MTh	  




No	  side	  differences	  were	  found	  in	  Soleus	  and	  TA	  silent	  periods	  at	  1.2MTh	  (figure	  4.6).	  	  Both	  




Soleus	   and	   TA	   cSP	   individual	   fitted	   curves	   revealed	   high	  midpoint	   values	   (X50)	   and	   highly	  
variable	  Max	  values	  on	  both	  sides	  of	  the	  body.	  X-­‐INT	  correlated	  poorly	  to	  SPTh	  unless	  using	  

































Soleus	   Tibialis	  Anterior	  
Figure	  4.6:	  Leg	  Silent	  Periods	  at	  1.2Mth	  (Mean±SEM)	  
	  	  	  B	   	  	  	  	  	  	  	  	  R1	  	  	  	  	  	   R2	   	  	  	  	  	  	  R3	   	   	  	  	  	  	  	  	  B	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  R1	  	  	  	  	  	  	  	  	  	  	  	  	  	  R2	   	  	  	  	  	  	  	  	  	  	  	  	  	  R3	  






Graded and Maximum Voluntary Contractions 
	  
Although	  subjects	  were	  asked	  to	  produce	  graded	  contractions	  (GC)	  at	  40%	  of	  their	  level	  4	  ES	  
MVC,	  they	  usually	  managed	  a	  slightly	   lower	  contraction	  of	  38.91±2.52%	  over	  the	  four	  time	  
points	   (table	  4.6).	   	  Although	  not	   targeting	  ES	  at	  T12,	   subjects	  produced	  29.53±2.46	  %MVC	  


















L	   R	   L	   R	   L	   R	   L	   R	  
Soleus	  
cSPTh	  (%MSO)	  	   25.26±0.95	   26.58±1.18	   25.59±1.95	   26.47±2.15	   27.19±1.08	   27.5±1.25	   26.56±1.15	   27.19±1.25	  
cSP	  Area	  (mVms)	   0.87±0.07	   0.93±0.14	   0.93±0.14	   0.85±0.11	   0.77±0.1	   0.8±0.07	   0.88±0.13	   0.72±0.06	  
cSP	  (ms)	   107.18±5.94	   102.59±5.6	   101.78±5.81	   105.3±5.2	   107.11±6.6	   104.22±5.42	   111.97±6.71	   103.41±5.32	  
RC	  R2	   0.505±0.07	   0.479±0.05	   0.595±0.06	   0.565±0.05	   0.601±0.06	   0.511±0.07	   0.606±0.04	   0.608±0.04	  
RC	  Slope	   5.78±0.87	   4.44±0.73	   4.66±0.61	   4.51±0.78	   7.3±2.22	   7.7±3.01	   6.72±1.47	   6.92±2.67	  
RC	  Max	  (ms)	   730.4±140.7	   955.5±215.8	   463.1±120.3	   552.5±115.3	   789.2±291	   957.8±323.7	   650.3±157.9	   812.2±233.9	  
X50(%MSO)	   85.24±14.82	   51.8±21.1	   77.34±13.88	   60.78±15.8	   70.42±13.99	   70.62±15.48	   57.42±14.53	   77.64±10.36	  
X-­‐INT(%MSO)	   27.6±4.81	   21.17±5.01	   24.13±4.75	   20.43±5.07	   27.83±6.45	   27.36±7.46	   23.22±4.87	   21.39±5.39	  
TA	  
cSPTh	  (%MSO)	  	   26.05±0.8	   26.58±0.92	   24.17±1.58	   25.56±1.92	   26.56±0.85	   26.25±0.83	   27.19±1.08	   26.56±1.15	  
cSP	  Area	  (mVms)	   1.28±0.16	   1.81±0.38	   1.25±0.19	   1.96±0.35	   1.09±0.1	   1.46±0.17	   1.22±0.18	   1.55±0.22	  
cSP	  (ms)	   110.97±6.73	   113.54±8.06	   110.35±7.05	   116.61±8.7	   103.25±6.83	   109.95±7.47	   107.26±6.24	   109.67±7.1	  
RC	  R2	   0.494±0.06	   0.54±0.06	   0.607±0.04	   0.675±0.04	   0.636±0.07	   0.603±0.06	   0.647±0.05	   0.619±0.07	  
RC	  Slope	   7.58±1.35	   6.16±1.97	   6.96±1.07	   5.78±1.1	   5.77±1.24	   5.24±0.42	   7.83±1.44	   5.67±0.66	  
RC	  Max(ms)	   639.5±164.1	   593.3±142.2	   587.8±137.9	   416.8±110.1	   439.5±156.3	   472.6±100.4	   707.2±156.3	   499.9±92.3	  
X50(%MSO)	   61.38±8.95	   68.68±9.39	   56.2±10.35	   31.67±17.32	   52.2±5.86	   66.16±9.57	   69.03±7.93	   65.13±7.1	  
X-­‐INT(%MSO)	   27.06±5.13	   22.24±3.93	   23.63±3.9	   19.53±5.13	   21.03±3.54	   25.09±3.17	   27.97±3.91	   25.68±2.98	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Side	   L	   R	   L	   R	   L	   R	   L	   R	  
ES	  
L4	  
MVC	  (V)	   0.14±0.02	   0.14±0.02	   0.14±0.02	   0.15±0.02	   0.13±0.02	   0.14±0.02	   0.14±0.02	   0.14±0.02	  
GC	  (%MVC)	   38.85±1.87	   39.8±1.67	   38.21±2.54	   40.16±3.45	   39.82±3.12	   37.61±2.96	   37.89±2.29	   38.92±2.21	  
ES	  
T12	  
MVC	  (V)	   0.19±0.03	   0.21±0.03	   0.24±0.04	   0.23±0.03	   0.2±0.03	   0.22±0.03	   0.23±0.04	   0.24±0.04	  
GC	  (%MVC)	   29.33±2.21	   29.93±2.17	   28.42±2.49	   33.48±2.7	   27.73±2.59	   28.59±2.21	   28.53±2.5	   30.27±3.0	  
	  
Subjects	   produced	   symmetrical	  MVC’s	   with	   ES	   and	   this	   was	   true	   at	   both	   levels,	   although	  
these	   were	   significantly	   higher	   at	   T12	   (0.14±0.02	   vs	   0.22±0.03	   V)	   over	   all	   time	   points	  
(P<0.05).	   	   This	  was	   also	   true	   for	   the	   raw	  pre-­‐stimulus	   EMG	   (0.052±0.01	  VS	   0.061±0.01	  V).	  	  
However	   both	   pre-­‐stimulus	   EMG	   and	   MVCs	   changed	   highly	   proportionally	   at	   both	   levels	  
(r=0.89	  and	  0.87	  respectively).	  	  
Consistency	  analysis	  over	  four	  time	  points	  showed	  no	  time	  effects	   in	  either	  muscles	  (F-­‐test	  
“P”	   in	   Table	   4.7).	   	   The	   consistency	   of	   MVCs	   over	   the	   four	   time	   points	   was	   excellent	  
(ICC>0.75)	  with	  narrow	  CI,	  and	  was	  higher	  in	  ES	  then	  in	  leg	  muscles.	  	  	  
	  
Table	  4.7:	  Long	  Term	  Consistency	  of	  Back	  Maximum	  Voluntary	  Contractions	  
	  
P	   ICC	   95%CI	   SEM	  (V)	  
L	   R	   L	   R	   L	   R	   L	   R	  
ES	  L4	   0.24	   0.46	   0.89	   0.86	   0.87:0.97	   0.73:0.94	   0.001	   0.001	  




At	   40.48±2.22	   VS	   39.28±1.7	   %MSO	   at	   L4	   and	   T12	   respectively	   (figure	   4.8),	   MTh	   were	  















Figure	   4.9	   displays	   ES	   nMArea	   at	   1.2MTh.	   	   Despite	   the	   fact	   that	   visual	   feedback	  
corresponded	   to	   L4,	   nMAreas	   were	   not	   significantly	   different	   (table	   4.8)	   between	   levels	  
(19.69±2.4	  VS	  19.74±2.57	  %MVC)	  although	   the	   raw	  values	  were	   significantly	  higher	   in	  T12	  
(2.79±0.49	   VS	   4.26±0.78	   mV).	   	   There	   were	   significant	   latency	   differences	   between	   levels	  
(15.31±0.44	  VS	  15.23±0.46).	  Although	  the	  MEP	  area	  curve	  fits	  yielded	  high	  R2	  values,	  the	  X50	  




RC	  x-­‐intercept	  values	  correlated	  poorly	  to	  visually	  guided	  MTh	  values	  (r<0.2)	  at	  both	  spinal	  
levels.	  	  There	  were	  no	  significant	  differences	  between	  RC	  slopes	  over	  the	  4	  sessions	  between	  


































LEFT	  ES	  L4	   RIGHT	  ES	  L4	  
	  	  B	   	  	  	  	  	  R1	   	  	  	  	  	  	  	  	  	  R2	  	  	  	  	  	  	  	  	  	  	  	  R3	   	  	  	  	  	  	  	  	  	  	  	  	  B	  	  	  	  	  	  	  	  	  	  	  	  	  R1	  	  	  	  	  	  	  	  	  	  	  	  R2	   	  	  	  	  	  	  	  R3	  














Although	   normalised	   P2P	   values	   were	   not	   significantly	   smaller	   in	   T12	   (5.57±0.42	   VS	  
4.58±0.45),	   they	  were	   significantly	  higher	   in	   raw	  values	   (0.67±0.08	  VS	  0.77±0.12	  mV)	  over	  
the	  four	  time	  points.	  	  nP2P	  recruitment	  were	  significantly	  steeper	  in	  T12	  then	  L4	  (0.55±0.17	  
vs	   0.43±0.08;	   P<0.05).	   	   X-­‐Intercept	   values	   correlated	   poorly	  with	   threshold	   values	   (r<0.2).	  
These	  were	   significantly	   lower	   in	  T12,	   as	  were	  MTh	   (31.71±3.3	  VS	  29.69±3.2	  %MSO),	  over	  
the	  4	  time	  points.	  
	  
	  














L	   R	   L	   R	   L	   R	   L	   R	  
ES	  L4	  
%	  MTh	   1.22±0.01	   1.23±0.01	   1.23±0.02	   1.22±0.02	   1.21±0.03	   1.22±0.02	   1.22±0.01	   1.21±0.02	  
MTh	  (%MSO)	  	   40.97±1.74	   40.12±1.77	   39.34±1.93	   39.7±1.67	   43.2±3.7	   40.16±2.32	   40.35±2.06	   39.96±2.52	  
Latency	  (ms)	   15.2±0.5	   14.87±0.46	   15.68±0.38	   15.2±0.47	   15.36±0.4	   14.89±0.44	   16.01±0.45	   15.27±0.37	  
nMArea	  	   17.29±2.19	   18.52±2.3	   20.96±2.07	   19.49±2.2	   19.68±2.49	   20.81±2.15	   18.94±2.75	   21.82±3.05	  
RC	  R2	   0.73±0.04	   0.71±0.07	   0.73±0.05	   0.75±0.04	   0.71±0.04	   0.72±0.06	   0.78±0.03	   0.78±0.04	  
RC	  Slope	   3.3±1.15	   3.8±1.5	   3.59±1.03	   3.23±0.73	   3.38±1.01	   3.34±0.7	   2.33±0.64	   4.53±1.97	  
RC	  Max	   70.32±29.04	   62.88±18.47	   65.39±21.37	   79.1±27.47	   66.82±22.01	   79.54±24.13	   49.45±8.64	   63.58±22.1	  
RC	  X50	   47.68±2.83	   58.09±9.92	   48.82±4.76	   53.23±5.56	   48.45±3.1	   50.37±4.05	   52.5±4.19	   48.43±3.5	  
X-­‐INT	   37.9±2.35	   41.04±4.75	   37.84±2.98	   39.93±3.35	   37.55±2.69	   38.85±3.07	   37.11±2.11	   37.24±2.78	  
ES	  T12	  
%	  MTh	   1.22±0.01	   1.23±0.02	   1.24±0.01	   1.22±0.01	   1.22±0.01	   1.23±0.01	   1.25±0.01	   1.22±0.01	  
MTh	  (%MSO)	  	   39.21±1.66	   39.41±1.44	   37.66±1.76	   39.01±1.4	   40.43±2.01	   39.43±1.69	   39.64±1.84	   39.48±1.83	  
Latency	  (ms)	   15.47±0.43	   14.96±0.37	   15.69±0.38	   15.94±0.6	   14.78±0.51	   14.51±0.43	   15.09±0.43	   15.41±0.47	  
nMArea	  	   18.13±2.36	   21.06±2.98	   21.1±2.17	   18.66±2.77	   17.27±2.17	   19.44±2.59	   20.14±2.46	   22.06±3.0	  
RC	  R2	   0.74±0.04	   0.76±0.03	   0.66±0.05	   0.66±0.07	   0.65±0.04	   0.64±0.07	   0.64±0.04	   0.7±0.03	  
RC	  Slope	   2.88±0.48	   2.94±0.58	   3.48±0.74	   4.3±1.05	   3.28±0.63	   2.56±0.4	   6.81±2.69	   4.68±1.13	  
RC	  Max	   62.62±13.17	   54.97±14.54	   52.84±10.23	   87.46±28.25	   48.57±8.3	   39.81±5.51	   63.25±24.6	   75.66±16.08	  
RC	  X50	   48.5±3.04	   46.76±2.31	   47.2±4.03	   53.71±5.84	   49.43±3.64	   45.13±2.69	   48.37±4.06	   55.19±5.62	  











ES	  cSPs	  at	  1.2MTh	  (figure	  4.11)	  significantly	  differ	  throughout	  the	  year	  of	  assessment	  at	  both	  
levels	  (89.47±5.58	  VS	  87.29±4.92	  ms).	  
	  
	  
This	   was	   also	   true	   for	   cSPTh	   (26.77±1.83	   VS	   27.33±1.75	   %MSO).	   	   There	   were	   high	   error	  























LEFT	  ES	  L4	  
RIGHT	  ES	  L4	  















L	   R	   L	   R	   L	   R	   L	   R	  
ES	  L4	  
nP2P	   5.34±0.48	   5.67±0.44	   5.75±0.4	   5.46±0.34	   5.41±0.45	   5.84±0.45	   5.44±0.41	   5.65±0.42	  
RC	  R2	   0.73±0.03	   0.74±0.04	   0.71±0.05	   0.72±0.05	   0.74±0.03	   0.74±0.04	   0.81±0.02	   0.76±0.04	  
RC	  Slope	   0.3±0.04	   0.49±0.14	   0.66±0.18	   0.56±0.13	   0.34±0.04	   0.4±0.05	   0.31±0.05	   0.35±0.03	  
RC	  Max	   12.36±2.93	   19.59±7.22	   26.66±11.55	   21.13±5.23	   13.73±3.08	   12.34±2.61	   10.24±1.97	   15.07±3.45	  
RC	  X50	   47.55±4.87	   38.03±11.5	   46.74±5.63	   57.52±7.79	   50.42±5.96	   48.02±5.19	   47.49±5.79	   55.33±9.04	  
X-­‐INT	   29.14±3.27	   29.12±4.13	   30.64±4.19	   31.39±3.37	   29.25±2.86	   31.16±2.19	   26.63±1.89	   30.2±3.67	  
ES	  T12	  
nP2P	   4.87±0.62	   4.88±0.5	   4.72±0.36	   4.49±0.41	   4.1±0.37	   4.49±0.52	   4.21±0.3	   4.87±0.56	  
RC	  R2	   0.73±0.04	   0.69±0.04	   0.7±0.04	   0.69±0.03	   0.7±0.04	   0.7±0.05	   0.69±0.05	   0.71±0.04	  
RC	  Slope	   0.57±0.15	   0.48±0.14	   0.62±0.18	   0.45±0.09	   0.46±0.14	   0.46±0.14	   0.78±0.33	   0.58±0.21	  
RC	  Max	   22.49±11.15	   20.68±7.65	   14.37±4.84	   15.24±4.46	   8.9±1.58	   19.58±10.78	   10.43±2.78	   25.04±11.64	  
RC	  X50	   52.32±5.95	   49.62±4.74	   46.18±6.98	   49.93±5.38	   47.58±4.04	   47.34±5.63	   49.57±6.23	   55.39±6.96	  
X-­‐INT	   33.5±3.73	   32.19±2.98	   30.43±4.01	   28.85±3.16	   31.75±1.69	   32.25±3.8	   32.35±3.32	   32.35±3.73	  























L	   R	   L	   R	   L	   R	   L	   R	  
ES	  L4	  
cSPTh(%MSO)	   24.74±2.34	   27.89±1.36	   27.78±1.43	   27.22±1.26	   26.25±2.19	   25.94±2.13	   26.25±2.32	   28.13±1.59	  
cSP	  (ms)	   95.36±5.86	   86.85±5.78	   90.21±5.47	   90.66±5.93	   92.52±4.88	   85.53±5.28	   88.03±6.03	   86.6±5.42	  
RC	  R2	   0.694±0.05	   0.69±0.03	   0.667±0.05	   0.632±0.05	   0.651±0.06	   0.65±0.05	   0.656±0.05	   0.673±0.04	  
RC	  Slope	   4.01±0.37	   4.48±0.65	   4.17±0.55	   4.74±0.64	   3.92±0.34	   4.86±0.84	   4.94±0.81	   5.09±1.01	  
RC	  Max	   249.7±54.5	   346±103.4	   304.4±57.7	   355.2±79.1	   339.4±78.8	   439.5±119.3	   407.9±106.6	   476.3±140.7	  
X50	   48.23±10.9	   58.96±9.18	   59±7.75	   60.77±7.82	   60.1±14.49	   69.65±10.44	   59.31±9.93	   70.68±13	  
X-­‐INT	   22.6±3.35	   27.08±4.05	   23.82±3.24	   27.32±3.51	   26.57±4.43	   31.25±5.02	   27.27±5.15	   29.19±5.66	  
ES	  T12	  
cSPTh(%MSO)	   26.32±1.93	   26.84±1.98	   28.06±1.42	   27.78±1.26	   26.56±2.15	   26.25±2.14	   28.44±1.58	   28.44±1.58	  
cSP	  (ms)	   87.58±4.91	   86.08±5.95	   85.7±4.14	   84.16±3.87	   89.5±4.61	   89.38±4.59	   87.81±5.89	   88.11±5.4	  
RC	  R2	   0.631±0.05	   0.674±0.05	   0.716±0.03	   0.542±0.06	   0.592±0.06	   0.658±0.05	   0.711±0.03	   0.668±0.06	  
RC	  Slope	   4.92±0.86	   6.34±2.14	   4.97±0.73	   5.95±1.24	   4.24±0.5	   5.77±1.26	   4.36±0.53	   5.65±1.22	  
RC	  Max	   302.5±92	   508±216.1	   322.7±56.9	   565.7±140.1	   288.9±60.4	   499.3±103.5	   362.8±56.8	   578.4±155.2	  
X50	   40.09±10	   61.63±9.19	   57.26±6.52	   64.44±10.94	   48.41±10.75	   78.56±10.45	   68.91±8.76	   63.61±13.01	  




Abdominal	  responses	  could	  be	  recorded	  16	  participants.	   	  Of	  those	  one	  participant	  was	  lost	  
to	  follow-­‐up	  at	  6	  weeks	  and	  one	  further	  subject	  was	  lost	  to	  follow	  up	  at	  one	  year.	  
	  
Graded	  and	  Maximum	  Voluntary	  Contractions	  
	  
Subjects	  were	   asked	   to	  produce	   graded	   contractions	   (GC)	   at	   30%	  of	   their	  maximum	   trunk	  
flexion	  (RA)	  and	  rotation	  (EO),	  and	  managed	  these	  levels	  (table	  4.11).	   	  Similar	  levels	  of	  raw	  















Side	   L	   R	   L	   R	   L	   R	   L	   R	  
RA	  
	  
MVC	  (V)	   0.18±0.02	   0.16±0.02	   0.17±0.03	   0.15±0.02	   0.16±0.02	   0.15±0.02	   0.17±0.03	   0.16±0.03	  
GC	  (%MVC)	   35.55±3.1	   34.54±3.27	   32.05±2.91	   30.43±3.29	   29.46±1.15	   32.22±1.92	   29.38±1.45	   32.92±2.91	  
EO	  
	  
MVC	  (V)	   0.14±0.02	   0.15±0.02	   0.13±0.02	   0.16±0.03	   0.14±0.02	   0.14±0.03	   0.14±0.02	   0.11±0.01	  
GC	  (%MVC)	   30.44±2.66	   36.1±3.9	   37.18±5.06	   35.87±2.92	   34.64±2.52	   36.72±2.82	   31.71±2.19	   33.84±2.3	  
	  
Consistency	  analysis	  over	  four	  time	  points	  showed	  no	  time	  effects	   in	  either	  muscles	  (F-­‐test	  
“P”	   in	   Table	   4.12).	   	   The	   consistency	   of	   MVCs	   over	   the	   four	   time	   points	   was	   excellent	  
(ICC>0.81)	  with	  narrow	  CI,	  and	  low	  measurement	  error.	  
	  
Table	  4.12:	  Long	  Term	  Consistency	  of	  Abdominal	  Maximum	  Voluntary	  Contractions	  
	  
P	   ICC	   95%CI	   SEM	  (V)	  
L	   R	   L	   R	   L	   R	   L	   R	  
RA	   0.67	   0.46	   0.89	   0.88	   0.87:0.97	   0.73:0.96	   0.001	   0.001	  





Mean	  active	  motor	  thresholds	  remained	  stable	  and	  symmetrical	  over	  the	  four	  study	  













Abdominal	  MEP	  areas	  at	  1.2MTh	  were	  highly	  variable	  in	  trunk	  rotations	  (Figure	  4.13),	  but	  
with	  no	  effect	  of	  time	  (P=0.58	  and	  0.64).	  The	  latencies	  in	  RA	  (table	  4.13)	  were	  higher	  than	  in	  












































LEFT	   RIGHT	  
Figure	  4.12:	  	  Abdominal	  Motor	  Thresholds	  (Mean±SEM)	  
	  
	  	  	  	  B	   	  	  	  	  	  R1	   	  	  	  	  	  	  	  R2	  	  	  	  	  	  	  	  	  	  	  	  R3	   	  	  	  	  	  	  	  	  	  	  B	  	  	  	  	  	  	  	  	  	  	  	  R1	  	  	  	  	  	  	  	  	  	  	  	  R2	   	  	  	  R3	  
	   EO	  RA	  















There	   was	   a	   positive	   correlation	   between	   RC	   x-­‐intercept	   values	   and	   visually	   guided	   MTh	  
values	   in	   RA	   at	   baseline	   (r<0.545,	   P=0.001,	   n=33)	   and	   in	   EO	   over	   all	   time	   points(r=0.790,	  
P<0.001,n=110)	   and	   this	   also	   significant	   for	   the	   P2P	   curve	   x-­‐intercepts	  
(r=0.327,P<0.001,n=110).	  	  
	  
Abdominal	  muscles	  produced	   large	  peaks	  with	   few	  phases.	  Unlike	   the	  paraspinal	  muscles,	  
abdominal	   muscles	   displayed	   steeper	   P2P	   recruitment	   (table	   4.14	   vs	   table	   4.13	   slope	  


















L	   R	   L	   R	   L	   R	   L	   R	  
RA	  
%	  MTh	   1.24±0.02	   1.25±0.01	   1.25±0.02	   1.28±0.03	   1.26±0.02	   1.3±0.04	   1.27±0.03	   1.27±0.02	  
MTh	  (%MSO)	  	   35.35±1.45	   35.26±1.27	   36.47±1.39	   36.15±1.33	   36.87±1.46	   36.28±1.57	   36.14±1.38	   36.39±1.25	  
Latency	  (ms)	   18.54±0.48	   18.92±0.59	   17.84±0.32	   17.32±0.38	   17.63±0.44	   18.13±0.52	   17.46±0.47	   17.47±0.57	  
NArea	  	   67.38±11.67	   53.35±7.29	   81.24±12.28	   70.34±8.49	   80.24±12.09	   83.76±12.87	   71.75±12.41	   66.61±9.01	  
RC	  R2	   0.7±0.04	   0.68±0.06	   0.64±0.09	   0.6±0.08	   0.75±0.03	   0.8±0.02	   0.68±0.07	   0.74±0.03	  
RC	  Slope	   29.12±17.56	   6.11±1.4	   13.94±5.59	   8.72±2.88	   16.54±9.6	   6.08±0.93	   29.28±23.33	   7.2±1.57	  
RC	  Max	   139.6±16.05	   146.9±53.04	   121.35±25.2	   110.4±18.7	   109.4±18.36	   113.0±15.65	   104.21±16.2	   114.8±18.5	  
RC	  X50	   42.23±26.6	   40.47±3.05	   43.24±4.76	   44.43±4.42	   41.09±1.65	   42.1±2.07	   41.45±1.62	   41.14±2.17	  
X-­‐INT	   30.24±22.7	   29.21±6.89	   30.92±3.6	   29.17±4.02	   32.65±1.66	   32.21±1.88	   31.63±2.27	   32.01±2.51	  
EO	  
%	  MTh	   1.21±0.02	   1.23±0.01	   1.23±0.02	   1.22±0.02	   1.24±0.02	   1.19±0.02	   1.25±0.02	   1.23±0.02	  
MTh	  (%MSO)	  	   37.63±1.38	   37.66±1.39	   37.56±1.5	   38.6±1.72	   37.89±1.65	   35.83±2.86	   37.85±1.46	   37.79±1.36	  
Latency	  (ms)	   14.78±0.41	   15.77±0.59	   14.97±0.49	   14.95±0.4	   15.05±0.46	   15.65±0.6	   14.68±0.55	   15.41±0.58	  
NArea	  	   62.82±9.78	   63.06±9.28	   95.74±19.58	   88.68±11.38	   89.52±9.93	   66.35±8.03	   93.18±14.59	   73.67±6.66	  
RC	  R2	   0.64±0.07	   0.71±0.07	   0.53±0.09	   0.6±0.06	   0.71±0.06	   0.71±0.05	   0.62±0.06	   0.79±0.04	  
RC	  Slope	   51.74±26.67	   13.16±4.81	   45.85±15.9	   29.89±7.45	   70.49±31.78	   16.47±6.16	   27.2±11.69	   15.13±4.86	  
RC	  Max	   151.2±20.6	   370.7±200.7	   417.3±164.5	   313.1±100.9	   310.2±135.6	   278.3±78.7	   203.2±41.9	   402.3±210.6	  
RC	  X50	   44.94±2.37	   49.66±4.22	   47.22±3.72	   48.11±4.5	   47.84±3.28	   48.31±4.23	   47.65±3.01	   51.00±3.87	  




Abdominal	  cSPs	  at	  1.2MTh	  (figure	  4.14)	  were	  constant	  and	  symmetrical	  throughout	  the	  year	  
of	  assessment	   in	  both	  muscles.	   	  This	  was	  also	  true	   for	  cSPTh,	  which	  did	  not	  correlate	  with	  
cSP	  curve	  x-­‐intercepts	  (r=0.437,	  P=0.450,	  n=110).	  	  














L	   R	   L	   R	   L	   R	   L	   R	  
RA	  
nP2P	   10.16±1.49	   8.17±0.89	   12.24±1.57	   10.33±1.16	   11.75±1.32	   12.01±1.65	   10.75±1.81	   9.72±1.09	  
RC	  R2	   0.74±0.05	   0.66±0.07	   0.63±0.09	   0.66±0.07	   0.82±0.02	   0.79±0.03	   0.74±0.07	   0.73±0.05	  
RC	  Slope	   0.82±0.36	   1.09±0.31	   0.97±0.46	   0.92±0.3	   0.98±0.19	   0.76±0.12	   0.91±0.17	   0.98±0.23	  
RC	  Max	   23.44±7.9	   16.5±7.28	   18.54±6.98	   21±10.71	   22.1±4.06	   17.08±2.94	   17.61±2.4	   18.48±3.72	  
RC	  X50	   43.49±5.11	   44.11±4.87	   42.36±5.28	   40.52±3.6	   44.37±3.65	   41.77±2.84	   42.62±3.83	   40.1±2.61	  
X-­‐INT	   28.64±4.24	   23.52±6.36	   29.34±3.84	   24.82±3.32	   31.04±2.38	   29.83±2.01	   30.14±2.52	   29.66±2.7	  
EO	  
nP2P	   8.56±1.32	   8.08±0.91	   13.43±2.6	   11.59±1.45	   11.99±1.41	   9.53±1.16	   11.95±2.06	   10.12±0.68	  
RC	  R2	   0.71±0.06	   0.56±0.09	   0.64±0.08	   0.7±0.06	   0.75±0.04	   0.72±0.05	   0.66±0.06	   0.8±0.04	  
RC	  Slope	   1.21±0.48	   2.1±0.63	   2.28±0.68	   3.59±1.02	   1.77±0.37	   3.11±1.14	   1.27±0.3	   1.19±0.22	  
RC	  Max	   21.25±2.57	   47.39±21.91	   58.58±18.01	   88.62±34.41	   37.74±11.43	   69.21±30.4	   24.98±4.88	   32.27±12.49	  
RC	  X50	   46.17±3.25	   46.54±4.91	   47.6±4.72	   50.97±5.39	   46.84±3.36	   46.44±4.88	   47.15±3.74	   48.89±3.9	  



























Figure	  4.14:	  Abdominal	  Silent	  Periods	  at	  1.2Mth	  (Mean±SEM)	  



















L	   R	   L	   R	   L	   R	   L	   R	  
RA	  
cSPTh(%MSO)	   28±2.27	   29±2.26	   30±1.49	   27.67±2.25	   29.67±1.2	   30±1.05	   30.36±1.47	   30.71±1.32	  
Offset	  (ms)	   105.99±4.3	   107.16±4.2	   109.27±4.53	   102.85±3.9	   111.91±2.99	   111.32±2.55	   108.01±2.78	   104.81±3.24	  
RC	  R2	   0.533±0.06	   0.516±0.07	   0.462±0.07	   0.508±0.07	   0.584±0.06	   0.536±0.06	   0.571±0.08	   0.532±0.07	  
RC	  Slope	   21.71±10.09	   10.6±5.4	   12.19±6.29	   15.2±6.56	   10.68±6.18	   17.05±8.02	   11.18±6.46	   10.73±6.01	  
RC	  Max	   382.2±116.3	   370.4±123.0	   227.1±58.8	   219.6±87.7	   269.3±62.4	   273.2±91.9	   394.4±99.7	   474.4±132.9	  
X50	   25.79±13.3	   27.6±9.84	   12.7±11.1	   16.99±9.02	   19.84±11.33	   26.97±9.77	   41.99±14.29	   46.62±12.65	  
X-­‐INT	   13.44±4.27	   11.33±3.61	   8.84±2.85	   8.95±2.63	   8.7±3.01	   11±2.83	   14.36±4.07	   12.52±3.77	  
EO	  
cSPTh(%MSO)	   28.31±3.01	   31.75±1.23	   28.33±2.34	   28.67±2.43	   27.33±2.98	   31±1.17	   31.07±2.53	   31.79±1.3	  
Offset	  (ms)	   103.64±6.36	   106.4±4.33	   105.84±5.64	   106.62±5.53	   105.57±5.1	   97.56±4.82	   107.63±4.69	   103.15±5.35	  
RC	  R2	   0.655±0.06	   0.666±0.06	   0.6±0.08	   0.647±0.07	   0.56±0.07	   0.696±0.05	   0.601±0.06	   0.715±0.03	  
RC	  Slope	   24.22±12.43	   10.93±5.93	   9.47±2.67	   7.48±1.83	   7.68±1.56	   5.58±0.92	   4.59±0.71	   5.72±1.51	  
RC	  Max	   254.7±55.1	   193.8±39	   257.9±69	   148.4±30.3	   412.8±92.9	   322.2±71.4	   219.9±49.4	   227.6±53.9	  
X50	   46.13±9.07	   32.79±6.98	   44.25±8.48	   37.65±4.49	   47.34±11.25	   39.23±9.36	   27.64±10.45	   43±7.82	  
X-­‐INT	   19.15±2.79	   19.04±2.86	   22.42±2.93	   22.01±2.29	   24.66±4.98	   20.47±4.44	   15.14±2.85	   15.45±3.18	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Long Term Reliability and Consistency 
	  
Looking	   at	   the	   ANOVA	   column	   entitle	   P,	   none	   of	   the	   left	   or	   right	   MEP	   or	   cSP	  
parameters	   and	   their	   respective	   RC	   measures	   showed	   any	   effect	   of	   time	   in	   the	  
muscle	   studied.	  MTh	  was	   found	   to	  be	  highly	   reliable	   in	   all	  muscles	   0.75≤ICC≤0.93,	  
apart	   from	   the	   left	   EO=0.68	   (table	   4.16).	   In	   ES	   and	   RA	   these	   were	   just	   below	   or	  
within	  the	  excellent	  range	  0.88≤ICC≤0.93.	  MEP	  latency	  was	  in	  the	  adequate	  range	  in	  
abdominal	  0.59≤ICC≤0.67	  and	  leg	  muscles	  were	  highly	  reliable	  0.80≤ICC≤0.85	  (apart	  
from	  left	  soleus	  ICC=0.62).	  MEP	  areas	  were	  generally	  poor	  to	  adequate	  in	  all	  muscles	  
(0.30≤ICC≤0.53).	   	   MEP	   area	   recruitment	   curve	   parameters	   displayed	   poor	   to	  
adequate	   reliability	   (X50:	   0.13≤ICC≤0.70,	   slope	   (≤0.54),	   Max	   (≤0.35))	   with	   the	  
exception	   of	   X-­‐intercepts,	   which	   had	   adequate	   to	   high	   reliability	   in	   leg	   muscles	  
0.54≤ICC≤0.81.	  
	  
P2P	  amplitudes	   fell	   in	   the	  poor	   to	  adequate	   range:	  0.22≤ICC≤0.64	   (table	  4.17)	  and	  
did	  not	  provide	  improved	  reliability	  for	  curve	  data:	  0.01≤ICC≤0.76.	  
	  
The	   cSPTh	   test-­‐retest	   reliability	  was	   high	   to	   excellent	   0.75≤ICC≤0.90	   in	   all	  muscles	  
apart	  from	  left	  ES	  at	  L4	  (ICC=0.53),	  T12	  on	  both	  sides	  (L:	  ICC=0.67;	  R:	  ICC=0.73)	  and	  
EO	  (L:	  ICC=0.61;	  R:	  ICC=0.53).	  
	  
	  




Table	  4.16:	  Long	  Term	  Reliability	  of	  MEP	  Areas	  at	  1.2MTh	  and	  Individual	  Curve	  Fit	  Parameters	  
	   P	   ICC	   95%CI	   SEM	   SRD	  
	   L	   R	   L	   R	   L	   R	   L	   R	   L	   R	  
SOLEUS	  
MTh	  (%MSO)	  	   0.58	   0.64	   0.88*	   0.75*	   0.77:0.95	   0.55:0.89	   9.59	   15.61	   26.57	   43.25	  
LATENCY	  (MS)	   0.51	   0.37	   0.8*	   0.62	   0.64:0.92	   0.39:0.82	   0.91	   2.89	   2.52	   8.02	  
nMArea	   0.7	   0.64	   0.45	   0.31	   0.2:0.71	   0.07:0.61	   26.55	   32.12	   73.6	   89.03	  
RC	  Slope	   0.21	   0.85	   0.54	   0.36	   0.29:0.78	   -­‐.15:0.31	   35.95	   14.69	   99.66	   40.72	  
RC	  Max	   0.68	   0.8	   0.07	   0.06	   -­‐.12:0.37	   -­‐.12:0.36	   1574	   6601	   1362	   1829	  
RC	  X50	   0.86	   0.77	   0.7	   0.55	   0.48:0.86	   0.31:0.78	   10.98	   55.69	   30.42	   154.37	  
X-­‐INT	   0.86	   0.68	   	  	  0.8*	   0.61	   0.63:0.91	   0.38:0.82	   5.08	   38.68	   14.07	   107.2	  
TA	  
MTh	  (%MSO)	  	   0.23	   0.42	   0.88*	   0.85*	   0.77:0.95	   0.71:0.95	   7.18	   8.58	   19.9	   23.77	  
LATENCY	  (MS)	   0.72	   0.23	   0.83*	   0.85*	   0.68:0.93	   0.72:0.94	   0.49	   1.57	   1.37	   4.35	  
nMArea	   0.75	   0.69	   0.34	   0.42	   0.11:0.61	   0.17:0.69	   19.59	   13.26	   54.29	   36.75	  
RC	  Slope	   0.88	   0.24	   0.47	   0.30	   0.19:0.74	   0.16:0.44	   0.64	   164.21	   1.76	   455.17	  
RC	  Max	   0.79	   0.53	   0.28	   0.16	   0.03:0.59	   0.01:0.46	   115.1	   791.88	   319	   2194	  
RC	  X50	   0.28	   0.43	   0.65	   0.13	   0.42:0.84	   -­‐.11:0.54	   34.05	   204.6	   94.39	   567.12	  
X-­‐INT	   0.11	   0.42	   0.76*	   0.54	   0.57:0.9	   0.21:0.84	   30.17	   47.33	   83.63	   131.19	  
ES	  L4	  
MTh	  (%MSO)	  	   0.66	   0.98	   0.93*	   0.9*	   0.86:0.97	   0.81:0.96	   2.67	   1.59	   7.4	   1.64	  
LATENCY	  (MS)	   0.37	   0.28	   0.36	   0.7	   0.12:0.65	   0.49:0.86	   2.52	   1.44	   6.99	   4.01	  
nMArea	   0.75	   0.47	   0.36	   0.48	   0.12:0.65	   0.23:0.73	   27.28	   50.2	   75.62	   139.14	  
RC	  Slope	   0.39	   0.11	   0.24	   0.05	   0.00:0.57	   -­‐.11:0.34	   25.25	   104	   69.99	   288.27	  
RC	  Max	   0.88	   0.28	   0.25	   0.1	   0.00:0.59	   -­‐.09:0.43	   1118	   1219	   3098	   3380	  
RC	  X50	   0.66	   0.71	   0.3	   0.36	   0.05:0.63	   0.1:0.67	   91.56	   267	   253.79	   740.09	  
X-­‐INT	   0.998	   0.84	   0.48	   0.42	   0.20:0.75	   0.14:0.71	   0.84	   49.87	   2.33	   138.22	  
ES	  T12	  
MTh	  (%MSO)	  	   0.62	   0.98	   0.93*	   0.89*	   0.85:0.97	   0.79:0.96	   4.19	   0.31	   22.7	   0.86	  
LATENCY	  (MS)	   0.47	   0.29	   0.39	   0.32	   0.15:0.67	   0.08:0.63	   1.8	   3.64	   4.99	   10.08	  
nMArea	   0.51	   0.85	   0.38	   0.53	   0.13:0.66	   0.27:0.78	   39.54	   21.15	   109.6	   58.61	  
RC	  Slope	   0.44	   0.34	   0.07	   0.03	   -­‐.13:0.41	   -­‐.13:0.33	   4.41	   99.07	   12.22	   274.61	  
RC	  Max	   0.71	   0.52	   0.03	   0.21	   -­‐.14:0.33	   -­‐.02:0.53	   7494	   1133	   20772	   3142	  
RC	  X50	   0.95	   0.76	   0.68	   0.31	   0.46:0.85	   0.06:0.62	   8.92	   76.97	   24.73	   213.34	  
X-­‐INT	   0.4	   0.67	   0.62	   0.16	   0.38:0.82	   -­‐.05:0.49	   49.08	   53.65	   136.03	   148.71	  
RA	  
MTh	  (%MSO)	  	   0.68	   0.89	   0.90*	   0.88*	   0.86:0.97	   0.78:0.98	   2.74	   0.57	   7.59	   1.58	  
LATENCY	  (MS)	   0.38	   0.28	   0.63	   0.67	   0.43:0.84	   0.34:0.80	   2.58	   1.39	   7.15	   3.85	  
nMArea	   0.77	   0.48	   0.33	   0.46	   -­‐0.1:0.49	   0.04:0.57	   27.95	   48.37	   77.47	   134.07	  
RC	  Slope	   0.4	   0.11	   0.42	   0.25	   0.14:0.65	   0.03:0.61	   25.87	   100.2	   71.71	   277.74	  
RC	  Max	   0.9	   0.28	   0.26	   0.35	   0.17:0.78	   0.1:0.52	   1145	   1175	   3174	   3257	  
RC	  X50	   0.68	   0.72	   0.28	   0.23	   0.06:0.56	   0.05:0.43	   93.8	   257.25	   260	   713.06	  
X-­‐INT	   0.89	   0.85	   0.44	   0.23	   0.07:0.57	   0.01:0.44	   0.86	   48.05	   2.38	   133.19	  
EO	  
MTh	  (%MSO)	  	   0.59	   0.65	   0.81*	   0.68	   0.70:0.97	   0.56:0.83	   9.82	   15.04	   27.22	   41.69	  
LATENCY	  (MS)	   0.52	   0.38	   0.74	   0.59	   0.43:0.84	   0.34:0.84	   0.93	   2.78	   2.58	   7.71	  
nMArea	   0.72	   0.65	   0.42	   0.3	   0.12:0.49	   0.04:0.57	   27.2	   30.95	   75.39	   85.79	  
RC	  Slope	   0.22	   0.86	   0.39	   0.22	   0.21:0.60	   -­‐0.04:0.5	   36.83	   14.15	   102.09	   39.22	  
RC	  Max	   0.7	   0.81	   0.32	   0.15	   0.07:0.45	   0.02:0.42	   1612	   6360	   4468	   17629	  
RC	  X50	   0.88	   0.78	   0.65	   0.23	   0.14:0.70	   0.04:0.43	   11.25	   53.66	   31.18	   148.74	  
X-­‐INT	   0.88	   0.69	   0.54	   0.33	   0.11:0.77	   0.05:0.54	   5.2	   37.27	   14.41	   103.31	  
	  
P:	  F-­‐test	  P	  value,	  ICC:	  	  intraclass	  correlation	  coefficient	  with	  its	  95%	  confidence	  intervals	  [95%CI],	  





	   	  
Table	  4.17:	  Long	  Term	  Reliability	  of	  1.2MTh	  P2P	  amplitude	  and	  Individual	  Curve	  Fit	  Parameters	  
	   P	   ICC	   95%CI	   SEM	   SRD	  
	   L	   R	   L	   R	   L	   R	   L	   R	   L	   R	  
SOLEUS	  
nP2P	   0.83	   0.53	   0.57	   0.34	   0.32:0.79	   0.1:0.63	   1.02	   3.77	   2.81	   10.46	  
RC	  Slope	   0.66	   0.61	   0.24	   0.13	   0.01:0.55	   -­‐.07:0.44	   1.93	   1.72	   5.35	   4.75	  
RC	  Max	   0.75	   0.3	   0.35	   0.28	   0.11:0.64	   0.05:0.58	   544.23	   2232.37	   1508	   6187	  
RC	  X50	   0.999	   0.56	   0.56	   0.48	   0.31:0.78	   0.23:0.73	   1.13	   361.86	   3.14	   1003	  
X-­‐INT	   0.98	   0.78	   0.62	   0.28	   0.38:0.82	   0.04:0.58	   4.03	   123.62	   11.17	   342.66	  
TA	  
nP2P	   0.93	   0.84	   0.22	   0.26	   -­‐.01:0.53	   0.02:0.57	   0.31	   2.07	   0.86	   5.73	  
RC	  Slope	   0.42	   0.68	   0.43	   -­‐0.06	   0.19:0.7	   -­‐.22:0.29	   0.02	   1.72	   0.05	   4.76	  
RC	  Max	   0.62	   0.41	   0.45	   0.17	   0.2:0.73	   -­‐.07:0.56	   5.42	   125.21	   15.03	   347.06	  
RC	  X50	   0.789	   0.42	   0.76	   0.32	   0.54:0.91	   0.03:0.7	   5.23	   196.04	   14.51	   543.38	  
X-­‐INT	   0.8	   0.47	   0.81*	   0.38	   0.61:0.93	   0.09:0.73	   3.86	   65.8	   10.7	   182.4	  
ES	  L4	  
nP2P	   0.75	   0.91	   0.48	   0.36	   0.23:0.73	   0.11:0.65	   0.7	   0.38	   1.94	   1.05	  
RC	  Slope	   0.33	   0.52	   0.26	   0.22	   0.02:0.59	   -­‐.01:0.56	   0.05	   0.04	   0.15	   0.1	  
RC	  Max	   0.61	   0.24	   0.01	   0.43	   -­‐.16:0.33	   0.17:0.71	   141.43	   281	   392	   778	  
RC	  X50	   0.776	   0.4	   0.29	   0.45	   0.03:0.62	   0.17:0.74	   112.26	   538	   311	   1491	  
X-­‐INT	   0.65	   0.94	   0.53	   0.7	   0.27:0.78	   0.46:0.88	   33.4	   7.69	   92.59	   21.32	  
ES	  T12	  
nP2P	   0.62	   0.93	   0.49	   0.64	   0.24:0.74	   0.41:0.84	   0.69	   0.28	   1.92	   0.76	  
RC	  Slope	   0.85	   0.58	   0.3	   0.21	   0.06:0.6	   -­‐.09:0.41	   0.2	   0.18	   0.56	   0.5	  
RC	  Max	   0.71	   0.69	   0.18	   0.20	   -­‐.04:0.49	   -­‐.02:0.51	   521.73	   492.65	   1446	   1365	  
RC	  X50	   0.727	   0.38	   0.74	   0.66	   0.54:0.9	   0.45:0.85	   85.18	   206.09	   236	   571	  
X-­‐INT	   0.91	   0.56	   0.36	   0.39	   0.09:0.67	   0.14:0.67	   29.88	   85.8	   82.81	   237.83	  
RA	  
nP2P	   0.73	   0.87	   0.44	   0.34	   0.86:0.97	   0.81:0.96	   0.72	   0.37	   1.14	   0.67	  
RC	  Slope	   0.32	   0.5	   0.24	   0.21	   0.43:0.84	   0.34:0.80	   0.05	   0.04	   0.09	   0.06	  
RC	  Max	   0.59	   0.23	   0.01	   0.41	   -­‐0.1:0.49	   0.04:0.57	   144.89	   270.74	   230.89	   498.85	  
RC	  X50	   0.76	   0.38	   0.29	   0.43	   -­‐0.1:0.65	   0.04:0.68	   115	   518.36	   183.18	   956.03	  
X-­‐INT	   0.63	   0.9	   0.62	   0.55	   0.17:0.78	   0.16:0.66	   34.22	   7.41	   54.54	   13.67	  
EO	  
nP2P	   0.91	   0.58	   0.40	   0.25	   0.21:0.59	   0.02:0.53	   0.32	   1.99	   0.51	   3.67	  
RC	  Slope	   0.41	   0.65	   0.4	   0.27	   0.19:0.7	   -­‐0.02:0.49	   0.02	   1.66	   0.03	   3.05	  
RC	  Max	   0.6	   0.39	   0.42	   0.16	   0.22:0.81	   -­‐.0.1:0.38	   5.55	   120.64	   8.85	   222.53	  
RC	  X50	   0.77	   0.4	   0.21	   0.31	   0.14:0.55	   0.03:0.62	   5.36	   188.88	   8.55	   348.42	  
X-­‐INT	   0.78	   0.45	   0.54	   0.35	   0.39:0.83	   0.11:0.53	   3.95	   63.4	   6.3	   116.95	  
P:	  F-­‐test	  P	  value,	  ICC:	  intraclass	  correlation	  coefficient	  with	  its	  95%	  confidence	  intervals	  [95%CI],	  SEM:	  






	    
Table	  4.18:	  Long	  Term	  Reliability	  of	  cSP	  at	  1.2MTh	  and	  Individual	  cSP	  Curve	  Fit	  Parameters	  
	   P	   ICC	   95%CI	   SEM	   SRD	  
	   L	   R	   L	   R	   L	   R	   L	   R	   L	   R	  
SOLEUS	  
cSPTh	   0.11	   0.74	   0.84*	   0.90*	   0.71:0.97	   0.78:1.02	   7.29	   1.43	   20.21	   3.97	  
cSP(ms)	   0.41	   0.99	   0.71	   0.76*	   0.57:0.85	   0.63:0.89	   241.9	   10.36	   670.5	   28.71	  
RC	  Slope	   0.34	   0.83	   0.38	   0.37	   0.09:0.72	   0.1:0.69	   109.22	   1.55	   302.73	   4.3	  
RC	  Max	   672	   0.39	   0.33	   0.28	   0.04:0.69	   0.05:0.58	   5375.7	   12279	   14971	   37387	  
RC	  X50	   0.37	   0.34	   0.48	   0.3	   0.21:0.76	   0.06:0.59	   35701	   3968.32	   98958	   10999	  
X-­‐INT	   0.31	   0.66	   0.56	   0.52	   0.28:0.82	   0.27:0.76	   453.3	   188.02	   1256.48	   521.16	  
TA	  
cSPTh	   0.21	   0.76	   0.78*	   0.7	   0.64:0.92	   0.55:0.85	   4.56	   2.47	   12.63	   6.86	  
cSP(ms)	   0.98	   0.9	   0.66	   0.85*	   0.43:0.85	   0.72:0.94	   17.43	   48.55	   48.3	   134.56	  
RC	  Slope	   0.4	   0.35	   0.55	   0.1	   0.21:0.86	   -­‐0.1:0.51	   5286.56	   3.82	   14215	   10.58	  
RC	  Max	   0.1	   0.78	   0.76	   0.17	   0.48:0.94	   -­‐0.1:0.59	   24354.5	   3530.02	   67653	   97375	  
RC	  X50	   0.33	   0.87	   0.51	   0.28	   0.17:0.84	   -­‐0.04:0.7	   6178.7	   166.88	   16806	   462.56	  
X-­‐INT	   0.46	   0.75	   0.58	   0.2	   0.22:0.89	   -­‐0.1:0.61	   119.26	   70.09	   330.56	   194.27	  
ES	  L4	  
cSPTh	   0.61	   0.63	   0.53	   0.85*	   0.39:0.67	   0.72:0.98	   1.97	   2.91	   5.46	   8.07	  
cSP(ms)	   0.74	   0.72	   0.66	   0.74	   0.54:0.78	   0.59:0.89	   87.82	   120.63	   243.43	   334.36	  
RC	  Slope	   0.19	   0.47	   0.19	   0.27	   -­‐0.01:0.39	   0.1:0.44	   8.99	   56.88	   24.92	   157.66	  
RC	  Max	   0.83	   0.75	   0.21	   0.23	   -­‐0.01:0.43	   0.02:0.44	   23789	   6743	   6593	   1869	  
RC	  X50	   0.8	   0.89	   0.48	   0.15	   0.34:0.62	   -­‐0.02:0.32	   353	   251	   978.47	   695.74	  
X-­‐INT	   0.79	   0.74	   0.2	   0.06	   -­‐0.01:0.41	   -­‐0.16:0.28	   100.28	   168	   277.96	   465.67	  
ES	  T12	  
cSPTh	   0.22	   0.77	   0.67	   0.73	   0.54:0.8	   0.61:0.85	   4.67	   2.38	   11.32	   6.02	  
cSP(ms)	   0.80	   0.91	   0.68	   0.55	   0.54:0.82	   0.42:0.68	   17.86	   46.78	   43.3	   117.67	  
RC	  Slope	   0.41	   0.36	   0.57	   0.31	   0.41:0.73	   0.1:0.52	   520.52	   3.68	   1274	   239.25	  
RC	  Max	   0.1	   0.79	   0.29	   0.18	   0.05:0.53	   -­‐0.04:0.4	   244.3	   3347	   6074	   851	  
RC	  X50	   0.34	   0.88	   0.62	   0.55	   0.44:0.8	   0.35:0.75	   610.07	   160.79	   14956	   404.51	  
X-­‐INT	   0.77	   0.78	   0.09	   0.21	   -­‐0.18:0.36	   -­‐0.08:0.5	   185.08	   176	   513.02	   487.85	  
RA	  
cSPTh	   0.63	   0.64	   0.75*	   0.89*	   0.56:0.97	   0.81:0.96	   2.02	   2.8	   5.6	   7.76	  
cSP(ms)	   0.76	   0.73	   0.67	   0.71	   0.48:0.855	   0.40:0.89	   89.97	   116.23	   249.38	   322.17	  
RC	  Slope	   0.19	   0.48	   0.20	   0.28	   0.09:0.49	   0.11:0.57	   9.21	   54.8	   25.53	   151.9	  
RC	  Max	   0.85	   0.76	   0.29	   0.24	   0.11:0.65	   0.04:0.60	   370.64	   446.88	   1027	   1239	  
RC	  X50	   0.82	   0.9	   0.62	   0.55	   0.22:0.79	   0.13:0.72	   361.63	   241.84	   1002.39	   670.35	  
X-­‐INT	   0.81	   0.75	   0.21	   0.33	   0.04:0.56	   0.11:0.53	   102.73	   161.87	   284.75	   448.68	  
EO	  
cSPTh	   0.22	   0.77	   0.61	   0.53	   0.86:0.97	   0.81:0.96	   4.67	   2.38	   12.94	   6.6	  
cSP(ms)	   0.82	   0.91	   0.68	   0.59	   0.43:0.84	   0.34:0.8	   17.86	   46.78	   49.51	   129.67	  
RC	  Slope	   0.41	   0.36	   0.58	   0.43	   0.38:0.78	   0.11:0.55	   5254	   3.68	   14563.34	   10.2	  
RC	  Max	   0.1	   0.79	   0.29	   0.30	   -­‐0.1:0.65	   -­‐0.04:0.63	   24914.3	   3847	   69059	   10663	  
RC	  X50	   0.34	   0.88	   0.60	   0.58	   0.17:0.78	   0.2:0.55	   61650.0	   160.79	   170885	   445.69	  
X-­‐INT	   0.47	   0.76	   0.55	   0.23	   0.19:0.76	   -­‐.15:0.43	   122.18	   67.53	   338.67	   187.18	  
P:	  F-­‐test	  P	  value,	  ICC:	  intraclass	  correlation	  coefficient	  with	  its	  95%	  confidence	  intervals	  [95%CI],	  SEM:	  






This	  study	  was	  the	  first	  to	  investigate	  the	  reliability	  of	  active	  TMS	  recruitment	  curve	  
parameters	  in	  trunk	  muscles	  and	  to	  quantify	  the	  expected	  long	  term	  (1	  year)	  stability	  
of	   TMS	  parameters	   in	   trunk	  and	   leg	  muscles	   in	  a	  healthy	  population.	   	  Rather	   than	  
using	   one	   repeat	   assessment,	   as	   has	   commonly	   been	   reported,	   three	   repeat	  
assessments	   were	   carried	   out	   at	   successfully	   longer	   intervals.	   	   Another	   departure	  
from	  past	  reliability	  assessments	  in	  TMS	  is	  that	  these	  repeat	  assessments	  were	  fixed	  
at	   successfully	   longer	   intervals	   (6	   weeks,	   6	  months	   and	   1	   year),	   as	   the	   long	   term	  
outcome	   assessments	   of	   a	   clinical	   intervention.	  Methodologically	   the	   assessments	  
were	  designed	  to	  minimise	  experiment	  time	  and	  maximise	  repeatability	  with	  a	  fixed	  
stimulation	   site,	   only	   an	   estimate	   of	   threshold,	   and	   specific	   background	   activation	  
level	  for	  each	  muscle	  based	  on	  previous	  reports	  of	  reliability.	   	  Test-­‐retest	  reliability	  
was	   measured	   using	   intraclass	   correlation	   coefficients	   (ICC(A,k0))	   and	   their	   95%	  
confidence	   limits	   using	   a	   two-­‐way	   random	   effects	   model	   indexed	   for	   absolute	  
agreement.	   	   In	  many	   ways,	   the	   ICC	   is	   a	  measure	   of	   the	   clinical	   usefulness	   of	   the	  
studied	  measure,	  with	   values	   above	   0.75	   indicating	   high	   reliability,	  measures	   over	  
0.90	   indicating	   measures	   that	   can	   be	   used	   for	   clinical	   decision	   making	   at	   an	  
individual	   level,	   and	   measures	   below	   0.40,	   poor	   reliability	   (Portney	   and	   Watkins,	  
2000).	  	  The	  standard	  error	  of	  measurement,	  derived	  from	  the	  ANOVA	  mean	  square	  
error	  term,	  provided	  a	  measure	  of	  the	  within-­‐subject	  absolute	  reliability	  of	  the	  data	  
in	   the	   same	   units	   as	   the	   measure	   of	   interest.	   	   	   With	   19	   participants	   and	   4	  
assessments,	  this	  study	  ranks	  amongst	  the	  highest	  powered	  reliability	  studies	  of	  TMS	  
parameters	   ever	   conducted	   using	   ICC,	   and	   a	   sufficient	   combination	   to	   assess	   the	  
most	  variable	  TMS	  parameters	  reported	  in	  the	  literature	  (Shoukri	  et	  al.,	  2004).	  
	  
With	   ICC	  values	   in	  the	  high	  to	  excellent	  range,	  MVC,	  MTh,	  Latency,	  cSPTh,	  and	  cSP	  
yielded	   the	   highest	   long	   term	   stability.	   	   The	   relatively	   narrow	   ICC	   confidence	  
intervals	  for	  these	  measures	  (<0.30)	  suggest	  that	  these	  results	  may	  be	  repeatable	  in	  
a	   larger	  sample.	   	   	  Although	  curve	  fits	  were	  satisfactory	  (r2>0.50),	  normalised	  areas,	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peak	  amplitudes	  and	  most	   individual	   recruitment	  curve	  parameters	  produced	  poor	  
to	   adequate	   test	   retest	   reliability,	   with	   Max	   values	   providing	   the	   least	   reliable	  




MTh	   was	   found	   to	   have	   high	   long	   term	   stability	   in	   most	   muscles	   (0.75≤ICC≤0.93)	  
with	   the	  exception	  of	   right	  EO	   (ICC=0.68).	   	  These	   results	  are	   in	  keeping	  with	  other	  
studies	  in	  upper	  and	  lower	  limbs	  (Cacchio	  et	  al.,	  2009,	  Cacchio	  et	  al.,	  2011,	  Carroll	  et	  
al.,	  2001,	  Christie	  et	  al.,	  2007,	  Kamen,	  2004,	  Malcolm	  et	  al.,	  2006)	  but	  now	  establish	  
this	  measure	  as	  reliable	  in	  long	  term	  analyses.	  	  MTh	  was	  a	  little	  less	  reliable	  in	  active	  
TA	  (R:0.88;	  L:0.85),	  then	  was	  reported	  by	  Cacchio	  et	  al.	  at	  rest	  (ICC=0.98(0.93-­‐0.99)).	  	  	  
As	   this	   is	   the	   first	   study	   to	   report	   MTh	   reliability	   in	   trunk	   muscles,	   it	   establishes	  
excellent	   long	   term	   reliability	   in	   ES	   and	   RA.	   It	   furthermore	   confirms	   a	   likely	  
independent	  relationship	  between	  active	  MTh	  variability	  and	  time	  interval	  within	  1	  
year,	  as	  was	  reported	  for	  resting	  MTh	  over	  a	  5.5	  year	  period	  (Kimiskidis	  et	  al.,	  2004).	  
Furthermore	  ICCs	  were	  in	  the	  clinical	  grade	  range	  (ICC≥0.90)	  in	  ES	  at	  both	  levels	  and	  
RA.	  	  Because	  the	  SRD	  was	  low	  (%MSO≤	  7.6	  on	  the	  left	  and	  %MSO≤1.64	  on	  the	  right),	  
MTh	  may	  be	  sensitive	  to	  change	  in	  ES	  L4	  and	  RA.	  
	  
	  
Latency	  of	  Cortical	  Responses	  
	  
Latencies	  were	  also	  mostly	   in	  the	  good	  and	  excellent	  reliability	  range	   in	  abdominal	  
and	  leg	  muscles	  (0.59≤ICC≤0.85),	  but	  not	  in	  the	  back	  muscles.	  	  ES	  latencies	  had	  poor	  
ICC	  ratings	  (apart	  from	  right	  ES	  L4	  which	  showed	  good	  reliability),	  even	  though	  the	  
SEMs	   were	   reasonably	   low	   (0.31-­‐4.19ms).	   	   This	   is	   because	   ICC	   is	   a	   measure	   of	  
individual	  reliability	  in	  the	  context	  of	  mean	  variability.	  	  ES	  muscles	  had	  the	  shortest	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latencies	  of	  all	  the	  muscles	  studied	  (15.31±0.36ms).	  These	  values	  are	  in-­‐keeping	  with	  
other	  TMS	  studies	  using	  vertex	  stimulation	  (Strutton	  et	  al.,	  2005,	  Kuppuswamy	  et	  al.,	  
2004,	   Kuppuswamy	   et	   al.,	   2008)	   	   but	   with	   a	   smaller	   range,	   concentrated	   on	   the	  
faster	  end	  of	  the	   latency	  spectrum	  compared	  to	  hemispheric	  mapping	  experiments	  
(12.05-­‐30.48ms)	   (O'Connell	   et	   al.,	   2007,	   Ferbert	   et	   al.,	   1992).	   	   This	   suggests	   that	  
vertex	  stimulation	  during	  voluntary	  BTEs	  at	  1.2MTh	  preferentially	  activated	  crossed	  
fibres	  and	  faster	  responses	  presumably	  mask	  any	  later	  MEP	  onsets	  from	  ipsilateral	  or	  
oligosynaptic	  pathways.	  	  However,	  even	  though	  subjects	  were	  restricted	  to	  isometric	  
extensions,	  some	  variability	  may	  be	  down	  to	  variations	  in	  individual	  multiple	  muscle	  
recruitment	  strategy.	  Participants	  graded	  ES	  T12	  contractions	  based	  on	  ES	  L4	  visual	  
feedback	   and	   the	   curvature	   of	   the	   spine	   was	   not	   controlled.	   Pushing	   out	  
asymmetrically	  against	  the	  Velcro	  strap	  with	  one	  shoulder	  during	  the	  extension,	  for	  
example,	  may	  result	  also	   in	   latency	  variations	   in	  the	  contralateral	  ES	  as	   in	  shoulder	  
abductions	   (Kuppuswamy	   et	   al.,	   2008).	   	   Some	   variability	   may	   also	   stem	   from	   the	  
general	   difficulty	   in	   accurately	   grading	   BTE	   contractions,	   but	   this	   would	   also	   be	  
limited,	  as	  we	  presume	  that	  contraction	  variations	  above	  10%	  of	  MVC	  may	  still	  affect	  
ES	  MEPs,	  but	   should	  no	   longer	  have	  a	   significant	   impact	  on	   latency	   (Kischka	  et	  al.,	  
1993).	   	   This	   was	   in	   contrast	   to	   RA	   and	   EO	   responses,	   which	   displayed	   higher	  
repeatability	  over	  the	  four	  assessments	  (0.59≤ICC≤0.74).	  	  With	  high	  amplitude	  MEPs	  
and	  few	  phases,	  these	  muscles	  have	  easily	  identifiable	  MEP	  onsets	  compared	  to	  the	  
low	  amplitude	  multiphasic	  ES	  responses	  over	  the	  background	  EMG.	  So	  the	  high	  40%	  
contraction,	  chosen	  for	  ES	  to	  improve	  MEP	  and	  cSP	  repeatability,	  may	  have	  made	  a	  
small	  contribution	  to	  onset	  inaccuracies	  where	  the	  MEP-­‐background	  EMG	  amplitude	  
converge.	  
	  
The	  Cortical	  Silent	  Period	  	  
	  
This	   is	   the	   first	   study	   to	   investigate	   the	   repeatability	   of	   the	   cSPTh.	   	   It	   had	   high	  
reliability	  over	  the	  year	  in	  leg	  muscles	  and	  RA	  (0.70≤ICC≤0.90)	  and	  adequate	  to	  high	  
reliability	  in	  ES	  and	  OE	  (0.55≤ICC≤0.85).	  	  Naturally	  the	  intensity	  at	  which	  the	  cSP	  first	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appears	  in	  the	  EMG	  trace,	  it	   is	  susceptible	  to	  changes	  in	  reading	  conditions	  such	  as	  
due	  to	  variations	  in	  Gaussian	  or	  50Hz	  interference	  noise	  as	  it	  only	  has	  a	  resolution	  of	  
5%MSO	   (the	   inter-­‐stimulator	   intensity	   interval	   used	   to	   construct	   RCs).	   	   This	  might	  
explain	   the	   poorer	   reproducibility	   in	   ES	   and	   EO.	   	   The	   cSP	   was	   also	   rated	   highly	  
reliable	   to	   excellent	   in	   the	   legs	   (0.62≤ICC≤0.85),	   and	   adequate	   to	   good	   in	   ES	  
(0.55≤ICC≤0.74)	   and	   abdominal	   (0.59≤ICC≤0.71)	   muscles.	   This	   is	   in	   keeping	   with	  
investigators	  reporting	  a	  variability	  of	  <5%	  (Orth	  and	  Rothwell,	  2004)	  and	  up	  to	  15%	  
(Koski	  et	  al.,	  2005)	  across	  sessions	  in	  hand	  muscles.	  	  Reliability	  results	  for	  TA	  (L:	  0.66;	  
R:0.85)	  are	  lower	  than	  reported	  by	  Cacchio	  and	  colleagues	  who	  reported	  a	  cSP	  ICC	  of	  
0.95(0.88–0.99)	  after	  a	  4	  week	  interval.	  These	  results	  were	  obtained	  using	  a	  circular	  
coil	   on	   the	   TA	  MEP	   hotspot	   and	   stimulating	   at	   up	   to	   100%MSO,	   and	   averaging	   3	  
stimuli	  per	  stimulus	  intensity	  (compared	  to	  the	  minimum	  of	  6	  in	  the	  present	  study).	  	  
However	  results	  were	  more	  reliable	  than	  those	  reported	  by	  van	  Hedel	  et	  al.	  (2007),	  
who	  found	  cSPs	  unreliable	  (ICC=0.40)	  using	  a	  figure-­‐8	  coil	  over	  the	  TA	  MEP	  hotspot.	  
Some	   of	   the	   critical	   parameters,	   such	   as	   the	   direction	   of	   the	   induced	   current	   and	  
whether	  multiple	   responses	  were	  averaged	  per	  measure	  were	  not	   reported	   in	   this	  
study,	   so	   it	   is	   difficult	   to	   interpret	   with	   any	   degree	   of	   certainty	   how	   robust	   the	  
variability	  reported	  is.	  	  
	  
This	   is	   the	   first	   study	   to	   investigate	   the	   reliability	   of	   cSP	   recruitment	   curve	  
parameters.	   	   The	   single	   previous	   relevant	   study	   found	   these	   parameters	   useful	   in	  
interpreting	   intracortical	   mechanisms	   of	   the	   drug	   oxcarbazepine.	   The	   authors	  
interpreted	  a	  change	  in	  the	  cSP	  curve	  X50	  and	  cSPTh,	  as	  opposed	  to	  the	  RC	  slope	  or	  
max	   values,	   as	   evidence	   that	   oxcarbazepine	   did	   not	   directly	   enhance	   intracortical	  
mechanisms	  (Kimiskidis	  et	  al.,	  2005).	  As	  the	  cSP	  has	  high	  inter-­‐subject	  variability,	  the	  
reliability	  of	  for	  example,	  a	  measure	  of	  GABAB-­‐mediated	  intracortical	  excitability	  (the	  
slope	   of	   the	   cSP	   curve)	   was	   worthy	   of	   investigation.	   Unfortunately	   these	   yielded	  
predominantly	  poor	  ICC	  ratings	  (0.10≤ICC≤0.62).	  	  As	  with	  MEP	  values,	  the	  very	  high	  
and	  variable	  Max	  values	  may	   indicate	   incomplete	  plateaux	  region	  for	  these	  curves,	  
leading	  to	  variable	  X50	  results.	  As	  the	  slope	  of	  cSP	  curves	  is	  lower	  than	  MEP	  curves,	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the	  slope	  parameter	  may	  also	  be	  affected.	   	  Unfortunately	  as	   the	  tolerability	  of	   the	  
double	  cone	  coil	  limited	  the	  stimulus	  intensity	  to	  75%	  in	  this	  study,	  further	  research,	  
perhaps	   with	   a	   more	   focal	   coil	   tolerable	   at	   high	   stimulus	   intensities,	   will	   be	  
necessary.	  
	  
Motor	  Evoked	  Potential	  RC	  Parameters	  
	  
MEP	  areas	  and	  P2P	  values	  generally	  fell	  in	  the	  poor-­‐adequate	  reliability	  ranges	  with	  
once	   again,	   unreliable,	   curve	   parameters.	   	   P2P	   amplitudes	   in	   ES	   ranged	   from	  
0.36≤ICC≤0.64.	   MEP	   area	   was	   equally	   unreliable.	   	   Goss	   et	   al.	   reported	   MEP	  
amplitude	  at	  rest	  to	  have	  excellent	  reliability	  0.91	  (0.68-­‐0.97),	  although	  participants	  
did	   not	   remove	   electrodes	   and	   returned	   30	  minutes	   later.	   It	   is	   possible	   that	  MEP	  
measures	  are	  more	  sensitive	  to	  long	  term	  changes	  in	  activity,	  fitness,	  alertness	  and	  
fatigue;	   however,	   it	   is	   likely	   that	   these	  would	   have	   varied	   randomly.	   	   As	  with	   cSP	  
values,	   the	   very	   high	   and	   variable	   Max	   values	   may	   indicate	   incomplete	   plateaux	  
region	  for	  MEP	  RC	  curves,	  leading	  to	  variable	  X50	  results.	  These	  were	  limited	  by	  the	  
tolerability	   of	   cone	   coil	   used	   for	   the	   stimulation	   (~75%).	   	   The	   RC	   Max	   reflects	   a	  
balance	   of	   inhibitory	   and	   excitatory	   inputs	   to	   the	   motor	   cortex	   and	   the	   motor	  
neuron	  pool	  (Devanne	  et	  al.,	  1997).	  	  As	  concluded	  by	  Carroll	  (2001),	  unlike	  MTh,	  the	  
RC	  max	  (and	  this	  RC	  X50)	  mechanisms	  are	  likely	  to	  be	  more	  sensitive	  to	  the	  degree	  of	  
phase	   cancelation	   that	   occur	   at	   recording	   electrodes	   resulting	   from	   the	  
asynchronous	   influx	   of	   action	   potentials	   at	   the	   muscle	   membrane.	   	   The	   triple	  
stimulation	   technique	   was	   developed	   to	   reduce	   this	   phase	   cancelation	   variability	  
(Magistris	   et	   al.,	   1998).	   	   It	   is	   not	   known	  whether	   the	   construction	   of	   recruitment	  






Methodological	  investigations	  of	  X-­‐INT	  
	  
Methodological	   investigations	  of	  the	  slope	  x-­‐intercepts	  (Carroll	  et	  al.,	  2001)	  proved	  
particularly	   stable	   in	   the	   leg	   muscles	   (0.61≤ICC≤0.80)	   regardless	   of	   the	   poorer	  
reliability	  of	  the	  parameters	  from	  which	  it	  was	  derived.	  Furthermore,	  it	  was	  found	  to	  
produce	   lower	   values	   than	   MTh	   and	   cSPTh,	   yet	   correlate	   with	   both	   leg	   and	  
abdominal	   MTh	   and	   cSPTh.	   In	   the	   leg	   muscles,	   measures	   of	   area	   produced	   the	  
closest	  match	  to	  visually	  guided	  threshold	  values.	  It	  is	  thus	  possible	  that	  an	  observer	  
bias-­‐free	  threshold	  calculation	  may	  be	  achievable	  with	  a	  figure-­‐of	  eight	  coil	  or	  in	  low	  
threshold	  muscles.	  	  
	  
This	  study	  had	  a	  number	  of	  limitations	  which	  should	  be	  noted	  when	  interpreting	  the	  
results.	   	   The	   tolerability	   of	   the	   double	   cone	   coil	   limited	   the	  maximum	   stimulation	  
intensity.	   The	   non-­‐linear	   regression	   and	   sigmoid	   curve	   fitting	   process	  was	   entirely	  
automated,	  and	  thus	  no	  outliers	  were	  omitted	  in	  fitting	  curves.	  	  Both	  of	  these	  factors	  
may	  have	  contributed	  to	  the	  low	  reliability	  of	  RC	  results.	  Finally	  the	  study	  population	  
consists	  of	  a	  relatively	  young	  and	  healthy	  population.	  	  As	  only	  central	  lesion	  (stroke	  
and	  SCI)	  populations	  have	  so	  far	  been	   investigated,	  studies	  will	  need	  to	  qualify	  the	  
reliability	  of	  corticomotor	  and	  intracortical	  excitability	  of	  trunk	  and	  leg	  parameters	  in	  
subjects	  with	  neuropathic	  and	  musculoskeletal	  disorders.	  	  
	  
In	  conclusion,	  this	  study	  has	  found	  that	  with	  the	  correct	  caveats	  and	  checks	  in	  place	  
(such	   as	   accurate	   electrode	   positioning,	   constant	   visual	   feedback	   of	   the	   target	  
muscle	  and	  optimum	  levels	  of	  background	  activation	  for	  specific	  muscles)	  measures	  
of	  MVC,	  MTh,	   Latency,	   cSPTh,	  and	  cSP	   in	  TA,	   soleus,	  RA,	  ES	  and	  EO	  can	  be	   readily	  
assessed	   in	   the	   long	   term	   and	   may	   prove	   very	   useful	   in	   a	   number	   of	   clinical	  
conditions.	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5.	  Long	  Term	  Corticospinal	  Excitability	  of	  Trunk	  Muscles	  in	  Chronic	  Low	  Back	  Pain	  	  






Changes	  in	  corticomotor	  excitability	  have	  been	  demonstrated	  in	  back	  and	  abdominal	  
muscles	  in	  chronic	  low	  back	  pain	  [LBP]	  (Tsao	  et	  al.,	  2011b,	  Tsao	  et	  al.,	  2008,	  Strutton	  
et	   al.,	   2005,	   Strutton	   et	   al.,	   2004b).	   	   LBP	   patients	   with	   accompanying	   neurologic	  
deficit	  or	  radicular	  pain	  were	  found	  to	  have	  elevated	  motor	  and	  inhibitory	  thresholds	  
to	  transcranial	  magnetic	  stimulation	  (TMS)	  in	  erector	  spinae	  (ES)	  at	  L4,	  although	  this	  
has	  not	  been	  confirmed	  in	  experimental	  or	  recurrent	  LBP	  (Tsao	  et	  al.,	  2011b,	  Tsao	  et	  
al.,	   2011c).	   As	   the	   minimum	   stimulator	   intensity	   to	   evoke	   motor	   and	   inhibitory	  
responses,	   these	   measures	   are	   thought	   to	   reflect	   global	   cortical	   and	   spinal	  
membrane	   excitability.	   Further	   alterations	   in	   intracortical	   inhibitory	   (ICI)	   activity	  
have	  been	  reported	  in	  low	  back	  pain	  (Masse-­‐Alarie	  et	  al.,	  2012),	  neuropathic	  (Turgut	  
and	   Altun,	   2009,	   Schwenkreis	   et	   al.,	   2010),	   and	   chronic	   pain	   conditions	   such	   as	  
fibromyalgia	   (Salerno	   et	   al.,	   2000,	  Mhalla	   et	   al.,	   2010),	   and	   complex	   regional	   pain	  
syndrome	  (Schwenkreis	  et	  al.,	  2005).	  Although	  some	  of	  these	  central	  changes	  have	  
been	   targeted	   by,	   and	   correlated	   to	   the	   functional	   outcomes	   of,	   physical,	  manual	  
and	   exogenous	   neuro-­‐stimulation	   therapy	   (Masse-­‐Alarie	   et	   al.,	   2013,	   Clark	   et	   al.,	  
2011,	   Tsao	   et	   al.,	   2010a),	   little	   is	   known	   about	   their	   expected	   profile,	   long	   term	  
stability	  or	  disease	  progression	  within	  the	  LBP	  patient	  spectrum.	  
	  
The	  maintenance	  of	  force	  output,	  despite	  a	  decrease	  in	  the	  firing	  rate	  of	   individual	  
motor	   units	   (MU)	   in	   a	  muscle	   subject	   to	   experimental	   nociceptive	   stimulation	   has	  
been	  difficult	  to	  account	  for,	  given	  that	  synergist	  muscles	  have	  been	  shown	  to	  also	  
respond	  with	  reduced	  activity	  (Hodges	  et	  al.,	  2008).	  Recent	  work	  has	  shown	  that	  this	  
maintenance	  of	  force	  output	  originates	  from	  differential	  recruitment	  of	  MUs	  within	  
the	  muscle	  itself	  (Tucker	  and	  Hodges,	  2009,	  Tucker	  et	  al.,	  2009).	  	  In	  response	  to	  deep	  
tissue	  nociception,	  a	  centrally	  mediated	  decrease	  in	  the	  firing	  rate	  of	  low	  threshold	  
motor	  units,	  with	  the	  simultaneous	  recruitment	  of	  additional	  new	  units,	  is	  thought	  to	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allow	   for	   an	   increase	   in	   twitch	   force	   to	   maintain	   output	   (Svensson	   et	   al.,	   2003,	  
Svensson	   et	   al.,	   2002,	   Tucker	   and	   Hodges,	   2009,	   Tucker	   et	   al.,	   2009).	   	   The	   task-­‐
specific	  biomechanical	  constraints	  on	   the	  greater	  musculoskeletal	   system,	  are	   then	  
though	   to	   govern	   compensatory	   strategy	   (Arendt-­‐Nielsen	   and	   Falla,	   2009).	   The	  
respective	   contributions	   from	   spinal,	   cortical	   or	   subcortical	   centres	   to	   this	  
mechanism	  is	  still	  undetermined	  and	  may	  differ	  in	  chronic	  and	  acute	  presentations.	  	  
For	   example,	   animal	   studies	   suggest	   increased	   cortical	   compared	   to	   spinal	  
excitability	  resulting	  from	  an	  intervertebral	  disc	  lesion	  (Hodges	  et	  al.,	  2009a).	  
	  
TMS	  has	  provided	  a	  useful	   tool	   for	  probing	   these	   changes	   from	   the	  perspective	  of	  
corticospinal	  excitability.	  However	  trunk	  musculature	  presents	  numerous	  challenges	  
both	   in	   terms	  of	  methodology	  and	   interpretation	  of	   the	  neuroplasticity	   implied	  by	  
TMS	   results.	   	   Trunk	  muscle	   function	   depends	   on	   a	   higher	   contribution	   from	   non-­‐
crossed	  oligosynaptic	  pathways	  (compared	  to	  distal	  muscles)	  and	  are	  almost	  always	  
required	  to	  be	  facilitated	  to	  evoke	  useful	  responses	  (Ferbert	  et	  al.,	  1992,	  Taniguchi	  
and	   Tani,	   1999).	   	   In	   terms	   of	   interpretation	   of	   results	   of	   different	   protocols,	   the	  
postural	   context	   and	   specific	   target	   muscle	   of	   this	   facilitation	   may	   render	  
corticomotor	  excitability	  and	  intracortical	  inhibitory	  measures	  more	  task-­‐specific	  and	  
less	   repeatable	   (Liepert	   et	   al.,	   1998,	   Butefisch	   et	   al.,	   2005,	   Ngomo	   et	   al.,	   2012,	  
Rizzolatti	  et	  al.,	  1988,	  Soto,	  2006,	  Goss	  et	  al.,	  2011,	  Nowicky	  et	  al.,	  2001),	   likely	  by	  
virtue	  of	  generally	  being	  more	   influenced	  by	  use-­‐dependent	  plasticity	  mechanisms.	  	  
Active	   measures	   of	   corticomotor	   excitability,	   like	   motor	   threshold	   (MTh),	  
recruitment	   curve	   slope	   (RC)	   and	   intracortical	   inhibitory	   activity,	   like	   the	   cortical	  
silent	   period	   (cSP),	   have	   high	   inter-­‐individual	   variability	   and	   may	   require	   large	  
samples	  (Malcolm	  et	  al.,	  2006,	  Carroll	  et	  al.,	  2001,	  Orth	  and	  Rothwell,	  2004).	  	  On	  the	  
other	   hand	   they	   have	   been	   reported	   to	   have	   high	   repeatability	   and	   may	   be	  
particularly	  attractive	  in	  monitoring	  long	  term	  changes	  in	  LBP	  (Malcolm	  et	  al.,	  2006,	  
Kukowski	  and	  Haug,	  1992,	  Kimiskidis	  et	  al.,	  2004,	  Mills	  and	  Nithi,	  1997,	  Carroll	  et	  al.,	  
2001,	   Orth	   and	   Rothwell,	   2004).	   	   Reducing	   the	   variability	   of	   coil	   positioning	   and	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orientation	  with	  non-­‐focal	  stimulation	  (Rosler	  et	  al.,	  1989,	  Gugino	  et	  al.,	  2001)	  may	  
also	  be	  desirable	  in	  monitoring	  long	  term	  neuroplastic	  changes	  in	  a	  clinical	  context.	  
	  
A	   solution	   to	   the	   variability	   imposed	   by	   surface	   electrode	   replacement	   between	  
assessments	  may	  be	  desirable.	   Electrodes	   are	   also	   important	  when	   comparing	   the	  
neuroplasticity	   of	   different	   muscle	   representations.	   A	   possibly	   important	  
consequence	  of	  the	  above	  nociception	  induced	  mechanism	  may	  be	  that	  corticospinal	  
excitability	  may	  not	  be	  comparable	  between	  different	  muscles	  by	  different	  electrode	  
types	   (i.e.	   surface	   electrodes	   compared	   to	   fine-­‐wire	   intramuscular	   electrodes	  
[FWIE]).	  This	  is	  because	  in	  the	  presence	  of	  on-­‐going	  deep	  tissue	  nociceptive	  stimulus,	  
assessing	  only	  a	  few	  motor	  units	  (FWIE)	  may	  statistically	  portray	  a	  different	  picture	  
(one	   of	   reduced	   excitability)	   compared	   to	   that	   of	   the	   whole	   muscle	   with	   surface	  
electrodes	  (one	  of	  increased	  excitability).	  
	  
Recent	  work	  has	  established	  multiple	  pathways	   to	   the	  erector	   spinae	   (ES)	  muscles	  
cortically	   accessible	   by	   TMS,	   with	   likely	   distinct	   characteristic	   latencies	   and	  
somatotopic	  organisation	  	  (Tsao	  et	  al.,	  2011b,	  O'Connell	  et	  al.,	  2007,	  Kuppuswamy	  et	  
al.,	  2008).	  	  Furthermore	  their	  differential	  activation	  is	  likely	  to	  be	  task	  specific,	  with	  
some	   postural	   tasks	   yielding	   reduced	   latencies	   and	   preferential	   somatospecific	  
activation	  (Kuppuswamy	  et	  al.,	  2008,	  Tsao	  et	  al.,	  2011a).	  Recent	  work	  facilitating	  the	  
deep	   multifidus	   muscle	   in	   an	   abdominal	   brace	   task,	   not	   only	   confirmed	   previous	  
reports	   of	   discrete	   pathways	   within	   ES	   fascicles,	   but	   that	   these	   are	   differentially	  
inhibited	   in	   recurrent	   LBP	   (Tsao	  et	  al.,	   2011a,	  Tsao	  et	  al.,	   2011b).	   	   The	  dominantly	  
inhibited	  pathway	   is	   thought	   to	   lie	  4cm	  anterior	   to	   the	  vertex,	  possibly	  originating	  
from	  the	  supplementary	  motor	  area	  (O'Connell	  et	  al.,	  2007,	  Tsao	  et	  al.,	  2011b,	  Tsao	  
et	  al.,	  2011c).	  	  
	  
It	   remains	   to	   be	   established	   whether	   the	   changes	   in	   corticomotor	   output	   and	  
intracortical	   inhibitory	   activity	   reported	   so	   far	   extend	   to	   other	   chronic	   LBP	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classifications	  and	  the	  extent	  to	  which	  these	  vary	   in	  the	   long	  term.	  The	  purpose	  of	  
this	   study	   is	   to	   monitor	   long	   term	   changes	   in	   paraspinal	   muscle	   parameters	   of	  
corticospinal	  and	  intracortical	  excitability	  in	  two	  untreated	  LBP	  clinical	  classifications	  
(chronic	  LBP	  with	  [LBLP]	  and	  without	  [LBP]	  leg	  pain	  radiating	  distal	  to	  the	  knee),	  and	  
to	   compare	   these	   between	   patients	   experiencing	   long	   term	   changes	   in	   pain	   and	  







With	  ethical	  approval	  and	  written	  informed	  consent,	  9	  participants	  with	  chronic	  low	  
back	  pain	  without	  leg	  pain	  (LBP;	  42.0±8.6[SD]	  years	  old,	  with	  body	  mass	  index	  [BMI]	  
of	  25.9±6.5[SD],	   including	  5	  males)	  and	  9	  with	  chronic	   low	  back	  pain	  with	   leg	  pain	  
radiating	   below	   the	   knee	   (LBPLP;	   38.7±15.4[SD]	   years	   old	   with	   a	   BMI	   of	  
24.95±4.1[SD]),	  were	  recruited	  from	  a	  spine	  clinic	  at	  London	  Charing	  Cross	  Hospital	  
and	  a	  local	  GP	  surgery.	  	  19	  healthy	  control	  participants	  were	  also	  recruited	  (14	  male	  
and	  5	  female;	  32.39±7.29[SD]	  years	  with	  a	  BMI	  of	  23.46±3.0[SD]).	  
	  
At	  baseline,	  15	  of	  the	  LBP	  and	  LBPLP	  participants	  were	  in	  full	  time	  employment,	  two	  
were	   on	   employment	   leave	   and	   one	  was	   early	   retired	   due	   to	  medical	   reasons,	   all	  
related	  to	  LBP.	  	  All	  subjects	  reported	  having	  back	  pain	  with	  a	  highly	  variable	  time	  of	  
onset	   between	   6	   months	   and	   30	   years	   prior	   to	   baseline	   (LBP:	   155.78±133.47[SD]	  
months;	  LBPLP:	  62.44±61.28[SD]	  months).	   	   In	  the	  LBPLP	  group	  there	  was	  a	  leg	  pain	  
history	   of	   43.89±29.88[SD]	   months.	   	   Seven	   participants	   attributed	   their	   back	  
problem	  onset	  to	  an	  incident	  (2	  [1	  in	  the	  LBPLP	  group]	  at	  work	  with	  ensuing	  claim	  or	  
compensation,	  1	  at	  home	  and	  4	  [2	  in	  the	  LBPLP	  group]	  at	  another	  location).	   	   In	  the	  
control	   group	   6	   of	   the	   18	   participants	   reported	   having	   experienced	   acute	   non-­‐
specific	  back	  pain	  lasting	  less	  than	  1	  week	  at	  some	  point	  in	  their	  lives.	  
	  
Exclusion	  criteria	  included	  current	  treatment	  with	  antidepressants/neuromodulatory	  
drugs	   (Ziemann,	   2004,	   Ziemann,	   2003),	   as	   well	   as	   the	   general	   TMS	   exclusions	  




Baseline	  Characteristics	  	  
	  
The	  LBPLP	  group	  mean	  disability	  scores	  (table	  5.1)	  were	  at	  	  their	  expected	  	  disability	  
range	  for	  its	  	  disease	  classification	  (46.67±2.67	  compared	  to	  meta	  data	  on	  prolapsed	  
disc/sciatica	  weighted	  average	  44.65	  [SD	  range	  10.5-­‐30.1]),	  but	  the	  LBP	  group	  lied	  on	  
the	  more	  disabled	  end	  of	  the	  chronic	  LBP	  spectrum	  (54.89±5.4	  compared	  weighted	  
average	  43.3	  [SD	  range	  10-­‐21]).	  
	  
Nevertheless	   there	   was	   no	   significant	   difference	   in	   neither	   ODI	   nor	   back	   pain	  
between	   the	   2	   groups	   (P>0.191).	   	   This	  was	   also	   true	   for	   fear	   avoidance	  behaviour	  
which	   fell	   in	   the	   high	   range	   (>15/24),	   health	   status	   and	   QOL,	   and	   psychological	  




Bipolar	  surface	  electrodes	  (Ag/AgCl,	  ARBO	  blue,	  2-­‐cm	  diameter)	  were	  positioned	  on	  
either	   side	   of	   the	   vertebral	   column	   over	   the	   palpable	   bulge	   of	   the	   erector	   spinae	  
muscle	   (≈3cm	   bilateral	   to	   the	   midline),	   both	   at	   the	   twelfth	   thoracic	   and	   fourth	  
lumbar	  levels	  (Vink	  et	  al.,	  1989,	  Nowicky	  et	  al.,	  2001).	  A	  ground	  reference	  electrode	  
Table	  5.1:	  	  Baseline	  Characteristics	  (MEAN±SEM)	  
Outcome	  Measure	   LBP	  (n=9)	   LBPLP	  (n=9)	  
Disability	  (ODI)	   54.89±5.4	   46.67±2.67	  
Average	  Pain	  (VAS)	   Back:	  44.41±5.74	   Back:	  36.7±7.4	  Leg:	  41.7±6.7	  
EQ-­‐5D	  QOL	  Index	  	  &	  Health	  State	   0.74±0.03	  &	  71.22±4.34	  
0.79±0.03	  	  &	  
68.75±8.53	  
Fear	  &	  Avoidance	  Beliefs	  (FAAB)	   15.78±1.5	   17.67±1.71	  





was	   placed	   on	   the	   iliac	   crest	   of	   the	   pelvis	   and	   on	   the	   left	   fibular	   head.	   The	   EMG	  
signals	   were	   bandpass	   filtered	   (10	   Hz-­‐2	   kHz)	   and	   amplified	   (usually	   at	   ×1000;	   Iso-­‐
DAM,	  WPI,	  UK)	  before	  being	  sampled	  at	  4	  kHz	  by	  a	  data	  acquisition	  interface	  (Power	  
1401	   Plus	   and	   Signal	   software	   Version	   3.1;	   Cambridge	   Electronic	   Design,	   UK)	  
connected	   to	  a	  personal	   computer.	   	  Participants	  were	  given	  visual	   feedback	  of	   the	  




TMS	  was	  delivered	  using	  a	  9cm	  angled	  double-­‐cone	  coil	  powered	  by	  a	  Magstim	  2002	  
stimulator	   (Magstim	   Co.	   Ltd.,	   UK),	   positioned	   symmetrically	   over	   the	   vertex	   and	  
polarised	   to	   induce	   posterior-­‐to-­‐anterior	   current	   flow	   in	   the	   motor	   cortex.	   	   Lying	  
prone	   on	   a	   flat	   horizontal	   couch	   with	   large	   Velcro	   bands	   restraining	   ankles	   and	  
scapulae,	   the	   protocol	   was	   repeated	   for	   erector	   spinae	   with	   bilateral	   extensions	  
(BTE)	  of	  the	  trunk	  to	  40%	  of	  MVC.	  Participants	  were	  asked	  	  to	  hold	  their	  breaths	  and	  
rigidly	  extend	  their	  trunks,	   imagining	  an	   inflexible	   lever	  along	  their	  spine	  extending	  
from	   the	   sacrum.	   	   Contractions	  were	   carried	   out	  while	   breath-­‐holding	   in	   order	   to	  
maintain	  equal	  trunk	  breathing	  cycle	  modulation.	   	   In	  order	  to	  minimise	  fatigue	  and	  
discomfort,	   only	   three	   stimuli	  were	   delivered	   between	   rests	   at	   higher	   (<40%MSO)	  
intensities.	  A	  full	  recruitment	  curve	  of	  TMS	  pulse	  intensities,	  delivered	  in	  sets	  of	  6	  to	  
30	   pulses,	   at	   intervals	   of	   5%	   of	   maximum	   stimulator	   output	   (%MSO),	   from	   the	  
threshold	   for	   the	   cortical	   silent	   period	   (cSPTh)	   to	   150%	  of	  motor	   threshold	   (MTh),	  
was	  then	  delivered	  in	  a	  randomised	  sequence	  for	  each	  muscle.	  	  	  
	  
Data	  and	  Statistical	  Analyses	  
	  
The	  MTh	   was	   assessed	   as	   the	   lowest	   intensity	   of	   TMS	   that	   produced	   identifiable	  
MEPs	   of	   at	   least	   200uV	   peak-­‐to-­‐peak	   amplitude	   on	   at	   least	   50%	   of	   stimulus	  
presentations.	  The	  cSPTh	  was	  defined	  as	   the	   intensity	  of	   the	   lowest	  appearance	  of	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the	   cSP	   valley	   in	   the	   averaged	   rectified	   trace.	   All	  MEP	   and	   cSP	   onsets	   and	   offsets	  
were	  visually	   identified	  and	  defined	  by	   intersection	  of	   the	  mean	  pre-­‐stimulus	  EMG	  
line.	  MEPs	  were	  quantified	  as	  the	  area	  above	  this	  line	  whereas	  the	  cSP	  was	  defined	  
as	   the	   return	  of	   rectified	   EMG	  activity	   to	  pre-­‐stimulus	   levels.	   	  MEPs	   and	   cSP	  were	  
quantified	  at	  1.2MTh.	  	  MEP	  areas	  (MArea)	  at	  all	  percentages	  of	  threshold	  were	  also	  
fitted	  to	  a	  Boltzmann	  function	  (Devanne	  et	  al.,	  1997)	  given	  by:	  MArea	  (%MTh)	  =	  Max	  
/(1	  +	  exp	   [X50-­‐MArea/k]),	  where	  Max	   is	   the	  recruitment	  curve	   (RC)	  plateau	  MArea	  
value,	  k	   is	  the	  slope	  parameter,	  and	  X50	  is	  the	  curve	  midpoint	  intensity	  normalised	  
to	  threshold.	  	  All	  EMG	  data	  processing	  was	  carried	  out	  using	  the	  set	  custom	  written	  
programs	  detailed	   in	  chapter	  3	  and	  executed	  using	  Signal	   (version	  3.13,	  Cambridge	  
Electronic	  Design).	   	  Group	  recruitment	  curve	  statistics	  were	  carried	  as	  described	   in	  
chapter	  3	  using	  Prism	  (Version	  5,	  Graphpad,	  Inc.)	  
	  
	  
Paired	   t-­‐tests	   were	   used	   to	   establish	   whether	   aside-­‐to-­‐side	   differences	   existed	   in	  
patients	  or	  controls	  at	  baseline.	  	  If	  not,	  parameters	  of	  corticospinal	  excitability	  (MTh,	  
MEP	  area,	  MEP	  duration,	  cSP,	  cSPTh,	  MEP	   latency)	  were	  pooled	  and	  analysed	  over	  
the	   four	   time	   points	   using	   two-­‐way	   repeated	   measures	   analyses	   of	   variances	  
(ANOVAs).	  	  Repeated	  measures	  ANOVAs	  factorised	  time	  (B,	  R1,	  R2,	  R3)	  and	  back	  pain	  
classification	  (LBP	  or	  LBPLP),	  and	  any	  interaction	  effects	  between	  these	  two	  factors.	  
Outcome	   groups	   (Improved	   [I],	   Worse	   [W],	   Stable	   [S])	   were	   identified	   based	   on	  
whether	   a	   minimum	   clinically	   significant	   change	   took	   place	   in	   back	   pain	   (>20mm	  
change)	  or	  ODI	  (>10	  ODI)	  (Ostelo	  and	  de	  Vet,	  2005b).	  In	  parameters	  where	  changes	  
took	  place,	  ANOVAs,	  factorising	  outcome	  group	  and	  time	  point	  compared	  parameter	  
changes	   in	   participants	   who	   improved	   and	   those	   who	   did	   not.	   	   All	   multiple	  
comparisons	  versus	  the	  control	  group	  were	  carried	  out	  using	  Bonferroni	  corrected	  t-­‐
tests.	   Repeated	   measures	   ANOVA	   results	   are	   presented	   as	   least	   square	   means	   ±	  
standard	  error.	  Standard	  error	  is	  always	  used	  unless	  specifically	  followed	  by	  [SD]	  to	  
indicate	   standard	   deviation.	   Statistical	   analyses	   were	   carried	   out	   using	   Sigmaplot	  







In	   the	   LBP	   group,	   3	   participants	   were	   lost	   to	   follow-­‐up	   at	   6	   weeks	   (R1)	   and	   one	  
further	  at	  the	  1	  year	  assessment	  (R3).	   	   In	  the	  LBPLP	  group,	  three	  participants	  were	  
lost	   R1.	   	   Reasons	   for	   non-­‐participation	   included	   surgery	   (1),	   moving	   (1)	   and	   the	  
tolerability	   of	   TMS	   (2).	   	   In	   the	   control	   group	   3	   subjects	   dropped	   out	   of	   the	   study	  
before	  completing	  all	  four	  sessions.	  
	  
Pain,	  Disability	  and	  Secondary	  Outcome	  Measures	  	  
	  
There	  were	  no	  effects	  of	  group	  (P>0.224)	  or	  time	  (P>0.184)	  in	  	  back	  pain	  VAS	  scores	  
(figure	  5.1).	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B R1 R2 R3
BACK now  
BACK over last week 
BACK most severe pain last week 
LBPLP Group: Leg pain over last week
Figure	  5.1:	  Mean±SEM	  VAS	  back	  pain	  and	  leg	  pain	  scores	  for	  the	  LBP	  (left)	  and	  LBPLP	  (right)	  groups	  
over	  the	  one	  year	  of	  assessment	  
Two	  control	  subjects	  reported	  details	  of	  acute	  self-­‐limiting	  muscular	  back	  pain	  of	  a	  




There	   was	   no	   significant	   effect	   of	   group	   (P=0.114)	   or	   time	   (P=0.067)	   in	   disability	  
scores	  (figure	  5.2)	  over	  the	  year	  of	  assessment.	  
Disability













Figure	  5.2:	  Mean±SEM	  disability	  over	  one	  year	  
	  
There	  were	  no	  differences	   in	  back	  pain	  groups	   (group	  effect;	  all	  P≥0.316)	   in	  any	  of	  
the	   secondary	   outcome	   measures	   (FAAB,	   health	   QOL,	   health	   state,	   anxiety	   or	  
depression)	  and	  these	  remained	  stable	  over	  the	  year	  of	  assessment	  (time	  effect;	  all	  
P≥0.272).	  
	  
As	  detailed	  in	  table	  5.2,	  of	  the	  participants	  who	  returned	  at	  R2	  only	  2	  experienced	  an	  
improvement	  in	  back	  pain	  (minimum	  clinically	  significant	  change	  >20mm),	  by	  which	  
time	  1	  participant	  had	  improved	  function	  (minimum	  clinically	  significant	  change	  >10	  
in	  ODI).	  A	  further	  participant’s	  ODI	  increased.	  At	  R3,	  there	  were	  4	  clinically	  significant	  
back	  pain	  reductions	  and	  2	  ODI.	  	  One	  participant’s	  back	  pain	  and	  ODI	  increased	  over	  
the	  year	  by	  a	  clinically	  significant	  amount.	  	  Overall,	  4	  participants	  were	  classified	  as	  





Table	  5.2:	  Changes	  in	  Pain	  and	  Function	  
Participant	   Group	  
After	  6	  Months	   After	  1	  Year	  
Pain	   ODI	   Pain	   ODI	  
106	   LBP	  	   -­‐3	   -­‐10	   14	   -­‐8	  
108	   LBP	  	   -­‐39	   -­‐8	   -­‐24	   -­‐10	  
110	   LBP	  	   11	   2	   -­‐38	   -­‐8	  
111	   LBP	  	   7	   -­‐4	   -­‐46	   -­‐14	  
113	   LBP	  	   -­‐19	   0	   -­‐8	   -­‐6	  
115	   LBP	  	   7	   2	   9	   -­‐4	  
116	   LBP	  	   -­‐10	   -­‐8	  
	   	  102	   LBPLP	   -­‐18(4)	   -­‐10	   -­‐18(4)	   -­‐10	  
103	   LBPLP	   -­‐71(-­‐58)	   -­‐22	   -­‐71(-­‐58)	   -­‐24	  
105	   LBPLP	   0(3)	   -­‐2	   -­‐6(8)	   -­‐2	  
114	   LBPLP	   18(-­‐4)	   0	   19(14)	   0	  
118	   LBPLP	   -­‐10(1)	   22	   34(22)	   12	  
Participant	  back	  pain	  (VAS)	  and	  functional	  outcome	  (ODI)	  after	  6	  months	  (R2)	  and	  1	  year	  (R3).	  	  LBPLP	  
participants	  also	  	  have	  leg	  pain	  change	  labelled	  in	  parentheses.	  Outcomes	  surpassing	  a	  minimum	  





There	  was	  a	  significant	  effect	  of	  group	  (P≤0.009)	  but	  not	  time	  (P≥0.207)	  in	  ES	  L4	  and	  
T12	  MVCs	   (figure	   5.3).	   MVCs	   were	   significantly	   lower	   than	   controls	   at	   T12	   in	   the	  
LBPLP	  group	  (P=0.035)	  but	  not	  significantly	  so	  in	  the	  LBP	  group	  (P=0.083).	  	  At	  L4	  only	  
the	  LBPLP	  tended	  to	  a	  significant	  reduction	  (LBPLP	  vs.	  Control;	  P=0.056	  compared	  to	  
LBP	   vs.	   Control;	   P=0.157)	   and	   the	   difference	  was	   significant	   at	   baseline	   (P=0.005).	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Figure	  5.3:	  	  Mean±SEM	  MVCs	  at	  ES	  L4	  (left)	  and	  T12	  (right)	  over	  one	  year	  
	  
L4	  vs.	  T12	  activation:	   	  L4	  MVCs	  were	  significantly	   lower	  than	  at	  T12	  in	  controls	  (L4:	  
0.14±0.01,	   T12:	   0.22±0.01;	   P<0.001)	   but	   not	   in	   LBP	   (B:	   0.08±0.01,R1:	   0.09±0.01;	  




There	  were	   neither	   group	   nor	   time	   effects	   in	  MEP	   latency	   in	   either	   L4	   or	   T12	   (all	  
P≥0.161;	  table	  5.3).	  
	  
Table	  5.3:	  MEP	  latencies	  at	  ES	  L4	  and	  T12	  over	  1	  year	  
	  Time	   LBP	   LBPLP	   Control	  
ES	  L4	  
B	   15.38±0.41	   14.77±0.43	   15.04±0.28	  
R1	   15.51±0.29	   14.73±0.64	   15.51±0.29	  
R2	   15.16±0.32	   13.43±0.64	   15.16±0.32	  
R3	   15.68±0.32	   13.57±0.64	   15.68±0.32	  
ES	  T12	  
B	   16.51±0.43	   16.65±0.43	   15.22±0.29	  
R1	   16.55±0.6	   16.63±0.6	   15.81±0.31	  
R2	   15.67±0.6	   15.55±0.6	   14.82±0.34	  





There	  was	  a	  significant	  group	  effect	  in	  MTh	  at	  both	  levels	  (all	  P<0.001)	  with	  no	  effect	  
of	  time	  (P>0.252;	  figure	  5.4).	   	  MThs	  were	  significantly	  higher	   in	  both	  groups	  and	  at	  
both	  L4	  and	  T12	  (P≤0.021).	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Figure	  5.4:	  	  Mean±SEM	  Motor	  Thresholds	  at	  ES	  L4	  (left)	  and	  T12	  (right)	  over	  one	  year	  
	  
Looking	  at	  pooled	  level	  data	  versus	  outcome,	  there	  was	  an	  effect	  of	  group	  (P<0.001)	  
but	   no	   effect	   of	   time	   (P=0.222).	   Both	   the	   improved	   group	   (I)	   and	   the	   participants	  
that	   experienced	   no	   change	   in	   pain	   remained	   with	   thresholds	   significantly	   higher	  
than	   controls	   (P<0.001).	   However,	   there	   was	   a	   non-­‐	   significant	   decrease	   in	   the	  
improved	   group	   	   (B:	   53.85±1.24,R1:	   52.06±1.24,R2:	   51.96±1.24,R3:	   48.55±1.24;	  
P=0.323)	   compared	   to	   the	   stable	   (S)	   group	   (B:	   50.86±0.93,R1:	   50.07±0.93,R2:	  
52.24±0.93,R3:	   52.47±1.03)	   and	   controls	   (B:	   40.55±0.8,R1:	   39.87±0.84,R2:	  
41.51±0.92,R3:	  40.01±0.92;	  P=0.006).	  	  The	  participant	  whose	  pain	  and	  ODI	  increased	  











At	   both	   L4	   and	   T12	   there	  was	   an	   effect	   of	   group	   in	   cSPTh	   (P<0.001)	   but	   not	   time	  
(P≥0.196;	  figure	  5.5).	  	  cSPTh	  was	  higher	  than	  control	  in	  the	  LBP	  group	  (P≤0.001)	  but	  
not	  LBPLP	  (P≥0.114).	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Figure	  5.5:	  	  Mean±SEM	  cortical	  silent	  period	  thresholds	  at	  ES	  L4	  (left)	  and	  T12	  (right)	  over	  one	  year	  
	  
In	   pooled	   outcome	   data	   	   (group:	   P<0.001,	   time:	   P=0.022,	   interaction	   effects:	  
P=0.002)	   cSPThs	  were	   higher	   in	   the	   improving	   cohort	   than	   controls	   (P<0.001)	   and	  
the	   participant	   whose	   symptoms	   worsened	   (W;	   P=0.027)	   throughout	   the	   year	   (I:	  
36.5±1.31	   vs.	   S:	   32.50±1.02	   vs.	   	   C:	   27.69±0.97	   vs.	   W:	   26.04±3.42).	   	   Furthermore	  
multiple	   comparisons	   also	   indicated	   significant	   reductions	   in	   the	   S	   (B-­‐R1,	   P=0.009)	  




There	  was	   a	   group	   effect	   in	   the	   duration	   of	  MEPs	   at	   both	   levels	   (P<0.001)	   but	   no	  
effect	   of	   time	   (P≥0.687;	   figure	   5.6).	   	   MEPs	   were	   significantly	   longer	   in	   the	   LBP	  
(P≤0.013)	  and	  LBPLP	  (P≤0.022)	  groups	  compared	  to	  controls.	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Figure	  5.6:	  	  Mean±SEM	  MEP	  durations	  at	  ES	  L4	  (left)	  and	  T12	  (right)	  over	  one	  year	  
	  
Pooled	  outcome	  data	  revealed	  that	  although	  there	  was	  no	  effect	  of	  time	  (P=0.329),	  
there	   was	   a	   group	   effect	   (P<0.001)	   of	  MEP	   duration.	   	   Improving	   participants	   had	  
significantly	   longer	  MEPs	  then	  stable	  participants	  and	  controls	  throughout	  the	  year	  





Both	   LBP	   and	   LBLP	   recruitment	   curve	   parameters	   were	   significantly	   different	   to	  
control	  at	  baseline	   (P<0.001).	  There	  were	  no	  significant	  differences	  within	  the	  LBP,	  
LBLP	  and	  control	   group	   recruitment	   curve	  parameters	   (k,	  Max,	  X50)	  between	   time	  
points	   (all	  P>0.371).	   	   ES	   L4	  MEP	   recruitment	   curve	  data	  was	   therefore	  pooled	   into	  
one	  representative	  curve	  for	  each	  group.	  	  In	  both	  LBP	  and	  LBPLP,	  recruitment	  curve	  
parameters	  were	  significantly	  different	  to	  controls	  (P<0.0001)	  figure	  5.7.	  	  There	  was	  






























Best	  fit	  non-­‐linear	  regression	  parameters: 
 LBP LBLP Control 
Max 34.77±3.69 32.78±5.00 35.35±1.89 
X50 0.980±0.033 0.992±0.050 1.188±0.029 
Slope (k) 0.117±0.019 0.126±0.027 0.202±0.017 
Figure	  5.7:	  Global	  ES	  L4	  MEP	  recruitment	  in	  LBP,	  LBPLP	  and	  Control.	  	  Group	  best	  fit	  non-­‐linear	  
regression	  parameters	  (plateau	  (Max),	  curve	  midpoint	  (X50)	  and	  slope	  (k))	  are	  listed.	  All	  MEP	  areas	  (y-­‐





There	  was	  an	  effect	  of	  group	  in	  cSPs	  at	  L4	  	  and	  T12	  (P≤0.008).	  	  cSPs	  were	  significantly	  
longer	  than	  control	   in	  the	  LBPLP	  	  group	  (P≤0.049)	  but	  not	   in	  the	  LBP	  group	  at	  both	  
levels	   (P≥0.0.98;	  table	  5.4).	  Stimulation	   intensity	  at	  1.2MTh	  was	  significantly	  higher	  
in	  pain	  groups	  than	  controls	  (LBP:	  56.65±6.24	  %MSO	  and	  LBPLP:	  58.12±2.60	  %MSO	  
vs.	   C:	   48.79±1.152;	   %MSO,	   both	   P≤0.008).	   ES	   L4	   cSPs	   were	   analysed	   at	   fixed	  







Table	  5.4:	  cSPs	  at	  ES	  L4	  and	  T12	  (ms)	  
Time	   LBP	   LBPLP	   Control	  
ES	  L4	  
B	   101.3±4.20	   118.59±4.45*	   91.1±2.89	  
R1	   103.8±5.50	   109.75±6.60	   91.59±3.05	  
R2	   87.09±5.94	   117.17±6.60*	   90.38±3.31	  
R3	   107.8±6.50	   114.7±6.60*	   88.66±3.31	  
ES	  T12	  
B	   93.53±4.85	   105.88±4.85*	   86.83±3.34	  
R1	   97.83±6.86	   101.16±6.86	   86.13±3.52	  
R2	   105.57±6.86	   116.34±6.86*	   89.87±3.82	  
R3	   100.49±7.52	   119.68±6.86*	   87.67±3.82	  
*significantly	  longer	  than	  controls	  (P<0.05)	  
	  
In	  pooled	  outcome	  analysis	   	  (group:	  P<0.001,	  time:	  P=0.608)	  cSPs	  were	  higher	  than	  
controls	   (P<0.001)	   and	   the	   stable	   group	   (P=0.018)	   in	   the	   improving	   cohort	  
throughout	   the	   year	   (I:	   118.03±5.25ms	   vs.	   	   S:	   98.73±4.07	   vs.	   C:	   90.43±3.88	   vs.	  W:	  
109.85±13.69).	  	  	  






This	  study	  is	  the	  first	  to	  monitor	  long	  term	  changes	  in	  paraspinal	  muscle	  parameters	  
of	   corticospinal	   and	   intracortical	   excitability	   in	   two	   untreated	   LBP	   clinical	  
classifications	  (chronic	  LBP	  with	  [LBLP]	  and	  without	  [LBP]	  leg	  pain	  radiating	  distal	  to	  
the	  knee),	  and	  to	  compare	  these	  between	  patients	  experiencing	  long	  term	  changes	  
in	  pain	  and	   function,	  and	   those	  with	  stable	  symptoms.	   	  Participants	  were	  assessed	  
on	  4	  increasingly	  longer	  time	  intervals	  over	  the	  period	  of	  1	  year.	   	  At	  both	  vertebral	  
levels,	   both	  groups	  were	   found	   to	  have	  a	   significantly	  elevated	  active	  MTh,	   longer	  
MEP	  durations	  (with	  no	  differences	  in	  raw	  MEP	  areas)	  and	  reduced	  MVCs	  (this	  was	  
not	  significant	  in	  the	  LBP	  group).	  	  Unlike	  in	  controls	  there	  was	  a	  smaller	  contribution	  
from	   T12	   to	   bilateral	   trunk	   extensions	   in	   both	   chronic	   back	   pain	   groups.	  	  
Furthermore	   a	   significantly	   steeper	   and	   left-­‐shifted	   MEP	   recruitment	   curve	  
normalised	   to	   those	  MVCs	   was	   found	   at	   ES	   L4.	   	   This	   unexpected	   result	   (reduced	  
excitability	   [high	   MTh]	   and	   enhanced	   recruitment)	   confirms	   the	   results	   of	   three	  
independent	  yet	  conflicting	  reports	  in	  different	  LBP	  populations.	  In	  contrast	  to	  MTh,	  
only	   the	   LBP	   group	  was	   found	   to	   have	   a	   significantly	   higher	   cSPTh.	   	   On	   the	   other	  
hand,	  a	  new	  finding	  of	  the	  this	  study,	  was	  a	  significantly	  longer	  cortical	  silent	  periods	  
resulting	   from	  stimulation	  at	  both	  1.2xMTh	  and	   fixed	  stimulation	   intensities	   (50,55	  
and	  60%MSO)	  in	  the	  LBPLP	  group.	  	  As	  with	  MVCs,	  a	  high	  degree	  of	  between-­‐subject	  
variability	  was	   found	   in	   these	   cSPs	   in	   the	   LBP	   group.	   	   Latency	   of	  motor	   responses	  
from	   the	   cortex	   were	   not	   significantly	   different	   to	   controls	   in	   either	   back	   pain	  
groups.	  
	  
Although	   sample	   size	   in	  participants	  experiencing	   “idiopathic”	   changes	   in	  pain	   and	  
function	  were	  small,	  the	  study	  makes	  a	  first	  step	  in	  comparing	  long	  term	  changes	  in	  
pain	  and	  function	  to	  changes	  corticomotor	  and	  intracortical	  pathways	  in	  chronic	  LBP.	  
Pooled	   data	   from	   both	   groups	   revealed	   that	   participants	   experiencing	   changes	   in	  
pain	   and	   function	  had	   longer	  MEPs	   and	   longer	   cSPs	   compared	   to	   stable	  back	  pain	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participants	  and	  controls.	  	  However,	  these	  findings	  are	  based	  on	  only	  one	  participant	  
who	  experienced	  a	  minimal	   clinically	   significant	  degradation	   in	  pain	  and	   functional	  
status.	  Finally,	   there	  was	  also	  a	  non-­‐significant	   reduction	   in	  MThs	   in	   the	   improving	  
cohort,	   and	   an	   increase	   in	   the	   patient	  who	  worsened	   over	   the	   year,	   compared	   to	  




MThs	   were	   significantly	   higher	   in	   ES	   confirming	   previous	   reports	   (Strutton	   et	   al.,	  
2005,	  Strutton	  et	  al.,	  2004b).	  This	  study	  extends	  this	  finding	  to	  thoracic	  levels	  (T12),	  
to	   chronic	   LBP	  without	   radicular	   pain,	   and	  establishes	   this	   feature	   as	   stable	   in	   the	  
long	  term	  in	  both	  chronic	  LBP	  classifications.	  	  The	  least	  square	  means	  and	  standard	  
error	  (LQM±SEM)	  of	  MThs	  over	  4	  time	  points	  reveal	  non-­‐significantly	  elevated	  MTh	  
results	   in	   the	   LBPLP	   group	   compared	   to	   this	   previous	   study	   (from	  bar	   graph	   data:	  
48.05±2.40	  vs.	  ~42.5±~4.0	  %MSO),	   less	   than	   in	  controls	   (40.48±1.33	  vs.	  ~36.0±~2.5	  
%MSO).	   	   The	   main	   difference	   between	   the	   two	   studies	   is	   that	   ES	   muscles	   were	  
facilitated	  at	  40%	  compared	  to	  20%	  of	  MVC,	  to	  produce	  more	  reliable	  cSP	  onset	  and	  
offsets.	   	   However	   facilitation	   at	   these	   levels	   is	   not	   known	   to	   alter	   MTh.	   	   These	  
differences	  may	  simply	  reflect	  the	  high	  inter-­‐subject	  variability	  in	  this	  measure.	  	  The	  
active	  MTh	   of	   the	   LBP	   group,	   was	   even	   higher,	   at	   50.81±2.45	   %MSO.	   	   Functional	  
disability	   was	   considerably	   high	   for	   this	   group,	   on	   the	   more	   disabled	   end	   of	   the	  
chronic	  LBP	  spectrum	  (54.89±5.4	  compared	  to	  weighted	  average	  43.3	  [SD	  range	  10-­‐
21])	   in	   the	   weighted	   averages	   calculated	   for	   the	   general	   chronic	   LBP	   population,	  
(Fairbank	  and	  Pynsent,	  2000).	  	  The	  higher	  MTh	  in	  the	  LBP	  group	  may	  further	  reflect	  
the	  significant	  correlative	  relationship	  between	  ODI	  and	  MTh	  found	  by	  Strutton	  et	  al.	  
(2005).	  
	  
In	  further	  agreement	  with	  such	  a	  correlative	  relationship,	  there	  was	  a	  non-­‐significant	  
reduction	   in	   MTh	   in	   the	   participants	   who	   improved	   over	   the	   year	   of	   assessment	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(from	   53.85±1.24	   to	   48.55±1.24	  %MSO),	   and	   an	   increase	   in	   the	   participant	  whose	  
pain	   and	   ODI	   started	   to	   increase	   at	   R2	   (B:	   42.39±3.01,	   R1:	   43.68±3.01,	   R2:	  
47.31±3.01,	  R3:	  44.41±3.01).	  MTh	  was	  comparatively	  constant	  in	  the	  stable	  group	  (B:	  
50.86±0.93,R1:	   50.07±0.93,R2:	   52.24±0.93,R3:	   52.47±1.03)	   and	   controls	   (B:	  
40.55±0.8,R1:	  39.87±0.84,R2:	  41.51±0.92,R3:	  40.01±0.92;	  P=0.006).	  	  	  If	  this	  finding	  is	  
confirmed	   in	   a	   larger	   or	   treatment	   based	   cohort,	   MTh	   may	   perhaps	   provide	   a	  
relatively	  stable	  functional	  measure	  of	  nociception-­‐motor	  affectation	  in	  chronic	  LBP	  
(for	  a	  review	  of	  nociception	  motor	  interaction	  see	  (Nijs	  et	  al.,	  2012)).	  	  An	  increased	  
MTh	  has	  also	  been	  reported	  in	  other	  chronic	  pain	  conditions,	  including	  fibromyalgia	  
(Salerno	  et	  al.,	  2000,	  Mhalla	  et	  al.,	  2010),	  rheumatoid	  arthritis	  (Salerno	  et	  al.,	  2000).	  
	  
However	   these	   results	   may	   be	   interpreted	   to	   conflict	   with	   previous	   reports	   of	  
increased	  excitability	  of	  ES	   in	  experimentally	   induced	  LBP	  (Tsao	  et	  al.,	  2011c).	   	  This	  
different	  posture	  and	  postural	  rather	  than	  voluntary	  contraction	  may	  be	  attributable	  
to	  this	  conflicting	  result.	   	  MTh	  or	  the	  size	  of	  MEPs,	  map	  hotspots	  and	   latencies	  are	  
known	  to	  be	  modified	  by	   the	  context	   in	  which	  ES	   is	  activated	   (Kuppuswamy	  et	  al.,	  
2008).	  Patient	  selection	  may	  be	  another	  factor.	  	  Recurrent	  LBP	  being	  arguably	  be	  less	  
severe,	  may	  result	  in	  less	  inhibition	  of	  MEPs	  than	  the	  chronic	  pain	  patients	  with	  disc	  
prolapse/stenotic	  degenerative	  changes,	   recruited	   in	   the	  Strutton	  et	  al.	   (2005)	  and	  
current	  study.	  However	  given	  the	  fact	  that	  this	  increased	  excitability	  was	  confirmed	  
in	   the	   current	   study,	   and	   that	   two	   differentially	   inhibited	   pathways	   have	   been	  
identified	  (Tsao	  et	  al.,	  2011b,	  Tsao	  et	  al.,	  2011a,	  Tsao	  et	  al.,	  2010b),	  these	  results	  are	  




cSPTh	   was	   higher	   than	   control	   in	   the	   LBP	   group	   confirming	   a	   previous	   report	  
(Strutton	  et	  al.,	  2005,	  Strutton	  et	  al.,	  2004b).	  	  In	  this	  study,	  this	  was	  not	  found	  in	  the	  
group	  with	  leg	  pain.	  As	  the	  current	  study	  was	  less	  powered	  than	  the	  study	  conducted	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by	  Strutton	  et	  al.	  (2005),	  who	  also	  recruited	  participants	  with	  leg	  pain,	  it	  may	  reflect	  
higher	   mean	   cSPThs	   in	   the	   LBP	   population	   without	   neurologic	   symptoms.	   cSPThs	  
over	  4	   time	  points	   reveal	   slightly	   lower	   results	  with	   similar	   variability	   in	   the	   LBPLP	  
group	   compared	   to	   this	   previous	   study	   (from	   bar	   graph	   data:	   31.12±2.23	   vs.	  
~35.5±~2.0	  %MSO).	  The	  LBP	  group,	  on	  the	  other	  hand	  closely	  matched	  those	  results	  
at	  35.30±2.03%MSO.	  The	  higher	  contraction	   levels	  might	  be	  said	  to	  have	   improved	  
the	  readability	  of	  this	  measure	  were	  it	  not	  for	  the	  evident	  identical	  variability.	  	  	  
	  
In	  comparing	  outcome	  groups,	  cSPTh	  was	  also	  found	  to	  be	  higher	   in	  the	   improving	  
patients,	   although	   this	   is	   likely	   to	   be	   due	   to	   the	   fact	   3	   of	   the	   four	   improving	  
participants	  were	  in	  the	  LBP	  group.	  	  However	  the	  reduction	  in	  the	  stable	  group	  and	  
the	   participant	   with	   worsening	   symptoms	   (with	   considerable	   neurological	  
symptoms)	   may	   indicate	   a	   differential	   mechanism	   affected	   by	   the	   presence	   of	  
neurologic	  deficit.	   	  Given	  the	  finding	  of	  prolonged	  cSPs	   in	  the	  LBPLP	  group,	   further	  
treatment	  based	  studies	  will	  be	  needed	  to	  determine	  how	  cSP	  recruitment	  may	  be	  




The	  cSP	  was	  highly	  variable	  in	  back	  pain	  groups	  compared	  to	  control.	  	  It	  was	  found	  to	  
be	  significantly	  higher	  than	  control	   in	  the	  LBPLP	  group	  but	  not	  the	  LBP	  group.	   	  This	  
was	   not	   reported	   by	   Strutton	   et	   al.	   (2005)	  who	  measured	   the	   cSP	   onset	   from	   the	  
MEP	  offset,	  rather	  than	  the	  magnet	  stimulus.	  	  A	  previous	  trunk	  muscle	  study,	  along	  
with	   pilot	   experiments	   had	   shown	   that	   the	   contraction	   level	   of	   40%	   and	   cSP	  
measured	   from	   the	   offset	   offered	   more	   reliable	   reading	   conditions	   for	   the	   cSP	  
(Damron	  et	  al.,	  2008).	  Nevertheless	  the	  ES	  L4	  cSPs	  were	  found	  to	  have	  ICCs	  of	  0.66-­‐
0.74	  in	  a	  previous	  reliability	  study	  over	  the	  same	  period	  (see	  chapter	  4),	  even	  though	  
measuring	   the	   cSP	   from	   the	   offset	   has	   been	   reported	   to	   reduce	   this	   inter-­‐subject	  
variability	  (at	  least	  in	  other	  muscles).	  	  Compared	  to	  MEP	  recruitment	  which	  plateaus	  
150	  
	  
at	   high	   stimulus	   intensities	   (see	   figure	   5.7),	   the	   cSP	   duration	   is	   known	   to	   linearly	  
increase	  with	   stimulus	   intensity	   (Inghilleri	  et	  al.,	  1993;	  Roick	  et	  al.,	  1993;	  Orth	  and	  
Rothwell	  2004).	  	  So	  a	  higher	  MTh	  in	  LBPLP	  participants	  might	  lead	  to	  longer	  cSPs	  at	  
1.2MTh.	   	  As	  a	   result	   this	  measure	  was	  quantified	  at	   fixed	   intensities	  of	  50,	  55	  and	  
60%	  MSO,	  and	  yielded	  even	  more	  significant	  results.	  
	  
The	  cSP	  is	  thought	  to	  represent	  a	  disruption	  of	  access	  of	  voluntary	  motor	  drive	  to	  the	  
primary	  motor	  cortex	  (Wassermann	  et	  al.,	  2008).	  The	  early	  50-­‐60	  ms	  component	  of	  
the	   cSP	   is	   believed	   to	  be	   caused	  by	   spinal	  mechanisms,	   including	   the	  motoneuron	  
after-­‐hyperpolarisation	   and	  Renshaw	   inhibition.	   The	   subsequent	  part	   is	   thought	   to	  
be	   of	   cortical	   origin,	   and	   is	   mediated	   by	   cortical	   inhibitory	   interneurons	   that	   are	  
depolarised	  by	  TMS	  (Ziemann	  et	  al.,	  1993,	  Chen,	  2004,	  Fuhr	  et	  al.,	  1991,	  Inghilleri	  et	  
al.,	  1993).	  The	  range	  (above	  100ms)	  of	  cSPs	  measured	  	  in	  LBPLP	  patients	  in	  this	  study	  
may	   indicate	  a	   cortical	  origin	   for	   this	  prolonged	  cSP.	   	   The	  cSP	   is	   thought	   to	   reflect	  
gamma-­‐aminobutyric	   acid	   B	   receptor	   (GABAB)	   mediated	   (Werhahn	   et	   al.,	   1999)	  
cortical	   inhibitory	   mechanisms.	   	   It	   is	   influenced	   by	   GABAergic	   drugs,	   such	   as	  
dopamine,	  carbamazepine,	  gabapentin	  and	  ethanol	  (Ziemann,	  2004,	  Ziemann	  et	  al.,	  
1996,	   Priori	   et	   al.,	   1994a,	   Ziemann	   et	   al.,	   1995). An	   increased	   cSP	   indicates	  
hyperactivity	   whereas	   decreased	   cSP	   hypoactivity	   of	   GABAergic	   cortical	   inhibitory	  
interneurons.	  
	  
Changes	   in	   intracortical	   inhibition	   (ICI)	   have	   been	   reported	   in	   neuropathic	   pain	  
(Turgut	  and	  Altun,	  2009,	  Schwenkreis	  et	  al.,	  2010),	  and	  other	  chronic	  pain	  conditions	  
such	  as	  fibromyalgia	  (Salerno	  et	  al.,	  2000,	  Mhalla	  et	  al.,	  2010),	  complex	  regional	  pain	  
syndrome	   (Schwenkreis	   et	   al.,	   2005),	   including	   low	   back	   pain	   (Masse-­‐Alarie	   et	   al.,	  
2012).	  	  Short	  intracortical	  inhibition	  (SICI),	  which	  was	  found	  to	  be	  reduced	  in	  chronic	  
LBP	   in	   the	   latter	   study,	   is	   believed	   to	   be	   mediated	   by	   GABAA-­‐receptor	   mediated	  
intracortical	  inhibition.	  	  Increased	  cSP	  and	  reduced	  SICI	  may	  be	  analogous	  in	  the	  long	  
term.	   	   GABAA-­‐receptor	   mediated	   ICI	   is	   inhibited	   by	   GABAB	   activity	   (Davies	   et	   al.,	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1990).	   GABAB	   receptors	   are	   both	   pre	   and	   postsynaptic	   so	   that	   the	   presynaptic	  
receptors	  end	  up	  inhibiting	  GABA	  release.	  
	  
This	   interaction	   has	   been	   used	   to	   explain	   how	   some	   drugs	   which	   increase	  
intracortical	   inhibition	   in	   the	   brain	   (seizures	   are	   associated	   with	   a	   reduced	   SICI	  
(Delvaux	   et	   al.,	   2001)	   as	   well	   as	   reduced	   GABAAR-­‐mediated	   inhibition	   (Roberts,	  
1986))	   are	   also	   associated	   with	   a	   heightened	   risk	   of	   seizure	   (Wassermann	   et	   al.,	  
2008).	   Baclofen	   is	   a	   good	   example.	   It	   is	   a	   GABABR	   agonist	   prescribed	   to	   treat	  
spasticity	   and	   dystonia	   and	   results	   in	   a	   prolonged	   cSP	   (Siebner	   et	   al.,	   1998).	   	   It	   is	  
associated	   with	   a	   considerably	   heightened	   risk	   of	   seizures	   (Schuele	   et	   al.,	   2005).	  	  
Those	  properties	  are	  thought	  to	  result	  from	  GABAB-­‐mediated	  attenuation	  of	  GABAA-­‐
mediated	  inhibitory	  neurotransmission	  (McDonnell	  et	  al.,	  2006).	  
	  
In	  agreement	  with	  this	  view	  is	  the	  finding	  by	  Masse-­‐Alarie	  and	  colleagues	  (2012)	  of	  a	  
strong	  negative	  correlation	  between	  the	  increases	   in	  the	  cSP	  and	  SICI	  reductions	   in	  
LBP	  patients	  (SICI	  conditioned	  MEP	  decrease	  vs.	  cSP	  in	  LBP	  patients	  (r=0.8,	  p=0.006)).	  	  	  
	  
But	  this	  not	  always	  strictly	  the	  case.	  	  For	  example	  a	  reduced	  cSP	  has	  been	  reported	  in	  
fibromyalgia	  (Salerno	  et	  al.,	  2000).	  	  In	  fact,	  although	  GABAergic	  mediation	  appears	  to	  
be	   central	   to	   chronic	   pain	   mechanisms,	   if	   a	   peripheral	   lesion	   or	   exacerbation	   of	  
afferent	  drive	  to	  the	  motor	  cortex	  are	  the	  cause	  (and	  in	  LBP	  we	  simply	  do	  not	  know),	  
these	  may	  have	  an	   important	  yet	  unpredictable	   impact	  on	  cortical	   inputs	  and	   thus	  
excitability	  (Lefaucheur,	  2006).	  
	  
In	  the	  LBP	  group	  most	  of	  the	  cSP	  prolongation,	  asymmetry	  and	  variability	  across	  the	  
year	  of	   assessment	   came	   from	  3	  participants.	   	   In	  pooled	  outcome	  analysis	   (group:	  
P<0.001,	   time:	   P=0.608)	   cSPs	   were	   higher	   than	   controls	   (P<0.001)	   and	   the	   stable	  
group	  (P=0.018)	   in	  the	   improving	  cohort	  throughout	  the	  year	  (I:	  118.03±5.25ms	  vs.	  	  
S:	  98.73±4.07	  vs.	  C:	  90.43±3.88	  vs.	  W:	  109.85±13.69).	   	  Therefore	   further	  studies	   in	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LBP	  participants	  with	  neurologic	  symptoms	  might	  help	  clarify	  whether	  a	   role	  exists	  
for	  this	  measure,	  perhaps	  in	  identifying	  or	  even	  classifying	  neuropathic	  LBP	  or	  some	  
level	  of	  central	  sensitization.	  	  	  
	  
MVCs,	  MEP	  latencies,	  durations	  and	  areas	  
	  
Latencies	  were	  not	  significantly	  different	  to	  controls	  at	  either	  vertebral	  levels.	  These	  
values	   are	   in-­‐keeping	  with	  other	   TMS	   studies	   using	   vertex	   stimulation	   (Strutton	   et	  
al.,	   2005,	   Kuppuswamy	  et	   al.,	   2004,	   Kuppuswamy	  et	   al.,	   2008)	   	   but	  with	   a	   smaller	  
range,	   concentrated	   on	   the	   faster	   end	   of	   the	   latency	   spectrum	   compared	   to	  
hemispheric	  mapping	  experiments	   (12.05-­‐30.48ms)	   (O'Connell	   et	   al.,	   2007,	   Ferbert	  
et	  al.,	  1992).	  	  This	  suggests	  that	  vertex	  stimulation	  during	  voluntary	  BTEs	  at	  1.2MTh	  
preferentially	   activated	   crossed	   fibres	   and	   faster	   responses	   presumably	   mask	   any	  
later	  MEP	   onsets	   from	   ipsilateral	   or	   oligosynaptic	   pathways.	   	   	   An	   alternative	   view	  
may	   be	   suggested	   by	   the	   fact	   that	   MEP	   durations	   were	   significantly	   longer	   in	  
controls.	  	  This	  was	  not	  reported	  by	  Strutton	  et	  al.	  (2005)	  and,	  along	  with	  differences	  
in	   cSPs	   reported,	   may	   have	   been	   affected	   by	   using	   a	   higher	   contraction	   level.	  
However,	   just	   like	   in	   that	   study	   raw	  MEP	   areas	  were	   not	   significantly	   different	   to	  
controls.	   This	   may	   suggest	   inhibition	   of	   contralateral	   drive	   resulting	   in	   a	   higher	  
contribution	   from	   a	   combination	   of	   contralateral	   and	   ipsilateral	   or	   oligosynaptic	  
pathways.	   	  This	  could	  explain	  the	  “smudging”	  referred	  to	  by	  Tsao	  et	  al.	   in	  mapping	  
experiments	  (Tsao	  et	  al.,	  2011a,	  Tsao	  et	  al.,	  2011b).	  	  This	  view	  is	  further	  clarified	  by	  
recruitment	  curve	  results	  below.	  	  
	  
Improving	   participants	   had	   significantly	   longer	   MEPs	   then	   stable	   participants	   and	  
controls	  throughout	  the	  year	  of	  assessment.	  	  Given	  that	  this	  is	  in	  line	  with	  results	  of	  
the	   cSP,	   a	   speculative	   viewpoint	   may	   be	   that	   high	   intracortical	   inhibitory	   activity,	  
reduced	  contralateral	  followed	  by	  additional	  low	  amplitude	  oligosynaptic	  MEPs,	  may	  




On	   the	   other	   hand,	   even	   though	   subjects	  were	   restricted	   to	   isometric	   extensions,	  
some	  variability	  may	  be	  down	  to	  variations	  in	  individual	  multiple	  muscle	  recruitment	  
strategy.	  Participants	  graded	  ES	  T12	  contractions	  based	  on	  ES	  L4	  visual	  feedback	  and,	  
although	  participants	  were	  guided	  by	  instruction,	  the	  curvature	  of	  the	  spine	  was	  not	  
strictly	  controlled.	  Controls	  recruited	  significantly	  more	  from	  the	  T12	  level	  compared	  
to	   back	   pain	   participants,	   who	   did	   not	   produce	   distinguishingly	   different	   EMG.	  	  
Pushing	   out	   asymmetrically	   against	   the	   Velcro	   strap	  with	   one	   shoulder	   during	   the	  
extension,	  for	  example,	  may	  result	  also	  in	  latency	  variations	  in	  the	  contralateral	  ES	  as	  
in	  shoulder	  abductions	  (Kuppuswamy	  et	  al.,	  2008).	  
	  
Simultaneously	  increased	  and	  reduced	  corticospinal	  excitability	  (RC	  slope,	  X50	  and	  MTh)	  
	  
MTh	  is	  thought	  to	  represent	  a	  general	  reflection	  of	  neuronal	  membrane	  excitability,	  
reflecting	   both	   spinal	   and	   cortical	   excitability	   (Wassermann	   et	   al.,	   2008).	   It	   is	  
increased	   by	   substances	   which	   block	   calcium	   and	   voltage	   gated	   sodium	   channels	  
(Ziemann,	  2003,	  Ziemann,	  2004).	  	  Administration	  of	  acute	  painful	  electrical	  (Urban	  et	  
al.,	   2004,	   Kofler	   et	   al.,	   1998,	   Kaneko	   et	   al.,	   1998)	   or	   laser	   (Valeriani	   et	   al.,	   2001,	  
Valeriani	   et	   al.,	   1999)	   stimuli	   to	   the	   skin	  have	  been	   shown	   to	   reduce	   corticospinal	  
motor	   (MEP)	   output	   to	   painful	   muscles.	   The	   interaction	   between	   nociceptive	  
afferents	  and	  size	  and	  location	  of	  the	  modulation	  in	  motor	  output	  are	  related	  to	  the	  
type	   of	   afferent	   pathways	   activated.	   	   So	   spinal	   rather	   than	   cortical	   inhibition	   is	  
known	   to	  be	   responsible	   for	   the	  MEP	  attenuation	   in	  electrical	   stimulation	  because	  
MEP	  reduction	  occurs	  within	  the	  (spinal)	  cutaneous	  silent	  period	  which	  has	  a	  latency	  
between	  	  40-­‐100	  ms	  (Kaneko	  et	  al.,	  1998;	  Kofler	  et	  al.,	  1998).	  	  Laser	  evoked	  potential	  
inhibition,	   on	   the	   other	   hand,	   peaks	   at	   160ms	   when	   these	   are	   known	   to	   reach	  
cortical	  interneurons	  (Valeriani	  et	  al.,	  1999,	  2001).	  	  	  
	  
In	  prolonged	   tonic	  muscle	  pain	  by	  hypertonic	   saline	   injection	   (Le	  Pera	  et	  al.,	  2001;	  
Svensson	   et	   al.,	   2003),	   the	   inhibition	   begins	   to	   outlast	   the	   duration	   of	   pain.	   	   The	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cortical	  precedes	  the	  spinal	   inhibition	  (as	  measured	  by	  H-­‐reflex	  attenuation).	   	  After	  
topical	   application	  of	   capsaicin	   (Cheong	   et	   al.,	   2003),	   the	   cSP	   is	   lengthened	  within	  
the	  application	  area	  but	  the	  effects	  do	  not	  outlast	  the	  pain.	  	  In	  the	  chronic	  scenario,	  
chronic	   knee	   pain	   is	   thought	   to	   have	   the	   effect	   of	   increasing	   the	   excitability	   of	  
surrounding	   musculature	   while	   MVCs	   and	   peripheral	   nerve	   responses	   are	  
significantly	  smaller	  than	  in	  controls	  	  (On	  et	  al.,	  2004).	  	  	  In	  hypertonic	  saline	  injection	  
of	   the	   lumbar	   interspinous	   ligaments,	   excitability	   of	   internal	   oblique,	   RA	   and	   ES	   is	  
thought	  to	  increase	  whereas	  	  that	  of	  transversus	  abdominis	  is	  thought	  to	  be	  reduced	  
(Tsao	  et	  al.,	  2011c).	  After	  the	  intramuscular	  injection	  of	  capsaicin	  in	  the	  masseter,	  a	  
reduction	  in	  the	  firing	  rate	  of	  single	  motor	  units	  (MU)	  is	  observed,	  but	  no	  reduction	  
in	  force	  (Sohn	  et	  al.,	  2000).	  This	  has	  been	  repeated	  with	  muscular	  and	  non-­‐muscular	  
deep	   tissue	   (Tucker	   and	   Hodges,	   2009,	   Tucker	   et	   al.,	   2009).	   A	   centrally	   mediated	  
decrease	   in	   the	   firing	   rate	   of	   low	   threshold	   motor	   units,	   with	   the	   simultaneous	  
recruitment	   of	   additional	   new	  motor	   units,	   is	   thought	   to	   allow	   for	   an	   increase	   in	  
twitch	  force	  to	  maintain	  output	  (Svensson	  et	  al.,	  2003,	  Svensson	  et	  al.,	  2002,	  Tucker	  
and	  Hodges,	  2009,	  Tucker	  et	  al.,	  2009).	  	  This	  fact	  is	  important	  when	  considering	  that,	  
even	  though	  excellent	  mapping	  work	  has	  identified	  discrete	  output	  zones	  to	  ES	  (one	  
of	   which	   is	   predominantly	   inhibited	   in	   LBP)	   a	   direct	   comparison	   of	   ES	   and	   TrA	  
recruitment	  in	  LBP	  or	  experimental	  LBP	  (active	  MTh	  or	  active	  RC),	  using	  identical	  fine	  
wire	   intramuscular	  electrodes	  (FWIE)	  has	  never	  been	  carried	  out.	   	  Given	  the	  above	  
mechanism,	   it	   is	  possible	  that,	  statistically,	   in	  the	  presence	  of	  on-­‐going	  deep	  tissue	  
nociceptive	  stimulation,	  assessing	  a	  few	  motor	  units	  (FWIE)	  may	  always	  present	  the	  
picture	  of	  reduced	  excitability	  compared	  to	  the	  whole	  muscle	  (surface	  electrodes).	  	  
	  
Global	   ES	   L4	  MEP	   recruitment	   was	   significantly	   steeper	   and	   shifted	   to	   the	   left	   by	  
0.2XMTh	  in	  both	  patient	  groups	  compared	  to	  controls.	  This	  increase	  in	  excitability	  of	  
ES	  L4	  is	  in	  agreement	  with	  the	  mechanisms	  described	  above,	  and	  recruitment	  curves	  
measured	  in	  acute	  low	  back	  pain,	  induced	  by	  administration	  of	  hypertonic	  saline	  into	  
the	  interspinous	  ligament	  (Tsao	  et	  al.,	  2011c),	  which	  had	  not	  reported	  an	  increased	  
active	   MTh.	   This	   increased	   excitability	   may	   reflect	   a	   combination	   of	   cortical	   and	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spinal	  mechanisms.	  An	  increased	  MTh	  and	  RC	  slope	  is	  not	  contradictory,	  given	  that	  
two	   pathways	   have	   been	   identified,	   and	   that	   one	   of	   these	   has	   been	   shown	   to	   be	  
preferentially	   inhibited	   by	   nociceptive	   stimulation.	   	   Furthermore,	   the	   dichotomy	   is	  
influenced	   by	   our	   current	   definition	   of	  MTh.	   	   Active	  MTh	   (defined	   as	   a	  minimum	  
peak	  to	  peak	  amplitude	  [P2P]	  of	  200µV	  in	  50%	  of	  responses),	  was	  originally	  defined	  
with	  more	  distal	  musculature	   in	  mind.	   	   These	  produce	  MEPs,	  preferentially	   from	  a	  
faster	   contralateral	   pathway,	   with	   usually	   one	   high	   amplitude	   compound	   action	  
potential	  with	  few	  phases;	  and	  thus	  threshold	  excitability	  can	  be	  accurately	  defined	  
by	  P2P.	  	  In	  comparison,	  ES	  MEPs	  are	  highly	  polyphasic.	  	  In	  some	  LBP	  participants	  in	  
this	   study,	   a	   stimulation	   intensity	   of	   60%MSO	   barely	   produced	   responses	   above	  
200µV.	  	  It	  is	  possible	  that	  the	  predominantly	  inhibited	  anterior	  pathway	  identified	  by	  
previous	  authors	  (speculated	  to	  originate	  from	  the	  SMA)	  predominantly	  contributes	  
to	  MEP	  amplitude,	  whereas	  the	  more	  medial	  pathway	  predominantly	  contributes	  to	  
MEP	   area.	   	   As	   a	   result,	   lower	   amplitude	   highly	   polyphasic	   MEPs	   (possibly	  
predominantly	  corresponding	  to	  the	  more	  medial	  pathway	   identified	  by	  Tsao	  et	  al.	  
(2011a))	   can	   still	   reach	   saturation	   (when	  normalised	   to	  peak	  EMG	   responses)	  with	  
comparatively	  less	  induced	  current	  in	  the	  cortex.	  	  	  
	  
It	  might	  thus	  be	  necessary	  to	  either	  develop	  a	  definition	  of	  MTh	  based	  on	  MEP	  area	  
specific	   to	   muscles	   of	   the	   trunk,	   or	   always	   combine	   MTh	   with	   recruitment	   curve	  
data.	   	   Furthermore,	   as	   pointed	   out	   by	   Goss	   (2012),	   methods	   of	   differentiating	  
between	   changes	   in	   excitability	   at	   the	   cortical	   and	   spinal	   level	   may	   be	   useful	   in	  
understanding	  these	  mechanisms	  and	  identifying	  suitable	  markers	  for	  rehabilitative	  
therapy	  (Goss	  et	  al.,	  2012).	  
	  
It	   is	   looking	   increasingly	   possible	   that	   patients	  with	   chronic	   LBP	  have	  differentially	  
inhibited	  discrete	  pathways	  to	  ES.	  	  This	  study	  found	  reduced	  corticomotor	  drive	  to	  ES	  
(increased	  MTh)	  to	  this	  muscle	  in	  all	  LBP	  participants	  and	  increased	  GABAB-­‐receptor	  
mediated	   intracortical	   inhibitory	   activity	   in	   the	   group	   of	   participants	   with	   either	  
symptoms	   of	   neurologic	   deficit	   or	   radicular	   pain.	   	   When	   analysing	   the	   area	   of	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corticomotor	   recruitment	   normalised	   to	  maximum	  voluntary	   EMG,	   excitability	  was	  
found	   to	   be	   higher	   in	   all	   back	   pain	   participants	   than	   controls,	   possibly	   to	   meet	  
functional	   force	   demands.	   Although	   the	   number	   of	   participants	   experiencing	  
changes	  in	  pain	  and	  function	  over	  the	  1	  year	  of	  assessment	  constituted	  relatively	  low	  
statistical	   power,	   changes	   in	   the	   above	   parameters	   were	   found	   to	   occur	  
predominantly	   in	   these	   unstable	   participants.	   	   On	   the	   other	   hand	   this	   study	   has	  
found	  measures	  of	   corticospinal	   activity	   to	  be	   relatively	   stable	   in	  participants	  with	  
stable	  neurophysiology.	  The	  possible	  usefulness	  of	  the	  cSP	  and	  other	  measures	  of	  ICI	  
in	   identifying	  or	  categorising	  more	  pronounced	  central	  or	  neuropathic	  elements	   to	  
functional	   changes	   in	   LBP	   requires	   investigation.	   Furthermore	   studies	   comparing	  
long	   term	   outcomes	   of	   clinical	   intervention	   to	   parameters	   of	   central	  
neurophysiology	   will	   need	   to	   establish	   the	   practical	   clinical	   usefulness	   of	   these	  
findings.	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6.	  Corticomotor	  and	  intracortical	  excitability	  in	  radicular	  pain	  and	  radiculopathy	  before	  and	  up	  to	  1	  year	  post-­‐surgery	  
	  





Altered	   corticomotor	   and	   intracortical	   inhibitory	  drive	   to	  painful	  muscles	  has	  been	  
reported	  in	  low	  back	  pain	  (LBP)	  (Tsao	  et	  al.,	  2011b,	  Tsao	  et	  al.,	  2008,	  Strutton	  et	  al.,	  
2005,	   Strutton	   et	   al.,	   2004b,	  Masse-­‐Alarie	   et	   al.,	   2012)	   and	   radicular	   pain	   in	   L4-­‐S1	  
nerve	   root	   pathology	   (Strutton	   et	   al.,	   2003b).	   	   In	   patients	   with	   chronic	   LBP	   with	  
neurologic	  deficit	  or	   radicular	  pain,	  a	  correlation	  was	   found	  between	  patient	   rated	  
pain	  and	  functional	  disability	  scores	  and	  thresholds	  for	  eliciting	  TMS	  responses	  (both	  
inhibitory	  and	  facilitory)	  in	  the	  back	  and	  leg	  muscles	  (Strutton	  et	  al.,	  2003b;	  Strutton	  
et	   al.,	   2005).	   	   Further	   alterations	   in	   intracortical	   inhibitory	   (ICI)	   activity	   have	   been	  
reported	  in	  neuropathic	  (Turgut	  and	  Altun,	  2009,	  Schwenkreis	  et	  al.,	  2010),	  chronic	  
pain	  conditions	  such	  as	   fibromyalgia	   (Salerno	  et	  al.,	  2000,	  Mhalla	  et	  al.,	  2010),	  and	  
complex	  regional	  pain	  syndrome	  (Schwenkreis	  et	  al.,	  2005).	  	  
	  
Surgical	   treatment	   accounts	   for	   one	   third	   of	   health	   care	   costs	   for	   spinal	   disorders	  
(Gibson	  et	  al.,	  2000).	  	  Decompression	  or	  discectomy	  surgery	  procedures	  are	  reserved	  
for	  a	  subset	  of	  cases	  of	  LBP	  with	  both	  degenerative	  (as	   in	  stenosis	  or	  degenerative	  
disc	  disease)	  and	  traumatic	  damage	  (as	  in	  disc	  prolapse),	  where	  neurologic	  deficit	  is	  
present	   and	   where	   conservative	   treatments	   have	   proven	   ineffective.	   However	  
outcomes	   have	   been	   variable.	   There	   is	   still	   no	   decisive	   evidence	   as	   to	   whether	  
surgery	  can	  benefit	  patients	  without	  clear	  and	  significant	  neurologic	  deficit	  (Gibson	  
and	  Waddell,	  2007,	  Gibson	  and	  Waddell,	  2005).	  	  A	  Cochrane	  review	  concluded	  that	  
in	  those	  carefully	  selected	  patients	  with	  radicular	  pain	  due	  to	  disc	  prolapse,	  surgical	  
discectomy	   provides	   faster	   relief	   than	   conservative	   management,	   although	   any	  
effects	  on	  the	  lifetime	  of	  the	  underlying	  disc	  disease	  are	  still	  unknown	  (Gibson	  and	  
Waddell,	   2007).	   More	   recently,	   a	   systematic	   review	   concluded	   that	   there	   is	   no	  
significant	  difference	  in	  the	  outcome	  of	  discectomy	  or	  conservative	  management	  by	  
1	   year	   post-­‐surgey	   (Jacobs	   et	   al.,	   2011).	   	   In	   decompression	   procedures	   for	   spinal	  
stenosis	   without	   fusion,	   69%	   have	   been	   reported	   to	   have	   a	   satisfactory	   outcome	  
(Mardjetko	  et	  al.,	  1994).	  	  However	  these	  procedures	  are	  associated	  with	  surprisingly	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limited	  satisfaction	  and	  improvements	  in	  pain	  and	  function	  (McGregor	  and	  Hughes,	  
2002b,	  McGregor	   and	  Hughes,	   2002a),	   a	   return	  of	   symptoms	   in	  many	   cases	   and	  a	  
reduction	  in	  improvements	  in	  the	  long	  term	  (Malmivaara	  et	  al.,	  2007,	  Anjarwalla	  et	  
al.,	  2007).	  	  	  
	  
It	   is	  necessary	   to	  establish	  whether	   surgery	  aimed	  at	   reducing	   leg	  pain	   reverses	  or	  
affects	   the	   changes	   observed	   in	   corticospinal	   control	   of	   trunk	   and	   leg	   muscles	  
(Strutton	   et	   al.,	   2003b,	   Strutton	   et	   al.,	   2005).	   If	   surgery	   does	   not	   actually	   reverse	  
these	   cortical	   changes	   induced	   by	   chronic	   pain	   or	   altered	   afferent	   drive	   to	   the	  
cortex,	  then	  this	  might	  explain	  the	  poor	  long	  term	  prognosis	  and	  functional	  outcome	  
observed	   in	  many	  patients.	   	  Alterations	   in	   intracortical	   inhibitory	   (ICI)	  activity	  have	  
been	  reported	  in	  low	  back	  pain	  (Masse-­‐Alarie	  et	  al.,	  2012),	  neuropathic	  (Turgut	  and	  
Altun,	   2009,	   Schwenkreis	   et	   al.,	   2010),	   and	   chronic	   pain	   conditions	   such	   as	  
fibromyalgia	   (Salerno	   et	   al.,	   2000,	  Mhalla	   et	   al.,	   2010),	   and	   complex	   regional	   pain	  
syndrome	   (Schwenkreis	  et	  al.,	  2005).	  Recently	   some	  of	   these	  central	   changes	  have	  
been	   targeted	   by,	   and	   correlated	   to	   the	   functional	   outcomes	   of,	   physical,	  manual	  
and	  exogenous	  electro-­‐	  therapy	  (Masse-­‐Alarie	  et	  al.,	  2013,	  Clark	  et	  al.,	  2011,	  Tsao	  et	  
al.,	  2010a).	  	  Active	  measures	  of	  corticomotor	  excitability	  and	  intracortical	  inhibitory	  
activity,	   like	   motor	   threshold	   (MTh),	   the	   cortical	   silent	   period	   (cSP)	   and	   cSP	  
threshold,	   have	   been	   reported	   to	   have	   high	   repeatability	   and	  may	   be	   particularly	  
attractive	   in	   monitoring	   long	   term	   changes	   in	   chronic	   LBP	   and	   radicular	   pain	  
(Malcolm	   et	   al.,	   2006,	   Kukowski	   and	  Haug,	   1992,	   Kimiskidis	   et	   al.,	   2004,	  Mills	   and	  
Nithi,	   1997,	   Carroll	   et	   al.,	   2001,	   Orth	   and	   Rothwell,	   2004).	   	   However	   our	   current	  
understanding	  of	  the	  expected	  profile,	  long	  term	  stability,	  and	  disease	  progression	  of	  
parameters	   of	   corticomotor	   and	   intracortical	   inhibitory	   control	   within	   the	   LBP	  
patient	  spectrum	  is	  still	  in	  its	  infancy.	  
	  
It	  is	  not	  known	  whether	  alterations	  in	  brain	  pathways	  to	  muscles	  affected	  by	  chronic	  
LBP	  and	  lumbosacral	  nerve	  root	  pathology	  have	  a	  role	  to	  play	  in	  long	  term	  changes	  in	  
pain	   and	   function	   following	   surgery.	   Furthermore	   there	   are	   still	   ambiguities	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regarding	  appropriate	  indications	  for	  surgery	  and	  patient	  clinical	  profiles	  which	  may	  
be	   associated	   with	   favourable	   outcome	   (Gibson	   and	   Waddell,	   2005,	   Gibson	   and	  
Waddell,	  2007).	  	  If	  baseline	  neuroplasticity	  measures	  are	  found	  to	  be	  related	  to	  the	  
capacity	   for	   functional	   improvements	   in	   surgery,	   then	   parameters	   of	   central	  
adaptations	  to	  these	  conditions	  may	  provide	  additional	  information	  to	  surgeons.	  
	  
The	  purpose	  of	  this	  study	  is	  to	  monitor	  long	  term	  changes	  in	  leg	  muscle	  parameters	  
of	   corticomotor	   and	   intracortical	   inhibitory	   excitability	   in	   surgery	   patients	   with	  
unilateral	  radicular	  pain	  or	  neurologic	  deficit	  as	  a	  result	  of	  either	  the	  L5	  or	  S1	  nerve	  
root	   compromise,	   and	   to	   compare	   these	   in	   different	   classifications	   of	   pain	   and	  
functional	  outcome.	  







With	  local	  ethical	  approval	  and	  informed	  consent,	  26	  participants	  on	  the	  waiting	  list	  
for	   a	   discectomy	   or	   decompression	   surgery	   with	   radiological	   evidence	   of	   a	  
lumbosacral	   disc	   prolapse	   or	   lateral	   nerve	   root	   stenosis,	   were	   recruited	   from	   the	  
department	   of	   neurosurgery	   at	   London	   Charing	   Cross	   hospital.	   Exclusion	   criteria	  
included	   previous	   spinal	   surgery,	   fracture,	   infection,	   malignancy,	   cauda	   equina	  
syndrome,	  current	  treatment	  with	  antidepressants	  or	  other	  neuromodulatory	  drugs,	  
along	  with	  general	  TMS	  contraindications	  detailed	   in	   chapter	  3.	  Of	   the	  24	  patients	  
who	  completed	  the	  baseline	  assessment	  and	  questionnaire,	  13	  (7	  male	  and	  6	  female,	  
aged	  40.54±13.41	  [SD]	  years	  with	  a	  BMI	  of	  25.3±4.3	  [SD])	  were	  clinically	  diagnosed	  
with	  radicular	  pain	  or	  neurologic	  deficit	  attributable	  to	  a	  nerve	  root	  compression	  of	  
the	  L5	  and	  11	  (5	  male,	  6	  female	  aged	  39.91±10.56	  [SD]	  years	  with	  BMI	  of	  25.0±8.3	  
[SD])	  of	   the	  S1	  nerve	   root.	   	   The	   same	  19	  healthy	   control	  participants	   recruited	   for	  
chapters	  4	  and	  5,	  comprised	  14	  males	  and	  5	  females;	  32.39±7.29	  [SD]	  years	  of	  age	  
with	  a	  body	  mass	  index	  of	  23.46±3.0	  [SD]).	  	  Corticospinal	  excitability	  of	  the	  lower	  leg	  
muscles	   (soleus	   and	   tibialis	   anterior	   [TA])	   was	   assessed	   prior	   to	   surgery	   (B),	   at	   6	  
weeks	   (R1),	   6	   months	   (R2)	   and	   1	   year	   (R3)	   following	   surgery,	   and	   at	   equivalent	  




Baseline	  Clinical	  Characteristics	  and	  Surgical	  Interventions	  
	  
Table	  6.1	  summarises	  features	  of	  the	  diagnosed	  nerve	  root	  compromise,	   its	  clinical	  
presentation	   (clinical	  history	  and	  neurological	  examination	   results),	   the	  MRI	   report	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confirmation	  and	  the	  surgical	  procedure	  which	  was	  carried	  out,	  as	  confirmed	  by	  the	  
neurosurgeon	   operation	   notes.	   	   Five	   participants,	   as	   indicated	   with	   “↔”,	   had	   a	  
dominant	   compression	  on	  one	   side,	   and	   also	  displayed	   a	   less	   extensive/conclusive	  
root	  compromise	  on	  the	  contralateral	  side	  at	  that	  level.	  	  	  	  
	  
Table	   6.1	   also	   details	   the	   intervention	   (discectomy	   (open	   or	   microscopic)	   and/or	  
decompression)	  procedure	  and	  segment.	  	  Overall	  at	  the	  dominant	  level	  indicated,	  a	  
total	   of	   3	   decompression	   and	   8	   discectomy	   procedures	  were	   performed	   in	   the	   S1	  
group	   and	   6	   decompressions	   and	   8	   discectomies	   in	   the	   L5	   group.	   	   Although	   some	  
MRI	  reports	  specified	  a	  secondary	  compression	  or	  degenerative	  changes	  above	  the	  
primarily	  affected	  root	  (indicated	  by	  the	  “↑”	  next	  to	  the	  root	  for	  participant	  22	  for	  
example),	   this	   was	   not	   always	   targeted	   by	   surgery	   (a	   left	   microdiscectomy	   and	  
medial	  facetectomy	  only	  at	  L5/S1	  in	  this	  example).	  Participant	  18	  on	  the	  other	  hand,	  
underwent	   a	   posterior	   decompression	   procedure	   (medial	   facetectomy	   and	  
foraminotomy)	   at	   L4/L5	   and	   L5/S1	   (specified	   by	   the	   “↑”	   next	   to	   the	   intervention	  
level).	  Although	  the	  patient’s	  radicular	  pain	  was	  present	  and	  attributed	  to	  a	  right	  S1	  
disc	   prolapse,	   neurologic	   deficit	   (numbness)	  was	   also	   present	   on	   the	   contralateral	  
side,	  and	  was	  not	  targeted	  by	  surgery.	  	  	  
	  
Secondary	  Outcome	  Measures	  
	  
Prior	   to	   the	   start	   of	   each	   assessment	   each	   participant	   completed	   a	   questionnaire,	  
comprising	  (as	  detailed	  in	  chapter	  3)	  an	  Oswestry	  Disability	  Index	  (ODI),	  10cm	  Visual	  
Analogue	  Scales	  of	  Leg	  and	  Back	  Pain	  Physical	  activity	  scale	  section	  of	  the	  Fear	  and	  
Avoidance	   Beliefs,	   EuroQol	   EQ-­‐5D	   health	   quality	   of	   life,	   Hospital	   Anxiety	   and	  
Depression	   Scale	   (HADS)	   forms,	   including	   specific	   drug	   intake	   and	   details	   of	   any	  


















Surgical	  Procedure	  φ	  
Side	   Root	   Level	   Discectomy	   Decompression	  
L5	  
3	   RP,LS,↓PP,P	   R	   L5	   L5/S1	   open	  
laminectomy	  
facetectomy	  
4	   RP,LS,↓LT	   R	   L5	   L5/S1	   open	   	  
5	   RP,LS	   R	   L5	   L5/S1	   micro	   	  
6	   RP,LS,D,↓LT	   R	   L5	   L4/L5	   open	   	  
7	   RP,LS,NC	   R	   L5↑L3	   L4/L5↑	   open	   laminectomy	  
8	   RP,LS,P,↑R↑T	   R	   L5↓	   L4/L5	   	  
lateral	  recess	  
10	   RP,LS	   L↔	   L5	   L4/L5	   open	   	  
13	   RP,LS,N,P,↓R	   R	   L5	   L4/L5	   micro	   	  
14	   RP,LS	   L	   L5	   L4/L5	   micro	   	  
16	   RP,LS,↑R↑T	   L	   L5	   L4/L5	   micro	   	  
20	   RP,LS	   L↔	   L5↓	   L5/S1	   open	   laminectomy	  
22	   RP,LS	   L	   L5↑	   L5/S1	   micro	   facetectomy	  
25	   RP,LS,↓R	   L↔	   L5↑	   L4/L5	   	   foraminotomy	  
S1	  
1	   RP,LS,↓R	   L	   S1	   L5/S1	   micro	   	  
2	   RP,LS	   R	   S1	   L5/S1	   micro	   	  
9	   RP,LS,N,W	   L	   S1	   L5/S1	   open	   	  
12	   RP,LS	   R	   S1	   L5/S1	   micro	   laminectomy	  
15	   RP	   R	   S1	   L5/S1	   micro	   	  
17	   RP,LS	   R	   S1	   L5/S1	   micro	   	  
18	   RP,LS	   R↔	   S1↑	   L5/S1↑	   	   facetectomy	  foraminotomy	  
19	   RP,LS	   L↔	   S1	   L5/S1↔	   micro	   lateral	  recess	  
21	   RP,LS,P	   L	   S1	   L5/S1	   open	   	  
23	   RP,LS,W	   R	   S1	   L5/S1	   micro	   	  
24	   RP,LS,↓R	   R	   S1	   L5/S1↔	   micro	   	  
Ψ	  Clinical	  history	  symptoms	  &	  exam	  results	  (RP:	  radicular	  pain,	  LS:	  	  positive	  Lasègue's	  sign,	  D:	  
dysaesthesia,	  NC:	  neurogenic	  claudication,	  P:	  paraesthesia,	  W:	  weakness,	  N:	  numbness,	  and	  
↑:	  increased	  or	  ↓:	  reduced:	  R:	  reflex,	  LT:	  light	  touch,	  PP:	  pinprick,	  T:	  muscle	  tone)	  relate	  to	  the	  
dominant	  side	  and	  myotomal/dermatomal	  distribution	  of	  the	  nerve	  root	  indicated.	  	  
Φ	  Arrows	  in	  MRI	  and	  surgery	  columns	  indicate	  the	  secondary	  involvement	  of	  an	  another	  level	  
(such	  as	  the	  adjacent	  level	  below	  (↓	  or	  a	  specific	  level	  above	  (↑L3))	  or	  contralateral	  side	  




Patient-­‐Reported	  Baseline	  Characteristics	  
	  
Table	   6.2	   details	   baseline	   pain,	   functional,	   health	   QOL,	   psychological	   and	   fear	  
avoidance	  scores	  at	  baseline.	  	  None	  of	  the	  patient-­‐reported	  baseline	  measures	  listed	  
differed	   between	   the	   L5	   and	   S1	   group	   (all	   P	   ≥	   0.331).	   	  With	   a	  Mean±SEM	  ODI	   of	  
56.62±2.99	   (L5)	   and	   56.73±4.57	   (S1),	   patients	   fell	   in	   the	   severely	   disabled	   range.	  




Bipolar	   surface	   electrodes	   (Ag/AgCl,	   ARBO	   blue,	   2-­‐cm	   diameter)	   were	   positioned	  
bilaterally	  over	  the	  midline	  of	  the	  soleus	  belly,	  the	  superior	  electrode	  about	  2.5	  cm	  
inferior	  to	  the	  inferior	  border	  of	  the	  medial	  head	  of	  the	  gastrocnemius	  muscle,	  and	  
parallel	  to	  the	  longitudinal	  axis	  of	  the	  leg	  to	  approximate	  the	  direction	  of	  the	  muscle	  
fibres.	   The	   tibialis	   anterior	   electrodes	   were	   placed	   over	   the	   most	   longitudinally	  
Table	  6.2:	  	  Patient	  Reported	  	  Baseline	  Characteristics	  (MEAN±SEM)	  
Radicular	  Pain/Neurologic	  Deficit:	   L5	  (n=13)	   S1	  (n=11)	  
Dominant	  Affected	  Side	  (Left	  :	  Right)	   6	  :	  7	   4	  :	  7	  
Average	  Back	  Pain	  (VAS)	   47.3±8.1	   42.8±9.5	  
Average	  Leg	  Pain	  (VAS)	   63.5±5.6	   53.6±8.6	  
Disability	  (ODI)	   56.62±2.99	   56.73±4.57	  
Health	  QOL	  Index	  	  (EQ-­‐5D)	  





Managing	  Daily	  Living	  Activities	  
(VAS)	   56.23±4.91	   61.00±5.33	  
Fear	  Avoidance	  Beliefs	   18.3±2.18	   18.86±1.68	  





prominent	   aspect	   of	   the	  muscle	   belly,	   aligned	   at	   a	   third	   of	   the	   distance	   from	   the	  
fibial	  to	  medial	  malleolus	  heads.	  A	  ground	  reference	  electrode	  was	  then	  positioned	  
on	  the	   left	   fibular	  head.	  The	  EMG	  signals	  were	  bandpass	  filtered	  (10	  Hz-­‐2	  kHz)	  and	  
amplified	  (usually	  at	  ×1000;	  Iso-­‐DAM,	  WPI,	  UK)	  before	  being	  sampled	  at	  4	  kHz	  by	  a	  
data	   acquisition	   interface	   (Power	   1401	   Plus	   and	   Signal	   software	   Version	   3.1;	  
Cambridge	   Electronic	  Design,	  UK)	   connected	   to	   a	   personal	   computer.	   	   Participants	  




Seated	   on	   a	   45	   cm	   high	   chair	   with	   restrained	   ankles	   in	   line	   with	   the	   vertical	  
projection	   of	   the	   knee	   joint	   and	   feet	   strapped	   flat	   to	   a	   board	   on	   the	   floor,	  
participants	   used	   visual	   feedback	   to	  maintain	   consistent	   isometric	   contractions	   of	  
20%	  of	  MVC,	  while	   bilateral	   responses	   to	   transcranial	  magnetic	   stimulation	   of	   the	  
motor	  cortex	  were	  recorded.	  	  The	  contraction	  of	  TA	  was	  achieved	  by	  dorsiflexion	  for	  
TA	  and	  plantar	  flexion	  for	  soleus.	  TMS	  was	  delivered	  using	  a	  9cm	  angled	  double-­‐cone	  
coil	   powered	   by	   a	   Magstim	   2002	   stimulator	   (Magstim	   Co.	   Ltd.,	   UK),	   positioned	  
symmetrically	  over	  the	  vertex	  and	  polarised	  to	   induce	  posterior-­‐to-­‐anterior	  current	  
flow	  in	  the	  motor	  cortex.	  	  A	  full	  recruitment	  curve	  of	  TMS	  pulse	  intensities,	  delivered	  
in	  sets	  of	  6	  to	  30	  pulses,	  at	  intervals	  of	  5%	  of	  maximum	  stimulator	  output	  (%MSO),	  
from	  the	  threshold	  for	  the	  cortical	  silent	  period	  (cSPTh)	  to	  150%	  of	  motor	  threshold	  
(MTh),	  was	  then	  delivered	  in	  a	  randomised	  sequence	  for	  each	  muscle.	  	  	  
	  
Data	  and	  Statistical	  Analyses	  
	  
The	  MTh	   was	   assessed	   as	   the	   lowest	   intensity	   of	   TMS	   that	   produced	   identifiable	  
MEPs	   of	   at	   least	   200uV	   peak-­‐to-­‐peak	   amplitude	   on	   at	   least	   50%	   of	   stimulus	  
presentations.	  The	  cSPTh	  was	  defined	  as	   the	   intensity	  of	   the	   lowest	  appearance	  of	  
the	  cSP	  valley	  in	  the	  averaged	  rectified	  trace.	  All	  MEP	  and	  cSP	  onsets	  and	  offset	  were	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visually	   identified	   and	   defined	   by	   intersection	   of	   the	  mean	  pre-­‐stimulus	   EMG	   line.	  
MEPs	  were	  quantified	  as	  the	  area	  above	  this	  line	  whereas	  the	  cSP	  was	  defined	  as	  the	  
return	  of	  rectified	  EMG	  activity	  to	  pre-­‐stimulus	  levels.	  	  MEPs	  and	  cSP	  were	  quantified	  
at	   1.2MTh.	   All	   EMG	  data	   processing	  was	   carried	   out	   using	   the	   set	   custom	  written	  
programs	  detailed	   in	  chapter	  3	  and	   included	   in	   the	  Appendices	  3-­‐8,	  written	   in	  CED	  
Signal	   scripting	   language	   and	   executed	   using	   Signal	   (version	   3.13,	   Cambridge	  
Electronic	  Design).	  	  
	  
Based	   on	   a	   study	   correlating	   VAS	   pain	   and	   ODI	   score	   outcomes	   to	   patient	   rated	  
Macnab	   classification	   of	   surgery	   outcome	   (Macnab,	   1971)	   in	   193	   patients	   (Tafazal	  
and	  Sell,	  2006),	  global	  procedure-­‐specific	  pain	  and	  functional	  outcome	  classifications	  
were	  derived.	  	  ODI	  changes	  were	  classified	  in	  the	  following	  manner	  for	  a	  discectomy	  
(and	  decompression	  in	  parentheses):	  excellent≥40(28),	  good≥24(16),	   fair≥10(10).	  All	  
participants	   falling	  below	   the	  minimum	  clinically	   significant	  ODI	   range	   (Hagg	  et	  al.,	  
2003)	   were	   rated	   as	   poor<10(10).	   	   VAS	   leg	   pain	   changes	   were	   classified	   in	   the	  
following	  way:	  excellent≥60(50),	  good≥40(30),	  fair≥10(10)	  and	  poor<10(10).	  	  In	  both	  
cases,	   a	   smaller	   change	   is	   required	   to	   classify	   the	   surgery	   as	   a	   success	   if	   the	  
procedure	   was	   a	   decompression.	   This	   classification	   system	   created	   cut-­‐offs	   to	  
compare	  primary	  outcomes	  post-­‐surgery.	  	  
	  
Paired	  t-­‐tests	  were	  used	  to	  establish	  whether	  a	  statistically	  significant	  left	  (L)	  to	  right	  
(R)	  difference	  or	  significant	  differences	  between	  the	  side	  of	  radicular	  pain/neurologic	  
deficit	   (IPSI	   radic)	   and	   the	   contralateral	   side	   (CONTRA	   radic)	   existed	   in	   patients	   or	  
controls	  at	  baseline.	   	   If	  so,	  parameters	  of	  corticospinal	  excitability	  (MTh,	  MEP	  area,	  
cSP,	  cSPTh,	  MEP	  latency)	  were	  analysed	  separately	  in	  each	  of	  those	  respective	  sides	  
(L	   and	   R	   or	   IPSI	   and	   CONTRA)	   over	   the	   four	   time	   points	   using	   two-­‐way	   repeated	  
measures	  analyses	  of	  variances	  (ANOVAs).	   	  When	  not	  statistically	  different,	  L	  and	  R	  
limb	   parameter	   values	   were	   averaged	   for	   unilateral	   analyses.	   Changes	   between	  
limbs	  over	  time	  were	  provided	  by	  asymmetry	  (AI)	  and	  laterality	  indices	  (LI)	  (between	  
IPSI	   and	   CONTRA	   radic	   sides).	   For	   a	   parameter	   (P)	   this	   was	   given	   by	   LI(P)=(PIPSI-­‐
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PCONTRA)/(PIPSI+PCONTRA),	  where	  AI(P)=|LI(P)|.	  Where	  no	  differences	  existed	  at	  baseline	  
left	   and	   right	   limb	   parameters	   were	   pooled	   in	   all	   groups.	   Repeated	   measures	  
ANOVAs	  factorised	  time	  (B,	  R1,	  R2,	  R3)	  and	  level	  of	  the	  clinically	  dominant/surgically	  
targeted	   nerve	   root	   compromise	   (radic	   groups:	   L5	   and	   S1),	   and	   any	   interaction	  
effects	  between	  these	  two	  factors.	  Two-­‐way	  repeated	  measures	  ANOVAs,	  factorising	  
outcome	   classification	   group	   and	   time	   point	   (with	   interactions	   analysis)	   compared	  
parameter	   changes	   in	   patients	   classified	   as	   having	   an	   excellent,	   fair,	   good	  or	   poor	  
outcome.	   	   Where	   outcome	   classification	   groups	   yielded	   too	   few	   participants	   for	  
analysis,	  these	  were	  also	  grouped	  into	  surgery	  high	  responders	  (excellent	  and	  good	  
outcome	   groups	   pooled	   together)	   and	   low	   responders	   (fair	   and	   poor	   outcome	  
groups	   pooled	   together).	   	   All	  multiple	   comparisons	   versus	   the	   control	   group	  were	  
carried	   out	   using	   Bonferroni	   corrected	   t-­‐tests.	   Repeated	  measures	   ANOVA	   results	  
are	  presented	  as	   least	   square	  means	  ±	   standard	  error	   (LSM±SEM)	   for	   group	   (radic	  
level/outcome	   group)	   x	   time.	   Statistical	   analyses	  were	   carried	   out	   using	   Sigmaplot	  
(version	  11.2,	  Systat	  Software,	  Inc.).	  
	  







In	   the	   L5	   group,	   2	   participants	   were	   lost	   to	   follow-­‐up	   at	   6	   weeks	   and	   a	   further	  
participant	  at	  1	  year.	   	   In	   the	  S1	  group,	  2	  were	   lost	   to	   follow	  up	  at	  6	  weeks,	  1	  at	  6	  
months	  and	  2	  at	  1	  year.	   	  Reasons	   for	  non-­‐participation	   included	  complications	  and	  
repeat	  operation	  (2),	  moving	  to	  another	  city	  (1)	  and	  finding	  TMS	  too	  unpleasant	  (2).	  	  
In	  the	  control	  group	  3	  subjects	  dropped	  out	  of	  the	  study	  before	  completing	  all	  four	  
sessions.	  
	  
Pain	  and	  Functional	  Outcome	  	  
	  
Figure	   6.1	   displays	   L5	   and	   S1	   group	   VAS	   pain	   outcome	   over	   the	   year	   following	  
surgery.	   This	   included	   leg	   and	   back	   pain	   levels	   during	   the	   assessment,	   on	   average	  
over	  the	  week	  preceding	  the	  assessment,	  and	  the	  most	  severe	  pain	  over	  that	  week.	  
There	  were	  significant	  decreases	   in	  all	   leg	  pain	  measures	  post-­‐surgery	   (time	  effect:	  
all	   P<0.001)	   irrespective	   of	   the	   level	   of	   primary	   lesion	   (radic	   group	   effect:	   all	  
P≥0.745).	   	   In	   the	   L5	   group,	   average	   leg	   pain	   decreased	   significantly	   by	   6	   weeks	  
(Mean±SEM	   from	   63.5±4.7	   pre-­‐surgery	   to	   24.8±5.4;	   (P<0.001)),	   whereas	   at	   S1	   the	  
reduction	   was	   not	   significant	   until	   6	   months	   post-­‐surgery	   53.0±5.1	   to	   13.5±6.6	  
(P<0.001)).	  	  Nevertheless	  this	  was	  not	  related	  to	  an	  interaction	  between	  radic	  group	  




There	  were	  no	  differences	  between	  groups	   (group	  effect:	   all	   P≥0.713)	   and	  general	  
reductions	  in	  all	  measures	  of	  back	  pain	  (time	  effect:	  all	  P≤0.02)	  in	  figure	  6.3	  (bottom	  
graphs).	  	  In	  average	  back	  pain,	  these	  reductions	  from	  baseline	  were	  only	  significant	  
in	  L5	  patients	  at	  6	  weeks	  and	  again	  at	  1	  year	  (B:	  47.3±5.1	  to	  21.2±6.0	  (P=0.050),	  R3:	  
33.3±6.0	   to	   20.3±6.3	   (P=0.049)).	   There	   were	   no	   interaction	   effects	   between	   radic	  
group	  and	  time	  (all	  P≥0.443).	  
	  
There	  was	  a	  main	  effect	  of	  time	  (P<0.001)	  in	  all	  patients,	  with	  significant	  reductions	  
in	  ODI	  score	  at	  every	  time	  point	  compared	  to	  baseline	  scores	  (P≤0.009).	  There	  were	  














effects:	   P=0.852).	   	   In	   the	   L5	   group	   there	   was	   a	   significant	   score	   reduction	  
(25.01±3.67)	  from	  baseline	  levels	  by	  R3	  (P<0.001),	  whereas	  in	  the	  S1	  group	  this	  was	  
significant	  only	  at	  R2,	  with	  a	  difference	  of	  means	  of	  20.79±3.55	  (P=0.024).	  	  	  
	  
	  
Surgery’s	   impact	   on	   health	   related	   QOL	   (table	   6.5)	   was	   not	   statistically	   significant	  
(main	  time	  effect:	  P=0.054).	  The	  increases	  in	  the	  UK	  population	  adapted	  EQ-­‐5D	  index	  
in	   L5	   and	   S1	  did	   not	   differ	   between	   groups	   (P	   =	   0.271).	   	   The	   ability	   of	   patients	   to	  
manage	   their	   daily	   living	   activities	   significantly	   increased	   only	   by	   the	   1	   year	  
assessment	  (main	  time	  effect:	  P<0.001)	  and	  was	  not	  affected	  by	  the	  dominant	  root	  
compromise	   level	   (main	   radic	   group	   effect:	   P=0.746).	   Nonetheless	   pairwise	  
comparisons	  revealed	  that	  the	  change	  was	  significant	  in	  the	  L5	  group	  (+26.08±5.47;	  
P=0.045)	  but	  not	  in	  the	  S1	  group	  (+29.27±7.10;	  P=0.192).	  	  Changes	  in	  self-­‐perceived	  
	  
Figure	  6.1:	  Mean±SEM	  disability	  before	  (B)	  and	  over	  1	  year	  following	  surgery	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health	   status	   (table	   6.3)	   were	   also	   not	   affected	   by	   the	   dominant	   lesion	   level	  
(P=0.999)	  and	  did	  not	  change	  significantly	  over	  time	  (P=0.192).	  	  	  
Psychological	  Scores	  
	  
Overall	  patient	  anxiety	  and	  depression	  did	  not	  change	  significantly	  (main	  time	  effect:	  
P=0.091	  and	  P=0.255,	  respectively)	  and	  remained	  in	  the	  “severe”	  range.	  	  There	  were	  
neither	  differences	  in	  these	  scores	  between	  L5	  and	  S1	  groups	  (P=0.379	  and	  P=0.332,	  
respectively)	  nor	  group	  specific	  changes	  over	  time	  (P=0.271	  and	  0.337,	  respectively).	  
Fear	   avoidance	   beliefs	   about	   physical	   activity	   decreased	   post-­‐surgery	   (P<0.001)	  
irrespective	  of	  group	  (P=0.618).	  This	  reduction	  was	  not	  significant	  until	  the	  6	  month	  
assessment	   (13.45±1.118,	   P=0.010)	   and	   by	   1	   year,	   was	   reduced	   to	   11.26±1.13	  
(P<0.001).	  
	  
Global	  Perceived	  Effect	  
	  
Patient	  expectations	  of	  surgery’s	  impact	  on	  their	  pre-­‐operative	  pain	  levels	  were	  high	  
and	  generally	  unaffected	  by	  radic	  level	  (P=0.983).	  	  Median	  expectations	  of	  1	  year	  leg	  
pain	   levels	   were	   projected	   at	   baseline	   to	   be	   5	   (0-­‐12	   [25-­‐75	   quartiles])	   and	   this	  
projection	  did	  not	  change	  significantly	  at	  6	  weeks	  and	  6	  months	  (R1:	  7	  (0-­‐14),	  R2:	  11	  
	   Table	  6.3:	  Surgery	  Health	  Quality	  of	  Life	  Outcome	  
B	   R1	   R2	   R3	  
Heath	  
QOL	  Index	  
L5	   0.76±0.03	   0.85±0.04	   0.83±0.04	   0.86±0.04	  




L5	   65.39±5.06	   75.48±5.91	   72.39±5.91	   75.98±6.24	  
S1	   63.91±5.49	   69.80±6.61	   75.42±7.11	   80.15±8.31	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(1-­‐27);	  P=0.546).	  Back	  pain	  levels	  at	  1	  year	  were	  projected	  at	  baseline	  to	  be	  8	  (4-­‐22)	  
and	  this	  projection	  shifted	  to	  median	  levels	  more	  realistic	  to	  the	  final	  outcome	  at	  6	  
months	  (R1:	  (0-­‐27),	  R2:	  23	  (9-­‐46);	  P=0.546).	  	  
	  
Mean	   patient	   satisfaction	   generally	   averaged	   above	   60%	   and	   did	   not	   significantly	  
increase	   from	  6	  weeks	   levels.	   	   Patient	   rated	   satisfaction	  with	   improvements	   in	   leg	  
pain	  was	   69.35±7.36%	   at	   six	  weeks	   and	   this	   number	   did	   not	   increase	   significantly	  
throughout	   the	   subsequent	   time	   points	   (6	   months:	   67.05±8.60%,	   1	   year:	   79.31±	  
8.60%;	   P=0.948).	   	   Satisfaction	   with	   improvements	   in	   back	   pain	   mirrored	   leg	  
satisfaction	   results	  with	   71.80±7.02%	   at	   six	  weeks	   and	   no	   significant	   increase	   at	   1	  
year	  (6	  months:	  68.26±7.54%,	  1	  year:	  77.43±	  6.23%;	  P=0.948).	  	  At	  a	  more	  functional	  
level,	   satisfaction	   with	   improvement	   in	   daily	   activities	   yielded	   similar	   results	   at	   6	  
weeks	   (68.75±6.70%),	   and	   increased	   for	   some	   in	   the	   second	   semester	   (6	  months:	  
73.62±6.68%,	  1	  year:	  101.56±	  13.640%;	  P=0.09).	  Satisfaction	  with	   improvements	   in	  
general	   health	   (6	   weeks:	   67.65±7.04%,	   6	   months:	   72.37±6.55%,	   1	   year:	   82.25±	  
5.45%;	   P=0.335)	   and	   with	   overall	   recovery	   (6	   weeks:	   64.55±6.90%,	   6	   months:	  
70.47±6.86%,	   1	   year:	   82.56±	   5.79%;	   P=0.188)	   followed	   similar	   patterns	   to	  
satisfaction	  with	  improvements	  in	  pain.	  
	  
	  Pain	  and	  Functional	  Outcome	  Classification	  
	  
In	   the	  11	  L5	  and	  9	  S1	  participants	  who	  were	  not	   lost	   to	   follow-­‐up,	  outcomes	  were	  
classified	   based	   on	   a	   changes	   in	   pain	   (VAS	   average	   pain)	   and	   function	   (ODI)	   and	  
surgery	  procedure	  (table	  6.4).	  Outcome	  was	  measured	  as	  a	  change	  in	  score	  between	  
baseline	  and	  1	  year	  (n=16)	  or	  at	  the	  last	  measure	  before	  dropping	  out	  of	  the	  study	  (6	  
months	  for	  2	  participants	  and	  6	  weeks	  for	  2	  participants).	   	  There	  was	  a	  median	  leg	  
pain	  reduction	  of	  -­‐42(range	  -­‐94	  to	  -­‐6)	  in	  the	  L5	  group	  and	  a	  -­‐23(-­‐71	  to	  -­‐5)	  in	  the	  S1	  
group.	  	  Back	  pain	  outcome	  was	  a	  median	  reduction	  of	  -­‐30(-­‐68	  to	  91)	  in	  the	  L5	  group	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and	  a	  median	  reduction	  of	  -­‐10(-­‐56	  to	  10)	  in	  S1	  group.	  	  ODI	  decreased	  by	  a	  median	  -­‐




	   	  
Table	  6.4:	  Classification	  of	  outcome	  based	  on	  change	  in	  disability	  (ODI),	  average	  leg	  





Change	  in	  Outcome	  Score	  
Outcome	  Classification	  
Discectomy	   Decompression	  
ODI	   PAIN	   ODI	   PAIN	   ODI	   PAIN	  
L5	  
3	   	   	   -­‐46	   -­‐35	   Excellent	   Good	  
4	   -­‐32	   -­‐78	   	   	   Good	   Excellent	  
6	   -­‐20	   -­‐62	   	   	   Good	   Excellent	  
7	   	   	   +6	   -­‐30	   Poor	   Good	  
8	   	   	   -­‐28	   -­‐42	   Excellent	   Good	  
10	   -­‐38	   -­‐60	   	   	   Good	   Excellent	  
13	   -­‐38	   -­‐28	   	   	   Good	   Fair	  
14	   -­‐36	   -­‐81	   	   	   Good	   Excellent	  
20	   	   	   +14	   -­‐33	   Poor	   Good	  
22	   	   	   +2	   -­‐15	   Poor	   Fair	  
25	   -­‐38	   -­‐94	   	   	   Good	   Excellent	  
S1	  
1	   -­‐16	   -­‐40	   	   	   Fair	   Good	  
2	   -­‐42	   -­‐71	   	   	   Excellent	   Excellent	  
9	   -­‐22	   -­‐5	   	   	   Good	   Poor	  
17	   -­‐18	   -­‐22	   	   	   Fair	   Fair	  
18	   	   	   -­‐42	   -­‐28	   Excellent	   Good	  
19	   	   	   -­‐12	   -­‐6	   Fair	   Poor	  
21	   +4	   -­‐17	   	   	   Poor	   Fair	  
23	   -­‐2	   -­‐23	   	   	   Poor	   Fair	  





L5	  and	  S1	  Radic	  Group	  Changes	  
	  
MVCs	  
TA:	   	   There	  was	   a	   group	   effect	   in	   TA	   (P<0.019)	   as	   patient	  MVCs	  were	   significantly	  
lower	  than	  controls	  at	  B	  and	  R1	  in	  both	  radic	  groups	  (P<0.033),	  apart	  from	  ipsi	  radic	  
in	  S1	  (P=0.150,	  table	  6.5).	  	  Although	  this	  was	  no	  longer	  significant	  after	  R2	  (P>0.585),	  
Mean±SEM	  MVCs	   significantly	   increased	   in	   the	   L5	  group	  between	  B	  and	  R3	  contra	  
radic	   (B:	  0.213±0.022mV	  to	  R3	   to	  0.306±0.027mV;	  P=0.026).	  This	  was	  not	   found	   in	  
the	  S1	  group.	  	  
SOL:	  A	  group	  effect	  (P<0.006)	  was	  also	  present	  in	  Soleus,	  where	  patient	  MVCs	  were	  
significantly	  lower	  than	  controls	  at	  B	  and	  R1	  (P<0.047).	  	  There	  was	  no	  effect	  of	  time	  
on	  soleus	  MVCs	  (P>0.920).	  
	  
Table	  6.5:	  TA	  and	  SOL	  MVCs	  (mV)	  
Radic:	   L5	   S1	   Control	  
IPSI	   Contra	   IPSI	   Contra	  
Time	   TA	  
B	   0.205±0.023*	   0.213±0.022*	   0.266±0.025	   0.24±0.024*	   0.351±0.019	  
R1	   0.257±0.027*	   0.262±0.026*	   0.226±0.030*	   0.251±0.029*	   0.376±0.021	  
R2	   0.27±0.027	   0.267±0.026	   0.265±0.032	   0.262±0.031	   0.326±0.022	  
R3	   0.318±0.028	   0.306±0.027	   0.253±0.038	   0.262±0.036	   0.356±0.022	  
Time	   SOL	  
B	   0.131±0.015*	   0.139±0.015*	   0.139±0.016*	   0.132±0.017*	   0.217±0.013	  
R1	   0.133±0.018*	   0.141±0.018*	   0.121±0.02*	   0.108±0.02*	   0.217±0.014	  
R2	   0.147±0.018	   0.151±0.018	   0.125±0.021	   0.121±0.022	   0.202±0.015	  
R3	   0.142±0.019	   0.133±0.019	   0.142±0.025	   0.132±0.025	   0.196±0.015	  




MEP	  latencies	  	  
	  
TA:	  TA	  MEP	   latencies	   (table	  6.6)	  were	  not	   significantly	  different	   to	   controls	  on	   the	  
IPSI	   or	   CONTRA	   sides	   (P>0.144)	   and	   there	   were	   no	   significant	   changes	   over	   time	  
(P>0.197).	  	  S1	  patient	  latencies	  displayed	  significantly	  more	  asymmetry	  than	  controls	  
(AI	  Group	  Effect:	  P=0.007)	  but	  only	  L5	  patients	  had	  significantly	  higher	   latencies	  on	  
the	  radic	  side	  (LI	  group	  effect:	  S1:	  0.0247±0.0080;	   	  L5:-­‐0.0004±0.0066;	  P=0.007).	  	  
SOL:	   Latencies	   (table	   6.6	   bottom)	   were	   higher	   in	   patients	   than	   controls	   with	   no	  
effect	  of	  time	  both	  IPSI	  (Group:	  P=0.002;	  Time:	  P=0.091)	  and	  CONTRA	  radic	  (Group:	  
P=0.012;	   Time:	   P=0.624).	   	   Latencies	   were	   significantly	   more	   asymmetrical	   than	  
controls	  with	  no	  effect	  of	  time	  (AI	  Group	  effect:	  	  Control:	   	  0.0208±0.0056;	   S1:	  
0.0484±0.0087;	  L5=0.0287±0.0071;	  P=0.032).	  	  This	  effect	  was	  not	  related	  to	  the	  radic	  
side	  (LI:	  P=0.743). 
	  
MTh	  
TA:	  	  An	  effect	  of	  time	  was	  found	  in	  TA	  MTh	  (P<0.001).	  Multiple	  comparisons	  revealed	  
a	   significant	   reduction	   in	   MTh	   in	   the	   L5	   group	   at	   R1	   (P<0.001),	   which	   remained	  
significantly	  reduced	  thereafter	  (P≤0.010).	  	  This	  was	  not	  found	  in	  the	  S1	  group	  (table	  
6.7	  left).	  
Table	  6.6:	  TA	  and	  SOL	  height	  normalised	  MEP	  Latencies	  (ms/m)	  
Radic:	   L5	   S1	   Control	  
IPSI	   CONTRA	   IPSI	   CONTRA	  
Time	   TA	  
B	   16.74±0.21	   16.46±0.21	   16.9±0.23	   15.85±0.23	   16.33±0.18	  
R1	   16.7±0.25	   17.33±0.24	   16.93±0.28	   16.01±0.27	   15.98±0.2	  
R2	   17.13±0.25	   16.86±0.24	   16.85±0.3	   16.6±0.29	   16.28±0.2	  
R3	   17.08±0.26	   17.05±0.26	   16.48±0.35	   15.58±0.34	   16.16±0.2	  
Time	   SOL	  
B	   19.19±0.5	   19.23±0.32	   18.42±0.55	   19.1±0.35	   17.61±0.42	  
R1	   18.7±0.59	   19.16±0.38	   20.98±0.66	   19.11±0.42	   17.8±0.46	  
R2	   18.79±0.59	   19.19±0.38	   17.89±0.71	   18.58±0.46	   17.63±0.48	  





Table	  6.7:	  TA	  and	  SOL	  Motor	  and	  Cortical	  Silent	  Period	  Thresholds	  (%MSO)	  
Time	  
MTh	   cSPTh	  
L5	   S1	   Control	   L5	   S1	   Control	  
TA	  
B	   38.74±0.67	   38.53±0.73	   36.40±0.56	   25.96±0.49	   27.96±0.54	   26.32±0.41	  
R1	   34.38±0.79	   38.13±0.88	   35.66±0.62	   25.96±0.57	   26.29±0.64	   26.32±0.45	  
R2	   34.9±0.79	   36.65±0.95	   34.83±0.64	   25.73±0.57	   26.34±0.69	   26.39±0.47	  
R3	   35.58±0.83	   37.99±1.10	   35.91±0.64	   26.80±0.61	   27.28±0.81	   26.86±0.47	  
SOL	  
B	   40.57±0.8	   46.2±0.87	   39.87±0.67	   29.23±0.52	   30.00±0.80	   26.25±0.43	  
R1	   41.66±0.94	   46.83±1.05	   40.88±0.74	   28.09±0.61	   30.56±0.96	   27.28±0.48	  
R2	   41.22±0.94	   42.9±1.13	   39.93±0.77	   28.32±0.61	   28.40±1.03	   27.23±0.50	  
R3	   41.49±0.99	   45.33±1.32	   41.6±0.77	   28.22±0.64	   32.15±1.20	   26.84±0.50	  
	  
SOL:	  There	  were	  reductions	  in	  the	  S1	  group	  in	  soleus	  but	  these	  were	  not	  significant	  
(soleus	  effect	  of	  time:	  P=0.058).	  
MEP	  area	  
There	  were	  no	  group	  differences	   in	  Mean±SEM	  MEP	  area	   in	  TA	   (S1:	  4.23±0.62,	  L5:	  
3.84±0.51,	   C:	   4.95±0.40	  mV/ms;	   P=0.137)	   or	   SOL	   (L5:	   3.65±0.37,	   S1:	   2.78±0.45,	   C:	  
3.11±0.292	  mV/ms;	  P=0.217).	   	  A	  significant	   interaction	  (group	  x	  time;	  P=0.043)	  was	  
found	  in	  TA,	  with	  multiple	  comparisons	  revealing	  that	  at	  R1	  only,	  L5	  group	  MEP	  areas	  
were	   significantly	   smaller	   than	   in	   controls	   (L5:	   3.52±0.45	   vs.	   5.51±0.36	   mV/ms;	  
P=0.031).	  
cSPTh	  
TA:	   	  TA	  cSPTh	  (table	  6.7	  right)	  were	  not	  significantly	  different	  to	  controls	  (P=0.822)	  
and	  did	  not	  significantly	  change	  over	  time	  (P=0.187).	  	  	  





TA:	  There	  were	  no	  group	  differences	  (P=0.379)	  or	  time	  effects	  (P=0.841)	  in	  TA	  cSPs	  
IPSI	   radic.	   L5	   group	   cSPs	   CONTRA	   radic	   were	   significantly	   higher	   than	   controls	   at	  
baseline	   (P=0.030),	   and	  were	   significantly	   reduced	   from	   B	   at	   R1	   and	   R2	   (P≤0.020;	  
figure	  6.3	  top).	  	  There	  were	  no	  significant	  group	  (P=0.455)	  or	  time	  (P=0.385)	  effects	  
of	  cSP	  asymmetry	  in	  TA	  (interaction	  effect:	  P=0.069).	  	  
SOL:	   In	  SOL	  cSPs,	   there	  was	  a	  group	   level	  effect	  both	   IPSI	  and	  CONTRA	  radic	   (both	  
P<0.001),	   and	   a	   time	   effect	   IPSI	   radic	   (P=0.003).	   IPSI	   radic,	   only	   L5	   cSPs	   were	  
significantly	  longer	  than	  control	  (P=0.041)	  at	  B,	  both	  groups	  were	  significantly	  longer	  
at	  R1	   (P≤0.008),	  after	  which	  only	   L5	  cSP	   remained	  significantly	   longer	   than	  control	  
(P≤0.010;	   figure	   6.3	   bottom).	   	   CONTRA	   radic	   L5	   cSPs	   remained	   significantly	   longer	  
	  
Figure	  6.3	  TA	  (top)	  and	  SOL	  (bottom)	  cSP	  in	  patients	  with	  L5	  (left)	  and	  S1	  (right)	  radicular	  





until	   R3	   (P≤0.008),	   whereas	   in	   S1,	   this	   was	   only	   the	   case	   until	   R2	   (P≤0.019).	   CSP	  
asymmetry	  only	  tended	  to	  a	  significant	  group	  effect	  (P=0.055).	  There	  was	  however	  a	  
significant	  group	  effect	  in	  cSP	  LI	  in	  SOL	  (P=0.006).	  cSPs	  were	  significantly	  lateralised	  
with	   longer	  contralateral	  cSPs	  at	  baseline	   in	  both	  patient	  groups	  (S1:	   -­‐0.121±0.029,	  
L5:	   -­‐0.084±0.027,	   C:	   0.021±0.022	   ms;	   P≤0.017)	   but	   not	   thereafter	   in	   L5	   patients	  
(P≥0.253).	   	   In	   the	   S1	   group	   this	   cSP	   laterality	   also	   ceased	   to	   be	   significant	   post-­‐
surgery	  (P≥0.224)	  apart	  from	  at	  R2	  (S1:	  -­‐0.096±0.038;	  P=0.037).	  
	  
As	  the	  cSPs	  primarily	  modulated	  by	  stimulus	  intensity,	  1.2MTh	  stimulator	  intensities	  
were	   compared	   between	   groups	   and	   over	   time.	   	   There	  were	   no	   significant	   group	  
differences	   between	   stimulator	   intensities	   delivered	   at	   1.2MTh	   in	   TA	   (L5:	  
43.66±1.83,	  S1:	  45.33±2.23,	  C:	  43.50±1.44	  %MSO;	  P≥0.706)	  or	  SOL	  (L5:	  50.10±2.04,	  
S1:52.95±2.47,	  C:	  48.79±1.60	  ms;	  P=0.257).	  
	  
Finally,	   most	   commonly	   at	   baseline,	   a	   clear	   second	   shorter	   period	   of	   EMG	  
suppression	  was	   noted	   in	   6	   participants	   in	   SOL	   following	   resumption	   of	   EMG	   IPSI	  
radic.	  	  These	  were	  not	  quantified	  but	  did	  	  not	  outlast	  the	  CONTRA	  radic	  cSP	  by	  more	  
than	  25ms.	  
	  
Neurophysiology	  vs.	  Outcome	  
	  
Sample	   sizes	   in	   outcome	   classification	   groups	   were	   as	   follows	   for	   leg	   pain	   [total:	  
L5,S1]:	   excellent[6:1,5],	   good[7:4,3],	   fair[5:2,3],	   poor[2:0,2]	   and	   ODI	   [total:	   L5,S1]:	  
excellent[4:2,2],	   good[7:6,1],	   fair[4:0,4],	   poor[5:3,2].	   	   No	   participants	   fell	   in	   the	   L5	  
ODI	   fair	  or	  L5	   leg	  pain	  poor	   category.	   	  Thus	   this	  classification	  was	  only	  suitable	   for	  
analysing	  pooled	  data	  (radic	  sides	  and	  root	   level	  groups).	   	  Stratified	   into	  responder	  
groups,	   sample	   sizes	   were	   as	   follows	   each	   outcome	   [total:	   high	   responders,	   low	  





TA:	   There	   was	   a	   significant	   effect	   of	   time	   in	   L5	   MTh	   (P=0.001)	   but	   not	   S1	   MTh	  
(P=0.071)	   in	   leg	   pain	   outcome	   responder	   groups.	   	   Post-­‐hoc	   analysis	   revealed	  
significant	   MTh	   reductions	   from	   baseline	   at	   in	   L5	   high	   responders	   from	   B	  
([Mean±SEM	  %MSO]	  38.97±0.87)	  at	  R1	  (34.14±0.87	  %MSO;	  P<0.001),	  R2	  (34.81±0.87	  
%MSO;	   P=0.003),	   R3	   (35.98±0.87	   %MSO;	   P=0.050)	   but	   not	   low	   responders	   (B:	  
37.43±1.43	   %MSO,	   R1:	   34.35±1.43	   %MSO,	   R2:	   34.46±1.43	   %MSO,	   R3:	   33.24±1.84	  
%MSO;	  P≥0.224).	  	  This	  was	  also	  found	  with	  ODI	  outcome	  (L5:	  P=0.003;	  S1:	  P=0.066),	  
where	   high	   responders	   (B:	   39.28±0.87,	   R1:	   34.08±0.87,	   R2:	   34.87±0.87,	   R3:	  
36.11±0.87;	   P≤0.032),	   but	   not	   low	   responders	   (B:	   36.59±1.42,	   R1:	   34.51±1.42,	   R2:	  
34.29±1.42,	  R3:	  32.88±1.83;	  P≥0.335)	  were	  significantly	  reduced	  at	  every	  time	  point	  
from	  baseline.	  
	  
SOL:	   There	   were	   no	   significant	   effects	   of	   time	   (nor	   sufficient	   statistical	   power)	   in	  
either	  ODI	  or	  leg	  VAS	  outcome	  groups	  (P≥0.065)	  within	  radic	  levels	  (L5,	  S1).	  	  Pooling	  
both	  radic	  groups	  revealed	  that	  a	  time	  effect	  was	  present	   in	  both	  ODI	  and	   leg	  VAS	  
responder	   groups	   (both	   P<0.001),	   with	   significant	   MTh	   reductions	   by	   R1	   and	   R2.	  	  
However	  only	  high	  ODI	  responders	  displayed	  significant	  MTh	  reductions	  by	  R1	  (from	  
39.42±0.70	   to	   35.68±0.70	  %MSO;	   P=0.015).	   	   Furthermore,	   post-­‐hoc	   analysis	   of	   leg	  
pain	  outcome	  revealed	  that	  only	  patients	  with	  excellent	  leg	  pain	  outcome	  retained	  a	  














TA:	   	   In	   the	   L5	   group	   on	   the	   radic	   side	   there	   was	   an	   interaction	   effect	   of	   ODI	  
responder	   group	   and	   time	   (P=0.017).	   	   There	   was	   a	   significant	   increase	   in	   cSP	  
between	   B	   and	   R1	   in	   low	   responders	   (107.97±11.32	   to	   164.66±11.32;	   P=0.002)	  
whereas	   in	   high	   responders,	   there	   was	   a	   non-­‐significant	   decrease	   134.15±6.93	   to	  
116.95±6.93;	  P=0.198).	  CONTRA	  radic	  there	  was	  also	  an	  interaction	  effect	  (responder	  
group	   x	   time;	   P=0.004).	   There	   were	   significant	   reductions	   from	   baseline	   at	   every	  
time	  point	   in	  high	  responders	   (B:	  154.29±8.03,R1:	  122.03±8.03,R2:	  108.43±8.03,R3:	  
119.32±8.03;	  P≤0.018),	  whereas	  	  no	  significant	  changes	  took	  place	  in	  low	  responders	  
(B:	  116.96±13.11,R1:	  92.71±13.11,R2:	  141.95±13.11,R3:	  139.17±16.93;	  P≥0.546).	  	  	  
	  
With	   respect	   to	   leg	  pain	  outcome	   in	   the	  L5	  group,	   there	  was	  a	   time	   (P=0.008)	  and	  
interaction	  effect	  (leg	  pain	  responder	  group	  x	  time;	  P=0.009)	  on	  the	  radic	  side,	  with	  a	  
significant	  cSP	  reduction	  between	  B	  and	  R3	  (P=0.018),	  which	  was	  not	  independently	  
significant	   in	   either	   leg	   pain	   responder	   groups.	   	   This	  was	   not	   found	  CONTRA	   radic	  
(time:	  P=0.636;	  interaction:	  P=0.939).	  	  	  
	  
In	   the	   S1	   group	   both	   IPSI	   and	   CONTRA	   radic,	   there	  were	   neither	   leg	   pain	   nor	  ODI	  
responder	   group	   (IPSI:	   P≥0.437,	   CONTRA:	   P≥0.132),	   time	   (IPSI:	   P≥0.369,	   CONTRA:	  
P≥0.765)	  nor	  interaction	  effects	  (IPSI:	  P≥0.512,	  CONTRA:	  P≥0.237)	  of	  cSP	  in	  TA.	  
	  
SOL:	  There	  was	  a	  significant	  group	  (P=0.001)	  and	  time	  (P=0.039)	  but	  not	  interaction	  
(P=0.068)	   effect	   in	   ODI	   responder	   group	   outcomes	   in	   L5	   patients	   IPSI	   radic.	   	   The	  
significant	   increase	   in	   cSP	   between	   B	   and	   R1	   (P=0.037)	   was	   not	   independently	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significant	   in	   either	   responder	   groups.	   	   Baseline	   IPSI	   radic	   cSPs	   were	   significantly	  
longer	   than	   controls	   in	   low	   (146.74±11.73	   vs.	   103.73±4.66;	   P=0.041)	   but	   not	   high	  
responders	  (123.69±7.18;	  P=0.217).	  These	  remained	  significantly	  longer	  in	  both	  ODI	  
responder	  groups	  at	  R1	  and	  R2	  (P≤0.048)	  and	  only	  high	  responders	  at	  R3	  (P=0.006).	  
CONTRA	   radic	   there	  was	   a	   group	   effect	   (P<0.001)	  with	   significantly	   longer	   cSPs	   in	  
both	   responder	   groups	   (P≤0.006).	   In	   S1	   IPSI	   radic	   there	  was	   a	   time	   (P<0.001)	   and	  
interaction	  (P=0.035)	  but	  not	  group	  (P=0.057)	  effect,	  with	  significant	  increases	  in	  cSP	  
by	   R1	   (P<0.001)	   and	   reductions	   from	   R1	   thereafter	   (P≤0.045).	   	   These	   were	   not	  
significant	   in	   individual	   ODI	   responder	   groups.	   	   CONTRA	   radic	   there	   were	   no	  
significant	  responder	  group	  (P=0.051)	  or	  time	  (P=0.448)	  effects.	  
	  
In	  L5	  both	  IPSI	  radic	  and	  CONTRA	  radic,	  a	  group	  effect	  (P<0.001)	  was	  present,	  with	  
high	   leg	   pain	   responders	   (P<0.001),	   but	   not	   low	   responders	   (P>0.299),	   having	  
significantly	  longer	  cSPs	  than	  controls.	  IPSI	  radic,	  all	  pairwise	  analysis	  revealed	  this	  to	  
be	   true	   at	   every	   time	   point	   (high	   B:	   136.71±7.53,R1:	   156.71±7.53,	   R2:	  
147.25±7.53,R3:	   147.98±7.53;	   P≤0.018	   and	   low	   B:	   112.03±12.29,R1:	   145.26±12.29,	  
R2:	  121.7±12.29,	  R3:	  124.69±15.87;	  P≥0.054).	  CONTRA	  radic,	   this	  was	  significant	  at	  
every	   time	   point	   (B:	   157.64±6.51,	   R1:	   155.05±6.51,	   R2:	   151.84±6.51,	   R3:	  
154.05±6.51;	   P<0.001)	   in	   high	   responders	   and	   only	   significant	   at	   R1	   (B:	  
131.82±10.63,	  R1:	  146.57±10.63,	  R2:	  108.5±10.63,	  R3:	  115.25±13.73;	  P=0.041)	  in	  low	  
responders.	  
	  
In	  S1	  IPSI	  radic	  there	  was	  a	  group	  (P=0.031),	  time	  (P<0.001)	  and	  interaction	  (P=0.013)	  
effect,	   with	   both	   leg	   pain	   responder	   group	   cSPs	   significantly	   increasing	   to	   R1,	   the	  
only	   time	   point	   at	   which	   they	   were	   significantly	   longer	   (high:	   151.31±7.67,	   low:	  
136.38±6.86,	  C:	  103.71±3.91;	  P≤0.029).	  In	  S1	  CONTRA	  radic	  there	  was	  a	  group	  effect	  
(P=0.038),	  but	  multiple	  comparisons	  revealed	  no	  significant	  differences	  between	  leg	  
pain	  responder	  groups.	  	  	  





This	   is	   the	  first	  study	  to	  examine	   long	  term	  changes	   in	  parameters	  of	  corticomotor	  
and	   intracortical	   inhibitory	  control	   following	  surgery	  for	   lumbosacral	  radiculopathy.	  	  
It	  was	  hypothesised	  that	  changes	  in	  these	  parameters,	  reported	  in	  a	  previous	  study,	  
would	  be	  related	  to	  the	  affected	  nerve	  root,	  and	  reversed	  by	  successful	  surgery.	  	  This	  
hypothesis	  was	  partially	  confirmed	  in	  that	  MTh,	  reported	  to	  be	  related	  to	  pain	  and	  
function	   in	   these	   patients	   (Strutton	   et	   al.,	   2003b),	   was	   significantly	   reduced	   and	  
stable	  by	  6	  months	  in	  TA	  in	  L5	  patients,	  only	  in	  patients	  with	  at	  least	  good	  functional	  
outcome	  (ODI)	  post-­‐surgery,	  while	  this	  was	  not	  the	  case	  in	  low	  functional	  responders	  
to	  surgery	  (fair	  and	  poor	  classification).	  	  Furthermore	  not	  only	  was	  MTh	  only	  reduced	  
in	  high	  ODI	  responders	  by	  6	  weeks,	  but	  only	  the	  group	  of	  patients	  with	  excellent	  leg	  
pain	  (VAS)	  outcome	  sustained	  a	  MTh	  reduction	  to	  6	  months	  post-­‐surgery.	  	  However	  
clinical	   groupings	   and	   baseline	   characteristics	   diverged	   from	   previous	   studies	   and	  
new	  findings	  have	  emerged.	  	  
	  
Patients	   produced	   significantly	   reduced	   MVCs	   compared	   to	   controls,	   and	   mean	  
MVCs	  in	  both	  L5	  and	  S1	  patients	  significantly	  increased	  in	  SOL	  and	  TA	  by	  6	  weeks.	  	  A	  
new	  finding	  of	  this	  study	  was	  a	  significantly	  prolonged	  cortical	  silent	  period	  in	  TA	  and	  
SOL	   which	   was	   significantly	   reduced	   by	   successful	   surgery.	   	   In	   general	   baseline	  
neuroplastic	  changes	  in	  TA	  were	  specific	  to	  L5	  patients,	  whilst	  changes	  in	  SOL	  were	  
common	  to	  both	  L5	  and	  S1	  groups	  or	  absent.	  	  Only	  in	  L5	  patients	  did	  MVCs	  continue	  
to	   reduce	   from	   baseline	   in	   TA	   following	   R1.	   	   Side-­‐to-­‐side	   limb	   latency	   differences	  
were	   significantly	   higher	   than	   controls	   in	   SOL	   in	   both	   radic	   groups	   but	   only	   in	   L5	  
patients	   in	   TA	  were	   these	   found	   to	   be	   lateralised	   towards	   longer	   latencies	   on	   the	  
affected	  (or	  dominantly	  affected	  in	  the	  case	  of	  5	  patients)	  side.	  	  Finally,	  a	  significant	  
asymmetry	  in	  cSPs	  was	  found	  at	  baseline	  in	  SOL	  in	  all	  patients	  which	  was	  lateralised	  
to	   feature	   shorter	   cSPs	   on	   the	   affected	   side.	   	   This	   was	   resolved	   (IPSI	   radic	   cSP	  
significantly	  increased)	  in	  all	  groups	  following	  surgery,	  regardless	  of	  outcome.	  Mean	  
cSPTh	   and	   MThs	   were	   not	   significantly	   elevated	   in	   either	   groups	   compared	   to	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controls.	  	  Furthermore	  neither	  cSPTh,	  latency,	  nor	  MEP	  area	  displayed	  group	  effects	  




Cortical	   silent	   periods	   were	   significantly	   longer	   than	   controls	   in	   SOL	   (only	   contra	  
radic	  at	  baseline)	  and	  TA.	  Following	  surgery,	  a	  bilateral	  cSP	  changes	  occurred,	  which	  
was	  radic	  level	  specific	  in	  TA	  and	  common	  to	  both	  radic	  groups	  in	  SOL.	  	  This	  process	  
appears	  to	  be	  significantly	  impacted	  by	  surgical	  outcome	  in	  L5	  radic	  patients.	  	  In	  L5	  
patients	   successful	   functional	   outcome	   from	   surgery	   involved	   sustained	   bilateral	  
reductions	  in	  cSP	  at	  every	  time	  point	  (from	  R1	  onwards	  for	  IPSI	  and	  from	  B	  onwards	  
for	   CONTRA	   radic),	   in	   contrast	   to	   non-­‐responders.	   On	   the	   other	   hand,	   significant	  
radic	  side	  lateralised	  asymmetry	  (LI)	  in	  the	  cSP,	  which	  existed	  in	  SOL	  pre-­‐surgery,	  was	  
significantly	   reduced	   at	   6	  weeks,	   regardless	   of	   outcome.	   	   A	   significantly	   lower	   cSP	  
was	   also	   noted	   IPSI	   radic	   (compared	   to	   CONTRA)	   in	   surgery	   patients	   in	   TA	   before	  
treatment.	   	  However	   there	  was	  no	   reduction	   in	  asymmetry	   (LI	  or	  AI)	  of	   the	   cSP	   in	  
these	  muscles	  over	   time.	   	  Although	   this	   LI	  was	   significant	  again	   in	  S1	  patients	  at	  6	  
months,	  this	  was	  dependent	  on	  the	  inclusion	  of	  both	  participants	  which	  experienced	  
an	   MRI	   confirmed	   recurrent	   prolapse	   (including	   discitis	   and	   a	   fenestrated	   disc)	  
following	   surgery.	   These	   participants	   were	   lost	   to	   follow-­‐up	   at	   this	   time	   point	   for	  
repeat	  surgery.	  
	  
The	  cSP	  provides	  a	  measure	  of	  gamma-­‐aminobutyric	  acid	  GABAB	  receptor	  mediated	  
(Werhahn	   et	   al.,	   1999)	   cortical	   inhibitory	   mechanisms.	   The	   early	   50-­‐60	   ms	  
component	   of	   the	   cSP	   is	   believed	   to	   be	   caused	   by	   spinal	   mechanisms	   and	   the	  
subsequent	  part	   is	   thought	   to	  be	  mediated	  by	  cortical	   inhibitory	   interneurons	   that	  
are	  depolarised	  by	  TMS	  (Ziemann	  et	  al.,	  1993,	  Chen,	  2004,	  Fuhr	  et	  al.,	  1991,	  Inghilleri	  
et	   al.,	   1993).	   Its	   lengthening	   in	  pathological	   conditions	   is	   usually	   associated	  with	   a	  
reduction	   in	  the	  afferent	  excitatory	  thalamo-­‐cortical	  or	  cortico-­‐cortical	   input	  to	  M1	  
(Wassermann	  et	  al.,	  2008).	  	  The	  cSP	  is	  prolonged	  by	  increased	  thalamofugal	  firing	  as	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a	   result	   of	   dopaminergic	   drug	   therapy,	   interventions	   to	   the	   basal	   ganglia	   and	  
stimulation	  of	  the	  subthalamic	  nucleus	  (Dauper	  et	  al.,	  2002,	  Young	  et	  al.,	  1997,	  Chen	  
et	  al.,	  2001).	  In	  Huntington’s	  disease,	  the	  severity	  of	  chorea	  is	  thought	  to	  be	  related	  
to	   the	   degree	   of	   prolongation	   of	   the	   cSP	   (Modugno	   et	   al.,	   2001,	   Schippling	   et	   al.,	  
2009,	  Priori	  et	  al.,	  1994b,	  Eisen	  et	  al.,	  1989).	  By	  contrast	  its	  shorting	  in	  epilepsy	  and	  
Parkinson’s	  disease	   (Cantello	  et	  al.,	  2002,	  Berardelli	  et	  al.,	  1996)	   is	  associated	  with	  
spastic	   (Cruz	   Martinez	   et	   al.,	   1998)	   or	   Parkinsonian	   movement.	   Cortical	   cSP	  
representations	   are	   completely	   lateralised	   (and	   longer)	   to	   the	   contralateral	  
hemisphere	   in	   distal	   muscles	   with	   an	   increasing	   bilateral	   distribution	   in	   trunk	  
muscles.	   	  The	  attractive	  clinical	  aspects	  of	  cSP	  measurements	  are	   interhemispheric	  
difference	  usually	  within	  10%,	  high	  retest	  reliability	  (sustainable	  over	  1	  year	  [chapter	  
4])	  but	  high	  inter-­‐individual	  variability	  (Kukowski	  and	  Haug,	  1992,	  Triggs	  et	  al.,	  1993,	  
Orth	  and	  Rothwell,	  2004).	  	  	  
	  
In	  the	  current	  study	  interhemispheric	  differences	  above	  30%	  were	  present	   in	  some	  
radiculopathy	  patients.	  When	  measured	  with	   respect	   to	   the	  most	  affected	  side,	  S1	  
patients	   had	   a	  mean	   cSP	   asymmetries	   of	   -­‐12.1±2.9%,	   compared	   to	   L5	   (-­‐8.4±2.7%),	  
and	  controls	   (2.1±2.2	  %;	  P≤0.017).	   	   IPSI	  radic	  cSPs	  before	  surgery	   in	  SOL	  had	  about	  
half	  the	  variability	  as	  any	  other	  time	  points	  (figure	  6.4),	  but	  not	  dissimilar	  to	  controls.	  	  
On	  the	  other	  hand	  the	  CONTRA	  radic	  side,	  and	  both	  sides	  at	  R1,	  are	  characterised	  by	  
significant	  prolonged	  cSPs,	  and	  successful	  functional	  outcome	  from	  surgery	  involved	  
sustained	   bilateral	   reductions	   in	   cSP	   at	   every	   time	   point	   henceforth,	  whereas	   this	  
was	   not	   found	   in	   patients	   with	   low	   response	   to	   surgery	   (poor	   and	   fair	   functional	  
outcome).	  	  In	  TA,	  this	  process	  was	  specific	  to	  L5	  participants.	  
	  
Altered	   ICI	   contralateral	   to	   the	   affected	   side	   has	   been	   found	   to	   differentiate	  
neuropathic	   pain	   resulting	   from	   nerve	   injury	   (neuralgia)	   from	   other	   chronic	   pain	  
conditions	   such	   as	   painful	   osteoarthritis	   (Schwenkreis	   et	   al.,	   2010).	   Schwenkreis	  
found	  SICI	   to	  be	   lateralised	  to	  the	  contralateral	  hemisphere	  from	  the	  side	  of	  nerve	  
injury,	  and	  this	  was	  not	  proportional	  to	  the	  severity	  of	  nerve	  injury.	  The	  motor	  cortex	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is	   mediated	   by	   sensory	   input	   from	   the	   somatosensory	   cortex	   via	   a	   direct	   and	  
reciprocal	   pathways	   from	   the	   thalamus	   (Darian-­‐Smith	   and	   Darian-­‐Smith,	   1993,	  
Yumiya	  et	  al.,	  1979,	  Asanuma	  et	  al.,	  1979a,	  Larsen	  and	  Asanuma,	  1979,	  Asanuma	  et	  
al.,	  1979b).	  Radiculopathy	  patients	  are	  known	  to	  produce	  abnormal	  sensory	  evoked	  
potentials	   from	   peripheral	   nerve	   stimulation	   (Beyaz	   et	   al.,	   2009).	   Intraoperative	  
monitoring	   of	   sensory	   evoked	   potentials	   in	   the	   minutes	   to	   hours	   following	   root	  
manipulations	   during	   surgery	   shows	   that	   cortical,	   brainstem,	   and	   spinal	   SEPs	   can	  
endure	   rapid	   and	   prolonged	   shifts	   in	   amplitude	   and	   latency	   (Matsui	   et	   al.,	   1995,	  
Epstein	  et	  al.,	  1993,	  Gepstein	  and	  Brown,	  1989,	  Herron	  et	  al.,	  1987,	  Sebastian	  et	  al.,	  
1997).	  It	  is	  thus	  possible	  to	  envisage	  acute	  lateralised	  reorganisation	  at	  one	  or	  more	  
central	  levels	  as	  a	  result	  of	  acute	  nerve	  root	  pathology.	  	  	  
	  
There	   are	   at	   least	   two	   possible	   interpretations	   of	   why	   patients	   begin	   abnormally	  
asymmetrical	  with	  marked	   prolonged	   cSP	   CONTRA	   radic	   at	   baseline,	   to	   then	   have	  
bilaterally	  marked	  prolonged	  cSPs	  at	  R1.	  	  ICI	  has	  been	  reported	  to	  be	  altered	  in	  non-­‐
neuropathic	  chronic	  pain	  conditions,	  such	  as	  LBP	  (Masse-­‐Alarie	  et	  al.,	  2012),	  complex	  
regional	  pain	  syndrome	  type	  1	  (Schwenkreis	  et	  al.,	  2005)	  and	  fibromyalgia	  (Salerno	  
et	  al.,	  2000,	  Mhalla	  et	  al.,	  2010).	  However	  in	  fibromyalgia	  (Salerno	  et	  al.,	  2000)	  and	  
in	   diabetic	   neuropathy	   (Turgut	   and	   Altun,	   2009)	   a	   reduction	   cSP	   was	   found.	  
Generally	  cSP	  changes	  have	  been	  bilateral	  in	  these	  conditions.	  A	  reduction	  in	  cSP	  has	  
also	   been	   reported	   in	   central	   canal	   stenosis	   (Kameyama	   et	   al.,	   1995).	   	   If	   altered	  
afferent	   drive	   to	   M1	   results	   in	   hemispheric	   differences	   in	   ICI,	   then	   recovery	   may	  
partially	   involve	   the	   restoration	  of	   interhemispheric	  mechanisms	   to	  normalise	   that	  
asymmetry.	   However	   in	   L5	   patients,	   successful	   surgery	   was	   not	   associated	   with	  
increases	  in	  cSP	  CONTRA	  radic	  between	  B	  and	  R1.	  	  In	  SOL	  those	  cSP	  increases	  were	  
neither	  level	  nor	  outcome	  specific.	  
	  
Another	  view	  may	  be	  that	  an	  additional	  mechanism	  is	  accounting	  for	  cSP	  asymmetry	  
in	  acute	  unilateral	  nerve	  root	  compression	  and	  that	  cSPs	  are	  bilaterally	  prolonged	  at	  
baseline	   but	   that	   this	   is	   occluded	   by	   an	   additional	   response	   on	   the	   affected	   side.	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Given	   the	   predominant	   SOL	   muscle	   involvement	   in	   this	   cSP	   asymmetry,	   a	   cSP	  
interruption	  by	   long	   latency	  responses	   like	  the	  soleus	   late	  response	  (a	  polysynaptic	  
response	  of	  the	  agonist	  and	  antagonist	  organization	  system	  which	  is	  mediated	  by	  the	  
cerebellofugal	  pathway	  with	  a	  ~100ms	  latency)	  is	  a	  possibility	  (Kurokawa-­‐Kuroda	  et	  
al.,	  2007,	  Sammut	  et	  al.,	  1995,	  Suga	  et	  al.,	  2001,	  Ertekin	  et	  al.,	  1995).	   	  As	  a	  second	  
cSP	  valley	  further	  along	  from	  the	  measures	  cSP	  offset	  was	  noted	  in	  5	  patients,	  such	  a	  
cSP	   interruptions	   cannot	   be	   excluded.	   If	   this	   is	   the	   case	   then	   reductions	   CONTRA	  
radic	   should	   be	   the	   only	   reliable	   market	   of	   normalisation	   of	   cortical	   inhibition.	  
Sustained	   reductions	   CONTRA	   radic	   is	   indeed	   such	   a	  marker	   for	   L5	   patients	   in	   TA,	  
where	   reductions	   from	   baseline	   at	   every	   time	   point	   in	   high	   responders	   (B:	  
154.29±8.03,R1:	   122.03±8.03,R2:	   108.43±8.03,R3:	   119.32±8.03;	   P≤0.018),	   whereas	  	  
no	   significant	   changes	   took	   place	   in	   low	   responders	   (B:	   116.96±13.11,R1:	  
92.71±13.11,R2:	  141.95±13.11,R3:	  139.17±16.93;	  P≥0.546).	   	  This	  might	  also	  explain	  
the	   finding	   that	   successful	   surgery	  was	  not	  dependent	  on	   specifically	   reducing	   this	  
asymmetry.	  	  
	  
Changes	   in	   intracortical	   inhibition	   (ICI)	   have	   been	   reported	   in	   neuropathic	   pain	  
(Turgut	  and	  Altun,	  2009,	  Schwenkreis	  et	  al.,	  2010),	  and	  other	  chronic	  pain	  conditions	  
such	  as	  fibromyalgia	  (Salerno	  et	  al.,	  2000,	  Mhalla	  et	  al.,	  2010),	  complex	  regional	  pain	  
syndrome	   (Schwenkreis	   et	   al.,	   2005),	   including	   low	   back	   pain	   (Masse-­‐Alarie	   et	   al.,	  
2012)But	   this	   not	   always	   strictly	   the	   case.	   	   For	   example	   a	   reduced	   cSP	   has	   been	  
reported	  in	  fibromyalgia	  (Salerno	  et	  al.,	  2000).	  	  	  
	  
	  Regardless	   of	   the	   interpretation,	   long	   term	   reductions	   in	   the	   cSP	   appear	   to	   be	  
associated	  with	  better	  functional	  outcome	  from	  surgery.	  This	  may	  be	  more	  reliably	  
measured	   contralateral	   to	   the	   affected	   side.	   	   However	   it	   may	   be	   necessary	   to	  
measure	  both	  sides	  in	  the	  cases	  of	  central	  prolapses	  or	  bilateral	  symptoms.	  	  TA	  also	  






Mean	   cSPTh	  were	  higher	   than	   controls	   in	   SOL,	   however,	   this	  was	  not	   found	   to	  be	  
significant.	   cSPTh	   was	   also	   neither	   found	   to	   exhibit	   an	   effect	   of	   time	   in	   radic	   or	  
outcome	  groups.	   	  This	  finding	  contrasted	  the	  results	  of	  Strutton	  (2003),	  who	  found	  
cSPThs	   higher	   in	   the	   combined	   TA	   and	   lateral	   gastrocnemius	   muscles	   (LGN)	   in	   9	  
participants	   with	   unilateral	   L4-­‐S1	   neurologic	   deficit	   and	   leg	   pain	   (from	   bar	   graph	  
data:	   ~20±0.9	   vs.	   ~23±1.5).	   	   There	   is	   no	  published	  data	   regarding	   cSPTh	   in	   LGN	  or	  
SOL	   but	   both	   patients	   and	   controls	   produced	   similar	   cSPThs	   in	   TA	   (Patients:	  
26.96±1.22;	   Controls:26.47±0.790).	   	   SOL	   cSPTh	  were	   higher	   (Patients:	   29.58	   ±2.56	  
Controls:	   26.96±1.65;)	   but	   not	   significantly	   so.	   	   As	   this	   is	   the	  muscle	   with	   highest	  
cSPs,	   this	   may	   indicate	   some	   right	   shifting	   of	   cSP	   recruitment	   curves.	   Apart	   from	  
being	  from	  different	  muscles,	  there	  are	  methodological	  reasons	  which	  may	  account	  
for	  the	  different	  results.	  In	  this	  study	  stimulator	  intensities	  were	  only	  administered	  in	  
intervals	  of	  5%MSO	  and	  all	   thresholds	  were	  calculated	   from	  RC	  data.	  For	  MTh	   this	  
would	   have	   little	   impact	   on	   accuracy	   given	   that	   the	   stimulus/MEP	   ratio	   at	   various	  
intensities	  were	  used	  to	  calculate	  MTh	  by	  linear	  interpolation.	  	  On	  the	  other	  hand,	  in	  
contrast	   to	   the	   study	  by	   Strutton	   (2003),	   increments	  of	   5%MSO	  do	  mean	   that	   the	  
cSPTh	  had	  a	  maximum	  resolution	  of	  5%MSO	   (the	   first	  5%MSO	   increment	  at	  which	  






No	   significant	   differences	  were	   found	   between	   the	  MEP	   latencies	   of	   patients	   and	  
controls	   in	   TA.	   In	   SOL,	   these	  were	   generally	   higher	   than	   in	   controls,	   regardless	   of	  
affected	   level,	   with	   no	   effect	   of	   time.	   	   Side	   to	   side	   differences	   were	   significantly	  
higher	   in	   both	   muscles	   for	   both	   groups,	   however	   these	   were	   only	   significantly	  
lateralised	  towards	  the	  radic	  side	  in	  L5	  patients	  in	  TA.	  	  Again	  there	  was	  no	  consistent	  
longitudinal	  change.	  	  Chapter	  4	  found	  that	  latencies	  to	  TA	  and	  SOL	  lied	  in	  the	  good	  
and	  excellent	   reliability	   range	   (0.59≤ICC≤0.85).	   	  However	   the	  sensitivity	  of	  MEPs	  to	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detect	  conduction	  slowing	  within	   the	  cauda	  equina	   in	   spinal	   stenosis,	   for	  example,	  
are	   known	   to	   be	   limited,	   because	   of	   the	   short	   length	   of	   the	   affected	   segment	  
compared	   to	   the	   long	  measurement	   length	   from	   the	  motor	   cortex	   to	  muscle.	   	   In	  
order	   to	  mitigate	  some	  of	   this	  disparity,	   latencies	  were	  normalised	  to	  body	  height.	  	  
The	   central	  motor	   conduction	   time	   (MEP	   latency	  minus	   the	   spinal	   cord	   to	  muscle	  
latency)	   	   have	   been	   reported	   to	   be	   abnormal	   in	   neurogenic	   claudication	   resulting	  
from	  spinal	   stenosis	   (Lang	  et	  al.,	  2002)	  and	  cauda	  equina	  syndrome	   (Saadeh	  et	  al.,	  
1994).	   	  However	  in	  radiculopathy	  inter-­‐side	  latency	  differences	  have	  been	  found	  to	  
be	  more	   sensitive	   (Mochizuki	   et	   al.,	   1999).	   Side-­‐to-­‐side	  differences	  have	  also	  been	  
reported	  but	  by	  subtracting	  the	  latency	  of	  a	  magnetic	  stimulus	  at	  the	  intervertebral	  
foramen	   from	   the	   cortical	   MEP	   latency	   (Banerjee	   et	   al.,	   1993).	   However,	   even	  
though	   these	  measures	   are	  more	   specific	   than	   the	   latency	  measures	   in	   this	   study	  
(reduced	   distance	   and	   needle	   EMG),	   TMS	   has	   not	   been	   found	   to	   be	   a	   reliable	  
diagnostic	   tool	   in	   radiculopathy.	   Side-­‐to-­‐side	   differences	   of	   1-­‐1.5ms	   have	   been	  
considered	   to	   be	   borderline	   abnormal,	   and	   latencies	   ≥1.5ms	   definitely	   abnormal	  
(Chokroverty	   et	   al.,	   1993).	   Furthermore	   the	   side-­‐to-­‐side	   difference	   in	   SOL	   was	   a	  
mere	  0.68ms,	  which	  is	  lower	  than	  the	  standard	  error	  of	  measurement	  calculated	  for	  
SOL	   in	   reliability	   analyses	   (0.91-­‐2.89ms).	   	   Latency	   measures	   to	   detect	   conduction	  
slowing	   are	   also	   much	   more	   effective	   in	   root	   compression	   in	   the	   presence	   of	  
weakness	   (35%	   vs.	   100%	   in	   the	   latter	   study).	   Weakness	   was	   only	   diagnosed	   in	   3	  




In	  contrast	  to	  those	  studied	  by	  Strutton	  et	  al.	  (2003),	  	  patients	  were	  able	  to	  produce	  
significantly	   lower	   MVCs	   than	   controls	   at	   baseline,	   also	   this	   slowly	   improved	  
throughout	  the	  post-­‐surgical	  year.	  This	  may	  be	  because	  of	  the	   lower	  power	   in	  that	  
study,	  the	  lower	  radic	  level	  specificity	  of	  recruitment	  (L4	  patients	  were	  included),	  	  or	  
simply	   reflect	   a	   different	   baseline	   population.	   	   Clinical	   examination	   revealing	  
weakness	  (3),	  neurologic	  claudication	  (1),	  increased	  reflexes	  and	  muscle	  tone	  (2),	  	  or	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reduced	   reflexes	   (4),	   along	   with	   the	   disuse	   that	  may	   accompany	   these	   symptoms	  
certainly	   may	   have	   contributed	   to	   this	   result.	   However	   no	   significant	   side-­‐to-­‐side	  
differences	  were	   found.	   Furthermore	   a	   high	   fear	   of	   pain	   upon	  movement	  may	   be	  




A	  previous	  report	  found	  MTh	  to	  be	  related	  to	  pain	  and	  function	  in	  a	  similar	  patient	  
population	  (Strutton	  et	  al.,	  2003b).	  Unlike	  that	  study,	  the	  cohort	  of	  this	  study	  did	  not	  
have	   significantly	   elevated	   leg	   MThs	   compared	   to	   controls.	   	   However	   the	  
relationship	   of	  MTh	   to	   pain	   and	   function	   was	   confirmed.	  MThs	   were	   significantly	  
reduced	  and	  stable	  by	  6	  months	   in	  TA	   in	  L5	  patients,	  only	   in	  patients	  with	  at	   least	  
good	   functional	   outcome	   (ODI)	   post-­‐surgery,	   while	   this	   was	   not	   the	   case	   in	   low	  
functional	  responders	  to	  surgery	  (fair	  and	  poor	  classification).	  	  Furthermore	  only	  the	  
group	  of	   patients	  with	   excellent	   leg	   pain	   (VAS)	   outcome	   sustained	   significant	  MTh	  
reductions	   to	   6	   months	   post-­‐surgery.	   MTh	   is	   thought	   to	   reflect	   both	   cortical	   and	  
spinal	   neuronal	   membrane	   excitability.	   As	   discussed	   in	   chapter	   5,	   deep	   tissue	  
nociceptive	   stimulation	   in	   nociceptive	   or	   inflammatory	   pain	   results	   in	   long	   lasting	  
inhibition	  of	  the	  primary	  motor	  cortex,	  mediated	  by	  both	  cortical	  and	  spinal	  circuits	  
(Le	   Pera	   et	   al.,	   2001).	   A	   significantly	   elevated	   MTh	   has	   been	   reported	   in	   other	  
chronic	   pain	   conditions,	   such	   as	   fibromyalgia	   (Salerno	   et	   al.,	   2000,	   Mhalla	   et	   al.,	  
2010),	   rheumatoid	   arthritis	   (Salerno	   et	   al.,	   2000)	   and	   complex	   regional	   pain	  
syndrome	  type	  1	  (Schwenkreis	  et	  al.,	  2005).	  As	  in	  those	  studies	  MTh	  was	  not	  found	  
to	   be	   specific	   to	   the	   side	   of	   pain.	   	   This	   may	   be	   because	   nociception-­‐activated	  
neurons	   in	   the	   somatosensory	   cortex	   are	   understood	   to	   produce	   a	   pain	   stimulus-­‐
dependent	   inhibitory	   input	   to	   both	   ipsilateral	   and	   contralateral	   primary	   motor	  
cortices	   (Arendt-­‐Nielsen	   et	   al.,	   1994,	   Nijs	   et	   al.,	   2012).	  	   In	   the	   current	   patient	  
population	   and	   the	   one	   study	   by	   Strutton	   et.	   al.	   (2003),	   changes	   in	  MTh	  may	   be	  
representative	   of	   changes	   in	   referred	   leg	   pain.	   	   To	   date	   no	   experiments	   have	  






Root	  Specificity	  of	  TA	  and	  SOL	  
	  
TA	   results	  were	   generally	   specific	   to	   the	   L5	   group	  whereas	   equivalent	   SOL	   results	  
related	   to	  both	   the	  L5	  and	  S1	  groups,	  or	  were	  absent.	   	  Compared	   to	  controls,	  SOL	  
cSPs	  were	   higher	   than	   in	   TA.	   	   It	   is	   possible	   that	  muscles	   innervated	  by	   roots	   lying	  
below	   the	   affected	   level	   are	   generally	   cumulatively	   impacted,	   given	   that	   SOL	  was	  
specifically	   selected	   to	  minimise	   segmental	   overlap.	  MEP	   abnormalities	   have	   been	  
found	   to	   have	   poor	   sensitivity,	   however	   these	   increase	   when	   patients	   have	   both	  
sensory	  and	  motor	  deficits	  (Linden	  and	  Berlit,	  1995).	  	  In	  electrodiagnostic	  testing,	  the	  
generally	  low	  specificity	  also	  increases	  with	  increasing	  neurophysiological	  symptoms.	  	  
One	   study	   found	   the	   best	   specificity	   resulting	   from	   the	   combined	   presence	   of	  
dermatomal	   pain	   or	   numbness	   with	   reflex	   loss	   and	   myotomal	   weakness,	   which	  
approached	  maximum	   specificities	   of	   78%	   for	   lumbosacral	   root	   disease	   (Hassan	  et	  
al.,	  2013).	  Because	  of	  variations	  in	  segmental	   innervation,	  it	   is	  possible	  that	  patient	  
baseline	  deficit	  also	  affect	  measures	  of	  corticospinal	  excitability.	   	  Patients	  had	  non-­‐
significantly	   lower	   leg	   pain	   scores	   (VAS:	   63.5±5.6	   vs.	   53.6±8.6mm)	   but	   similar	   ODI	  
(56.62±2.99	  vs.	  56.73±4.57).	  However,	  overall	  the	  S1	  group	  had	  a	  higher	  number	  of	  
drop-­‐outs	  and	  twice	  the	  number	  of	  poor	  responders.	  There	  was	  also	  a	  larger	  number	  
of	   L5	   participants	   with	   concurring	   secondary	   S1	   root	   involvement	   according	   to	  
radiology	   reports	   (4	   patients).	   	   TA	   and	   SOL	   have	   been	   used	   to	   detect	   prolonged	  
latencies	  in	  S1	  and	  L5	  with	  magnetic	  stimulation	  of	  lumbosacral	  roots	  at	  the	  foramen	  
magnum	  (Chokroverty	  et	  al.,	  1989).	  Assessing	  nerve	  roots	  by	  their	  direct	  stimulation	  
during	   surgery,	   a	   study	   reported	   that	   TA	   was	   exclusively	   L5	   innervated	   whereas,	  
gastrocnemius	  was	  mostly	  S1	  and	  both	  long	  and	  short	  heads	  of	  biceps	  femoris	  (BF)	  
were	  exclusively	  S1	   innervated	  (Tsao	  et	  al.,	  2003).	   It	   is	   thus	  possible	  that	  BF	  would	  
have	   made	   a	   better	   muscle	   to	   study	   S1	   CE	   changes.	   On	   the	   other	   hand	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electrodiagnostic	  sensitivity	  is	  reported	  to	  be	  generally	  higher	  for	  L5	  than	  S1	  (Weber	  
and	  Albert,	  2000).	   	  Future	  studies	  of	  further	  lower	  limb	  muscles	  will	  be	  required	  to	  
answer	  this	  question.	  
	  
	  
It	   was	   hypothesised	   that	   previously	   reported	   alterations	   in	   the	   intracortical	  
inhibitory	  and	  corticomotor	   control	  of	   leg	  muscles	   could	  be	   reversed	  by	   successful	  
surgery	   to	   relieve	   radicular	   pain	   and	   neurologic	   deficit.	   This	   hypothesis	   was	  
confirmed	  in	  that	  TA	  MTh	  was	  reduced	  only	  in	  high	  functional	  responders	  to	  L5	  root	  
surgery,	  with	   further	   significant	   reductions	   by	   6	  months	   occurring	   only	   in	   patients	  
achieving	  excellent	  outcome	  in	  terms	  of	  pain	  relief.	  A	  new	  finding	  of	  this	  study	  was	  a	  
significantly	   prolonged	   cortical	   silent	   period	   in	   TA	   and	   SOL	  which	  was	   significantly	  
reduced	  by	  surgery.	  In	  TA	  this	  reduction	  was	  exclusive	  to	  high	  functional	  responders	  
to	   L5	   surgery.	   MVCs	   were	   significantly	   reduced	   pre-­‐surgery	   in	   both	   muscles	   at	  
baseline	  until	  6	  months	  post-­‐surgery.	  	  	  At	  baseline	  SOL	  cSPs	  were	  asymmetrical	  with	  
longer	   cSP	   CONTRA	   radic	   and	   this	   was	   resolved	   by	   R1,	   regardless	   of	   outcome.	  	  
Further	  studies	  are	  required	  to	  establish	  whether	  MTh	  and	  ICI	  measures	  such	  as	  the	  
cSP	   may	   provide	   useful	   information	   relating	   to	   the	   level	   nociception-­‐motor	  
affectation	  and	  neuropathic	  affectation.	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7.	  The	  Impact	  of	  Spinal	  Steroid	  Injections	  on	  Corticospinal	  Excitability	  of	  the	  Trunk	  and	  Legs	  






Spinal	   steroid	   injections	   (SI)	   are	   amongst	   the	   most	   common	   non-­‐surgical	  
interventions	   for	   chronic	   low	   back	   pain	   with	   radicular	   pain,	   and	   this	   is	   despite	  
considerable	  uncertainty	  regarding	  their	  efficacy	  (Manchikanti	  et	  al.,	  2010,	  McLain	  et	  
al.,	  2005,	  Staal	  et	  al.,	  2009,	  Sayegh	  et	  al.,	  2009,	  Riew	  et	  al.,	  2000,	  Lynch	  and	  Taylor,	  
1986,	  Carette	  et	  al.,	  1991,	  Marks	  et	  al.,	  1992).	  Carette	  et	  al.	  for	  example	  reported	  a	  
loss	  of	  treatment	  effect	  2-­‐3	  months	  post	  epidural	  (Carette	  et	  al.,	  1997).	  Duration	  of	  
facet	  joint	   injections	  have	  also	  been	  reported	  to	  be	  highly	  unpredictable,	  1–4	  week	  
duration	  of	  pain	  relief	  has	  been	  reported	  anywhere	  between	  42	  to	  92	  %	  of	  patients	  
(Lynch	   and	   Taylor,	   1986,	   Carette	   et	   al.,	   1991),	   whereas	   durations	   of	   up	   to	   three	  
months	   have	   been	   reported	   in	   18%	   to	   62%	  of	   treated	   patients	   (Lynch	   and	   Taylor,	  
1986,	  Marks	  et	  al.,	  1992).	  	  In	  a	  follow	  up	  of	  212	  patients	  receiving	  caudal	  epidurals,	  
another	  study	  found	  that	  although	  only	  half	  of	  patients	  significantly	   improved	  by	  2	  
weeks,	   those	   responders	   went	   on	   to	   further	   improve	   by	   the	   6	  month	   and	   1	   year	  
follow	  up	  (Hopwood	  and	  Abram,	  1993).	  	  	  
	  
Nevertheless	  the	  SI	  treatment	  has	  obvious	  advantages	  over	  oral	  systemic	  analgesics,	  
including	   the	   potential	   for	   effective	   high-­‐dosed	   patho-­‐anatomically	   targeted	   anti-­‐
inflammatory	  action.	  Furthermore	  glucocorticoids	  act	  higher	  up	  in	  the	  inflammatory	  
cascade	  and	   inhibit	   the	  arachidonic	  acid	  pathway	   that	   serves	  as	  a	  precursors	   for	  2	  
inflammatory	   cascades	   (cyclooxygenase	   and	   lipoxygenase	   synthesis),	   whereas	  
NSAIDs	  only	   inhibit	   1	   of	   these	   (cyclooxygenase),	   leading	   to	   inhibited	  prostaglandin	  
and	   thromboxane	   production	   (McLain	   et	   al.,	   2004).	   Despite	   the	   anatomical	  
uncertainty	   of	   adequate	   injectate	   delivery,	   even	   with	   fluoroscopy	   guidance,	  
uncertainty	  regarding	  the	  existence	  of	  an	  effective	  pain	  generating	  target	  is	  always	  a	  
factor	   for	   first	   procedures.	   Factors	   predicting	   failure	   have	   included	   numerous	  
previous	  treatments,	  chronic	  symptoms	  durations	  greater	  than	  6	  months,	  and	  non-­‐
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radicular	  pain	  (Jamison	  et	  al.,	  1991,	  Hopwood	  and	  Abram,	  1993).	  Patient	  selection	  is	  
an	   important	   factor	  as	   in	  surgical	   treatment.	   	   It	   is	  not	  known	  whether	  aspects	  of	  a	  
patient’s	   central	   neurophysiological	   profile,	   or	   initial	   short	   term	   effect	   of	   SIs	   on	  
central	  neurophysiology,	  may	  predispose	  a	  patient	  to	  better	  long	  term	  outcome.	  	  	  
	  
Neuropathic	   and	   non-­‐neuropathic	   LBP	   is	   associated	   with	   abnormal	   functional	   and	  
structural	  changes	  in	  the	  brain,	  which	  have	  been	  correlated	  with	  pain	  duration	  (Flor,	  
2003,	   Apkarian	   et	   al.,	   2004).	   Assessments	   with	   transcranial	   magnetic	   stimulation	  
(TMS),	   have	   reported	   abnormal	   corticomotor	   and	   intracortical	   inhibitory	   drive	   to	  
painful	  muscles	   in	   low	  back	  pain	  with	   (Strutton	  et	  al.,	  2005;	  Strutton	  et	  al.,	  2003b)	  
and	   without	   (Tsao	   et	   al.,	   2011b,	   Tsao	   et	   al.,	   2008,	   Strutton	   et	   al.,	   2004b,	  Masse-­‐
Alarie	  et	  al.,	  2012)	  neurologic	  deficit	  or	  radicular	  pain.	  	  Further	  reports	  of	  abnormal	  
intracortical	   inhibitory	   (ICI)	   activity	   have	   emerged	   from	   other	   neuropathic	   (Turgut	  
and	   Altun,	   2009,	   Schwenkreis	   et	   al.,	   2010)	   and	   chronic	   pain	   conditions	   such	   as	  
fibromyalgia	   (Salerno	   et	   al.,	   2000,	  Mhalla	   et	   al.,	   2010),	   and	   complex	   regional	   pain	  
syndrome	   (Schwenkreis	  et	  al.,	  2005).	   	   In	   LBP	  with	   radicular	  pain,	  a	   correlation	  was	  
found	   between	   patient	   rated	   pain	   and	   functional	   disability	   and	   thresholds	   for	  
eliciting	   inhibitory	   and	   motor	   responses	   in	   back	   and	   leg	   muscles	   (Strutton	   et	   al.,	  
2003b;	  Strutton	  et	  al.,	  2005).	  	  	  
	  
Some	   of	   these	   central	   changes	   measured	   by	   TMS	   have	   been	   reported	   to	   be	  
reversible	  by	  successful	  treatment	  (Masse-­‐Alarie	  et	  al.,	  2013,	  Clark	  et	  al.,	  2011,	  Tsao	  
et	  al.,	  2010a).	  	  In	  a	  recent	  study,	  structural	  changes	  in	  grey	  matter	  organisation	  and	  
altered	  cognitive	  function	  associated	  with	  chronic	  LBP	  with	  leg	  pain	  were	  found	  to	  be	  
reduced	  by	  successful	  facet	  joint	  injections	  and	  surgery	  (Seminowicz	  et	  al.,	  2011).	  	  At	  
the	  6-­‐month	  post-­‐procedure	   assessment,	   the	   study	   found	  an	   increase	   thickness	  of	  
the	   primary	   motor	   cortex,	   which	   was	   associated	   with	   reduced	   disability.	   An	  
increased	   	   thickness	   of	   the	   dorsolateral	   pre-­‐frontal	   cortex	   (DLPFC)	   also	   correlated	  
with	  the	  reduction	  of	  pain	  and	  physical	  disability,	  whilst	  DLPFC	  cognitive	  activity	  also	  
normalised.	  	  It	  is	  interesting	  to	  note	  that	  the	  excitability	  of	  the	  corticospinal	  tract	  is	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decreased	   (as	  measurable	  by	  an	   increase	   in	  motor	   threshold)	  as	  a	   consequence	  of	  
reduced	  activity	  of	  the	  prefrontal	  cortex	  (De	  Gennaro	  et	  al.,	  2007).	  	  	  
	  
It	   is	   still	   necessary	   to	   establish	   whether	   successful	   SIs,	   with	   the	   assumption	   of	  
accurate	   glucocorticoid	   delivery,	   reverses	   or	   alters	   the	   changes	   observed	   in	  
corticospinal	  drive	   to	   trunk	  and	   leg	  muscles	   (Strutton	  et	  al.,	  2003b;	  Strutton	  et	  al.,	  
2005).	   	   Furthermore	   if	   baseline	   neuroplasticity	   measures	   have	   a	   role	   to	   play	   in	  
functional	   improvements,	  then	  parameters	  of	  corticospinal	  excitability	  may	  provide	  
information	  which	  may	  be	  of	  use	  in	  classifying	  patients	  likely	  to	  benefit	  in	  the	  longer	  
term	  from	  such	  procedures.	  
	  
The	  purpose	  of	   this	   study	   is	   to	  monitor	   long	   term	  changes	   in	  back	  and	   leg	  muscle	  
parameters	  of	   corticomotor	  and	   intracortical	   inhibitory	  excitability	   in	  patients	  with	  
chronic	  LBP	  and	  radicular	  pain,	  and	  to	  compare	  these	  parameters	  in	  patients	  which	  













Study	  Population	  	  
	  
With	   local	  ethical	  approval	  and	   informed	  consent,	  14	  participants	  with	  chronic	   low	  
back	   pain	   and	   leg	   pain	   radiating	   below	   the	   knee	   on	   the	   waiting	   list	   for	   a	   spinal	  
injection	  intervention	  for	  pain	  relief	  were	  recruited.	  19	  healthy	  control	  participants,	  
comprising	  14	  males	  and	  5	  females	  (32.39±7.29	  [SD]	  years	  of	  age	  with	  a	  body	  mass	  
index	  of	  23.46±3.0	  [SD])	  were	  also	  recruited.	  Of	  the	  spinal	  injection	  (SI)	  participants	  
who	   completed	   the	   baseline	   questionnaire,	   2	   did	   not	   tolerate	   TMS	   and	  withdrew	  
before	   completing	   a	   full	  muscle	   assessment.	   	   The	   12	  who	   completed	   the	   baseline	  
assessment	   (6	   males	   and	   6	   females	   aged	   46.58±9.25	   [SD]	   years	   with	   a	   BMI	   of	  
25.62±6.94	  [SD])	  comprised	  patients	  with	  chronic	  LBP	  with	  leg	  pain	  radiating	  below	  
the	  knee,	  attributable	  to	  a	  nerve	  root	  compression	  as	  a	  result	  of	  disc	  prolapse	  and/or	  
stenotic	   changes	   in	   the	   lumbar	   spine.	   All	   patients	   were	   on	   the	   waiting	   list	   for	   a	  
fluoroscopy	  guided	  spinal	  injection	  procedure	  for	  pain	  relief	  (caudal	  epidural	  or	  facet	  
joint	   injection)	   at	   London	   Charing	   Cross	   hospital.	   Participants	   were	   studied	   on	   4	  
visits,	  before	  and	  1	  week	  (B),	  	  6	  weeks	  (R1)	  and	  6	  months	  (R2)	  following	  intervention.	  	  	  
Exclusion	  criteria	  included	  current	  treatment	  with	  antidepressants/neuromodulatory	  
drugs	   (Ziemann,	   2004,	   Ziemann,	   2003),	   as	   well	   as	   the	   general	   TMS	   exclusions	  
outlined	  in	  chapter	  3.	  
	  
Secondary	  Outcome	  Measures	  
	  
Prior	   to	   the	   start	   of	   each	   assessment,	   each	   participant	   completed	   a	   questionnaire	  
(detailed	   in	   chapter	   3),	   comprising	   body	   schema	   to	   describe	   pain	   location	   and	  
radiation,	  an	  Oswestry	  Disability	   Index	  (ODI)	   form,	   	  10cm	  Visual	  Analogue	  Scales	  of	  
Leg	   and	   Back	   Pain,	   the	   physical	   activity	   scale	   section	   of	   the	   Fear	   and	   Avoidance	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Beliefs	   Questionnaire,	   the	   EuroQol	   EQ-­‐5D	   health	   quality	   of	   life	   questionnaire,	  
Hospital	  Anxiety	  and	  Depression	  Scale	  (HADS)	  forms,	   including	  detailed	  drug	   intake	  
and	  details	  of	  any	  other	  treatments	  (such	  as	  physiotherapy).	  	  	  
	  
Patient	  Reported	  Baseline	  Characteristics	  
	  
Participants	  all	  reported	  both	  a	  history	  of	  back	  (mean	  onset	  6.73±2.35	  years)	  and	  leg	  
pain	   (mean	  onset	   5.53±2.35	   years).	   	   Four	   participants	   presented	  with	   left	   leg	   pain	  
radiating	  below	  the	  knee	  (with	  VAS	  scores	  of	  31.25±3.71	  for	  back	  pain	  and	  25.75±4.5	  
leg	   pain	   during	   the	   baseline	   assessment).	   	   Eight	   participants	   presented	   with	  
predominantly	  right	  sided	  leg	  pain	  radiating	  below	  the	  knee	  (back	  pain:	  52.88±10.56,	  
leg	  pain:	  38.13±9.77	  during	  the	  first	  assessment).	  	  On	  questionnaire	  body	  diagrams,	  
five	  participants	  also	  labelled	  symptoms	  on	  the	  contralateral	  side	  (1	  participant	  with	  
pins	  and	  needles	  to	  the	  foot,	  2	  intermittent	  pain	  to	  the	  foot	  and	  2	  pain	  to	  the	  thigh).	  
	  
With	  an	  ODI	  of	  61.2±3.0%,	  patients	  fell	  in	  the	  severely	  disabled	  range	  (table	  7.1).	  	  In	  
a	   scale	   of	   0	   (not	   at	   all)	   to	   100	   (no	   problems),	   they	   rated	   their	   ability	   to	   manage	  
activities	   of	   daily	   living	   at	   55.73±6.03.	   	   Their	   pain	   levels	   over	   the	   week	   preceding	  
baseline	  averaged	  higher	   for	  back	   than	   leg	  pain	   (59.42±4.67	   [back]	  and	  49.08±5.77	  
[leg]).	   Participants	   scored	   a	   UK	   adjusted	   health	   quality	   of	   life	   (QOL)	   index	   of	  
0.72±0.03	  and	   their	   self-­‐perceived	  health	   state	  was	  65.5±4.28%.	   	   Furthermore	   this	  
population	  was	  rated	  as	  both	  anxious	  and	  depressed	  [anxiety	  and	  depression	  in	  the	  








Baseline	  Clinical	  Characteristics	  and	  Spinal	  Injection	  Intervention	  
	  
Table	  7.2	   summarises	   features	  of	   the	  dominant	  nerve	   root	  compromise,	   its	   clinical	  
presentation	   (clinical	   history	   and	   neurological	   examination	   results	   where	   available	  
[n=8]),	   the	  MRI	   report	   details	   (including	   secondary	   degenerative	   changes)	   and	   the	  
spinal	   injection	   procedure	   which	   was	   carried	   out	   (caudal	   epidural	   or	   facet	   joint	  
injection).	  	  Five	  participants	  (as	  indicated	  with	  “↔”)	  had	  a	  dominant	  compression	  on	  
one	   side,	   and	   also	   displayed	   a	   less	   extensive/conclusive	   root	   compromise	   on	   the	  
contralateral	  side	  at	  that	  level.	  	  	  Seven	  of	  the	  participants	  also	  displayed	  a	  secondary	  
less	   conclusive	   root	   compromise	   at	   a	   higher	   or	   lower	   adjacent	   level	   (indicated	   by	  
arrows	   in	   the	   root	   column	   of	   table	   7.2).	   	   Furthermore	   widespread	   degenerative	  
changes	  were	   noted	   in	   6	   participants	   (degenerative	   discs	   [n=4],	   facet	   joints	   [n=4],	  
spondylolisthesis	  [n=1]).	  
	  
	  A	  total	  of	  9	  caudal	  epidural	  injection	  procedures	  (4	  at	  L4-­‐L5,	  4	  at	  L5-­‐S1	  and	  1	  at	  L3-­‐
L4)	  and	  3	  facet	  joint	  injection	  procedures	  (1	  bilaterally	  at	  all	  levels	  from	  L3-­‐L4	  to	  L5-­‐
S1,	  1	  at	  L4-­‐L5	  and	  L5-­‐S1,	  and	  1	  at	  L4-­‐L5)	  were	  carried	  out.	  	  In	  most	  cases	  (n=10),	  this	  
was	   the	   first	   SI	   procedure	   patients	   had	   received,	   apart	   from	   patient	   304	   and	   314	  
Table	  7.1	  :	  Questionnaire	  Derived	  Baseline	  	  Characteristics	  	  
Participant	  Rated	  Outcome	  Measure:	   Mean±SEM	  (n=12)	  
Average	  Back	  Pain	   59.42±4.67	  
Average	  Leg	  Pain	   49.08±5.77	  
EQ-­‐5D	  Health	  QOL	  Index	  &	  health	  state	   0.72±0.03	  &	  65.5±4.28	  
Disability	  (ODI)	   61.17±3.00	  
Managing	  daily	  activities	   55.73±6.03	  
Fear	  &	  Avoidance	  Beliefs	   17.17±1.52	  
HADS	  Anxiety	  &	  Depression	   18.17±0.6	  &	  16.25±0.55	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(previous	  caudal	  epidural	   injection	  at	   least	  5	  months	  prior	  to	  baseline	  assessment).	  	  
In	  all	  cases	  the	  injection	  medium	  contained	  triamcinolone	  and	  	  lignocaine.	  
	  
	   	  














Injection	  Procedure	  φ	  
Side	   Root	   Facet	  Joint	  Injection	  
Caudal	  
Epidural	  
301	   LBP,RP,	  LS	   L	   L5↓	   All	  Discs:	  L1-­‐S1	   	   L4-­‐L5	  
302	   LBP,RP,LS,W	   R	   S1	   	   	   L5-­‐S1	  
303	   LBP,RP,LS,↓R	   R↔	   L5	   SP/FJH:	  L4-­‐L5	   	   L4-­‐L5	  
304	   LBP,RP	   R↔	   L4↓	   FJH:L4-­‐L5,	  All	  Discs:	  L1-­‐L3	  
L3-­‐L4	  &L4-­‐L5	  
&L5-­‐S1	   	  
306	   LBP,RP	   L	   L5	   	   L4-­‐L5	  &L5-­‐S1	   	  
307	   LBP,RP,NC	   R↔	   L5↓	   FJH:	  L4-­‐L5	  &	  Disc:	  L5-­‐S1	   	   L4-­‐L5	  
308	   LBP,RP,LS,W	   R	   L5↓	   	   	   L5-­‐S1	  
310	   LBP,RP,LS	   R	   L5	   	   L4-­‐L5	   	  
311	   LBP,RP,LS,N	   R↔	   S1↑	   FJH:	  L5-­‐S1	   	   L5-­‐S1	  
312	  
LBP,RP,LS,↑R
↑T	   R	   S1	  
	   	   L5-­‐S1	  
313	   LBP,RP	   R↔	   L4↓	   All	  Discs:	  L1-­‐L4	  FJH:L2-­‐L5	   	   L3-­‐L4	  
314	   LBP,RP	   R	   L5↓	   Disc:L4-­‐L5	  &L5-­‐S1	   	   L4-­‐L5	  
	   Ψ	  Clinical	  history	  symptoms	  &	  exam	  results	  (LBP:	  low	  back	  pain,	  RP:	  radicular	  pain,	  LS:	  	  
positive	  Lasègue's	  sign,	  NC:	  neurogenic	  claudication,	  W:	  weakness,	  N:	  numbness,	  and	  
↑:	  increased	  or	  ↓:	  reduced	  R:	  reflex,	  T:	  muscle	  tone)	  relate	  to	  the	  dominant	  side	  and	  
myotomal/dermatomal	  distribution	  of	  the	  nerve	  root	  indicated.	  Degenerative	  
changes:	  FJH:	  facet	  joint	  hypertrophy,	  SP:	  spondylolisthesis 	  
Φ	  Arrows	  in	  MRI	  and	  injection	  procedure	  columns	  indicate	  the	  secondary	  involvement	  
of	  an	  another	  level	  (such	  as	  the	  adjacent	  level	  below	  (↓)	  or	  contralateral	  side	  (↔)	  in	  
the	  MRI	  report	  (‘Root’	  column).	  All	  injection	  procedures	  were	  fluoroscopy	  guided	  to	  






Bipolar	   surface	   electrodes	   (Ag/AgCl,	   ARBO	   blue,	   2-­‐cm	   diameter)	   were	   positioned	  
bilaterally	  over	  the	  midline	  of	  the	  soleus	  belly,	  the	  superior	  electrode	  about	  2.5	  cm	  
inferior	  to	  the	  inferior	  border	  of	  the	  medial	  head	  of	  the	  gastrocnemius	  muscle,	  and	  
parallel	  to	  the	  longitudinal	  axis	  of	  the	  leg	  to	  approximate	  the	  direction	  of	  the	  muscle	  
fibres.	   Electrode	   pairs	   were	   the	   bilaterally	   placed	   and	   aligned	   at	   a	   third	   of	   the	  
distance	  from	  the	  fibial	  to	  medial	  malleolus	  heads.	  Electrode	  pairs	  were	  then	  affixed	  
on	  either	  side	  of	  the	  vertebral	  column	  over	  the	  palpable	  bulge	  of	  the	  erector	  spinae	  
muscle	   (≈3cm	   bilateral	   to	   the	   midline),	   both	   at	   the	   twelfth	   thoracic	   and	   fourth	  
lumbar	  levels	  (Vink	  et	  al.,	  1989,	  Nowicky	  et	  al.,	  2001).	  	  A	  ground	  reference	  electrode	  
was	   placed	   on	   the	   iliac	   crest	   of	   the	   pelvis	   and	   on	   the	   left	   fibular	   head.	   The	   EMG	  
signals	   were	   bandpass	   filtered	   (10Hz	   -­‐	   2kHz)	   and	   amplified	   (usually	   at	   ×1000;	   Iso-­‐
DAM,	  WPI,	  UK)	  before	  being	  sampled	  at	  4	  kHz	  by	  a	  data	  acquisition	  interface	  (Power	  
1401	   Plus	   and	   Signal	   software	   Version	   3.1;	   Cambridge	   Electronic	   Design,	   UK)	  
connected	   to	  a	  personal	   computer.	   	  Participants	  were	  given	  visual	   feedback	  of	   the	  




Seated	   on	   a	   45	   cm	   high	   chair	   with	   restrained	   ankles	   in	   line	   with	   the	   vertical	  
projection	   of	   the	   knee	   joint	   and	   feet	   strapped	   flat	   to	   a	   board	   on	   the	   floor,	  
participants	   used	   visual	   feedback	   to	  maintain	   consistent	   isometric	   contractions	   of	  
20%	  of	  MVC,	  while	   bilateral	   responses	   to	   transcranial	  magnetic	   stimulation	   of	   the	  
motor	  cortex	  were	  recorded.	  	  The	  contraction	  of	  TA	  was	  achieved	  by	  dorsiflexion	  for	  
TA	  and	  plantar	   flexion	   for	  soleus.	   Lying	  prone	  on	  a	   flat	  horizontal	  couch	  with	   large	  
Velcro	  bands	  restraining	  ankles	  and	  scapulae,	  the	  protocol	  was	  repeated	  for	  erector	  
spinae	  with	  bilateral	  extensions	  (BTE)	  of	  the	  trunk	  to	  40%	  of	  MVC.	  Participants	  were	  
asked	   	   to	  hold	   their	  breaths	  and	  rigidly	  extend	   their	   trunks,	   imagining	  an	   inflexible	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lever	  along	  their	  spine	  extending	  from	  the	  sacrum.	  	  In	  order	  to	  minimise	  fatigue	  and	  
discomfort,	   only	   three	   stimuli	  were	   delivered	   between	   rests	   at	   higher	   (<40%MSO)	  
intensities.	   TMS	  was	   delivered	   using	   a	   9cm	  angled	   double-­‐cone	   coil	   powered	   by	   a	  
Magstim	  2002	  stimulator	  (Magstim	  Co.	  Ltd.,	  UK),	  positioned	  symmetrically	  over	  the	  
vertex	   and	   polarised	   to	   induce	   posterior-­‐to-­‐anterior	   current	   flow	   in	   the	   motor	  
cortex.	  	  A	  full	  recruitment	  curve	  of	  TMS	  pulse	  intensities,	  delivered	  in	  sets	  of	  6	  to	  30	  
pulses,	  at	  intervals	  of	  5%	  of	  maximum	  stimulator	  output	  (%MSO),	  from	  the	  threshold	  
for	   the	   cortical	   silent	   period	   (cSPTh)	   to	   150%	   of	   motor	   threshold	   (MTh),	   or	   the	  
highest	   tolerated	   intensity,	  was	   then	  delivered	   in	  a	   randomised	   sequence	   for	  each	  
muscle.	  	  	  
	  
Data	  and	  Statistical	  Analyses	  
	  
The	  cSPTh	  was	  defined	  as	  the	  intensity	  of	  the	  lowest	  appearance	  of	  the	  cSP	  valley	  in	  
the	  averaged	  rectified	  trace.	  The	  MTh	  was	  assessed	  as	  the	   lowest	   intensity	  of	  TMS	  
that	   produced	   identifiable	   MEPs	   of	   at	   least	   200uV	   peak-­‐to-­‐peak	   amplitude	   on	   at	  
least	  50%	  of	  stimulus	  presentations.	  All	  MEP	  and	  cSP	  onsets	  and	  offset	  were	  visually	  
identified	   and	   defined	   by	   intersection	   of	   the	   mean	   pre-­‐stimulus	   EMG	   line.	   MEPs	  
were	   quantified	   as	   the	   area	   above	   this	   line	   whereas	   the	   cSP	   was	   defined	   as	   the	  
return	  of	  rectified	  EMG	  activity	  to	  pre-­‐stimulus	  levels.	   	  All	  MEP	  parameters	  and	  the	  
cSP	  were	  quantified	  at	  1.2MTh.	  	  	  
	  
Paired	  t-­‐tests	  were	  used	  to	  establish	  whether	  a	  statistically	  significant	  left	  (L)	  to	  right	  
(R)	  difference	  or	  significant	  differences	  between	  the	  side	  of	  radicular	  pain/neurologic	  
deficit	   (IPSI	   radic)	   and	   the	   contralateral	   side	   (CONTRA	   radic)	   existed	   in	   patients	   or	  
controls	  at	  baseline.	   	   If	  so,	  parameters	  of	  corticospinal	  excitability	  (MTh,	  MEP	  area,	  
MEP	  duration,	  MEP	   latency,	   cSP,	   cSPTh,	  MEP	   latency)	  were	   analysed	   separately	   in	  
each	   of	   those	   respective	   sides	   (L	   and	   R	   or	   IPSI	   and	   CONTRA)	   over	   the	   four	   time	  
points.	  When	  analysing	   IPSI	  or	  CONTRA	  vs	  control	  group,	   left	  and	  right	  parameters	  
were	  averaged	  in	  controls	  (provided	  no	  significant	  left	  and	  right	  differences	  existed	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in	   controls	   at	   baseline).	   Changes	   between	   limbs	   over	   time	   were	   provided	   by	   the	  
laterality	  indicex	  (LI)	  (between	  IPSI	  and	  CONTRA	  radic	  sides).	  For	  a	  parameter	  (P)	  this	  
was	   given	   by	   LI(P)=(PIPSI-­‐PCONTRA)/(PIPSI+PCONTRA).	   Where	   no	   differences	   existed	   at	  
baseline	   left	   and	   right	   limb	   parameters	   were	   pooled	   in	   all	   groups.	   Repeated	  
measures	  ANOVAs	   factorised	   time	   (B,	   R1,	   R2,	   R3)	   and	   group	   (patients	   or	   controls)	  
and	  any	   interaction	  effects	  between	   these	   two	   factors.	  Where	   significant	   group	  or	  
time	   effects	   were	   found,	   parameter	   changes	   were	   then	   compared	   between	  
responders	  (R)	  and	  responders	  (NR)	  to	  treatment.	   	  Given	  the	  clinical	  characteristics	  
of	   the	   study	   population,	   responder	   classification	   was	   arbitrarily	   based	   on	   a	   study	  
correlating	  VAS	  pain	  and	  ODI	  score	  outcomes	  to	  patient	  rated	  Macnab	  classification	  
(Macnab,	   1971)	   in	   decompression	   surgery	   patients	   (Tafazal	   and	   Sell,	   2006).	  
Responders	   required	   a	   minimum	   reduction	   of	   30	   VAS	   points	   and	   a	   minimally	  
significant	  change	   in	  ODI	   (≥10).	  ALL	  multiple	  comparisons	  versus	   the	  control	  group	  
were	   carried	   out	   using	   Bonferroni	   corrected	   t-­‐tests.	   Repeated	   measures	   ANOVA	  
results	  are	  presented	  as	   least	  square	  means	  ±	  standard	  error	  (LSM±SEM)	  for	  group	  
(radic	   level/outcome	   group)	   x	   time	   unless	   specifically	   indicated	   to	   be	   standard	  
deviations	   by	   [SD].	   Statistical	   analyses	   were	   carried	   out	   using	   Sigmaplot	   (version	  
11.2,	  Systat	  Software,	  Inc.).	  







1	  participant	  was	  lost	  to	  follow-­‐up	  at	  1	  week,	  2	  at	  6	  weeks	  and	  3	  at	  6	  months.	  The	  
only	  stated	  reason	  for	  non-­‐compliance	  was	  an	  early	  repeat	  procedure	  due	  to	  a	  poor	  
outcome	  of	  the	  first	  (3).	  	  	  Furthermore,	  of	  the	  8	  participants	  who	  attended	  their	  final	  
6	  month	  assessment,	  4	  attended	  the	  assessment	  between	  2	  and	  5	  weeks	  early	  just	  
prior	  to	  a	  scheduled	  repeat	  procedure.	  	  In	  the	  control	  group	  1	  participant	  was	  lost	  to	  
follow-­‐up	  at	  6	  weeks	  and	  2	  further	  at	  6	  months.	  
	  
Secondary	  Intervention	  Outcome	  Measures	  
	  
Figures	  7.1	  and	  7.2	  display	  participant	  VAS	  pain	  scores	  over	  the	  6	  months	  following	  
their	   spinal	   injection.	   	   There	   was	   neither	   an	   effect	   of	   time	   in	   week	   average	   leg	  
(F=1.644,	   P=0.204	   [power=0.161])	   or	   back	   pain	   (F=1.270,	   P=0.067	   [power=0.382]).	  
However,	   both	   leg	   and	   Back	   pain	   at	   the	   time	   of	   the	   assessment	   (“pain	   now”)	  
exhibited	  a	  significant	  effect	  of	   time	   (leg:	  F=3.464,	  P=0.031;	  back:	  F=4.670,	  P=0.01)	  
with	  significant	  reductions	  at	  1	  week	  (leg:	  34.0±6.74%	  to	  14.72±6.74,	  P=0.005;	  back:	  
45.67±7.61%	  to	  27.18±6.34,	  P=0.001).	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Figure	  7.1:	  Mean±SEM	  VAS	  Leg	  Pain	  Outcome	  at	  baseline	  (B),	  6	  weeks	  (R1),	  	  
6	  months	  (R2)	  and	  1	  year	  (R3)	  
	  
	  
Figure	  7.2:	  Mean±SEM	  VAS	  Back	  Pain	  Outcome	  at	  baseline	  (B),	  6	  weeks	  (R1),	  	  





Median	  ODI	  scores	  (figure	  7.3)	  box	  centre	  lines,	  25%	  and	  75%	  quartiles	  [box	  edges],	  
maximum	  and	  minimum	  values	  [bars]	  and	  outliers	  [circles]).	  	  Because	  of	  the	  limited	  
samples	   available	   at	   R3,	   ODI	   scores	   had	   to	   be	   analysed	   as	   means	   rather	   than	  
medians	   on	   ranks.	   	   An	   effect	   of	   time	   was	   noted	   (P=0.042)	   with	   comparison	  
procedures	   revealing	   a	   significant	   reduction	   in	  mean	  ODI	   scores	   between	  baseline	  
and	   1	   week	   (61.17±3.0%	   to	   51.64±4.53%,	   P=0.007).	   	   Improvements	   were	   most	  
consistently	  noted	  in	  “standing”	  (P=0.031)	  and	  “social	  life”	  (P=0.014).	  
	  
Figure	  7.3	  Median	  Change	  in	  Disability	  (ODI)	  	  
	  
Percentages	   of	   the	   Epidural	   population	   reporting	   problems	   in	   mobility,	   self-­‐care,	  
usual	  activities,	  pain/discomfort	  and	  anxiety/depression	  are	  presented	  in	  figure	  7.4.	  	  
Notably	   the	   largest	   drop	   in	   pain/discomfort	   (affecting	   45.5%	   of	   the	   population)	  
occurs	  between	  baseline	  and	  1	  week,	  before	   returning	   to	  baseline	  at	   the	  6	  month	  
assessment.	   	   In	   the	   long	   term,	   improvements	   in	  mobility	   and	  day	   to	   day	   activities	  
affect	   the	   largest	   proportion	   of	   the	   epidural	   group,	   with	   29.2%	   and	   41.7%	   less	  
reporting	   problems	   over	   baseline	   at	   6	   months.	   	   Reported	   as	   the	   UK	   population	  
adapted	  QOL	   index	  which	  accounts	   for	   severity	  of	  problems,	  an	  effect	  of	   time	  was	  



















B	   	  	  	  	  	  	  	  	  	  R1	   	  	  	  	  R2	   	  	  	  	  	  	  	  	  	  	  	  	  	  R3	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found	   in	   health	   QOL	   (P<0.001).	   	   Multiple	   comparison	   procedures	   revealed	   an	  
improvement	   from	  baseline	   to	  R1	  assessment	   (P<0.001),	  and	  no	   further	   significant	  
changes	  between	  time	  points.	  	  These	  improvements	  did	  not	  extend	  to	  self-­‐perceived	  
general	  health	  state	  (P=0.072).	  	  
	  
Figure	  7.4	  Health	  QOL	  Outcome	  
	  
Anxiety	   (B:	   18.16±0.60,	   R1:	   18.64±0.66,	   R2:	   18.22±0.80,	   R3:	   19.00±0.96;	   P=0.250)	  
and	   depression	   (B:	   16.25±0.55,	   R1:	   16.55±0.62,	   R2:	   17.22±0.36,	   R3:	   17.00±0.38;	  
P=0.881)	  scores	  remained	  stable.	  	  Fear	  and	  avoidance	  beliefs	  also	  were	  not	  impacted	  
by	   treatment	   (B:	   17.17±1.52,	   R1:	   16.91±1.76,	   R2:	   18.67±2.54,	   R3:	   16.13±2.26;	  
P=0.637).	  
	  
Epidural	  Group	  Pain	  and	  Functional	  Outcome	  at	  1	  Week	  
	  
In	   the	   11	   participants	   who	   returned	   at	   1	   week,	   an	   outcome	   could	   be	   calculated	  
based	  on	  a	  change	  in	  pain	  or	  function	  (ODI).	  Only	  3	  participants	  retained	  minimum	  
clinically	  significant	  pain	  improvements	  at	  3	  weeks	  (≥20mm)	  and	  only	  one	  of	  these,	  
functional	  improvements	  (≥10	  ODI).	  	  Therefore	  outcome	  was	  measured	  as	  a	  change	  
	  
Figure 7.4: Health QOL -Epidural Participants with Problems
















































in	   score	   between	   baseline	   and	   1	   week	   (Table	   7.3).	   Six	   participants	   qualified	   as	  
responders	   to	   treatment	   at	   1	   week	   with	   3	   of	   those	   achieving	   good	   functional	  











	   	  
Table	  7.3	  Outcome	  based	  on	  change	  in	  disability	  (ODI),	  leg	  pain	  (VAS)	  and	  back	  
pain	  (VAS)	  at	  1	  week	  
Patient	  
No.	  
Change	  in	  Outcome	  Measure	  
ODI	   BACK	  PAIN	   LEG	  PAIN	  
301	   -­‐28ψ	   -­‐45	  ψ	   -­‐44ψ	  
302	   -­‐12	  	  ψ	   -­‐36ψ	   -­‐58	  ψ	  
303	   -­‐32	  ψ	   -­‐33	  ψ	   -­‐30	  ψ	  
304	   +8	   -­‐1	   +7	  
306	   -­‐8	   -­‐14	   -­‐11	  
307	   -­‐10	  ψ	   -­‐40	  ψ	   -­‐33	  ψ	  
308	   -­‐20	  ψ	   -­‐37	  ψ	   -­‐48	  ψ	  
311	   -­‐4	   0	   -­‐2	  
312	   0	   -­‐1	   -­‐3	  
313	   -­‐14	  ψ	   -­‐40	  ψ	   -­‐51ψ	  
314	   +6	   -­‐1	   -­‐5	  








There	  was	  a	  group	  effect	  (both	  P<0.001)	  and	  no	  effect	  of	  time	  (both	  P>0.291)	  with	  
MVCs	  remaining	  stable	  and	  significantly	  smaller	  than	  controls	  (table	  7.4)	  both	  at	  L4	  
and	  T12.	  
	  
	  Table	  7.4:	  Erector	  Spinae	  Maximum	  Voluntary	  Contractions	  (mV)	  
Level	   ES	  L4	   ES	  T12	  
Time	   SI**	   Control	   SI**	   Control	  
B	   0.0479±0.0058**	   0.140±0.0042	   0.0644±0.0107**	   0.201±0.0077	  
R1	   0.0485±0.0064**	   0.148±0.0045	   0.0644±0.0118**	   0.237±0.0082	  
R2	   0.0414±0.0076**	   0.137±0.0048	   0.0672±0.0139**	   0.207±0.0089	  
R3	   0.0363±0.0076**	   0.139±0.0048	   0.0582±0.0139**	   0.224±0.0089	  
**	  multiple	  comparisons	  analysis	  indicated	  lower	  than	  controls	  (P<0.001)	  
	  
MEP	  Latency	  
There	  was	  a	  significant	  effect	  of	  group	  (P=0.028)	  and	  a	  significant	  interaction	  effect	  
(group	  x	  time;	  P=0.002)	  in	  L4	  ES	  MEP	  latencies	  (table	  7.5	  left).	  	  Multiple	  comparisons	  
revealed	   that	   SI	   patients	   had	   longer	   latencies	   at	   L4	   (P<0.045).	   There	   was	   also	   a	  
significant	  reduction	  in	  the	  SI	  group	  ES	  L4	  latencies	  between	  B	  and	  R1	  (P=0.003).	  
This	   was	   not	   found	   in	   ES	   T12,	   where	   there	   were	   no	   significant	   effects	   of	   group	  
(P=0.125)	  or	  time	  (P=0.164;	  table	  7.5	  right).	  
	  
Outcome	   group	   analysis:	   revealed	   a	   group	   effect	   (P=0.030)	   but	   no	   time	   effect	  
(P=0.131).	   	   Non	   responders	   to	   treatment	   had	   longer	   latencies	   than	   controls	   at	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baseline	  (P=0.031	  R:	  15.24±0.79;	  NR:	  17.26±0.68;	  C:	  15.34±0.36)	  but	  responders	  did	  
not	  (P=0.425).	  
	  
Table	  7.5:	  Erector	  Spinae	  MEP	  latencies	  (ms)	  
Level	   ES	  L4	   ES	  T12	  
Time	   SI*	   Control	   SI	   Control	  
B	   17.39±0.39*	   15.22±0.28	   16.40±0.33	   15.036±0.24	  
R1	   15.46±0.43↓	   15.81±0.30	   15.54±0.37	   15.505±0.25	  
R2	   16.65±0.51*	   14.82±0.32	   16.35±0.43	   15.16±0.28	  
R3	   17.32±0.51*	   15.51±0.32	   16.83±0.43	   15.68±0.28	  
*	  multiple	  comparisons	  analysis	  indicated	  longer	  than	  control	  (P<0.05)	  &	  ↓	  
change	  from	  baseline	  (P<0.05).	  
	  
MEP	  duration	  and	  area	  
An	  effect	  of	  group	  (P=0.015)	  and	  time	  (P=0.021)	  was	  found	  in	  MEP	  duration	  in	  ES	  L4.	  
ES	  MEPs	  at	  L4	  were	  longer	  in	  the	  SI	  group	  than	  in	  controls	  (P=0.030;	  table	  7.6	  left).	  
There	  was	  also	  a	  significant	  prolongation	  of	  ES	  L4	  MEPs	  between	  B	  and	  R1	  (P=0.021).	  
At	  T12	  there	  was	  a	  group	  effect	   (P<0.001)	  with	  no	  effect	  of	  time	  (P=0.790).	  ES	  T12	  
MEPs	  were	   longer	   in	   the	  SI	  group	  than	   in	  controls	   (P=0.002;	   table	  7.6	  right).	  There	  
were	  no	  corresponding	  group	  (P=0.491)	  or	  time	  effects	  (P=0.170)	  in	  MEP	  area.	  
	  
Outcome	   group	   analysis:	   revealed	   effects	   in	   ES	   L4	   (group	   P=0.016,	   time:	   P=0.002;	  
interaction	   P=0.003).	   Non	   responders	   had	   longer	   MEP	   durations	   than	   controls	   at	  
baseline	   (P=0.036)	   but	   not	   responders	   (P=0.140).	   Responders	   experienced	   an	  
increase	   in	   MEP	   duration	   between	   B	   and	   R1	   (P=0.003)	   followed	   by	   a	   significant	  
decrease	   back	   to	   baseline	   levels	   between	   R1	   and	   R2	   (P=0.002;	   B:	   28.67±1.65;	   R1:	  
38.51±1.65:	   R2:	   27.11±2.02ms).	   Non	   responder	   MEP	   durations	   remained	   stable	  








	  Table	  7.6:	  Erector	  Spinae	  MEP	  durations	  (ms)	  
Level	   ES	  L4	   ES	  T12	  
Time	   SI*	   Control	   SI**	   Control	  
B	   30.03±1.08	   27.11±0.78	   33.49±0.92*	   27.65±0.67	  
R1	   34.42±1.19*↑	   27.01±0.82	   33.61±1.02*	   27.79±0.71	  
R2	   28.78±1.4	   26.17±0.89	   34.15±1.2*	   28.61±0.77	  
R3	   31.44±1.4*	   26.16±0.89	   33.15±1.2*	   27.97±0.77	  
*	  multiple	  comparisons	  analysis	  indicated	  longer	  than	  control	  (P<0.05)	  &	  ↑	  
change	  from	  baseline	  (P<0.05).	  
	  
MTh	  
There	  were	  effects	  of	  group	  (P≤0.016)	  but	  no	  effect	  of	  time	  (P≥0.096)	   in	  ES	  L4	  and	  
T12	  MThs.	  	  MThs	  were	  significantly	  higher	  than	  controls	  in	  ES	  at	  L4	  (P=0.027;	  figure	  
7.5	  left)	  and	  T12	  (P=0.035;	  figure	  7.5	  right).	  	  	  
ES T12 MTh























Figure	  7.5:	  	  Mean±SEM	  Erector	  Spinae	  Motor	  Thresholds	  
cSPTh	  
There	  were	  effects	  of	  group	  (P≤0.005)	  and	  no	  effect	  of	  time	  (P≥0.096)	   in	  ES	  L4	  and	  
T12	   cSPThs.	   	   At	   L4	   an	   interaction	   effect	   was	   also	   found	   (P=0.027).	   cSPThs	   were	  
significantly	   higher	   than	   controls	   in	   ES	   at	   L4	   (P=0.009;	   figure	   7.8	   left)	   and	   T12	  
(P=0.012;	  figure	  7.6	  right).	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Outcome	   group	   analysis:	   revealed	   effects	   in	   ES	   L4	   (group	   P=0.035,	   time:	   P=0.085;	  
interaction	   effect:	   P<0.001).	   Non	   responders	   cSPThs	   increased	   between	   B	   and	   R3	  
(P=0.003;	  B:	  33.00±	  0.88;	  R1:	  31.50±0.87:	  R2:	  35.69±1.03:	  R3:	  37.53±1.03	  %MSO).	  
ES T12 cSPTh




























Figure	  7.6:	  	  Mean±SEM	  Erector	  Spinae	  cSP	  Thresholds	  
cSP	  
At	   L4	   there	  was	  neither	  an	  effect	  of	   group	   (P=0.141)	  nor	   time	   (P=0.506;	   figure	  7.9	  
left).	  	  At	  T12	  a	  group	  effect	  was	  present	  (P=0.010,	  with	  no	  time	  effect	  P=0.427;	  figure	  
7.9	  right).	  cSPs	  were	  longer	  than	  in	  controls	  (P=0.022)	  at	  T12.	  
ES T12 cSP


























There	  were	  effects	  of	  group	  (P<0.001)	  but	  not	  time	  (P≥0.917)	   in	  TA	  and	  SOL	  MVCs.	  	  
MVCs	  were	  significantly	   lower	  in	  the	  SI	  group	  than	  in	  controls	   in	  both	  TA	  (P<0.001;	  
table	  7.7	  left)	  and	  SOL	  (P<0.001;	  figure	  7.7	  right).	  	  	  
	  
	  Table	  7.7:	  TA	  and	  SOL	  Maximum	  Voluntary	  Contractions	  (mV)	  
Level	   TA	   SOL	  
Time	   SI**	   Control	   SI**	   Control	  
B	   0.207±0.017**	   0.351±0.014	   0.118±0.012**	   0.217±0.009	  
R1	   0.241±0.019**	   0.376±0.015	   0.127±0.014**	   0.217±0.011	  
R2	   0.229±0.022*	   0.326±0.016	   0.137±0.016*	   0.202±0.011	  
R3	   0.226±0.023*	   0.356±0.016	   0.131±0.016*	   0.196±0.011	  
*	  multiple	  comparisons	  analysis	  indicated	  lower	  than	  control	  *(P<0.05)**(P<0.001)	  
	  
MEP	  Latency	  
There	  were	   effects	   of	   group	   (P≤0.016)	   but	   not	   time	   (P≥0.187)	   in	   TA	   and	   SOL	  MEP	  
latencies.	  	  MEP	  latencies	  were	  significantly	  longer	  in	  the	  SI	  group	  than	  in	  controls	  in	  
both	  TA	  (P=0.033;	  table	  7.7	  left)	  and	  SOL	  (P<0.001;	  figure	  7.7	  right).	  	  	  
	  
	  Table	  7.8:	  TA	  and	  SOL	  MEP	  latencies	  (ms)	  
Level	   TA	   SOL	  
Time	   SI*	   Control	   SI*	   Control	  
B	   30.08±0.27*	   28.38±0.21	   34.63±0.32**	   30.77±0.25	  
R1	   29.65±0.29	   28.08±0.24	   34.01±0.35*	   31.29±0.27	  
R2	   30.03±0.33	   28.2±0.25	   34.61±0.41**	   30.86±0.29	  
R3	   30.55±0.36*	   28.36±0.25	   34.24±0.41**	   30.49±0.29	  





In	  TA	  an	  effect	  of	  participant	  group	  (P=0.003)	  and	  but	  not	  time	  (P=0.148)	  was	  found	  
(table	  7.9	   top	   right).	   	   Patients	  had	  higher	  MThs	   than	  controls	   (P=0.008).	   	   In	   soleus	  
MThs,	   there	  were	   neither	   effects	   of	   group	   (P≤0.220)	   nor	   time	   (P≥0.560;	   table	   7.9	  
bottom	  right)	  in	  MTh.	  
	  
cSPTh	  
There	  were	  effects	  of	  group	  (P≤0.016)	  but	  not	  time	  (P≥0.187)	  in	  TA	  and	  SOL	  cSPThs.	  	  
cSPThs	  were	  significantly	  higher	  in	  the	  SI	  group	  than	  in	  controls	  in	  both	  TA	  (P=0.033;	  
table	  7.9	  left)	  and	  SOL	  (P<0.001;	  figure	  7.9	  right).	  	  	  
	  
	  
Table	  7.9:	  TA	  and	  SOL	  Motor	  and	  Cortical	  Silent	  Period	  Thresholds	  (%MSO)	  
Time	  
MTh	   cSPTh	  
SI	   Control	   SI*	   Control	  
TA	  
B	   44.21±0.57*	   36.4±0.45	   30.00±0.55	   26.32±0.44	  
R1	   42.64±0.62*	   35.66±0.50	   30.91±0.60*	   26.32±0.48	  
R2	   43.88±0.71*	   34.83±0.52	   31.71±0.68*	   26.39±0.50	  
R3	   44.97±0.76*	   35.91±0.52	   31.29±0.73	   26.86±0.50	  
SOL	  
B	   43.66±0.87	   39.87±0.66	   33.86±0.61*	   26.25±0.46	  
R1	   44.62±0.95	   40.88±0.74	   31.61±0.66*	   27.28±0.51	  
R2	   44.31±1.10	   39.93±0.77	   31.96±0.77*	   27.23±0.53	  
R3	   43.91±1.10	   41.6±0.77	   31.65±0.77*	   26.84±0.53	  




There	  was	  an	  effect	  of	   group	   (P≤0.025)	  but	  no	  effect	  of	   time	   (P=0.395)	   in	  TA	   cSPs	  
(figure	  7.8	  left).	  	  cSPs	  were	  significantly	  longer	  than	  controls	  IPSI	  radic	  at	  R1.	  	  In	  SOL	  
there	   was	   an	   effect	   of	   group	   (P<0.001),	   time	   (P=0.001)	   and	   interaction	   effect	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(P=0.049).	   	   cSPs	  were	   significantly	   longer	  CONTRA	   (P=0.001)	  but	  not	   IPSI	   (P=0.113)	  
radic.	  	  There	  was	  	  also	  a	  significant	  increase	  in	  cSP	  between	  B	  and	  R1	  (P=0.002).	  This	  
change	  was	  no	  longer	  significant	  at	  6	  weeks	  (P=0.118).	   In	  terms	  of	  asymmetry,	  SOL	  
cSPs	  were	  more	  asymmetrical	  than	  controls	  (LI:	  -­‐-­‐0.063	  vs.	  0.022;	  P=0.03)	  without	  a	  
change	  over	  time	  (P=0.630)	  
	  
SOL cSP







































This	   is	   the	   first	   study	   to	   examine	   changes	   in	   parameters	   of	   corticomotor	   and	  
intracortical	   inhibitory	   control	   elicited	   by	   TMS	   following	   caudal	   epidural	   and	   facet	  
joint	  injections	  for	  chronic	  LBP	  with	  radicular	  pain.	  	  It	  was	  hypothesised	  that	  changes	  
in	  these	  parameters,	  reported	  in	  a	  previous	  studies,	  would	  be	  mitigated	  by	  changes	  
in	  back	  and	  leg	  pain	  and	  function	  resulting	  from	  successful	  spinal	  steroid	  injections.	  	  
In	  ES	  patients	  were	  found	  to	  have	  longer	  latencies	  to	  ES	  L4,	  higher	  cSPTh,	  MThs	  and	  
longer	   MEPs	   at	   both	   levels,	   and	   longer	   cSPs	   at	   T12.	   	   In	   leg	   muscles,	   cSPThs	   and	  
latencies	   were	   higher	   in	   both	  muscles,	  MThs	  were	   higher	   in	   TA,	   and	   in	   SOL,	   cSPs	  
were	  both	  asymmetrical	  and	  significantly	  prolonged	  CONTRA	  radic.	  	  At	  1	  week	  there	  
was	  a	  transient	  decrease	  in	  ES	  L4	  latency,	  and	  an	  increase	  in	  SOL	  cSP	  on	  the	  side	  of	  
pain.	   Participants	  who	   did	   not	   responded	   to	   treatment	   had	   longer	   ES	   L4	  MEPs	   at	  
baseline	  and	  experienced	  a	  small	   increase	   in	  cSPTh	  over	  the	  6	  months.	  Responders	  
on	   the	   other	   hand	   experienced	   an	   increase	   in	   MEP	   duration	   between	   B	   and	   R1	  
(P=0.003)	  followed	  by	  a	  significant	  decrease	  back	  to	  baseline	  levels	  between	  R1	  and	  
R2.	   Patients	  were	   able	   to	  produce	   significantly	   lower	  MVCs	   in	   all	  muscles	   and	   this	  





ES	  MEP	  Latencies	  and	  Durations	  
	  
SI	   patients	   had	   longer	   latencies	   at	   L4	   but	   not	   at	   T12.	   There	  was	   also	   a	   significant	  
transient	   reduction	   in	   SI	   group	   ES	   L4	   latencies	   between	   B	   and	   R1.	   Only	   non-­‐
responders	   to	   treatment	   had	   longer	   latencies	   than	   controls	   at	   baseline	   while	  
responders	  had	  normal	  L4	  latencies	  (R:	  15.24±0.79;	  NR:	  17.26±0.68;	  C:	  15.34±0.36).	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ES	  MEPs	  at	  both	  L4	  and	  T12	  were	   longer	   in	  the	  SI	  group	  than	   in	  controls,	  however	  
only	  at	  L4	  did	  they	  transiently	  increase	  	  at	  1	  week.	  	  Non-­‐responders	  had	  longer	  MEP	  
durations	   than	   controls	   at	   baseline	   (P=0.036)	   but	   not	   responders	   (P=0.140).	  
Responders	  experienced	  an	   increase	   in	  MEP	  duration	  between	  B	  and	  R1	   (P=0.003)	  
followed	   by	   a	   significant	   decrease	   back	   to	   baseline	   levels	   between	   R1	   and	   R2	  
(P=0.002).	  
	  
Cortical	  latencies	  to	  ES	  have	  been	  found	  to	  increase	  in	  unilateral	  postural	  tasks	  such	  
as	   back	   adjustments	   to	   contralateral	   arm	   abductions	   by	   ~3ms	   (Davey	   et	   al.,	   2002,	  
Kuppuswamy	  et	  al.,	  2008).	  	  Mapping	  studies	  have	  also	  identified	  ipsilateral	  responses	  
elicited	  slightly	   lateral	   to	  contralateral	  hotspots	   (Ziemann	  et	  al.,	  1999,	  O'Connell	  et	  
al.,	  2007)	  with	  latencies	  which	  are	  prolonged	  by	  about	  4ms	  (O'Connell	  et	  al.,	  2007).	  
The	  difference	  in	  ipsi	  to	  contra	  projection	  latencies	  in	  RA	  have	  been	  reported	  at	  2ms	  
(Tunstill	   et	   al.,	   2001)	   and	   in	   EO	   at	   3ms	   (Wightman	   et	   al.,	   2011)	   and	   their	   cortical	  
representations	  are	  reported	  to	  be	  symmetrical.	  Furthermore	  an	  additional	  anterior	  
(4cm)	   hotspot	   was	   found	   in	   both	   ES	   and	   diaphragm	   muscles,	   producing	   fast	  
contralateral	   responses	   and	   suggesting	   perhaps	   direct	   projections	   from	   the	  
supplementary	  motor	  areas	  to	  these	  trunk	  muscles	  (O'Connell	  et	  al.,	  2007,	  Sharshar	  
et	   al.,	   2004,	   Tsao	   et	   al.,	   2011a).	   ES	   latency	   values	   are	   in-­‐keeping	   with	   other	   TMS	  
studies	   using	   vertex	   stimulation	   (Strutton	   et	   al.,	   2005,	   Kuppuswamy	   et	   al.,	   2004,	  
Kuppuswamy	  et	  al.,	  2008)	  	  but	  on	  the	  faster	  end	  of	  the	  spectrum	  	  of	  those	  reported	  
by	   mapping	   experiments	   (12.05-­‐30.48ms)	   (O'Connell	   et	   al.,	   2007,	   Ferbert	   et	   al.,	  
1992).	   	  This	  may	  indicate	  the	  vertex	  TMS	  activated	  a	  number	  of	  pathways	  and	  that	  
faster	   responses	   likely	   mask	   the	   onset	   of	   slower	   ones.	   	   Using	   FWIE	   electrodes,	  
mapping	   experiments	   to	   discrete	   fascicles	   of	   ES	   Tsao	   at	   al.	   (2011)	   found	   discrete	  
hotspots	   and	   latencies	   for	   deep	   multifidus	   (15.2±0.9ms)	   and	   longissimus	   erector	  
spinae	   (18.3±3.0ms-­‐corresponding	   to	   the	   anterior	   site	   described	   above)	   fascicles	  
(Tsao	  et	  al.,	  2011a)	  and	  did	  not	  find	  any	  changes	  in	  these	  latencies	  in	  a	  recurrent	  LBP	  
population	   (Tsao	   et	   al.,	   2011b).	   	   However	   a	   reduction	   in	   the	   excitability	   of	   the	  
anterior	   ES	   hotspot	   was	   found	   in	   recurrent	   LBP.	   Similarly	   cortical	   mapping	   of	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transversus	  abdominis	   (TrA)	   (Tsao	  et	  al.,	   2008),	   LBP	  yielded	  a	  posterior	  and	   lateral	  
centre	  of	  gravity	  (CoG),	  compared	  to	  the	  controls	  which	  had	  a	  CoG	  2cm	  anterior	  and	  
lateral	   to	   the	   vertex.	   So	   reduced	   excitability	   of	   anterior	   sites,	   which	   have	   longer	  
latencies	  appears	   to	  be	  a	  distinguishing	   feature	  of	   LBP.	   	   In	  TrA,	   skilled	   training	  has	  
been	   associated	   with	   increasing	   excitability	   of	   this	   anterior	   site	   with	   no	   reported	  
changes	  in	  latency	  (Tsao	  et	  al.,	  2009).	  
	  
Both	   responders	   and	   controls	   had	   latencies	   corresponding	   to	   the	   faster	   posterior	  
hotspot,	   suggesting	   that	   these	   mask	   the	   onset	   of	   slower	   anterior	   responses	   (R:	  
15.24±0.79;	  NR:	  17.26±0.68;	  C:	  15.34±0.36).	  As	  responders	  experienced	  a	  significant	  
10ms	  increase	  in	  MEP	  duration	  between	  B	  and	  R1	  (P=0.003)	  followed	  by	  a	  significant	  
decrease	   back	   to	   baseline	   levels	   between	   R1	   and	   R2	   (P=0.002;	   B:	   28.67±1.65;	   R1:	  
38.51±1.65:	   R2:	   27.11±2.02ms),	  may	   indicate	   a	   reduced	   nociceptive	   inhibition	   and	  
thus	   increased	   contribution	   of	   this	   anterior	   pathway,	   resulting	   from	   adequate	   or	  
effective	  glucocorticoid	  delivery.	  The	   fact	   that	  non-­‐responders	  had	   longer	   latencies	  
at	   baseline	   may	   suggest	   a	   different	   pathology	   without	   the	   possibility	   for	   such	   an	  
anterior	  expansion.	  
	  
On	   the	   other	   hand	   ES	   latencies	   had	  mixed	   ICC	   ratings	   with	   high	   reliability	   on	   the	  
right,	  but	  poor	  reliability	  on	  the	  left,	  even	  though	  the	  SEMs	  were	  low	  (0.31-­‐4.19ms).	  	  
Nevertheless	  the	  2ms	  difference	  between	  responders	  and	  non-­‐responders	  reported	  
in	   this	   study	   is	  within	   this	   standard	   error.	   Nevertheless	  MEPdur	   and	   corticomotor	  
changes	  in	  successful	  treatment	  will	  require	  further	  exploration.	  
	  
ES	  MTh	  and	  cSPTh	  
	  
MThs	   were	   significantly	   higher	   than	   controls	   in	   ES	   at	   L4	   and	   ES	   T12.	   	   This	   is	   in	  
agreement	  previous	  reports	  which	  found	  MThs	  to	  be	  elevated	  in	  LBP,	  and	  this	  to	  be	  
related	  to	  pain	  and	  function	  in	  these	  patients	  (Strutton	  et	  al.,	  2005b,	  Strutton	  et	  al.,	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2004b).	   	   The	   patient	   vs.	   control	   results	   obtained	   in	   this	   previous	   report	   (from	  bar	  
graph	  data:	   48.05±2.40	   vs.	   ~42.5±~4.0	  %MSO),	   	   are	   similar	   to	   the	   results	  obtained	  
from	  the	  current	  cohort	  (48.27±2.89	  vs.	  40.48±1.86	  %MSO),	  regardless	  of	  the	  higher	  
contraction	  strength	  used	  (40%	  vs.	  20%).	  	  MThs	  were	  stable	  and	  this	  may	  be	  related	  
to	  the	  lack	  of	  significant	  change	  in	  back	  pain	  or	  functional	  scores.	  
	  
As	  previously	  reported	  (Strutton	  et	  al.,	  2005b),	  cSPTh	  were	  significantly	  higher	  than	  
controls	  at	  ES	  L4	  but	  this	  was	  also	  found	  at	  T12	  in	  this	  study.	  	  ES	  L4	  cSPThs	  were	  in	  a	  
similar	  range	  in	  this	  previous	  report	  (from	  bar	  graph	  data:	  ~35.5±~2.0	  	  vs.	  31.12±2.23	  	  
%MSO)	   and	   the	   current	   study	   (34.11±2.0	   	   vs.	   27.69±1.28	   	   %MSO),	   despite	   slight	  
methodological	  variations.	  There	  was	  a	  small	  significant	  increase	  in	  non-­‐responders	  
over	   the	   duration	   of	   the	   6	   months.	   This	   was	   not	   found	   in	   responders.	   This	   may	  





cSP	  were	  higher	  than	  in	  controls	  and	  this	  was	  only	  significant	  at	  	  T12.	  	  This	  was	  also	  
reported	   in	   LBP	   patients	  with	   leg	   pain	   distal	   to	   the	   knee	   reported	   in	   chapter	   5.	   A	  
speculative	  explanation	  of	  the	  higher	  distribution	  of	  cSP	  at	  T12	  could	  be	  related	  to	  
higher	  affected	  nerve	  roots,	  but	  no	  MRI	  or	  clinical	  data	  was	  reported	  in	  that	  study.	  
Changes	   in	   intracortical	   inhibition	   (ICI)	   have	   been	   reported	   in	   neuropathic	   pain	  
(Turgut	  and	  Altun,	  2009,	  Schwenkreis	  et	  al.,	  2010),	  and	  other	  chronic	  pain	  conditions	  
such	   as	   fibromyalgia	   and	   rheumatoid	   arthritis	   (Salerno	   et	   al.,	   2000,	  Mhalla	   et	   al.,	  
2010),	   and	   low	   back	   pain	   (Masse-­‐Alarie	   et	   al.,	   2012).	   	   One	   study	   reports	   that	  
significantly	  larger	  ICI	  changes	  than	  in	  chronic	  nociceptive	  or	  inflammatory	  pain	  may	  
be	   the	   hallmark	   of	   neuropathic	   pain	   (Schwenkreis	   et	   al.,	   2010).	   In	   chapter	   5,	   only	  
chronic	  LBP	  participants	  had	  significantly	  increased	  cSPs.	  	  The	  cSPs	  in	  this	  study	  may	  
confirm	   this	   finding,	   a	   study	   with	   more	   samples	   could	   examine	   whether	   patho-­‐
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anatomy	   is	   related	   to	   ES	   cSPs	   at	   different	   levels.	   	   Reduced	   short	   intracortical	  
inhibition	  (SICI)	  reported	  in	  chronic	  LBP	  by	  Masse-­‐Alarie	  and	  colleagues	  (2012)	  has	  a	  
strong	  negative	  correlation	  with	  increases	  in	  the	  cSP	  (SICI	  conditioned	  MEP	  decrease	  
vs.	   cSP	   in	  LBP	  patients	   (r=0.8,	  p=0.006)).	   	  As	  a	   result	   the	  cSP	  and	  SICI	  may	  actually	  






MVCs	  were	  lower	  than	  controls	  in	  both	  TA	  (0.207±0.017	  vs.0.351±0.014	  mV)	  and	  SOL	  
(0.118±0.012vs.0.217±0.009	   mV).	   Unlike	   the	   surgery	   patients	   reported	   in	   the	  
previous	  chapter,	  there	  were	  no	  significant	  changes	  in	  MVC	  over	  time.	  	  Compared	  to	  
the	  long	  term	  reductions	  in	  that	  study,	  effects	  of	  SI’s	  were	  very	  modest	  and	  transient	  
and	  this	  may	  be	  related	  to	  the	  lack	  of	  response	  of	  this	  measure.	  
	  
Leg	  MEP	  Latencies	  
	  
MEP	   latencies	   were	   longer	   in	   patients	   than	   control	   with	   no	   effect	   of	   time	   (TA:	  
30.08±0.27	   vs.28.38±0.21ms;	   SOL:	   34.63±0.32vs.30.77±0.25).	   	   MEP	   latencies	   have	  
been	   shown	   to	   increase	   in	   both	   lateral	   (peripheral	   conduction	   time)	   and	   central	  
lumbosacral	   root	   compressions	   (central	   conduction	   time)	   (Bischoff	   et	   al.,	   1993),	  
however	   this	   has	   been	   shown	   to	   be	   more	   specific	   with	   the	   presence	   of	   motor	  
disturbances	  (Banerjee	  et	  al.,	  1993).	  Motor	  disturbances	  were	  present	  in	  at	  least	  5	  of	  







cSPThs	  were	  significantly	  higher	  in	  the	  SI	  group	  than	  in	  controls	  in	  both	  TA	  and	  SOL	  
legs.	   This	   finding	   is	   in	   agreement	   with	   Strutton	   (2003),	   who	   found	   cSPThs	  
significantly	  	  higher	  in	  the	  combined	  TA	  and	  lateral	  gastrocnemius	  muscles	  (LGN)	  in	  9	  
participants	   with	   unilateral	   L4-­‐S1	   neurologic	   deficit	   and	   leg	   pain	   (from	   bar	   graph	  
data:	  ~20±0.9	  vs.	  ~23±1.5).	  Although	  these	  cannot	  be	  directly	  compared,	  this	  study	  
found	  cSPThs	  of	  30.00±0.55	  vs.	  26.32±0.44	   in	  TA	  and	  33.86±0.61	  vs.	  26.25±0.46	   in	  
SOL	   (patients	   vs.	   controls).	   As	   these	   values	  were	   found	   in	   this	   former	   study	   to	   be	  
related	  to	  disability,	  the	  high	  baseline	  disability	  61.17±3.00	  (ODI)	  of	  this	  cohort	  may	  




Patients	  had	  higher	  MThs	  than	  controls	  in	  TA	  only.	  This	  may	  be	  related	  to	  the	  clinical	  
cohort	  which	  included	  2	  L4,	  7	  L5	  and	  only	  3	  S1	  radicular	  symptoms.	  	  These	  results	  are	  
in	  keeping	  with	  previous	  reports	  of	  significantly	   increased	  MTh	   in	  patients	  with	   leg	  
pain	  (radicular	  or	  referred)	  and	  neurologic	  deficit	  (Strutton	  et	  al.,	  2005).	  	  This	  study	  
found	  MTh	  to	  correlated	  with	  pain	  intensity	  and	  functional	  disability.	  	  An	  significantly	  
elevated	   MTh	   has	   been	   reported	   in	   other	   chronic	   pain	   conditions,	   such	   as	  
fibromyalgia	   (Salerno	   et	   al.,	   2000,	   Mhalla	   et	   al.,	   2010)	   and	   rheumatoid	   arthritis	  
(Salerno	  et	  al.,	  2000).	  	  Furthermore,	  in	  the	  study	  described	  in	  chapter	  6,	  reductions	  
in	   MTh	   in	   TA	   were	   found	   to	   occur	   only	   in	   patients	   with	   at	   least	   good	   functional	  
outcome	   (ODI)	   post-­‐surgery,	   with	   reductions	   reductions	   to	   6	  months	   post-­‐surgery	  
found	   in	  patients	  with	  excellent	   leg	  pain	   (VAS)	  outcome.	   	  Both	   the	  very	  short	   time	  
course	   (~1	   week)	   and	   highly	   reduced	   pain	   improvement	   (only	   the	   “pain	   now”	  
measure	   was	   significantly	   reduced	   at	   1	   week)	   may	   explain	   the	   lack	   of	   change	   in	  
threshold	  at	  1	  week	   in	   the	  current	   study.	   	  Further	   studies	   involving	  patients	  which	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actually	  achieve	  a	  long	  term	  benefit	  in	  leg	  pain	  and	  function	  are	  required	  to	  establish	  




In	  SOL	  cSPs	  were	  significantly	  longer	  CONTRA	  (this	  was	  not	  significant	  at	  every	  time	  
point	  in	  TA)	  and	  cSPs	  were	  more	  asymmetrical	  than	  controls.	  	  Higher	  CONTRA	  radic	  
cSPs	   is	   in	  agreement	  with	  the	  results	  of	  the	  study	  reported	  in	  the	  previous	  chapter	  
involving	  surgery	  patients,	   	  However	  unlike	   in	   that	  study,	   there	  were	  no	  significant	  
reductions	   in	   cSP	  CONTRA	   radic.	   	   This	  may	  be	  explained	  by	   the	  very	   transient	   and	  
modest	   changes	   in	   leg	   pain	   reported	   in	   this	   study,	   compared	   to	   the	   gradual	   long	  
term	  reductions	  in	  cSP	  reported	  in	  that	  study.	  	  At	  R1	  there	  was	  a	  transient	  increase	  
in	   cSP	   on	   the	   side	   of	   pain	   which	   was	   not	   specific	   to	   responder	   groups.	   A	   similar	  
change	  was	  reported	  in	  chapter	  6,	  however	  this	  produced	  a	  reduction	  in	  asymmetry	  
of	   SOL	   cSP	   responses	   at	   6	   weeks	   following	   surgery.	   	   SOL	   cSP	   asymmetry	   was	   not	  
significantly	  reduced	  in	  the	  present	  study.	  	  	  
	  
It	   was	   hypothesised	   that	   previously	   reported	   alterations	   in	   the	   intracortical	  
inhibitory	   and	   corticomotor	   control	   of	   back	   and	   leg	  muscles	   could	   be	   reversed	   by	  
successful	  spinal	  injections	  to	  relieve	  back,	  radicular	  pain	  and	  neurologic	  deficit.	  This	  
hypothesis	  was	  not	  confirmed	  as	  only	  an	  insignificant	  transient	  (at	  1	  week)	  reduction	  
in	   leg	   pain	   was	   reported	   by	   patients	   following	   their	   intervention.	   	   However	   in	  
patients	  who	  responded	  at	  1	  week,	  changes	  were	  observed	  in	  the	  latency	  and	  MEP	  
durations	  in	  ES	  L4	  which	  may	  suggest	  transient	  corticomotor	  changes	  resulting	  from	  
glucocorticoid	  treatment.	  	  The	  fact	  that	  non-­‐responders	  had	  different	  baseline	  MEP	  
durations	   which	   may	   indicate	   an	   inability	   to	   achieve	   the	   corticomotor	   changes	  
described	   above,	   requires	   further	   investigation.	   A	   larger	   study	   with	   a	   larger	  
treatment	  effect	  may	  indicate	  whether	  a	  baseline	  corticomotor	  profile	  may	  actually	  
preclude	  any	  long	  term	  efficacy	  of	  spinal	  steroid	  injections.	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8.	  The	  Cortical	  Silent	  Period	  




Cortical	  silent	  periods	  were	  significantly	  longer	  than	  controls	   in	  soleus	  (contra	  radic	  
only	  at	  baseline)	  and	  TA,	  and	  to	  a	  much	  lesser	  extent	  in	  ES	  in	  patients	  with	  leg	  pain	  
radiating	  below	  the	  knee.	  	  In	  ES	  this	  was	  not	  found	  in	  chronic	  low	  back	  pain	  without	  
leg	  pain,	  although	  variable	  and	  prolonged	  cSPs	  were	  present	  in	  3	  of	  those	  patients.	  
Following	  surgery,	  cSP	  changes	  took	  place	  which	  were	  radic	  level	  specific	  in	  TA,	  and	  
common	   to	   both	   radic	   groups	   in	   SOL.	   	   This	   process	   was	   significantly	   impacted	   by	  
surgical	   outcome.	   	   In	   L5	   patients	   successful	   functional	   outcome	   from	   surgery	  
involved	  sustained	  bilateral	  reductions	  in	  the	  cSP	  at	  every	  time	  point,	  in	  contrast	  no	  
non-­‐responders.	  On	  the	  other	  hand,	  significant	  radic	  side	  lateralised	  asymmetry	  (LI)	  
in	  the	  cSP,	  which	  existed	  in	  SOL	  pre-­‐surgery,	  was	  reduced	  at	  6	  weeks,	  regardless	  of	  
outcome.	  	  The	  bilateral	  reductions	  in	  cSPs	  from	  6	  weeks	  to	  1	  year,	  on	  the	  other	  hand,	  
were	  found	  to	  be	  related	  to	  patient	  outcome.	  	  
	  
A	  significantly	  lower	  cSP	  was	  also	  noted	  IPSI	  radic	  (compared	  to	  CONTRA)	  in	  surgery	  
patients	  in	  TA	  and	  epidural	  patients	  in	  SOL	  before	  treatment.	  	  However	  there	  was	  no	  
reduction	  in	  asymmetry	  (LI	  or	  AI)	  of	  the	  cSP	  in	  these	  muscles	  following	  treatment.	  In	  
both	  patients	  who	  experienced	  a	  recurrent	  prolapse	  (as	  confirmed	  by	  a	  post-­‐surgical	  
MRI),	  this	  LI	  returned	  in	  SOL.	  
	  
The	   mechanisms	   of	   the	   changes	   in	   intracortical	   inhibition	   found	   in	   patients	   with	  
lumbosacral	  neurologic	  deficit,	  radicular	  or	  neuropathic	  LBP	  studied	  in	  this	  thesis	  are	  
still	  very	  poorly	  understood.	  	  Given	  the	  different	  timing	  of	  changes	  in	  cSP	  asymmetry	  
in	  SOL	  and	  general	  reductions	  in	  cSP	  prolongation	  post-­‐surgery	  incurred	  in	  affected	  
leg	   muscles,	   it	   is	   possible	   that	   the	   two	   physiological	   processes	   are	   mediated	   by	  
different	   mechanisms,	   which	   may	   or	   may	   not	   be	   physiologically	   exclusive.	   	   The	  
reduced	   standard	   error	   in	   cSPs	   reported	   IPSI	   radic	   compared	   to	   other	   time	   points	  
(inter-­‐individual	   variability	   is	   known	   to	   be	   generally	   high	   in	   the	   cSP)	   also	   lends	  
support	  for	  this	  hypothesis.	   	  This	  section	  will	  therefore	  explore	  some	  of	  the	  clinical	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features	  of	  the	  cSP	  and	  intracortical	  inhibition	  and	  list	  various	  hypotheses	  as	  to	  how	  
it	  may	  be	  implicated	  in	  lumbosacral	  radiculopathy	  and	  chronic	  low	  back	  pain.	  
	  
Neurophysiological	  and	  clinical	  properties	  of	  the	  cSP	  
	  
Cortical	   cSP	   representations	   are	   completely	   lateralised	   to	   the	   contralateral	  
hemisphere	   in	   distal	   muscles	   with	   a	   decreasing	   duration	   and	   increasing	   bilateral	  
distribution	   as	   we	   move	   towards	   trunk	   muscle	   representations.	   	   The	   attractive	  
clinical	   aspects	   of	   cSP	   measurements	   are	   a	   small	   interhemispheric	   difference	  
(typically	   less	   than	   10%,	   in	   contrast	   to	   SOL	   results	   in	   patients	   with	   radicular	  
pain/neurologic	   deficit	   studied	   in	   chapters	   6	   and	   7)	   and	   a	   high	   retest	   reliability	   in	  
contrast	   to	  high	   inter-­‐individual	   variability	   (Kukowski	   and	  Haug,	  1992,	  Triggs	  et	  al.,	  
1993,	  Orth	  and	  Rothwell,	  2004).	  As	  such	  a	  change	  of	  30ms	  has	  been	  considered	  as	  
pathological	  in	  hand	  muscles	  (Triggs	  et	  al.,	  1999).	  The	  significant	  prolongation	  of	  the	  
cSP	   (already	   abnormally	   long	   in	   TA)	   on	   the	   side	   of	   pain	   by	   6	   weeks	   post-­‐surgery	  
hence	   takes	   the	   cSP	   from	   one	   pathological	   state	   (asymmetry)	   to	   another	  
(prolongation).	  	  	  
	  
The	   cSP	   represents	   a	   disruption	  of	   access	   of	   voluntary	  motor	  drive	   to	   the	  primary	  
motor	   cortex	   and	   this	   is	   apparent	   in	   fact	   that	   the	   difference	   between	   active	   and	  
resting	  motor	   thresholds	   (often	   about	   10%MSO),	   disappears	   during	   the	   cSP	   valley	  
(Wassermann	  et	  al.,	  2008).	  The	  early	  50-­‐60	  ms	  component	  of	  the	  cSP	  is	  believed	  to	  
be	  caused	  by	  spinal	  mechanisms,	   including	  the	  motoneuron	  after-­‐hyperpolarisation	  
and	   Renshaw	   inhibition,	   and	   the	   subsequent	   part	   has	   been	   confirmed	   to	   be	   of	  
cortical	   origin,	   and	   is	   mediated	   by	   cortical	   inhibitory	   interneurons	   that	   are	  
depolarised	  by	  TMS	  (Ziemann	  et	  al.,	  1993,	  Chen,	  2004,	  Fuhr	  et	  al.,	  1991,	  Inghilleri	  et	  
al.,	   1993).	   The	   cSP	   hence	   provides	   a	  measure	   of	   gamma-­‐aminobutyric	   acid	  GABAB	  
receptor	   mediated	   (Werhahn	   et	   al.,	   1999)	   cortical	   inhibitory	   mechanisms.	   	   It	   is	  
influenced	  by	  GABAergic	  drugs,	  such	  as	  dopamine,	  carbamazepine,	  gabapentin	  and	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ethanol	   (Ziemann,	   2004,	   Ziemann	   et	   al.,	   1996,	   Priori	   et	   al.,	   1994a,	   Ziemann	   et	   al.,	  
1995). An	  increased	  cSP	  indicates	  hyperactivity	  whereas	  decreased	  cSP	  hypoactivity	  
of	  GABAergic	  cortical	  inhibitory	  interneurons.	  A	  comparative	  reduction	  of	  excitatory	  
interneurons	   can	  also	   result	   in	   a	  prolonged	   cSP	   (Wassermann	  et	   al.,	   2008).	   	   These	  
inhibitory	  cells	  are	  central	  to	  motor	  control	   in	  that	  they	  modulate	  voluntary	  output	  
from	   the	   motor	   cortex.	   The	   effect	   of	   too	   much	   GABAB-­‐receptor	   mediated	  
intracortical	  inhibition	  in	  the	  form	  of	  the	  cSP	  would	  manifest	  as	  an	  inability	  to	  initiate	  
voluntary	  movement	  such	  as	   in	  motor	  neglect	   in	  hemiparetic	  stroke	  (Classen	  et	  al.,	  
1997),	  whereas	  pathological	  reductions	  would	  produce	  spastic	  (Cruz	  Martinez	  et	  al.,	  
1998)	  dyskinetic	   or	   parkinsonian	  movement.	   The	   cSP	   is	   thus	   shortened	   in	   epilepsy	  
and	   in	   patients	  with	   Parkinson’s	   (Cantello	   et	   al.,	   2002,	   Berardelli	   et	   al.,	   1996)	   and	  
prolonged	  by	  increased	  thalamofugal	  firing	  as	  a	  result	  of	  dopaminergic	  drug	  therapy,	  
interventions	   to	   the	   basal	   ganglia	   and	   stimulation	   of	   the	   subthalamic	   nucleus	  
(Dauper	   et	   al.,	   2002,	   Young	   et	   al.,	   1997,	   Chen	   et	   al.,	   2001).	   Huntington’s	   disease	  
severity	  of	  chorea	  is	  thought	  to	  be	  related	  to	  the	  degree	  of	  prolongation	  of	  the	  cSP	  
(Modugno	  et	  al.,	  2001,	  Schippling	  et	  al.,	  2009,	  Priori	  et	  al.,	  1994b,	  Eisen	  et	  al.,	  1989).	  
	  
The	  cSP	  in	  chronic	  LBP	  
	  
A	  recent	  study	  found	  ICI	  to	  be	  altered	  in	  trunk	  muscles	  of	  participants	  with	  chronic	  
LBP	  (Masse-­‐Alarie	  et	  al.,	  2012).	  	  The	  study	  found	  a	  drastic	  reduction	  in	  short	  interval	  
intracortical	   inhibition	  (SICI)	   in	   internal	  oblique	  and	  transversus	  abdominis	  muscles.	  
Unlike	  the	  cSP,	  SICI	   is	  mediated	  by	  GABAA-­‐receptor	  mediated	   intracortical	  neurons.	  
Masse-­‐Alarie	  and	  colleagues	  (2012)	  found	  a	  strong	  negative	  correlation	  between	  cSP	  
prolongation	  and	  SICI	   reduction	   in	  LBP	  patients	   (SICI	  conditioned	  MEP	  decrease	  vs.	  
cSP	   in	   LBP	   patients	   (r=0.8,	   p=0.006)).	   This	   suggests	   agreeing	   results	   and	   cSP	  
prolongations	   are	   often	   associated	  with	   reductions	   in	   SICI.	   This	   is	   because	  GABAA-­‐
receptor	   mediated	   ICI	   is	   inhibited	   by	   GABAB	   activity	   (Davies	   et	   al.,	   1990).	   GABAB	  
receptors	   are	   both	   pre	   and	   postsynaptic	   so	   that	   the	   presynaptic	   receptors	   act	   to	  




The	  properties	  of	  some	  GABAergic	  drugs	  are	  thought	  to	  reflect	  this	  GABAB-­‐mediated	  
attenuation	   of	   GABAA-­‐mediated	   inhibitory	   neurotransmission	   (McDonnell	   et	   al.,	  
2006).	   Substances	   which	   increase	   intracortical	   inhibition	   in	   the	   brain	   are	   also	  
associated	  with	  a	  heightened	  risk	  of	  seizure	  (Wassermann	  et	  al.,	  2008).	  	  Seizures	  are	  
associated	  with	   a	   reduced	   SICI	   (Delvaux	   et	   al.,	   2001)	   as	   well	   as	   reduced	   GABAAR-­‐
mediated	  inhibition	  (Roberts,	  1986).	  Baclofen	  is	  such	  a	  GABABR	  agonist	  prescribed	  to	  
treat	  spasticity	  and	  dystonia	  and	  results	  in	  a	  prolonged	  cSP	  (Siebner	  et	  al.,	  1998).	  	  It	  
is	  associated	  with	  a	  considerably	  heightened	  risk	  of	  seizures	  (Schuele	  et	  al.,	  2005).	  	  	  
	  
The	  study	  by	  Masse-­‐Alarie	  and	  colleagues	  (2012)	  recruited	  patients	  from	  a	  pain	  clinic	  
but	   did	   not	   specify	   the	   presence	   of	   leg	   pain	   or	   neurological	   signs	   in	   that	   cohort.	  	  
There	  was	  also	  an	   identical	  sample	  number	  as	   in	   the	  LBPLP	  group	  (n=9).	  Given	  the	  
high	  inter-­‐individual	  variability	  of	  the	  cSP,	  SICI	  may	  provide	  a	  more	  useful	  measure	  in	  
cross-­‐sectional	   studies.	   Furthermore	   if	   ICI	   is	   altered	   in	   LBP	   but	   less	   so	   than	  when	  
radicular	  pain/neurologic	  deficit	  is	  present,	  then	  the	  fact	  that	  a	  change	  was	  detected	  
with	   SICI	   but	   not	   the	   cSP	   in	   the	   LBP	   cohort	   in	   that	   study	   may	   indicate	   a	   more	  
sensitive	  measure.	   On	   the	   other	   hand,	   as	   SICI	   is	   reduced	   and	   its	   reliability	   is	   also	  
reduced	  during	  background	  contractions	   (Ngomo	  et	  al.,	  2012),	   the	  cSP	  may	  still	  be	  
more	   attractive	   for	   longitudinal	   comparisons.	   SICI	   was	   calculated	   to	   have	   an	  
ICC=0.75	   in	   ES	   based	   on	   two	   trials	   separated	   by	   30	   minutes	   and	   retaining	   all	  
electrodes	  in	  position	  (Goss	  et	  al.,	  2011).	  	  By	  comparison	  the	  cSP	  in	  ES	  was	  found	  to	  
have	  an	  ICC=0.70	  (chapter	  4)	  based	  on	  4	  assessments	  across	  1	  year.	  
	  
The	  question	  remains	  as	  to	  whether	  significantly	  altered	  trunk	  muscle	  ICI	  in	  chronic	  
LBP	  is	  indicative	  of	  a	  neuropathic	  element	  in	  the	  sensory	  drive	  to	  M1.	  	  Because	  of	  the	  
small	  sample	  of	  chronic	  LBP	  participants	  free	  of	  radicular	  pain	  or	  neurologic	  deficit,	  
this	   question	   will	   need	   to	   be	   readdressed	   in	   a	   large	   cross-­‐sectional	   study.	   This	   is	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important	   given	   the	   possible	   interventional	   utility	   of	   a	   central	   measure	   of	  
nociception	  motor	  impairment	  (MTh)	  and	  neuropathic	  impairment	  (cSP	  or	  SICI).	  
	  
The	  cSP	  in	  neuropathic	  pain	  conditions	  
	  
A	   high	   level	   of	   ICI	   involvement	   (usually	   a	   reduction	   in	   SICI)	   has	   been	   found	   to	  
differentiate	   neuropathic	   pain	   from	   other	   chronic	   pain	   conditions	   (Schwenkreis	   et	  
al.,	  2005).	  Schwenkreis	  and	  colleagues	  (2005)	  found	  reduced	  SICI	  only	  in	  neuropathic	  
patients	   (with	  neuralgia	  resulting	   from	  incomplete	  median	  or	  ulnar	   lesions	  and	  not	  
painful	  osteoarthritis)	  and	  this	  was	  specific	  to	  the	  side	  of	  the	  lesion	  (the	  contralateral	  
hemisphere).	  Fibromyalgia	  patients	  were	  found	  to	  have	  to	  have	  bilaterally	  increased	  
MTh,	   reduced	   ICF	   (intracortical	   facilitation)	   and	   SICI	   (Mhalla	   et	   al.,	   2010).	   	   Is	   thus	  
possible	  that	  the	  finding	  that	  cSPs	  are	  elevated	  in	  LBPLP	  but	  not	  LBP	  indicates	  some	  
form	   of	   nerve	   injury	   or	   an	   additional	   level	   of	   altered	   afferent	   drive.	   	   However	   a	  
reduced	  SICI	  or	  even	  prolonged	  cSP,	   is	  not	  uniformly	  reported	   in	  neuropathic	  pain.	  
An	  earlier	  study	  involving	  both	  fibromyalgia	  and	  rheumatoid	  arthritis	  patients	  found	  
no	   group	   differences.	   This	   study	   found	   MTh	   to	   be	   increased	   and	   cSP	   decreased	  
bilaterally	   in	   TA	   and	   the	   first	   dorsal	   interosseous	  muscle	   (FDI),	  with	   no	   changes	   in	  
spinal	  excitability	  (Salerno	  et	  al.,	  2000).	  In	  patients	  with	  painful	  diabetic	  neuropathy,	  
one	  study	  also	  reported	  a	  reduction	  is	  the	  cSP	  	  in	  the	  FDI	  (Turgut	  and	  Altun,	  2009).	  	  
	  	  
Lesions	  affecting	  the	  cSP	  
	  
Studies	   involving	   stroke	   patients	   have	   established	   that	   lesions	   outside	   the	   motor	  
cortex	  usually	  prolong	  the	  cSP,	  while	  lesions	  with	  an	  exclusive	  impact	  on	  the	  motor	  
cortex	  shorten	  or	  even	  eradicate	  the	  cSP	  (Liepert	  et	  al.,	  2005a,	  Classen	  et	  al.,	  1997).	  	  
GABAergic	  interneurons	  in	  M1	  are	  particularly	  vulnerable	  to	  ischemic	  stress	  (Jin-­‐Hui,	  
2003)	   and	   this	   can	   result	   in	   very	   pronounced	   reduction	   in	   the	   cSP	   duration.	   	   In	  
contrast	   its	   lengthening	   in	   pathological	   conditions	   is	   usually	   associated	   with	   a	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reduction	  in	  the	  afferent	  excitatory	  thalamo-­‐cortical	  or	  cortico-­‐cortical	  input	  to	  M1,	  
ensuing	  a	  swing	  from	  excitability	  to	  inhibition	  (Wassermann	  et	  al.,	  2008).	  	  
	  
Lesions	   to	   posterior	   columns	   of	   the	   cervical	   spinal	   cord	   (part	   of	   the	   central	  
somatosensory	  pathway)	  can	  result	   in	  a	  prolongation	  of	  cSP	  while	  MTh	  and	  central	  
conduction	   time	   remain	   normal	   (Nardone	   et	   al.,	   2008).	   	   The	   patient	   in	   Nardone’s	  
report	  had	  reduced	  proprioception,	  dexterity	  and	  vibration	  sense.	  	  In	  a	  recent	  study	  
involving	   low	   cervical	   spinal	   cord	   injury	  patients,	   an	   increased	  active	  MTh	  and	   cSP	  
was	  found	  (Freund	  et	  al.,	  2011).	  	  The	  CoG	  of	  the	  extensor	  digitorum	  communis	  of	  the	  
forearm	   (EDC)	   map	   was	   located	   more	   posteriorly	   towards	   the	   anatomical	   hand	  
representation	   of	   M1	   compared	   to	   controls.	   	   Cortical	   reorganization	   presumably	  
took	   place	   to	  maximise	   output	   to	  muscles	   of	   the	   impaired	   forearm	   following	   cord	  
injury.	  Cortical	  reorganisation	  after	  injuries,	  but	  more	  generally	  the	  maintenance	  of	  
cortical	   motor	   representations,	   are	   believed	   to	   depend	   on	   GABAergic	   (GABAA	  
receptor	  mediated)	  circuits	  (Jacobs	  and	  Donoghue,	  1991).	  It	  is	  thought	  that	  adjacent	  
cortical	   regions	   expand	   when	   pre-­‐existing	   lateral	   excitatory	   connections	   are	  
unmasked	  by	  decreased	   intracortical	   inhibition	  (SICI)	   (Jacobs	  and	  Donoghue,	  1991).	  	  
Similar	  lateral	  reorganisation	  has	  been	  reported	  in	  chronic	  LBP	  in	  somatosensory	  and	  
motor	   cortices	   (Flor	   et	   al.,	   1997,	   Tsao	   et	   al.,	   2010a)	  with	   a	   shift	   of	   cortical	   output	  
maps.	  
	  
Root	  Pathology	  and	  Sensory	  Deprivation	  	  
	  
The	  motor	  cortex	  is	  mediated	  by	  sensory	  input	  from	  the	  somatosensory	  cortex	  via	  a	  
direct	  and	  reciprocal	  pathways	   from	  the	   thalamus	   (Darian-­‐Smith	  and	  Darian-­‐Smith,	  
1993,	   Yumiya	   et	   al.,	   1979,	   Asanuma	   et	   al.,	   1979a,	   Larsen	   and	   Asanuma,	   1979,	  
Asanuma	   et	   al.,	   1979b).	   Evidence	   from	   other	   conditions	   suggests	   that	   the	  
prolongation	  of	  the	  cSP	  may	  be	  a	  direct	  consequence	  of	  reduced	  sensory	  input	  to	  M1	  
(Wassermann	  et	  al.,	  2008).	   	  Similarly	  certain	  ischemic	  thalamic	  or	  cerebellar	  lesions	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(the	   cerebellum	   exerts	   usually	   an	   inhibitory	   tone	   on	   M1	   via	   the	   thalamus),	   for	  
example,	   can	   result	   in	  a	   significantly	   increased	  cSP	   (Teo	  et	  al.,	   2008,	   Liepert	  et	  al.,	  
2005a,	   Liepert	   et	   al.,	   2005b).	  Abnormal	   sensory	   evoked	  potentials	   from	  peripheral	  
nerve	   stimulation	   in	   radiculopathy	   (Beyaz	   et	   al.,	   2009)	   would	   support	   this	   view.	  	  
Mechanical	  compression	  	  or	  inflammatory	  changes	  at	  the	  dorsal	  root	  may	  also	  have	  
prolonged	   effects.	   Intraoperative	   recordings	   of	   nerve	   root	   manipulations	   during	  
lumbar	   discectomies	   and	   decompressions	   are	   known	   to	   cause	   rapid	   changes	   in	  
conduction	  through	  the	  roots	  (Matsui	  et	  al.,	  1995)	  (Sebastian	  et	  al.,	  1997).	  However,	  
intraoperative	   monitoring	   of	   sensory	   evoked	   potentials	   in	   the	   minutes	   to	   hours	  
following	   these	   root	  manipulations	   shows	   that	   cortical,	   brainstem,	   and	   spinal	   SEPs	  
can	  endure	  rapid	  shifts	  in	  amplitude	  and	  latency	  (Matsui	  et	  al.,	  1995,	  Epstein	  et	  al.,	  
1993,	  Gepstein	   and	  Brown,	   1989,	  Herron	   et	   al.,	   1987,	   Sebastian	   et	   al.,	   1997).	   It	   is	  
thus	   possible	   to	   envisage	   acute	   reorganisation	   at	   one	   or	  more	   central	   levels	   as	   a	  






There	   are	   various	   possible	   interpretations	   of	   why	   patients	   begin	   abnormally	  
asymmetrical	  with	  marked	   prolonged	   cSP	   CONTRA	   radic	   at	   baseline,	   to	   then	   have	  
bilaterally	  marked	  prolonged	  cSPs	  at	  R1.	  Two	  of	  which	  will	  be	  explored.	   	   If	  altered	  
afferent	   drive	   to	   M1	   results	   in	   hemispheric	   differences	   in	   ICI,	   then	   recovery	   may	  
partially	   involve	   the	   restoration	  of	   interhemispheric	  mechanisms	   to	  normalise	   that	  
asymmetry.	   However	   in	   L5	   patients,	   successful	   surgery	   was	   not	   associated	   with	  
increases	  in	  cSP	  CONTRA	  radic	  between	  B	  and	  R1.	  	  In	  SOL	  those	  cSP	  increases	  were	  





Proprioceptive	   input	   in	   the	   form	   of	   lateralised	   exercise,	   have	   been	   reported	   to	  
impact	  on	  inhibitory	  input	  to	  M1	  and	  ipsilateral	  pathways.	  	  Self-­‐initiated	  phasic	  hand	  
movements,	  for	  example,	  inhibit	  ipsilateral	  MEPs	  35-­‐70ms	  after	  EMG	  onset	  not	  only	  
in	   the	   muscle	   stimulated	   but	   adjacently	   represented	   muscles,	   whilst	   increasing	  
intracortical	   facilitation	   in	   the	   contralateral	   hemisphere	   (Sohn	   et	   al.,	   2003).	   As	   a	  
result	   the	   cSP	   is	   significantly	   reduced.	   This	   use-­‐dependent	   plasticity	  mechanism	   is	  
most	   likely	   to	   impact	   leg	   muscles,	   because	   as	   a	   presumably	   transcallosal	   (via	   the	  
trans-­‐hemispheric	   pathway	   across	   the	   corpus	   callosum)	   mediated	   mechanism,	  
current	   wisdom	   might	   assume	   it	   to	   be	   absent	   in	   ES.	   	   Vibration	   and	   electrical	  
stimulation	  also	  activate	  similar	  use	  dependent	  plasticity	  mechanisms	  in	  the	  cortex.	  	  	  
Vibration	   has	   a	   similar	   impact	   of	   reducing	   GABAA	  mediated	   intracortical	   inhibition	  
(SICI-­‐reductions	  are	   thought	   to	  be	   important	   in	   cortical	   reorganisations	  mentioned	  
above)	  and	  increasing	  GABAB	  mediated	  intracortical	  inhibition	  in	  the	  stimulated	  hand	  
while	   producing	   the	   opposite	   effect	   in	   the	   contralateral	   hand	   (Rosenkranz	   and	  
Rothwell,	  2003).	   	   It	   is	   thus	  conceivable	   that	  aberrant	   lateralised	  signalling	   resulting	  
from	  a	  unilateral	  lesion	  may	  provoke	  the	  type	  of	  cSP	  asymmetry	  found	  patients	  with	  
radicular	  pain/neurologic	  deficit.	  	  
	  
Long	  Latency	  Responses	  in	  Soleus	  
	  
Another	  view	  may	  be	  that	  an	  additional	  mechanism	  is	  accounting	  for	  cSP	  asymmetry	  
in	  acute	  unilateral	  nerve	  root	  compression	  and	  that	  cSPs	  are	  bilaterally	  prolonged	  at	  
baseline	   but	   that	   this	   is	   occluded	   by	   an	   additional	   response	   on	   the	   affected	   side.	  
Given	   the	   predominant	   SOL	   muscle	   involvement	   in	   this	   cSP	   asymmetry,	   a	   cSP	  
interruption	   by	   long	   latency	   responses	   specific	   to	   soleus	   may	   be	   involved.	   As	  
discussed	  at	  the	  start	  of	  this	  chapter	  reduced	  cSP	  offset	  variability,	  timing	  (~median	  
100ms)	  and	  the	  rapidity	  (at	  least	  compared	  to	  the	  cSP	  reduction	  rate	  in	  the	  CONTRA	  
side	   and	   both	   IPSI	   and	   CONTRA	   radic	   at	   subsequent	   time	   points)	   and	   the	  
effectiveness	  of	  its	  mitigation	  by	  surgery	  in	  most	  outcomes	  may	  suggest	  silent	  period	  
interruptions	   by	   non-­‐cortical	   long	   latency	   responses.	   Because	   of	   the	   extended	   cSP	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duration	  beyond	  normal	  limits	  in	  surgery	  and	  LBPLP	  patients,	  there	  may	  be	  a	  higher	  
susceptibility	   for	  cSP	   interruptions	  by	   long	   latency	  response	  mechanisms	  (<100ms).	  
The	   soleus	   late	   response	   (SLR)	   is	   such	   a	   long	   latency	   (~100ms)	   response	   primarily	  
evoked	  in	  antagonistically	  resting	  SOL	  during	  mild	  contractions	  of	  TA	  (and	  vice	  versa)	  
during	  TMS.	  Large	  and	  unilateral	  responses	  such	  as	  these	  were	  indeed	  often	  visible	  
in	  the	  resting	  antagonist	  trace	  in	  patients	  and	  very	  occasionally	  in	  controls.	  	  The	  SLR	  
is	  a	  polysynaptic	  response	  of	  the	  agonist	  and	  antagonist	  organization	  system	  which	  is	  
mediated	  by	  the	  cerebellofugal	  pathway	  (Kurokawa-­‐Kuroda	  et	  al.,	  2007,	  Sammut	  et	  
al.,	  1995,	  Suga	  et	  al.,	  2001,	  Ertekin	  et	  al.,	  1995).	  	  As	  a	  result,	  the	  SLR	  is	  abnormal	  in	  
people	  with	  cerebellar	  ataxia	  (Kurokawa-­‐Kuroda	  et	  al.,	  2007).	  The	  SLR	   is	  elicited	  by	  
cortical	   stimulation	   and	   not	   by	   brainstem	   stimulation	   (Ertekin	   et	   al.,	   1995).	   	   It	   is	  
enhanced	  with	  mild	   TA	   contraction	   and	   ankle	   immobilisation	   (as	   in	   the	   chapter	   6	  
study)	   and	   is	   normally	   abolished	  during	   contraction	  of	   soleus	   (Ertekin	   et	   al.,	   1995,	  
Sammut	  et	  al.,	  1995,	  Suga	  et	  al.,	  2001).	  	  Whether	  a	  hypothetical	  disinhibition	  of	  this	  
response	   on	   one	   side	   only,	   might	   lead	   to	   any	   functional	   implication	   (such	   as	   the	  
reduced	   coordination	   of	   muscle	   movements	   and	   feed-­‐forward	   control	   in	   mild	  
sensory/spinocerebellar	   ataxia)	   is	   unknown.	   In	   fact	   this	   is	   unlikely	   given	   that	   a	  
reduction	  of	  SOL	  cSP	  asymmetry	  was	  not	   found	   in	   itself	   to	  be	  related	  to	  functional	  
outcome	  in	  most	  surgery	  patients.	  However	  given	  that	  late	  responses	  with	  a	  latency	  
of	  40ms	  can	  also	  be	  elicited	  in	  SOL	  by	  stimulation	  at	  the	  foramen	  magnum	  (Sakihara	  
et	   al.,	   2004),	   a	   unilateral	   disruption	   of	   this	   pathway	   by	   acute	   nerve	   root	  
inflammation	   and	   compression	   is	   a	   possibility.	   Patients	  with	   spinocerebellar	   ataxia	  
have	  an	  increased	  cSP	  threshold	  and	  increased	  cSP	  in	  various	  muscle	  representations	  
(Teo	  et	  al.,	  2008,	  Tamburin	  et	  al.,	  2004,	  Restivo	  et	  al.,	  2004,	  Restivo	  et	  al.,	  2002).	  This	  
is	  because	  Purkinje	  cells	  of	  the	  cerebellum	  inhibit	  a	  tonic	  thalamic	  facilitation	  of	  M1	  
through	   the	   cerebello-­‐thalamo-­‐cortical	   pathway	   (Ugawa	  et	   al.,	   1991,	  Ugawa	  et	   al.,	  
1995b,	  Ugawa	  et	  al.,	  1995a,	  Ugawa	  et	  al.,	  1997,	  Ugawa	  et	  al.,	  1994,	  Di	  Lazzaro	  et	  al.,	  
1994).	   However	   the	   implication	   of	   this	   pathway	   in	   the	   cSP	   prolongation	   effects	   in	  
lumbar	  nerve	  root	  compression	  is	  unlikely.	  One	  study	  reports	  that	  this	  M1	  inhibition	  
has	  been	  found	  to	  be	  normal	  in	  patients	  with	  a	  lesion	  in	  the	  afferent	  pathway	  to	  the	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cerebellum	  (Ugawa	  et	  al.,	  1997).	  	  Nevertheless	  a	  non-­‐functionally	  significant	  impact	  
of	  this	  pathway	  on	  cSP	  asymmetry	  is	  possible.	  
	  
Regardless	   of	   the	   interpretation,	   long	   term	   reductions	   in	   the	   cSP	   have	   been	  
associated	  with	  better	  functional	  outcome	  from	  surgery.	  This	  may	  be	  more	  reliably	  
measured	   contralateral	   to	   the	   affected	   side.	   	   Furthermore	   it	  may	   be	   necessary	   to	  
measure	   both	   sides	   in	   the	   cases	   of	   central	   prolapses,	   bilateral	   symptoms	   or	  
radiological	   uncertainty.	   TA	   appears	   to	   be	   a	   reliable	   muscle	   to	   make	   CE	  
measurements	   in	   L5	   radiculopathy	   and	   it	   is	   possible	   that	   a	   more	   exclusively	   S1	  
enervated	  muscle	  may	   be	   required	   to	   reliably	   assess	   S1	   pathology.	   	   Furthermore,	  
with	  further	  studies	  and	  refinements	  to	  current	  measures,	  a	  cSP	  (with	   its	  high	   long	  
term	  reliability)	  or	  SICI	   (with	   its	   reduced	   inter-­‐individual	  variability	  when	  measured	  
at	  rest)	  derived	  parameter	  may	  eventually	  provide	  a	  measure	  of	  central	  adaptations	  
to	   neuropathy.	   	   This	   may	   have	   important	   implications	   in	   developing	   effective	  
treatment	  based	  classification	  systems	  which	  predict	  the	  likelihood	  that	  a	  patient	  will	  
benefit	   from	   surgery	   and	   other	   current	   procedures	   with	   unpredictable	   long	   term	  
outcomes.	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  9.	  Discussion	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This	   thesis	   explored	   changes	   in	   the	   central	   nervous	   system	   (CNS)	   pathways	  
controlling	   trunk	  and	   leg	  muscles	   in	  patients	  with	   chronic	   low	  back	  pain	   (LBP)	   and	  
investigated	  whether	  surgery	  or	  conservative	  treatment	  impact	  upon	  these	  changes	  
in	  the	  long	  term.	  Participants	  were	  recruited	  into	  LBP	  classification	  groups	  (9	  LBP,	  21	  
with	   leg	   pain	   distal	   to	   the	   knee	   (LBPLP),	   12	   with	   radicular	   pain/neurologic	   deficit	  
(radic)	  at	  L5	  (L5)	  and	  12	  at	  S1	  (S1))	  and	  EMG	  activity	  was	  recorded	  from	  TA,	  SOL,	  and	  
ES	  	  muscles	  at	  level	  T12	  &	  L4.	  	  
	  
The	  first	  long	  term	  (1	  year)	  reliability	  study	  of	  parameters	  of	  corticospinal	  excitability	  
(CE)	   in	   trunk	   and	   leg	  muscles	   also	   included	   additional	   investigations	   of	   RA	   and	   EO	  
muscles.	  	  This	  analysis	  revealed	  a	  high	  to	  excellent	  reliability	  in	  maximum	  voluntary	  
contractions	   (MVC),	   cortical	   silent	   periods	   (cSP),	   motor	   and	   cSP	   thresholds	   (MTh,	  
cSPTh),	  and	  leg	  motor	  evoked	  potential	  (MEP)	  latencies	  (Lat);	  but	  adequate	  to	  poor	  
reliability	   of	  MEPs,	   some	   ES	   latencies	   and	   recruitment	   curve	   parameters.	   Reliable	  
parameters	  of	  CE	  were	  examined	  on	  4	  occasions	  in	  patients	  prior	  to,	  at	  6,	  26	  weeks	  
and	  52	  weeks	   following	   lumbar	   decompression	   surgery	   and	   equivalent	   intervals	   in	  
conservative	  treatment.	  	  In	  an	  investigation	  of	  spinal	  steroid	  injections	  (SI),	  patients	  
were	   studied	   over	   the	   course	   of	   1	   procedure,	   so	   that	   a	   1	   week	   assessment	   was	  
added	  and	  the	  1	  year	  assessment	  was	  not	  carried	  out.	  
	  
Reduced	  MVCs	  were	   found	   in	   all	  muscles.	   	   LBP	  and	   LBPLP	  groups	  had	   significantly	  
elevated	   MThs,	   cSPThs,	   altered	   MEP	   recruitment	   and	   longer	   MEP	   durations	  
(MEPdur)	   in	   ES.	   Prolonged	   ES	   cSPs	  were	   significant	   in	   LBPLP.	   Although	   there	  were	  
limited	   samples,	   untreated	   patients	   experiencing	   long	   term	   change	   had	   higher	  
baseline	  ES	  MEPdur	  and	  cSP.	  Responders	  to	  SIs	  experienced	  a	  transient	   increase	   in	  
ES	  MEPdur	  and	  a	  reduction	  in	  Lat	  at	  ES	  L4.	  	  
	  
	  TA	  was	  exclusively	  sensitive	  to	  L5	  group	  changes.	  All	   leg	  pain	  groups	  displayed	  cSP	  
asymmetry	  and	   significantly	  prolonged	  cSPs,	  which	  were	  gradually	   reduced	   in	  high	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function	   and	   pain	   responders	   to	   surgery.	   Leg	   MThs	   were	   only	   reduced	   in	   high	  
functional	   responders	  by	  6	  weeks,	  whilst	   further	  reductions	  occurred	   in	   those	  with	  
excellent	  leg	  pain	  outcome.	  In	  contrast	  to	  SI,	  asymmetry	  was	  reduced	  post-­‐surgery	  at	  
6	  weeks.	  
	  
These	  studies	  have	  confirmed	  CE	  changes	  related	  to	  long	  term	  outcome	  from	  surgery	  
and	  conservative	  treatment.	  	  Furthermore,	  in	  TA	  these	  changes	  and	  their	  relation	  to	  
functional	   outcome	  were	   found	   to	   show	  nerve	   root	   level	   (MTh)	   and	   side	   (cSP	   and	  
Lat)	  specificity.	  Further	  work	  is	  required	  to	  establish	  whether	  MEPdur,	  cSP,	  and	  MTh	  
may	   be	   useful	   in	   classifying	   central	   adaptations	   to	   LBP	   or	   other	   musculoskeletal	  
(MSK)	  conditions.	  Alternative	  strategies	  to	  normalise	  altered	  of	  CE	  in	  non-­‐responders	  





















Figure	  9.1:	  Concluding	  schematic	  of	  main	  findings:	  Long	  term	  changes	  in	  parameters	  
of	  corticomotor	  and	  intracortical	  inhibitory	  control	  found	  to	  impact	  ES	  L4,	  TA	  and	  SOL	  
in	   chronic	   low	   back	   pain	   with	   (LBPLP)	   and	   without	   (LBP)	   leg	   pain,	   and	   root-­‐level-­‐
specific	   changes	   (L5	   or	   S1	   radicular	   pain/deficit).	   Arrows	   designate	   a	   baseline	  
↑increase,	   ↓decrease,	   or	   ↔	   side-­‐to-­‐side	   differences	   (LI)	   present	   in	   the	   patient	  
group.	   ψ	   indicates	   that	   the	   parameter	   is	   at	   least	   partially	   mitigated	   by	   surgery.	  	  
®indicates	  affected	  by	  spinal	  steroid	  injection.	  
	  
TA	  
LBP	  L5:	  	  	  ↑cSPψ,	  ↓MVCψ,	  MThψ	  
	  	  	  	  	  	  	  	  	  	  	  	  LBP	  S1:	  	  	  	  ↓MVCψ	  
	  
ES	  L4	  
	  	  	  	  	  	  	  	  	  LBP:	  	   ↑	  MTh	  ↓MVC	  ↑RC	  Slope,	  ↓RC	  X50,	  	  
↑MEPdur	  
LBPLP:	  	  	  	  	  	  	  ↑cSP	  ↑	  MTh	  ↓MVC	  ↑RC	  Slope,	  ↓RC	  	  	  	  
↑MEPdur®,	  ↑cSPTh,	  Lat®	  
	  
SOL	  
LBP	  L5:	  	  	  ↑cSPψ,	  ↔cSP	  LIψ,	  ↓MVCψ,	  ↔Lat	  LI	  






Patient	  Baseline	  Characteristics	  and	  Outcome	  Bias	  	  
	  
The	   patient	   retention	   statistics	   for	   the	   longitudinal	   surgery	   patient	   study	   were	  
nothing	  short	  of	  a	  triumph.	  Some	  patients	  and	  participants	  who	  voluntarily	  took	  part	  
committed	   in	  excess	  of	  12	  hours	  of	  their	  time	  over	  nearly	  14	  months.	   	   	  One	  of	  the	  
limitations	   of	   a	   longitudinal	   study	   of	   this	   type,	   particularly	   when	   considering	   the	  
physical	  effort	  and	  nerve	  stimulation	  involved	  in	  a	  chronic	  pain	  population,	  is	  patient	  
retention.	   	  Regular	  contact	  was	  maintained	  with	  participants	  at	  bimonthly	   intervals	  
to	  check	  on	   their	  progress.	   	  The	  most	  common	  reasons	   for	   leaving	   the	  study	  were	  
related	  to	  the	  time	  commitment	   involved,	  tolerance	  of	  cortical	  stimulation	  and	  the	  
fear	  of	  back	  injury.	  	  
	  
A	  lack	  of	  long	  term	  responsiveness	  of	  psychological	  scores	  within	  this	  time	  frame	  has	  
already	   been	   reported	   (McGregor	   and	   Hughes,	   2002a).	   Questionnaires	   confirmed	  
that	  all	   four	  patient	  populations	   studied	  were	   severely	  anxious	  and	  depressed	  and	  
these	   scores	   were	   not	   significantly	   impacted	   by	   treatment.	   	   Patients	   accepting	   to	  
undertake	  and	   stick	  with	   such	  a	   long	   commitment	   to	   research	   into	   their	   condition	  
are	  already	  likely	  to	  embody	  a	  psychosocial	  bias	  within	  the	  chronic	  pain	  population.	  
Randomisation	   at	   recruitment	   was	   obviously	   not	   possible.	   Furthermore	   low	  
recruitment	  numbers,	  differences	  in	  baseline	  clinical	  characteristics,	  inconsistency	  of	  
clinical	   examination	   (and	   classification	   procedure)	   in	   the	   LBPLP	   population,	   also	  
meant	  that	  it	  was	  impractical,	  as	  originally	  intended,	  to	  recruit	  a	  non-­‐treated	  LBPLP	  
group	  with	  L5	  or	  S1	  deficit/radicular	  pain	  to	  study	  the	  impact	  of	  surgery.	  	  	  
	  
Fear	   avoidance	   behaviour	   was	   also	   prominent	   and	   only	   significantly	   mitigated	   by	  
surgery.	  It	  may	  be	  interesting	  to	  correlate	  the	  relationship	  between	  FAAB	  and	  MVCs	  
in	   a	   future	   longitudinal	   study.	   Some	   patients	   certainly	   found	   isometric	   trunk	  





	  All	  of	  these	  factors	  take	  on	  additional	  weight	  in	  the	  psychosocial	  backdrop	  of	  poor	  
outcome.	  	  Surgery	  patients	  with	  poor	  outcomes	  were	  very	  difficult	  to	  retain.	  The	  two	  
surgery	  patients	  who	  changed	  their	  minds	  to	  return	  for	  reassessment	  only	  managed	  
that	  further	  assessment,	  were	  fearful	  of	  pain	  or	  aggravating	  any	  existing	  anatomical	  
instability,	   so	   that	   some	   parts	   of	   the	   assessment	   had	   to	   be	   dropped.	   Epidural	  
patients	  with	  poor	  outcome	  were	  offered	  a	  chance	  to	  jump	  the	  waiting	  list	  cue	  in	  the	  
case	  of	  cancellations	  with	   little	  notice	  and	  3	  were	  excluded	  from	  the	  study	   for	   this	  
reason.	   	   In	   the	   chronic	   group,	   flexibility	   of	   appointments	   had	   to	   be	   conceded	   to	  
acute	   LBP	   flare	   ups,	   somewhat	   defeating	   the	   scope	   for	   including	   acute	   changes	  
within	  long	  term	  neurophysiological	  profiles.	  
	  
The	  treatment	  results	  are	  therefore	  biased	  towards	  positive	  outcome	  and	  this	  may	  
have	   reduced	   the	   scale	   of	   changes	   and	   thus	   sensitivity	   of	   the	   neurophysiology	  
measures	  to	  characterise	  negative	  outcome.	  
	  
Trunk	  and	  Leg	  Muscle	  Results	  from	  Vertex	  Stimulation	  
	  
Much	  of	  the	  limitations	  of	  this	  thesis	  relate	  to	  the	  difficulty	  in	  studying	  trunk	  and	  leg	  
muscles	   because	   of	   their	   higher	   threshold	   to	   TMS	   evoked	   responses	   compared	   to	  
the	  extensively	   investigated	  distal	  cervical	   root	  muscles.	   	  This	   is	  partly	  due	  to	   their	  
reduced	   cortical	   representation	   compared	   to	   hand	  muscles	   (although	   TA	   is	   almost	  
the	  exception	  with	  its	  “dexterity”	  for	  the	  purpose	  of	  minute	  adjustments	  during	  gait	  
swing	  phase),	  and	  less	  accessible	  deeper	  central	  somatotopic	  layout	  on	  the	  edge	  of,	  
and	   inside	   the	   great	   longitudinal	   fissure.	   This	   predicament	   requires	   the	   use	   of	   a	  
70mm	  double	  cone	  coil	  to	  reliably	  evoke	  bilateral	  responses,	  which	  is	  not	  always	  well	  
tolerated	   at	   high	   stimulus	   intensities.	   	   This	   had	   repercussions	   on	   the	   reliability	   of	  
recruitment	  profiles	  measured,	  particularly	   in	   the	  back	  muscles,	  where	   the	  chronic	  




Nevertheless,	   the	   convenience	   of	   simply	   positioning	   the	   coil	   crossover	   over	   the	  
vertex	   and	   recording	   sets	  of	   stimuli	   from	   the	   stimuli	   below	   the	   appearance	  of	   the	  
cSP	  to	  about	  150%	  of	  MTh	  meant	  that	  more	  muscles	  could	  be	  studied	  systematically.	  	  
As	   the	   technique	   does	   not	   demand	   an	   accurate	  measurement	   of	  MTh	   during	   the	  
experiment,	  or	  accurate	  coil	  repositioning,	  responses	  were	  more	  reliably	  evoked	  and	  
simpler	   to	   apply	   than	   hemispheric	   hotspot	   responses	   or	   cortical	   output	   maps	   in	  
these	  muscles	  (Tsao	  et	  al.,	  2008,	  Ferbert	  et	  al.,	  1992,	  O'Connell	  et	  al.,	  2007,	  Lotze	  et	  
al.,	   2003,	   Kuppuswamy	   et	   al.,	   2008,	   Harraf	   et	   al.,	   2008,	   Strutton	   et	   al.,	   2004a,	  
Plassman	   and	   Gandevia,	   1989).	   	   The	   problem	   of	   current	   spread	   to	   the	   opposite	  
hemisphere	   is	   another	   experimentally	   challenging	   factor	   in	   these	   protocols,	   given	  
that	   the	   quality	   of	   the	   higher	   threshold	   ipsilateral	   pathway	   responses	   may	   not	  
always	   establish	   an	   discrete	   latency	   difference	   between	   ipsi-­‐	   and	   contralateral	  
pathways	  (Colebatch	  et	  al.,	  1990,	  Carr	  et	  al.,	  1994,	  Ferbert	  et	  al.,	  1992,	  MacKinnon	  et	  
al.,	   2004).	   	   Furthermore	   reading	   any	   serial	   changes	   in	   excitability	   of	   cortical	  maps	  
require	  inactive	  MEPs	  	  (Ridding	  et	  al.,	  1995),	  which	  would	  be	  nearly	  impossible	  in	  the	  
muscles	   studied	   in	   this	   thesis.	   	   And	   although	   only	   rigourous	   mapping	   at	   rest	   can	  
detect	  changes	   in	  the	  distribution	  of	  excitability	  within	  the	  cortical	  output	  zone,	  or	  
irregular	   enlargements	   in	   its	   periphery	   (Ridding	   et.	   al,	   1997),	   recruitment	   curves	  
provide	  equivalent	  data	  about	  corticospinal	  excitability	  to	  cortical	  maps	  under	  many	  
conditions	   	   (Wassermann	  et	  al.,	  1992).	   	  Furthermore	  graded	  background	  activation	  
to	   visual	   feedback	   produces	   less	   variable	  MEPs	   (Kamen,	   2004,	   Carroll	   et	   al.,	   2001)	  
and	  eliminate	  the	  need	  to	  wait	  20	  seconds	  to	  avoid	  the	  hysterisis	  effects	  that	  resting	  
MEPs	  of	  different	  stimulator	  intensities	  have	  on	  one	  another	  (Möller	  et	  al.,	  2009)	  .	  
	  
Vertex	   stimulation	   hence	   activates	   in	   each	   hemisphere,	   via	   cortical	   interneurons,	  
contralateral	  and	  ipsilateral	  responses	  in	  trunk	  and	  leg	  muscles	  (Ferbert	  et	  al.,	  1992;	  
Plassman	   and	   Gandevia,	   1989;	   Harraf	   et	   al.,	   2008;	   Strutton	   et	   al.,	   2004).	   	   This	   is	  
supported	   by	   anatomical	   studies	   showing	   proximal	   and	   axial	   motorneurons	  
inervated	   by	   uncrossed	   descending	   motor	   fibers	   predominantly	   located	   in	   the	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ventromedial	   white	   matter	   (MacKinnon	   et	   al.,	   2004).	   	   These	   are	   thought	   to	   be	  
mediated	   by	   oligosynaptic	   pathways,	   including	   corticobulospinal	   and	  
corticopropriospinal,	  rather	  than	  by	  corticospinal	  or	  transcallosal	  pathways	  (Ziemann	  
et	  al.,	  1999).	  The	  EMG	  responses	  which	  they	  produce	  not	  only	  have	  a	  later	  onset	  and	  
higher	  MTh,	  but	  usually	  require	  background	  activation	  (Colebatch	  et	  al.,	  1990,	  Carr	  
et	  al.,	  1994),	  and	  will	  often	  have	  different	  somatotopical	  organisations	  (maps)	  with	  a	  
remotely	   located	   centre	   of	   gravity	   (hotspot)	   compared	   to	   contralateral	   responses	  
(Strutton	  et	  al.,	  2004,	  MacKinnon	  et	  al.,	  2004,	  O'Connell	  et	  al.,	  2007).	  	  	  
	  
Furthermore	   these	   ipsilateral	   cortical	   representations	   are	   often	   assymmetrical	   and	  
highly	  lateralised	  (MacKinnon	  et	  al.,	  2004,	  Strutton	  et	  al.,	  2004).	  	  In	  upper	  limbs,	  they	  
are	  much	  more	   easily	   ellicited	   in	   children	   of	   up	   to	   10	   years	   of	   age	   (Muller	   et	   al.,	  
1997).	  Furthermore	  their	  low	  threshold	  persist	  in	  conditions	  like	  cerebral	  palsy	  (Carr	  
et	  al.,	  1993,	  Maegaki	  et	  al.,	  1997),	  congenital	  mirror	  movements	  (Farmer	  et	  al.,	  1990,	  
Wassermann	   et	   al.,	   1991,	   Cohen	   et	   al.,	   1991b,	   Cohen	   et	   al.,	   1991a,	   Britton	   et	   al.,	  
1991)	  and	  in	  CNS	  lesions	  in	  adulthood	  such	  as	  stroke	  (Homberg	  et	  al.,	  1991,	  Turton	  
et	   al.,	   1996).	   Remarkably,	   their	   shortened	   latencies	   in	   congenital	   conditions	   have	  
even	  been	  linked	  to	  axonal	  branching	  of	  corticospinal	  cells	  (Farmer	  et	  al.,	  1990,	  Carr	  
et	  al.,	  1993).	   	   	  Although	   trunk	  and	  axial	  muscles	  are	  characterised	  by	  an	   increased	  
contribution	  from	  these	  ipsilateral	  pathways	  in	  postural	  control,	  the	  degree	  of	  ipsi	  to	  
contralateral	  input	  varies	  between	  muscles	  (Galea	  et	  al.,	  2010,	  Cohen	  et	  al.,	  1991a).	  	  
This	   is	   supported	   by	   the	   notion	   that	   the	   recovery	   of	   trunk	   function	   after	   stroke	   is	  
associated	   with	   an	   increase	   in	   ipsilateral	   motor	   evoked	   potentials	   in	   the	   external	  
oblique	   and	   trapezius	   but	   not	   erector	   spinae	   	   (although	   they	  were	   elicited	   in	   less	  
controls)	  upon	  stimulation	  of	  the	  unaffected	  hemisphere,	  indicating	  strong	  bilateral	  
projections	  to	  ES	  from	  both	  hemispheres,	  and	  a	  role	  for	  compensatory	  activation	  of	  
ipsilateral	  pathways	  in	  recovery	  of	  trunk	  function	  	  (Fujiwara	  et	  al.,	  2001,	  Misawa	  et	  
al.,	  2008).	   	  A	  recent	  animal	  study	  not	  only	  confirms	  monosynaptic	  (and	  di-­‐synaptic)	  
connections	  between	  reticulospinal	  neurons	  and	  erector	  spinae	  motoneurons	  (MNs)	  
but	   also	   synaptic	   coupling	   (di-­‐,tri-­‐and	   poly-­‐)	   between	   both	   contralateral	   and	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ipsilateral	  pyramidal	  tract	  neurons	  and	  ES	  MNs	  (Galea	  et	  al.,	  2010).	  	  This	  level	  of	  bi-­‐
hemispheric	   innervation	   explains	   the	   fact	   that	   ES	   often	   seems	   little	   impaired	   after	  
unilateral	  stroke	  (Horak	  et	  al.,	  1984,	  Dickstein	  et	  al.,	  2004).	  
	  	  
As	   a	   result	   ES	   responses	   studied	   in	   this	   thesis	   are	   evoked	   by	   both	   crossed	  
corticospinal	   and	  oligosynaptic	   ipsilateral	  pathways	  which	  are	  most	   likely	   recruited	  
via	  different	  cortical	  interneuron	  populations.	  	  By	  using	  a	  fixed	  stimulation	  point	  and	  
increasing	  the	  intensity	  we	  are	  essentially	  producing	  a	  recruitment	  profile	  or	  map	  of	  
the	   total	   bihemispheric	   cortical	   output	   drive	   to	   a	   specific	   muscle.	   	   	   So	   as	   the	  
stimulator	   intensity	   increases,	  we	  might	  expect	  to	  see	  a	  smaller	   ipsilateral	  pathway	  
contribution	  to	  the	  slope	  of	  the	  MEP	  curves	  at	  very	  high	  intensities	  in	  the	  leg	  muscles	  
and	  an	   increasing	   	  percent	  contribution	  at	  somewhat	   lower	  stimulator	   intenities	   in	  
ES.	  	  	  
	  
Semi-­‐Automated	  Measurements	  of	  Changes	  in	  Corticospinal	  Excitability	  using	  
Individual	  and	  Group	  Recruitment	  Curves	  	  
	  
Stimulus	   response	   curves	   (RCs)	   deliver	   information	   about	   the	   strength	   of	  
corticospinal	   projections	   (Brouwer	   and	  Ashby,	   1990,	   Boroojerdi	   et	   al.,	   2001).	   They	  
may	   be	  modulated	   by	   ischemic	   limb	   deafferentation	   (Ziemann	   et	   al.,	   1998,	   Brasil-­‐
Neto	   et	   al.,	   1992b),	   including	   amputations	   (Ridding	   and	   Rothwell,	   1997)	   ,	   and	   by	  
acquiring	  new	  motor	  skills	  (Pascual-­‐Leone	  et	  al.,	  1995a).	  	  Drug	  experiment	  have	  also	  
found	   individual	   RC	   parameters	   to	   be	   sensitive	   to	   changes	   to	   the	   GABAergic	   and	  
monoaminergic	  systems,	  and	  Na+	  and	  Ca2+	  channel	  properties	  and	  as	  such,	  the	  most	  
sensitive	  parameters	  of	  motor	  system	  excitability	  (Boroojerdi	  et	  al.,	  2001).	  	  	  
	  
A	   single	   MN’s	   motor	   unit	   pool’s	   discharge	   probability	   increases	   linearly	   with	  
magnetic	  field	  intensity	  (Devanne	  et	  al.,	  1997).	  	  The	  sigmoid	  shape	  of	  the	  curve	  thus	  
reflects	   the	   wide	   distribution	   of	   spike	   amplitudes	   in	   the	   system	   (Devanne	   et	   al.,	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1997),	  or	  the	  fact	  that	  stimuli	  of	  increasing	  strength	  recruit	  MNs	  of	  increasing	  motor	  
unit	   (MU)	   potentials	   (Henneman,	   1957).	   	   As	   Devanne	   et	   al.	   (1997)	   point	   out;	   the	  
plateau	  value	  characterises	  the	  balance	  of	  excitatory	  and	   inhibitory	  components	  of	  
the	  corticospinal	  volley	  rather	  than	  the	  maximum	  response.	  	  This	  includes	  recurrent	  
inhibition	  of	  MNs	  recruited	  late	  by	  earlier	  recruited	  MNs.	  	  The	  slope	  is	  a	  measure	  of	  
excitability	  or	  gain,	  taking	  into	  account	  augmented	  synchronisation	  of	  MU	  discharges	  
and	   multiple	   corticospinal	   volleys	   (Devanne	   et	   al.,	   1997).	   	   Because	   of	   Henman’s	  
principle	  of	  orderly	  recruitment,	  this	  curve	  is	  generally	  thought	  to	  be	  repeatable.	  
	  
Many	  researchers	  have	  attempted	  automatic	  parameterisation	  of	  the	  MEP	  and	  cSP	  
but	   experienced	   raters	   have	   usually	   proved	   more	   accurate	   judges	   of	   parameter	  
onsets	  and	  offsets	  (Nilsson	  et	  al.,	  1997,	  Daskalakis,	  2003,	  King	  et	  al.,	  2006,	  Garvey	  et	  
al.,	   2001).	   The	   semi-­‐automated	   program	   interface	   developed	   to	   process	   TMS	  
responses	  provides	  a	  powerful	  graphical	  tool	  to	  maximise	  the	  accuracy	  and	  efficiency	  
of	   this	   process,	   while	   retaining	   the	   judgement	   that	   only	   an	   experienced	  
neurophysiologist	   can	   bring.	   	   For	   example,	   it	   automatically	   identifies	   and	   counts	  
MEPs,	   only	   to	   point	   the	   user	   to	   the	   relevant	   near-­‐MTh	   intensities	   to	   impose	   his	  
judgement.	  It	  also	  allows	  the	  user	  to	  process	  and	  output	  cortical	  excitability	  results	  
on	  a	  threshold,	  individual	  recruitment	  curve,	  and	  group	  recruitment	  curve	  basis.	  	  The	  
group	   curve	   functionality	   is	   simply	   an	   automated	   output	   format	   produced	   by	   the	  
AllCurves	   program	  which	  was	  added	  when	  enough	  participants	   confirmed	   that	   the	  
double	   cone	   coil	   participant	   tolerance	   ceiling	   of	   about	   70%MSO	   compromised	   at	  
least	   one	   quarter	   of	   recruitment	   curve	   plateau	   values.	   It	   was	   not	   felt	   that	  
disqualifying	  such	  a	   large	  percentage	  of	   the	  data	  due	  to	  non-­‐converging	  regression	  
fits	  and	  disproportionate	  Max	  values	  was	   justifiable.	   	  The	  only	  way	  to	  fully	  validate	  
this	  approach	  with	  the	  double	  cone	  coil	  and	  muscles	  of	  interest	  would	  have	  been	  to	  
increase	   stimulator	   output	   all	   the	   way	   up	   to	   100%MSO	   as	   some	   authors	   have	   in	  
other	  trunk	  muscles	  (Sharshar	  et	  al.,	  2003).	  	  This	  usually	  takes	  its	  toll	  on	  the	  quality	  
of	   the	   resultant	   EMG	   trace	   in	   the	   form	   stimulus	   and	   movement	   artefacts.	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Furthermore,	   as	   a	   discectomy	   patient	   put	   it:	   “70%	   is	   when	   it	   starts	   to	   feel	   like	  
torture.”	  	  
	  
Nonetheless	   individual	   recruitment	   curves	   provide	   extra	   information	   about	  
excitability	   and	   plasticity,	   which	   can	   be	   correlated	   to	   outcome,	   analysed	   on	   a	  
repeated	   measures	   basis	   to	   monitor	   changes	   in	   motor	   control	   pathways,	   and	  
averaged	   to	   compare	   groups.	   	   The	   software	   interface	   developed	   in	   this	   thesis	   is	  
hence	  a	  powerful	   tool	  which	  may	  reach	   its	   full	  potential	  when	  used	  with	  the	  more	  
common	   figure-­‐of-­‐eight	   coil.	   Although	   individual	   recruitment	   curves	   provide	  
participant	  specific	  information	  about	  the	  excitability	  changes	  in	  the	  cortex,	  they	  are	  
rarely	   carried	   out	   in	   the	   literature,	   due	   to	   the	   computationally	   intensive	  
requirements	  of	  fitting	  multiple	  curves	  per	  muscle	  per	  individual	  (over	  24,000	  were	  
computed	  by	   the	  AllCurves	  program	   in	   total	   in	   this	   study)	   and	   the	   requirement	   to	  
populate	  these	  curves	  with	  a	  wide	  spectrum	  of	  stimulation	  intensities	  to	  satisfy	  both	  
MEP	   and	   cSP	   recruitment.	   	   However,	   as	   both	   cSPTh	   and	   MTh	   had	   already	   been	  
implicated	  in	  LBP	  and	  radiculopathy	  (Strutton	  et	  al.,	  2003b,	  Strutton	  et	  al.,	  2005),	  the	  
entire	  inhibitory	  and	  excitatory	  recruitment	  profile	  was	  deemed	  worthy	  of	  analysis.	  
	  
Moreover	  as	  maximum	  raw	  background	  activation	  (MVCs	  and	  thus	  raw	  pre-­‐stimulus	  
facilitation	  levels)	  were	  significantly	  lower	  in	  patients	  in	  all	  trunk	  muscles	  and	  in	  leg	  
muscles	   in	   the	   leg	   pain	   groups,	   MEPs	   could	   no	   longer	   be	   compared	   directly	   at	  
1.2MTh	   and	   the	   focus	   of	   the	   analysis	   shifted	   to	   repeated	   measures	   and	   group	  
comparisons	  of	   stimulus	   response	  curves.	   	  Group	   recruitment	  curves	  did	  not	  allow	  
for	  repeated	  measures	  analysis	  but	  Prism	  software	  was	  set	  to	  calculate	  SEM	  values	  
based	  on	  individual	  regression	  fits	  within	  the	  group	  data.	  This	  enabled	  the	  statistical	  
analysis	  of	  the	  Max,	  k	  (slope),	  and	  X50	  parameters	   in	  order	  to	  compare	  participant	  
groups,	  establish	  significant	  time	  point	  changes,	  or	  justify	  merging	  left	  and	  right	  sides	  




TMS	  Parameters	  in	  Pain	  Resulting	  from	  Other	  MSK	  Pathologies	  
 
Schwenkreis	   and	   colleagues	   (2005)	   compared	   TMS	   parameters	   in	   neuropathic	   and	  
non-­‐neurpathic	  MSK	  pathologies.	   	  26	  neuralgia	  patients	   (isolated	   incomplete	   lesion	  
of	  the	  median	  or	  ulnar	  nerve),	  20	  patients	  with	  painful	  osteoarthritis	  of	  the	  hand	  and	  
14	   controls.	   	   The	   authors	   	   found	   ICI	   changes	   to	   be	   altered	   (SICI	   reduced)	   only	   in	  
neuropathic	  patients	  and	  this	  was	  specific	  to	  the	  side	  of	  the	  lesion	  (the	  contralateral	  
hemisphere)	   (Schwenkreis	   et	   al.,	   2005).	   An	   additional	   study	   found	   fibromyalgia	  
patients	  to	  have	  bilaterally	  increased	  MTh,	  reduced	  ICF	  (intracortical	  facilitation)	  and	  
SICI	   (Mhalla	   et	   al.,	   2010).	   	   In	   those	   patients,	   MTh	   did	   not	   correlate	   with	   clinical	  
features	  such	  as	  pain,	  fatigue,	  anxiety,	  depression	  and	  catastrophizing.	  However	  the	  
reduced	   ICF	   and	   SICI	   did	   correlate	  with	   fatigue,	   catastrophizing	   and	  depression.	   In	  
complex	   regional	   pain	   syndrome,	   a	   reduced	   SICI	   is	   typically	   found	   bilaterally	  
(Schwenkreis	  et	  al.,	  2003,	  Krause	  et	  al.,	  2004,	  Schwenkreis	  et	  al.,	  2005,	  Di	  Pietro	  et	  
al.,	  2013).	  
	  
However	  a	  reduced	  SICI	  or	  even	  prolonged	  cSP,	  and	  increased	  MTh	  is	  not	  the	  only	  ICI	  
profile	  reported	  in	  neuropathic	  pain.	   In	  an	  earlier	  study	  involving	  both	  fibromyalgia	  
and	  rheumatoid	  arthritis	  patients,	  no	  group	  differences	  were	  found.	  	  Bilaterally	  in	  TA	  
and	  the	  first	  dorsal	   interosseous	  muscle	   (FDI),	  MTh	  was	   found	  to	  be	   increased	  and	  
cSP	  decreased,	  with	  no	  changes	  in	  spinal	  excitability	  (Salerno	  et	  al.,	  2000).	  In	  patients	  
with	  painful	  diabetic	  neuropathy,	  one	  study	  also	  reported	  a	  reduction	   is	   the	  cSP	   in	  
the	   FDI	   (Turgut	   and	   Altun,	   2009).	   	   However	   as	   a	   generalised	   non-­‐MSK	   pathology,	  
generalised	  rather	  than	  a	  muscle	  specific	  effects	  might	  be	  expected.	  
	  	  
Because	   of	   the	   lack	   of	   anatomical	   specificity	   of	   the	   above	   results	   and	   because	  
patients	   in	   the	   former	   study	   did	   not	   differ	   in	   measures	   of	   CE	   with	   patients	   with	  
rheumatoid	  arthritis,	  at	  least	  some	  of	  these	  features,	  notably	  increased	  MTh,	  might	  
be	   perceived	   to	   result	   from	   central	   adaptations	   to	   chronic	   nociceptive	   or	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inflammatory	   pain.	   	   Unfortunately,	   in	   the	   current	   studies,	   no	   patho-­‐anatomically	  	  
unrelated	  muscles	  were	  studied.	  	  However	  if	  referred	  pain	  can	  be	  construed	  to	  affect	  
the	   same	   central	   mechanisms	   thought	   to	   mediate	   the	   reduction	   in	   corticospinal	  
excitability	   associated	  with	   deep	   tissue	   pain	   (such	   as	   in	   the	   effects	   resulting	   from	  
hypertonic	   saline	   injections	   into	   the	   interspinous	   ligaments),	   the	   fact	   that	   level	  
specific	   changes	   in	   MTh	   in	   TA	   were	   reduced	   only	   in	   L5	   patients	   who	   had	   good-­‐
excellent	  functional	  and	  pain	  outcomes,	  might	  suggest	  somatotopic	  and	  anatomically	  
specific	   changes.	   However	   this	   is	   unlikely	   given	   that	   even	   such	   experimental	  
procedures	  are	  associated	  with	  changes	   in	  excitability	  and	  coordination	   in	  multiple	  
muscles	  surrounding	  the	  site	  of	  pain	  (Hodges	  et	  al.,	  2009b,	  Tsao	  et	  al.,	  2010b,	  On	  et	  
al.,	  2004).	  Nevertheless	  surgery	  results	  may	  suggest	  that	  the	  breadth	  of	  changes	   in	  
MTh	  may	   increase	   with	   proximity	   to	   the	   enervation	   area	   of	   nociceptive	   stimulus,	  
even	   by	   referred	   mechanisms.	   	   The	   lack	   of	   root	   level	   specificity	   of	   changes	   and	  
higher	   cSPs	   in	   SOL	  may	   in	   part	   relate	   to	   this,	   if	  muscles	   innervated	   by	   roots	   lying	  
below	  the	  affected	  level	  are	  found	  to	  be	  generally	  impacted.	  	  However,	  as	  discussed	  
in	  chapter	  6,	  because	  of	  the	  higher	  S1	  group	  drop-­‐outs,	  reduced	  outcome,	  and	  larger	  
number	  of	  L5	  participants	  with	  concurring	  S1	  MRI	  root	  involvement	  (4	  patients),	  this	  
thesis	  has	  not	  supplied	  enough	  evidence	  to	  support	  this	  view.	  	  	  
	  
TMS	  Parameters	  in	  LBP	  and	  Leg	  Pain	  Compared	  to	  those	  Reported	  in	  Disuse	  
	  
Given	  that	  the	  patient	  populations	  studied	  in	  this	  thesis	  have	  a	  wide	  ranging	  history	  
of	   chronic	   pain	   onset,	   it	   is	   necessary	   to	   attempt	   to	   distinguish	   between	   cortical	  
reorganisation	  and	  neuromuscular	  changes	  that	  may	  have	  arisen	  as	  a	  result	  of	  limb	  
or	  muscle	   group	   disuse.	   	  M1	   is	   thought	   to	   play	   a	   critical	   role	   in	   early	  motor	   task	  
consolidation	   (Muellbacher	   et	   al.,	   2002).	   	   It	   has	   been	   demonstrated	   that	   an	  
increased	   excitability	   takes	   place	   during	   both	   the	   acquisition	   and	   consolidation	   of	  
new	  motor	  skills	  (Doyon	  and	  Benali,	  2005,	  Pascual-­‐Leone	  et	  al.,	  1994,	  Muellbacher	  et	  
al.,	   2001).	   For	   example	   a	   30min	   motor	   skill	   training	   with	   TA	   is	   associated	   with	  
increased	   excitability	   (RC	   slopes)	   and	   reduced	   SICI,	   but	   not	   passive	   or	   non-­‐skilled	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training	   (Perez	   et	   al.,	   2004).	   There	   is	   a	   distinction	   between	   skilled	   training	   and	  
strength	  training,	  which	  has	  been	  reported	  to	  have	  the	  opposite	  effect	  of	   reducing	  
CE	  (RC	  slopes)	  (Jensen	  et	  al.,	  2005).	  However	  increased	  excitability	  also	  occurs	  during	  
the	  motor	  “unlearning”	  required	  by	  deafferentation	  (Werhahn	  et	  al.,	  2002,	  Ziemann	  
et	   al.,	   1998),	   prolonged	   altered	   limb	   positions	   (Sanes	   et	   al.,	   1992,	   Sanes	   and	  
Donoghue,	   1997)	   and	   sensorimotor	   restriction	   in	   limb	   immobilisation	   and	   disuse	  
(Zanette	   et	   al.,	   2004,	   Zanette	   et	   al.,	   1997,	   Roberts	   et	   al.,	   2010).	   Although	   these	  
mechanisms	  are	  poorly	  understood,	  it	  is	  believed	  that	  these	  changes	  result	  from	  an	  
imbalance	  between	  intracortical	  inhibition	  and	  facilitation	  resulting	  in	  motor	  hyper-­‐
excitability	   (Zanette	   et	   al.,	   2004,	   Roberts	   et	   al.,	   2010).	   One	   author	   proposed	   that	  
deafferentation	   may	   increase	   excitability	   to	   allow	   M1	   to	   receive	   larger	   afferent	  
signals	  to	  the	  residual	  peripheral	  input	  (Millan,	  1999).	  	  Another	  proposed	  hypothesis	  
is	   that	   motor	   hyperexcitability	   is	   simply	   a	   compensation	   mechanism	   to	   achieve	  
optimal	   force	   generation	   making	   up	   for	   the	   reduced	   ﬁring	   rate	   of	   motor	   units	  
resulting	  from	  atrophy	  or	  immobilization	  (Seki	  et	  al.,	  2001).	  	  This	  view	  has	  the	  benefit	  
of	  providing	  a	  single	  adaptive	  mechanism	  to	  explain	  the	  combined	  impact	  of	  disuse,	  
nociception-­‐motor	  inhibition	  and	  fibre	  changes	  occurring	  within	  affected	  muscles	  in	  
LEG	  or	  back	  muscles	  studied	  in	  this	  thesis.	  
	  
Compared	  to	  controls,	  patients	  did	  not	  adopt	  a	  strategy	  of	  recruiting	  a	  significantly	  
higher	  contribution	  of	  ES	  from	  level	  T12.	  	  Patients	  also	  featured	  significantly	  reduced	  
ES,	  SOL,	  and	  TA	  MVCs	   in	  all	   studied	  patient	  groups	  by	  some	  ~30-­‐40%	  compared	  to	  
levels	   achieved	   by	   controls.	   An	   alternative	  muscle	   recruitment	   strategy	  may	   have	  
been	  adopted	  in	  order	  to	  protect	  the	  lumbar	  region	  from	  further	  painful	   insults.	   	  A	  
reduced	   EMG	   with	   a	   rigid	   	   ‘guarding’	   activation	   of	   ES	   and	   RA	   (along	   with	   their	  
delayed	   relaxation)	   has	   been	   reported	   for	   simple	   voluntary	   trunk	   flexion	   and	  
extension	   tasks	   like	   the	  one	   in	   chapter	   5	   (Ahern	   et	   al.,	   1988,	  Watson	   et	   al.,	   1997,	  
Geisser	  et	  al.,	  2004)	  and	  postural	  tasks,	  such	  as	  adjustments	  to	  perturbations	  (Wilder	  
et	  al.,	  1996,	  Radebold	  et	  al.,	  2000),	  and	  gait	  (Ahern	  et	  al.,	  1988,	  Arendt-­‐Nielsen	  et	  al.,	  
1996,	   Lamoth	   et	   al.,	   2004).	   	   Structural	   changes	   in	   physiology	   accompany	   this	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weakness	  and	  altered	  strategy,	  with	  atrophy	  of	  erector	  spinae	  reported	  in	  20-­‐60%	  of	  
people	  with	  chronic	  LBP	  (Laasonen,	  1984,	  Hides	  et	  al.,	  1994).	  More	  specifically	   this	  
involves	   a	   pain-­‐lateralised	   reduced	   cross-­‐section	   of	   the	   multifidus	   (part	   of	   the	   ES	  
EMG	   signal)	   in	   LBP	   and	   radiculopathy	   at	   the	   L4-­‐L5	   level	   (Campbell	   et	   al.,	   1998,	  
Danneels	   et	   al.,	   2000,	   Freeman	  et	   al.,	   2010,	  Hides	   et	   al.,	   2008,	   Kader	   et	   al.,	   2000,	  
Hyun	   et	   al.,	   2007).	   	   This	   is	   has	   been	   reported	   to	   be	   	   precipitated	   by	   denervation	  
related	   to	   disc	   herniation	   and	   compression	   of	   the	   nerve	   root	   (Zoidl	   et	   al.,	   2003,	  
Hodges	   et	   al.,	   2006),	   resulting	   in	   loss	   of	   short-­‐angled	   fibres	   and	   re-­‐enervation	   by	  
grouped	   fibres	   [producing	   polyphasic	   action	   potentials]	   (Yoshihara	   et	   al.,	   2001),	  
reductions	   in	   type	   I	   and	   II	   muscle	   fibre	   sizes	   (Yoshihara	   et	   al.,	   2001,	   Zhao	   et	   al.,	  
2000),	  and	  finally	  infiltration	  by	  intramuscular	  fat	  (Alaranta	  et	  al.,	  1993,	  Hultman	  et	  
al.,	  1993).	  	  
 
ES	   recruitment	   curves	   reflected	   significantly	   increased	   CE	   (RC	   slope	   and	   X50	  
normalised	  to	  MVC),	  perhaps	  providing	  an	  explanation	  of	  why	  patients	  were	  able	  to	  
meet	   force	   demands	   of	   everyday	   tasks,	   despite	   reduced	  MEP	   amplitudes	   (marked	  
increased	   motor	   threshold).	   	   The	   fact	   that	   patients	   produced	   significantly	   longer	  
MEPs	  lends	  itself	  to	  the	  possibility	  of	  increased	  repeat	  firing	  of	  MNs	  as	  a	  result	  of	  the	  
fibre	   changes	   within	   ES.	   These	   prolonged	   MEPS	   may	   also	   suggest	   the	   additional	  
recruitment	   and	   temporal	   summation	   of	   action	   potentials	   with	   responses	   of	  
increased	  latencies	  (i.e.	  oligosynaptic	  pathway	  responses).	  Denervation	  and	  atrophy	  
has	  been	  reported	  to	  materialise	  on	  the	  side	  of	  pain	  in	  a	  matter	  of	  days	  from	  acute	  
and	  sub-­‐acute	  onset	  of	  LBP	  (Hides	  et	  al.,	  1994);	  and	  although	  rapid	  research	  ground	  
has	  been	  covered,	  still	  little	  is	  known	  about	  its	  recovery	  (Hides	  et	  al.,	  2011).	  	  	  
	  
In	  conclusion	  the	  studies	  in	  this	  thesis	  have	  confirmed	  CE	  and	  ICI	  changes	  in	  chronic	  
LBP	  and	  that	   these	  are	   reversed	  by	  successful	   surgery	  and	  conservative	   treatment.	  
The	   reliability	  of	   some	  of	   these	   cortical	  parameters	   (particularly	   the	   cSP	  and	  MTh)	  
have	  been	  shown	  to	  have	  potential	  as	  clinical	  neuroplasticity	  outcome	  measures.	  In	  
TA	   both	   cSP	   and	  MTh	   changes	   and	   their	   relation	   to	   pain	   and	   functional	   outcome,	  
248	  
	  
which	  was	   sensitive	   in	   long	   term,	  were	   found	   to	  have	  both	  nerve	   root	   level	   (MTh)	  
and	  side	  (cSP	  and	  Lat)	  specificity.	  	  
	  
The	  further	  elucidated	  mechanism	  of	  cortically	  maintained,	  trunk	  nociception-­‐driven	  
postural	  control	  deficits	  in	  chronic	  LBP,	  have	  implications	  for	  physical	  rehabilitation.	  	  
It	   implies	   that	   it	   may	   be	   necessary	   to	   effectively	   target	   nociceptive/inflammatory	  
pain	  generating	  anatomy	  or	  afferent	  pathways	  to	  the	  motor	  cortex	  (with	  for	  example	  
pharmaceutical	  or	  exogenous	  neuro-­‐stimulation	  therapies),	  before	  physical	   therapy	  
can	  be	  effective.	  	  
	  
More	  generally,	  predominantly	  neuropathic/radiculopathic	  and	  nociceptive	  muscles	  
had	   distinct	   cortical	   profiles	   (predominantly	   altered	   asymmetrical	   ICI	   or	   bilaterally	  
altered	   MTh).	   With	   current	   efforts	   to	   classify	   LBP	   patients	   according	   to	   CNS	  
adaptations,	  further	  work	  is	  still	  required	  to	  establish	  the	  practicality	  and	  usefulness	  
of	  MEP	  duration,	  the	  cSP,	  and	  MTh	  in	  classifying	  central	  adaptations	  and	  treatment	  
response	  to	  chronic	  LBP;	  or	  even	  other	  musculoskeletal	  chronic	  pain	  conditions.	  Now	  
that	  the	  reversibility	  of	  these	  cortical	  plasticity	  parameters	  have	  been	  established	  in	  
radicular	  and	  neuropathic	  pain	  profiles	  with	  successful	  treatment,	  further	  research	  is	  
required	   to	   establish	   whether	   cortical	   motor/somatosensory	   or	   even	   thalamic	  
markers	   exist	   with	   reduced	   inter-­‐individual	   variability	   (SICI,	   for	   example,	   may	  
improve	  upon	  the	  cSP	  for	   leg	  muscles	  at	  rest).	  Cross-­‐sectional	  comparisons	  may	  be	  
important	  given	  that	  patients	  who	  improved	  had	  more	  abnormal	  baseline	  measures.	  
Further	   study	   characterising	   the	   cortical	   profiles	   of	   patients	   developing	   central	  
sensitization	  may	   also	   be	   useful.	   Presently,	   parameters	   such	   as	   the	   cSP,	   SICI,	  MTh	  
and	   recruitment	   curves	   may	   be	   useful	   in	   characterising	   the	   level	   of	  
nociceptive/inflammatory	   to	   neuropathic	   CNS	   adaptations	   in	   chronic	   LBP	   patients.	  
Even	   the	   development	   of	   a	   simple	   ratio	   reflecting	   these	   relative	   contributions	   to	  
patient	   pain	   and	   function	   could	   have	   an	   important	   impact	   on	   the	   development	   of	  
effective	   treatment	   based	   classification	   systems	   for	   chronic	   LBP	   and	   lumbosacral	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radiculopathy,	   with	   particular	   potential	   in	   helping	   surgeons	   make	   more	   informed	  
prognoses.	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Department of Biosurgery and Surgical Technology 
Division of Surgery, Oncology, Reproductive 
biology and Anaesthetics 
Imperial College London 
 
The Nick Davey Laboratory, 7th floor laboratory 
block 
Charing Cross Hospital 
London, W6 8RF 
Tel: +44 (0)20 8383 8834 






 Dr Paul H Strutton BSc PhD  
                 Mr. Yoann Buisson BEng MSc 
               Dr Alison McGreggor MCSP MSc PhD 
   
 
[ date ] 
 
Dear [ name ], 
 
Re: Spinal Surgery Research Study: The impact of surgery to relieve leg pain on cortical control 
of trunk and leg muscles (Ealing & West London Mental Health Trust Research Ethics 
Committee: 07/Q0410/5).   
 
I am writing to you because, as a patient on the waiting list for a lumbar microdiscectomy 
operation, I would like to invite you to join the research study based at Charing Cross Hospital. The 
aim of the study is to find out more about the causes and effects of the sciatica/ lumbar nerve root 
compressions which you are experiencing with the view to, eventually help to improve the outcome of 
its treatment.   
If you decide to join the study, you will be asked on more than one occasion (up to 3 times) to come 
to Charing Cross Hospital, and we would like your first visit to take place before your epidural. The 
study assessments consist of measuring the ability of your brain to control your trunk and leg muscles 
and how this is progressing at various stages.  This is done using entirely non-invasive and painless 
techniques and by completing a short questionnaire. 
Please read the attached information sheet and be aware that, as a participant, you can withdraw from 
the study at any time without giving a reason.  
The study is run by a team of researchers from Imperial College London based at Charing Cross 
Hospital. 
Please do not hesitate to contact me on the above telephone or email address to discuss any questions 
which you may have. 
             
Yours sincerely, 
 
Yoann Buisson 	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The Nick Davey Laboratory 
Department of Biosurgery and Surgical Technology 
Division of Surgery, Oncology, Reproductive biology 
and Anaesthetics 
Imperial College London 
Charing Cross Hospital 
London, W6 8RF 
Tel: +44 (0)20 8383 8837 
Fax: +44 (0)20 8383 8835 
 
 
6th March 2007  
 
The impact of surgery to relieve leg pain on cortical control of 
trunk and leg muscles 
 
Patient Information Sheet 
We would like to invite you to join a research study.  Before you decide it is 
important for you to understand why the research is being done and what it 
will involve.  Please take time to read the following information carefully and 
discuss it with others if you wish.  Ask us if there is anything that is not clear or 
if you would like more information.  Take time to decide whether or not you 
wish to take part. 
What is the purpose of the study? 
Surgery to relieve the symptoms of back and leg pain is often undertaken 
when more conservative treatments have had limited success. However, poor 
functional outcome and patient satisfaction and the return of symptoms in 
many cases warrant further investigation. It is not clear whether the changes 
we have observed in the brain pathways to the muscles in chronic low back 
pain and sciatica patients yet to undergo surgery can be reversed by such 
surgery. This project will provide novel insights into the time course of the 
changes occurring at the level of the brain and central nervous system and 
furthermore which of these changes are reversed by surgery. 
Why have I been chosen? 
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We are asking you to think about joining this study because you are a chronic 
low back pain sufferer and, if you also have leg pain, are on a waiting list for 
decompression surgery to relieve this pain.  
Do I have to take part? 
No. It is entirely up to you.  If you would like to take part, you will be asked to 
sign a consent form.  Even after you have signed this consent form and 
agreed to join the study, you are free to withdraw from the study at any time.  
If you decide not to take part or withdraw from the study it will not affect your 
treatment by this Department in any way.  At all times we will aim to give you 
the best possible treatment. 
What will happen to me if I take part? 
At least a week after receiving this letter you will receive a telephone call from 
one of our research team.  The researcher will have already checked with 
your consultant that you are eligible to take part in this study. He or she will 
then discuss the study with you further and answer any questions you may 
have.   
 
At a convenient time, you will come to the Nick Davey laboratory at Charing 
Cross hospital to undertake these assessments. This is a working laboratory 
and as such contains many pieces of equipment, some of which look more 
frightening than they actually are. However, only some of the equipment will 
be used in this study, and each piece will be explained to you.  
 
You will be asked to complete some questionnaires that will be asking you 
about your general health, daily activities and pain; these should take no 
longer than 15 minutes to complete. 
 
We will then investigate the way the brain controls voluntary movements of 
your back and leg muscles. To do this we will activate the nervous system by 
a small magnetic stimulus to the nerves in the brain, this is not painful and is 
over so quickly you will hardly notice. We will record the electrical activity from 
the muscles (electromyography) under study in response to this stimulus. 
Magnetic stimuli will be applied using a safe and painless investigative 
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procedure called Transcranial Magnetic Stimulation (TMS). Recordings of 
your muscle activity will be made using self adhesive surface electrodes stuck 
to the skin overlying the muscle of interest. The relation between the stimulus 
and the responses in the muscle will be analysed by computer. This part of 
the assessment will take no longer than 60 minutes. We would like to carry 
out these tests on more than one occasion (prior to your surgery, 6 weeks 
following surgery, 6 months and 1 year following surgery) so we can 
understand how our measurements are influenced by the surgery and relate 
these to the outcome of the surgery.  
What do I have to do? 
All patients who take part in the study will be asked to fill in the questionnaires 
described above.  This will take around 15 minutes each time.  You will then 
have measurements described above performed. You will lie on a couch and 
make small contractions of your back muscles while these assessments are 
being performed and then you will then sit in a chair and make small 
contractions of your calf muscles while these assessments are being 
performed. In total you will be with us no more than one and a half hours.  
What is the drug or procedure that is being tested? 
There are no drugs being tested in this study and no new treatments. This 
study is simply looking at how the movement pathways to your back and leg 
muscles are affected by your low back pain and leg pain (if you have leg 
pain). All testing protocols have been in use for many years. 
What are the side effects of any treatment received when taking part? 
There are no additional treatments being tested in this study. 
What are the possible disadvantages and risks of taking part? 
The assessment techniques are safe and non-invasive and there are no known risks 
from having these test performed under strict safety guidelines. All tests will be 
performed within your limits of tolerance. 
What are the possible benefits of taking part? 
There are no clear benefits of taking part. However, this research may lead to 
knowledge into what happens in the brain and nervous system as a result of 
low back pain and the effects that surgery has on these systems.  
What if new information becomes available? 
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Any new information derived through this study will be made available to all of the 
patients should they request this.  
What if something goes wrong? 
In the event of any adverse effects as a consequence of participation in the 
study, compensation arrangements will be governed by the Public Liability and 
"No Fault" Compensation insurance policy held by Imperial College of Science 
Technology and Medicine. 
Will my taking part in this study be kept confidential? 
Any information you give us will be kept confidential. If the study is published in a 
book or scientific journal, no individual will be identified in any way. 
What will happen to the results of the research study? 
The results of the study will be analysed by the research team and presented at 
orthopaedic, neurological and other health care conferences and published in scientific 
journals.  No individual patient will be identified in any report or presentation arising 
from the research. 
Who is organising and funding the research? 
This research is being funded by the spinal charity DISCS. The study will be 
run by a research team based at Imperial College, London. 
Who has reviewed the study? 
This study has been approved by the Ealing & West London Mental Health 
Trust Research Ethics Committee. 
Contact for further information. 
If you are unsure about this study and would like to consider further before 
you make your decision, please take your time to do so. You may ask for 
further information by telephoning 020 8383 8837, which has a 24-hour 
answerphone. The person to speak to, who is responsible for the study, is Dr 
Paul Strutton. 
 
Criteria for exclusion. 
You CANNOT take part in this study if you: 
1) Have any metal implants or an artificial cardiac pacemaker. 
2) Have a history of epilepsy or fits or a family history of epilepsy or fits. 
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3) Have a history of brain damage (or neurosurgery), neurological or 
psychiatric disorders. 
4) Are currently on antidepressants or other neuromodulatory drugs. 
5) Are a child younger than 16. 
6) Are (or think you may be) pregnant. 



























Department of Biosurgery and Surgical 
Technology 
Division of Surgery, Oncology, 
Reproductive biology and Anaesthetics 
Imperial College London 
 
The Nick Davey Laboratory, 7th floor 
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'Step 1: StimINT: 
 
'Derandomise, tag simulator intensities, and calculate and tag MVCs to file extensions 
'Script to Enter Stimulator Intensities and Contraction Type Tag to all files in 
Folder 
'Frame 1 Comment becomes Muscle Contract TAG=i.e TF (Trunk Flexion) or BE (Back 
Extension) 
'this script will create a new folder based on the tag and rename the files to include 
stim intensity and tag 
'while also labeling stimulator intensity in channel comment. The following may also 
be added in frame1 user 
'variables to be processed by other scripts in the "6 Step" System: 
'Frame 1 User Variables: 
' 3=Number of Channels (Useful to tell when contralateral muscles were recorded -
i.e.16 channels) 
' 5=Handedness - This is entered by the user -to get rid of this just comment out line 
51 (add a ' before the line) 
'Yoann Buisson 11 02 2010 
'global variables 
var data%; 
var q%, logg%,MVCTag$,StarTag$,StartINT$,boo%; 
var f$, nf$, cf$, sf$, y, ef$, Hand, name$, chmax%, chmax, ch$, frmax%, MEPs,MVCS[19]; 
var MVC, floc$, nfloc$, Com$; 
var datafile$[1000], fcount%, idx%; 
var bh%; 
var ch%,dstr$[40]; 
var fr, int, chanconf%, UsrVarOf%, oldINT$; 
var okk%,ng%[40],nt%[200]; 
var MVCPrompt$, CheckMVCs$, InfoMessg$, DispMeans$[18], DispMVCs$[18]; 
var MinMeans[18],MnMean, MnMean1; 
var mean, means[10],minimeans[10]; 
var MeanCalc; 
var startf$; 
' user-defined global variables: 
var NewINT$,Tag$; 
var MTag$; 
'NewMVC%(); 'Start with an MVC? 
'--------------------------------------------------------------------- 
'CHANCONFIG: SPECIFY what channel config you have: 
'--------------------------------------------------------------------- 
'if you have rectified even channels then set chanconf%=2 otherwise chanconf%=1 if all 
of your channels are different and 
you have 

















'browse and retrieve folder files 
data%:=FileOpen("",0); 'open the file dialog 








if fcount%=0 then 





'HANDEDNESS (delete if not required): 
Hand:=Input("HANDEDNESS INDEX|Please enter the handedness index for this 
subject",FrameUserVar(5)); 
floc$:=FilePath$(); 
'process all files 
While idx%<=fcount%-1 do 
data%:=FileOpen(datafile$[idx%],0); 'open file 
view(data%); 




NewINT$:=filecomment$(); 'Reset NewINT$ to whatever's in the filecomment ' 




chmax%:=ChanCount(-1); ' count how many channels there are 
view(data%); 
'------------------------------------------------------------- 
'Enter new variables: 
'------------------------------------------------------------- 
FileComment$(NewINT$); 





int:=Val(NewINT$); ' Frame 1 User Variables: 
FrameUserVar(1,int); ' 1=File intensity 
FrameUserVar(3,chmax%); ' No of Channels 
FrameUserVar(5,Hand); ' Handedness 
FrameSave(0); 
FileSave(); 
For ch%:=chanconf% to chmax% do 'Enter MVCs ("if they have have changed" Future work-
would be nice to add condition to 
save processing time **) 
view(data%); 
if FrameCount()>1 then 
Frame(2); 












nf$:=Tag$+"_" + NewINT$ + "_" + Filename$(3) + Filename$(4) + Filename$(5); 
ef$:=Tag$+"_" + NewINT$ + "_" + Filename$(0); 
FilePathSet(nfloc$,0,1); 'create new folder based on new File Tag or simply set to 
existing folder based on tag 
'cf$:=nf$ + ".cfs"; 
'sf$:=nf$ + ".sgs"; 
FileSaveAs(nf$,1); 'rename file to include intensity 
'FileexportAs(sf$,6); 
FilePathSet(floc$,0,1); 








'Function to generate the dialog 









ArrConst(ng%[],0); ArrConst(nt%[],0);'clear previous group and button item numbers 
var bh%,vh%,nn%; 
'var dstr$; 
vh%:=View();'remember current view 
bh%:=FileOpen("Dlg.dat",9,1); 











x[0]:=17.6; y[0]:=42.0; wi[0]:=140.0; hi[0]:= 8.0; 
x[6]:=65.0; y[6]:= 3.5; wi[6]:=10.0; lo[6]:=20.0;' item 6: NewINT$ 
x[7]:=65.0; y[7]:= 6.0; wi[7]:=10.0; lo[7]:=20.0;' item 7: Tag$ 
x[10]:=15.0; y[10]:= 3.5;list$[10]:="New Intensity for file "+f$+" (previous was 
"+oldINT$+"%):"; 'item: nt%[0] 
x[11]:=15.0; y[11]:= 6.0;list$[11]:="Contraction Tag for file "+f$+":"; 'item: nt%[1] 
x[12]:=85.0; y[12]:= 6.0; lo[12]:= 2.0; hi[12]:= 7.5;list$[12]:="NewMVC"; 
x[13]:=100.0; y[13]:= 6.0; lo[13]:= 3.0;list$[13]:="Done"; 
DlgCreate(dttl$,x[0],y[0],wi[0],hi[0]); 
' DlgAllow(allow%);'optional allow/idle/change functions 
i%+=5; 




















' update user-defined variables 
BRead(NewINT$,Tag$); 
if InStr(MTag$,Tag$)=0 











'This is to integrate the Basic MVC script and record the values in the first 















PrintLog("%s\t %s\n","Basic MVC Script (19/03/2009) Filename: ",f$); 
chmax:=ChanCount(-1); ' count how many channels there are 
for ch%:=chanconf% to chmax step 2 do 'select all available rectified channels 
PrintLog("%s\n"," "); 





ArrConst(means[], -100000000); ' Initialise Mean Array to very small numbers 
ArrConst(minimeans[], 10); ' Initialise Mean Array to positive numbers 





if (MeanCalc > means[0]) then ' if mean is in top 3 biggest then add to "stack" 
means[0] := MeanCalc; 
endif; 
ArrSort(means[]); ' get the means array so that the smallest is in means[0] 
'minima stack 
if (MnMean1 < minimeans[0]) then ' if mean is in bottom 3 biggest then add to "stack" 
minimeans[0] := MnMean1; 
endif; 








PrintLog("%s\n","TOP Averages from x=0 to 0.5 seconds of each frame (in ascending 
order) and MVCs (based on top 3 
averages) for File:"+f$+"."); 
'InfoMessg$:="%s\n","TOP Averages from x=0 to 0.5 seconds of each frame (in ascending 
order) and MVCs (based on top 
3 averages) for File:"+f$+"."); 
PrintLog("%s\n","Check for abnormally large top values for validity of MVC (last 
value(s) in top 10 list)."); 






PrintLog("%s,%.6f\n"," MVCs so far:",MVCS); 
'minima check: 
PrintLog("%s,%.6f\n","Channel "+ch$+" MINIMA:",minimeans); 
PrintLog("%s,%.6f\n",""+ChanTitle$(ch%-1)+" MinMeans[ch%]:",MinMeans[ch%]); 
PrintLog("%s,%.6f\n"," MinMeans so far:",MinMeans); 













CheckMVCs$:="Check the log file for abnormal MVCs and click OK. If some frames are 
abnormally high, make a note of frames 

















'Step 2: AUTOMEPCount 
 
'Automatically Counts MEPs in all of the files in a folder and exports a summary to a 
text file 
'and stores the results in the frame varialble. It automatically detects if muscles 
are active 
'or at rest based on the prestimulus emg and applies the appropriate definition 
(algorythm) 
'whose constants can be calibrated below for multiple muscles. 
'For this script to work stimulator intensities must be located 
'or entered manually in the file comment. 
' 1_StimINT program will automatically in the frame variables (if StimINT script has 
been used) 
'copy these over from the magstim serial line control "power A" frame variable if you 
have used this function. 
'This automation is a preliminary estimation and is to be used with "Step 3 
ThreshCalc" and "Step 4 ManualMEP" 
'to visually confirm threholds. 
'Yoann Buisson 01/01/2010 









var f$, Name$, chmax, frmax, cursor$, ch$, Mus$, lq%, chanconf%, UsrVarOf%, 
overwrite%; 
var meansd, INT%, INT$, MVCS[18], MEPS[18],MEP,SPTh%,SPTh[18],MTh[18],MTh%,PerMTh; 'SD 





var PreStimMeanmultsd; 'horizontal cursor placed at x multiples of SD 
var ch%; 
var PreStimMax; 
var PreActiveConst, PreRestConst; 
var REST; 
var file, MEPLAT, MEPdur, INHIBlat, INHIBdur, INHIBEnd, MEPArea, InhibCurvArea, 
InhibArea, PreStimMean, P2P, Hand, CONT; 
var datafile$[1000], fcount%, edx%; 
var c1, c2, fr, dur, amp, avamp, floc$,Act,Rst; 
'--------------------------------------------------------------------- 
'CHANCONFIG: SPECIFY what channel config you have: 
'--------------------------------------------------------------------- 
'if you have rectified even channels then set chanconf%=2 otherwise chanconf%=1 if all 
of your channels are different 
chanconf%:=2; 
UsrVarOf%:=chanconf%-1; 
'Default Threshold Algorythm Constants: These default or muscle/contraction specific 




overwrite%:=0; 'Setting value of 1 instructs this AUTO script to overwrite existing 




















data%:=FileOpen("",0); 'open the file dialog 
if data% < 1 then 




if fcount%=0 then 










'process all files 
While edx%<=fcount%-1 do 
data%:=FileOpen(datafile$[edx%],0); 'open file 
view(data%); 
f$:=Filename$(3) + Filename$(4); 
FrameTag(-1,0); 'untag all frames' 
INT$:= FileComment$(); 
'average -used for multiphasic muscle threshold determination 











chmax:=ChanCount(-1); ' count how many channels there are 
frmax:=framecount(); 
'PrintLog("%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s\n","file","No of Stimuli","L 
Muscle","SigCHAN","StimINT","MEPS","%Mth","R 
Muscle","SigCHAN","StimINT","MEPS","%MTh"); 
PrintLog("%s\t %0d\t %s",f$,framecount(),""); 




for ch%:=chanconf% to allch step chanconf% do 'select all available rectified channels 














Chanshow(-1,0); 'turn off all channels before placing cursors 
Chanshow(Ch%,1); 'only show the relevant channel 
if chanconf%=2 then 
Chanshow(Ch%-1,1); 'use this if you also want to see the unrectified counterpart of 
the above channel 
endif; 
Optimise(-2,0.005); 'optimises view to exclude artefacts 
XRange(Xlow(),0.4); 
CursorSet(0); 
CursorSet(2,mintime(),-0.005); 'defining area for pre-stim meanline calculation 
var PreStimRMS, PreStimRectMax; 
326	  
	  
PreStimMeanmultsd:=2; 'horizontal cursor placed at 2x SD i.e 95% CI 
if chanconf%=2 then 
PreStimMean:=ChanMean(ch%,cursor(1),cursor(2),meansd); 'redefining mean and SDs before 












'Resting and Active muscles based on contraction type (Estimates Active or resting 
states in any without this files) 
'Please change the contract tag (say "TU") with your own (if you have used them) and 
'customize the four constants to suit your muscle. If no tags have been used simply 
change global constants 
docase 





































































































'-------'This is the Default Definition of Resting State: 



















HCursorDelete(-1); 'getting rid of all horizontal cursors 
HCursorNew(ch%,PreStimMean); 'set new meanline cursor on required channel 
HCursorNew(ch%,PreStimMean+MEPDef); 'set new minimum active Mep cursor on required 
channel 
if chanconf% > 1 then 
HCursorNew(ch%-1,(MEPDefpk+(PreStimMean/2))); 'set 100uV cursors on required channel 
HCursorNew(ch%-1,(-MEPDefpk-(PreStimMean/2))); 
endif; 
CursorSet(0); 'delete all V cursors (not necessary) 
'--------------------------------------------------------------- 




if chanconf% > 1 then 
chLabel$:= ChanTitle$(ch%-1); 
else chLabel$:= ChanTitle$(ch%); 
endif; 
docase 
case InStr(chLabel$,"TA") then 
CursorSet(2,0.024,0.053); 
case InStr(chLabel$,"SOL") then 
CursorSet(2,0.027,0.060); 
case InStr(chLabel$,"Brev") then 
CursorSet(2,0.027,0.053); 
case InStr(chLabel$,"Gas") then 
CursorSet(2,0.027,0.053); 
case InStr(chLabel$,"12") then 
CursorSet(2,0.012,0.045); 
case InStr(chLabel$,"4") then 
CursorSet(2,0.012,0.045); 
case InStr(chLabel$,"EO") then 
CursorSet(2,0.015,0.040); 










FrameTag(-1,0); 'untag all frames' 
n%:=0; 
'for i% := 1 to FrameCount() do 
' frame(i%); 
' n% += FrameTag(i%); 
'next; 
var MEPrms, MEPrect; 
if n%=0 then 
for fr%:= 1 to framecount() do 
Frame (fr%); 









case MEPAmp > (PreRestConst*PreStimMean+(Rst*MEPDef))and MEPAmp > PreStimMax and 





case MEPAmp > (PreActiveConst*PreStimMean+(Act*MEPDef))and MEPAmp > PreStimMax and 










'case buttonsel% = 1 then 
t%:=0; 
for i% := 1 to FrameCount() do 
frame(i%); 
t% += FrameTag(i%); 
Next; 
MEP:=t%; 
if InStr(f$,"mvc")> 0 or InStr(f$,"MVC")> 0 or InStr(f$,"breath")> 0 or 
InStr(f$,"Breath")> 0 or InStr(f$,"BREATH")> 0 or 




































if chanconf%=1 then 














FileSave(); 'Save and get out of there 





























'Step 3: TheshCalc 
 
'Script which is to be used with the ManualMEPCouunt or AUTOMEPCount scripts. All files in folder 
must be of 
'the same contraction (if active) and contain the same number of channels (ideally processed with 
the StimINT 
'script). This Script 
'automatically calculates the thresholds of each channel using the number of MEPs counted per 
channel at all 
'intensities and 
'recorded into frame 4 variables. The script then offers to record these threshold values to file 
in frame 3 
'frame variables 
'(as usual frame variable number is indicative of the channel to which it corresponds. It outputs 
at text file 




var MEPSAbove[20], MEPSBelow[20],SweepsAbove[20],SweepsBelow[20]; 
var Sweepies[20],chlist[20]; 
var AboveTh[20], BelowTh[20],INTAbovTH,INTBelowTH,pcThBelowTH,pcThAbovTH,cINT%,cMEP%; 





'Thf%:=query("Calculate Motor Threshold from MEPs previously written to frame variables?", "Yes", 
"No"); 





'CHANCONFIG: SPECIFY what channel config you have: 
'--------------------------------------------------------------------- 
'if you have rectified even channels then set chanconf%=2 otherwise chanconf%=1 if all of your 
channels are different and you have 
'rectified all channels in order to use this script (note that the P2P MEP AMP will be off 
chanconf%:=2; 
UsrVarOf%:=chanconf%-1; 
overwrite%:=1; 'Setting value of 1 instructs this AUTO script to overwrite existing Recorded 
Thresholds in frame variables 
'Debug Option: 
TESTMODE%:=0; 'Select TESTMODE%:=1 to see all steps printed in this script or 0 to simply print 
out thresholds 
askFolder%:=0; ' If you want to be prompted about which folder to process -otherwise will be 
current worling folder 
'--------------------------------------------------------------------- 
'endif; 
''***Load intensities and and MEPs for each Channel to a Matrix: 







if askFolder%=0 then 
data3%:=FileOpen(datafile$[0],0,1); 'open the file dialog 
else 
data3%:=FileOpen("",0,1); 'open the file dialog 
endif; 
if data3% < 1 then 





if fcount%=0 then 




chmax:=ChanCount(-1); ' count how many channels there are 
FileClose(-1,-1); 
for ch%:=chanconf% to chmax step chanconf% do 'select all available rectified channels 'select all 
available rectified channels 
ArrConst(chlist[],ch%); 'ignore (for debugging) 
ch$:=Str$(ch%); 




edx%:=0; 'reset file counter 







data3%:=FileOpen(startf$,0); 'open the file dialog 
if data3% < 1 then 





if fcount%=0 then 
Message("No relevant file found"); 
Halt; 
endif; 
'process all files 
While edx%<=fcount%-1 do 
data3%:=FileOpen(datafile$[edx%],0); 'open file 
view(data3%); 
f$:=Filename$(3) + Filename$(4); 
bingo%:=0; ' bets are in for no MTh calc necessary 
'----------------------------------------------------- 
'load pre-processed data from Frame User Variables: 
'----------------------------------------------------- 
frmax%:=FrameCount(); 







































'delete this is using regression to calc threshold 
if pcThlist[edx%]=0.5 then MThch[ch%]:=INTlist[edx%]; 
bingo%:=1; 
endif; 
if TESTMODE%=1 and bingo% = 1 then 
PrintLog("%s\n","Bingo!: No Calc Necessary (50% of stimuli cooresponds to file below)"); 
PrintLog("%s,%.0d\n"," Channel" +ch$+": ",MThch[ch%]); 
endif; 
fileclose(-1); 
edx%:= edx% + 1; 
wend; 

















for n%:=0 to 19 do 






if TESTMODE%=1 then 
PrintLog("%s\n"," "); 
PrintLog("%s\n","Sorted Above Threshold:"); 
PrintLog("%s\n"," "); 






for n%:=0 to 19 do 
if pcThlist[n%]=1 then 
sdx%:=sdx%+1; 
endif; 






if TESTMODE%=1 then 
PrintLog("%s\n"," "); 
PrintLog("%s\n","Sorted Below Threshold:"); 
PrintLog("%s\n"," "); 







if bingo%=0 then 
for n%:=0 to 19 do 
if pcThlist[n%]>0.5 then 
bdx%:=bdx%+1; 
endif; 

























if bdx%<1 then 
n%:=Max(pcThlist[]); 


































case bingo%=1 then MThch1:=MThch[ch%]; 









'if fit%=0 then 
'ThreshFit[ch%]:=FitValue(0.5); 
'endif; 
case INTAbovTH=0 and INTBelowTH=0 then MThch1:=0; 





if TESTMODE%=1 then 
PrintLog("%s\n"," "); 
PrintLog("%s,%.2f,%.2f\n","Above TH ",INTAbovTH, pcThAbovTH); 
PrintLog("%s,%.2f,%.2f\n","Below TH ",INTBelowTH, pcThBelowTH); 
PrintLog("%s\n"," "); 





'Print out Results: 
docase 




PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\n"," 
Channel___________:",Chans[2],Chans[4],Chans[6],Chans[8]); 
PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\n"," LOW 
INT___________:",BelowTh[2],BelowTh[4],BelowTh[6],BelowTh[8]); 
PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\n"," LOW 
MEPS__________:",MEPSBelow[2],MEPSBelow[4],MEPSBelow[6],MEPSBelow[8]); 
PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\n"," LOW 
Sweeps________:",SweepsBelow[2],SweepsBelow[4],SweepsBelow[6],SweepsBelow[8]); 
PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\n"," HIGH 
INT__________:",AboveTh[2],AboveTh[4],AboveTh[6],AboveTh[8]); 
PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\n"," HIGH 
MEPS_________:",MEPSAbove[2],MEPSAbove[4],MEPSAbove[6],MEPSAbove[8]); 
PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\n"," HIGH 
Sweeps_______:",SweepsAbove[2],SweepsAbove[4],SweepsAbove[6],SweepsAbove[8]); 
PrintLog("%s\n"," "); 
PrintLog("%s\t %.2f\t %.2f\t %.2f\t %.2f\n"," 
Thresholds________:",MThch[2],MThch[4],MThch[6],MThch[8]); 




PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\n"," 
Channel___________:",Chans[2],Chans[4],Chans[6],Chans[8],Chans[10 
],Chans[12],Chans[14],Chans[16]); 
PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\n"," Low 
INT___________:",BelowTh[2],BelowTh[4],BelowTh[6],BelowTh[8], 
BelowTh[10],BelowTh[12],BelowTh[14],BelowTh[16]); 
PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\n"," Low 
MEPS__________:",MEPSBelow[2],MEPSBelow[4],MEPSBelow[6], 
MEPSBelow[8],MEPSBelow[10],MEPSBelow[12],MEPSBelow[14],MEPSBelow[16]); 
PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\n"," Low 
Sweeps________:",SweepsBelow[2],SweepsBelow[4],SweepsBelow[6], 
SweepsBelow[8],SweepsBelow[10],SweepsBelow[12],SweepsBelow[14],SweepsBelow[16]); 





PrintLog("%s\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\t %.0d\n"," HIGH 
MEPS_________:",MEPSAbove[2],MEPSAbove[4],MEPSAbove[6], 
MEPSAbove[8],MEPSAbove[10],MEPSAbove[12],MEPSAbove[14],MEPSAbove[16]); 











PrintLog("%s\t %.0d\n"," No of Channels____:",chmax); 
PrintLog("%s\t %.0d\n"," Channel___________:",Chans); 
PrintLog("%s\t %.0d\n"," Below_INT_________:",BelowTh); 
PrintLog("%s\t %.0d\n"," MEPS_Below________:",MEPSBelow); 
PrintLog("%s\t %.0d\n"," Sweeps_Below______:",SweepsBelow); 
PrintLog("%s\t %.0d\n"," Above_INT_________:",AboveTh); 
PrintLog("%s\t %.0d\n"," Above_MEPS________:",MEPSAbove); 
PrintLog("%s\t %.0d\n"," Above_Sweeps______:",SweepsAbove); 
PrintLog("%s\n"," "); 
PrintLog("%s\t %.2f\n"," Thresholds________:",MThch); 
endcase; 
'Optional -showing curve fitted Thresholds 
if TESTMODE%=1 then 
PrintLog("%s\n"," "); 
PrintLog("%s\t %.2f\n"," Fitted TH_________:",ThreshFit[]); 













aif%:=query("Tag THRESHOLDS to all files in folder? (will be written to frame variables corr to 
ch% in frames 3 and 4)", "Yes", "No"); 











var floc$, idx%; 
FileClose(-1); 
''***Record THRESHOLDS to frame variables to all files in folder: 
data2%:=FileOpen(startf$,0); 'open the file dialog 
if data2% < 1 then 





if fcount%=0 then 
Message("No relevant file found"); 
Halt; 
endif; 
'process all files 
While idx%<=fcount%-1 do 
data2%:=FileOpen(datafile$[idx%],0); 'open file 
view(data2%); 
f$:=Filename$(3) + Filename$(4); 
chmax:=ChanCount(-1); ' count how many channels there are 
frmax%:=framecount(); 
For ch%:=chanconf% to chmax step chanconf% do 'select even channels 
view(data2%); 
'load frame 3 and enter MTh if available 
if frmax% > 4 and MThch[ch%] > 0 then 
Frame(4); 
docase 
case overwrite%=0 and FrameUserVar(ch%-UsrVarOf%)>0 then 










































'Step 4: MANUALMEP 
 
'Allows user to quickly check counts of MEPs around presumed (automatically by 
ThreshCalc script for example) 
'and confirm MTh Intensity 
'and also specify cSP Threshold. All this information is stored in the 
'file extension of the data files, ready to be printed out or used by other scripts in 
the 6 script system. 
'Yoann Buisson 01/01/2010 









var f$, Name$, chmax, frmax, cursor$, ch$, Mus$, chanconf%, UsrVarOf%; 
var meansd, INT%, INT$, MEPS[18],MEP,SPTh%,SPTh[18],MTh[18],MThr,PerMTh; 'SD of the 





var PreStimMeanmultsd; 'horizontal cursor placed at x multiples of SD 






var file, PreStimMean, P2P; 
var Act,Rst; 
'--------------------------------------------------------------------- 
'CHANCONFIG: SPECIFY what channel config you have: 
'--------------------------------------------------------------------- 
'if you have rectified even channels then set chanconf%=2 otherwise chanconf%=1 if all 
of your channels are different and 
you have 













PrintLog("%s \t %s\t %s\t %s\t %s \t %s\t %s\t %s\t %s\t %s\t %s \t 
%s\t","file","Sweeps","LMus","Chan", 
"INT","MEPS","Sweeps","%Mth","MTh","SPTh","R/A",""); 























FrameTag(-1,0); 'untag all frames' 
INT$:= FileComment$(); 











chmax:=ChanCount(-1); ' count how many channels there are 
frmax:=framecount(); 
'PrintLog("%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s\n","file","No of Stimuli","L 
Muscle","SigCHAN","StimINT","MEPS","%Mth","R 
Muscle","SigCHAN","StimINT","MEPS","%MTh"); 
PrintLog("%s\t %0d\t %s",f$,framecount(),""); 





for ch%:=chanconf% to allch step chanconf% do 'select all available rectified channels 











Chanshow(-1,0); 'turn off all channels before placing cursors 
Chanshow(Ch%,1); 'only show the relevant channel 
if chanconf% = 2 then 
Chanshow(Ch%-1,1); 'use this if you also want to see the unrectified counterpart of 
the above channel 
endif; 
Optimise(-2,0.005); 'optimises view to exclude artefacts 
XRange(Xlow(),0.25); 
CursorSet(0); 
CursorSet(2,mintime(),-0.005); 'defining area for pre-stim meanline calculation 
PreStimMeanmultsd:=2; 'horizontal cursor placed at 2x SD i.e 95% CI 
PreStimMean:=ChanMean(ch%,cursor(1),cursor(2),meansd); 'redefining mean and SDs before 
deleting h cursors 
PreStimMeansd1:=PreStimMean-(PreStimMeanmultsd*meansd); 
PreStimMeansd2:=PreStimMean+(PreStimMeanmultsd*meansd); 
HCursorDelete(-1); 'getting rid of all horizontal cursors 
HCursorNew(ch%,PreStimMean); 'set new meanline cursor on required channel 
HCursorNew(ch%,PreStimMean+0.2); 'set new meanline cursor on required channel 
if chanconf% > 1 then 
HCursorNew(ch%-1,0.1); 'set 100uV cursors on required channel 
HCursorNew(ch%-1,-0.1); 
endif; 
CursorSet(0); 'delete all V cursors 
'--------------------------------------------------------------- 


















Chanshow(-1,0); 'turn off all channels before placing cursors 
Chanshow(Ch%,1); 'only show the relevant channel 
if chanconf%=2 then 
Chanshow(Ch%-1,1); 'use this if you also want to see the unrectified counterpart of 
the above channel 
endif; 
Optimise(-2,0.005); 'optimises view to exclude artefacts 
XRange(Xlow(),0.4); 
CursorSet(0); 
CursorSet(2,mintime(),-0.005); 'defining area for pre-stim meanline calculation 
var PreStimRMS; 
PreStimMeanmultsd:=2; 'horizontal cursor placed at 2x SD i.e 95% CI 
if chanconf%=2 then 
PreStimMean:=ChanMean(ch%,cursor(1),cursor(2),meansd); 'redefining mean and SDs before 












'Resting and Active muscles based on contraction type (Estimates Active or resting 
states in any without this files) 
docase 
























































































































HCursorDelete(-1); 'getting rid of all horizontal cursors 
342	  
	  
HCursorNew(ch%,PreStimMean); 'set new meanline cursor on required channel 
HCursorNew(ch%,PreStimMean+MEPDef); 'set new minimum active Mep cursor on required 
channel 
if chanconf% > 1 then 
HCursorNew(ch%-1,(MEPDefpk+(PreStimMean/2))); 'set 100uV cursors on required channel 
HCursorNew(ch%-1,(-MEPDefpk-(PreStimMean/2))); 
endif; 
CursorSet(0); 'delete all V cursors (not necessary) 
'--------------------------------------------------------------- 
'Expected Mep onset and offset (for cursor positions)-this helps identifying MEPS 
'--------------------------------------------------------------- 
if chanconf% > 1 then 
chLabel$:= ChanTitle$(ch%-1); 
else chLabel$:= ChanTitle$(ch%); 
endif; 
docase 
case InStr(chLabel$,"TA") then 
CursorSet(2,0.024,0.053); 
case InStr(chLabel$,"SOL") then 
CursorSet(2,0.027,0.060); 
case InStr(chLabel$,"Brev") then 
CursorSet(2,0.027,0.053); 
case InStr(chLabel$,"Gas") then 
CursorSet(2,0.027,0.053); 
case InStr(chLabel$,"12") then 
CursorSet(2,0.012,0.050); 
case InStr(chLabel$,"4") then 
CursorSet(2,0.012,0.050); 
case InStr(chLabel$,"EO") then 
CursorSet(2,0.015,0.040); 






'Tag Frames which are likely to be MEPs 
'--------------------------------------------------------------- 
n%:=0; 
for i% := 1 to FrameCount() do 
frame(i%); 
n% += FrameTag(i%); 
next; 
var MEPrms; 
if n%=0 then 
for fr%:= 1 to framecount() do 
Frame (fr%); 









case MEPAmp > (PreRestConst*PreStimMean+(Rst*MEPDef))and MEPAmp > PreStimMax and 





case MEPAmp > (PreActiveConst*PreStimMean+(Act*MEPDef))and MEPAmp > PreStimMax and 


















if chanconf%<2 then 
Mus$:=ChanTitle$(ch%); 
Cursor$:="Tag "+ChanTitle$(ch%)+" MEPS or Specify MEPs or SPTh:'"; 
else 
Mus$:=ChanTitle$(ch%-1); 






while buttonsel% = 5 do 
if frmax > 4 then 
Frame(4); 
MTh[ch%]:=Input("Specify MTh|Please enter Stimulator Intensity at Motor 
Threshold",FrameUserVar(ch%-UsrVarOf%)); 








'if frmax > 3 then 
'Frame(3); 
'MEP:=Input("Specify MEPs|Please enter number of MEPs counted in this 
file",FrameUserVar(ch%-UsrVarOf%)); 
'endif; 
while buttonsel% = 7 do 
if frmax > 5 then 
Frame(5); 
SPTh[ch%]:=Input("Specify SPTh|Please enter Stimulator Intensity at SP 
Threshold",FrameUserVar(ch%-UsrVarOf%)); 








'for i% := 1 to FrameCount() do 
' frame(i%); 
' t% += FrameTag(i%); 
' Next; 
'if t% > 0 
'then MEP:=t%; 
'else Frame (3); 




case buttonsel% = 1 then 
t%:=0; 
for i% := 1 to FrameCount() do 
frame(i%); 
t% += FrameTag(i%); 
Next; 
MEP:=t%; 
case buttonsel% = 2 then 
if frmax > 3 then 
Frame(3); 
MEP:=Input("Specify MEPs|Please enter number of MEPs counted",FrameUserVar(ch%-
UsrVarOf%)); 
else MEP:=Input("Specify MEPs|Please enter number of MEPs counted",FrameUserVar(ch%-
UsrVarOf%)); 
endif; 
case buttonsel% = 3 then 
MEP:=framecount(); 
case buttonsel% = 4 then 
MEP:=0; 
case buttonsel% = 6 then 
344	  
	  








case buttonsel% = 8 then 
MEP:=FrameUserVar(ch%-UsrVarOf%); 









'Set Frame Variables Corresponding to MEP and SP parameters 












if SPTh[ch%] > 0 and 











if MEP > 0 then 
PerMTh:=MEP/frmax; 
endif; 
FrameTag(-1,0); 'untag all frames' 
FrameSave(); 
FileSave(); 
if chanconf%=1 then 































if ArrSum(SPTh[]) > 0 








var f$, aif%, fcount%, floc$, idx%, chmax%, frmax%, datafile$[1000]; 
aif%:=query("Tag THRESHOLDS to all files in folder? (will be written to frame 
variables corr to ch% in frames 3 and 4)", 
"Yes", "No"); 
if aif%=1 then; 
FileClose(-1,-1); 
''***Record THRESHOLDS to frame variables to all files in folder: 
data2%:=FileOpen(startf$,0); 'open the file dialog 
if data2% < 1 then 





if fcount%=0 then 
Message("No relevant file found"); 
Halt; 
endif; 
'process all files 
While idx%<=fcount%-1 do 
data2%:=FileOpen(datafile$[idx%],0); 'open file 
view(data2%); 
f$:=Filename$(3) + Filename$(4); 
chmax%:=ChanCount(-1); ' count how many channels there are 
frmax%:=framecount(); 
For ch%:=chanconf% to chmax% do 'select even channels 
view(data2%); 
'load frame 3 and enter MTh if available 






if frmax% > 5 and SPTh[ch%] > 0 then 




FileSave(); 'Save and get out of there 
Next; 
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'Step 5: CURSORS 
'Asks for user to position 3 cursors for MEP and csP Offset and calculated and outputs all immaginable Prestim, 
MEP and cSP characteristics, including normalised values (to MVC but can be set to 
'M Wave). P2P Amplitudes are based on non-averaged single stimulus frames whereas MEP areas and cSP are 
calculated from a created average frame. 
'A new Inhibition area calculation is now measured under the mean emg line and returned as a positive value -this 
uses Curve Area 
'This area under the mean line is taken as a % of the total area from mean line to x axis i.e. 100% = no EMG 
during silent period (SP) and 25% means 75% EMG remaining. 
'Yoann Buisson 27/10/2008 
'revised with frame state info 02/02/2010 
'Added P2P function based on non-averaged single stimulus frames 22/10/2010 
var data%, ave1%,frmax%,chAVdata%; 
var q%, oldchan%; 
var P2Ps[40], MEPp2pRaw[18],P2PRaw; 
var MedFreq[40], FrP2Ps[40],FrP2PsRaw[40],MEPp2p[40]; 
var fr%,PreStimRMS,MEPraw,RMSmin,EndMEP,StartMEP,RMSmax,PostStimMean; 
var avg$, Muscle$, pcMTh; 
var f$, Name$, chmax, cursor$, ch$, chanconf%, UsrVarOf%; 




var PreStimMeanmultsd%; 'horizontal cursor placed at x multiples of SD 
var ch%,floc$, nfloc$; 
var frnam$:= "Power A"; 'Frame variable name for Magstim stimulator output: This will be zero if the frame state feature 
is disabled 
'from the config file. 
'Config File settings: States Tab: select Static and Select Magstim 200 
var file, MEPLAT, MEPdur, INHIBlat, INHIBdur, INHIBEnd, MEPArea, InhibCurvArea, InhibArea, PreStimMean, P2P, Hand; 
var CONT,Threshx120,pThresh,SPtoAREA,SPtoP2P,nP2P,nMArea; 
q%:=1; 
PreStimMeanmultsd%:=2; 'horizontal cursor placed at 2x SD i.e 95% CI 
'Print the Guinness Header 
PrintLog("%s\r ","5-CURSORS Script v27/10/2010"); 
PrintLog("%s\t %s \t %s \t %s \t %s \t %s \t %s \t %s \t %s \t %s \t 
%s", 
"CHAN","file","MEP LAT","MEP DUR","MEPA","InLat","InDur","InEnd","SP cA","%In(cA)",""); 
PrintLog("%s\t %s\t %s\t %s\t %s\t %s\t %s\t %s","SP A(X-Ax)","PreStMean","SP(L)","P2P","M","Hand","INT", 
""); 




PrintLog("%s\t %s\t %s\t %s\t %s","P2P(Raw)","Breath","PoStimM","nP2P","nMArea"); 
PrintLog("\n "); 
'Please begin by answering 2 questions about your data: 
'--------------------------------------------------------------------- 
'CHANNEL CONFIGURATION: 
'1-SPECIFY what channel config you have: 
'--------------------------------------------------------------------- 
'if you have rectified even channels then set chanconf%=2 otherwise chanconf%=1. Use chanconf%:=1 for unrectified 
multichannel files: the script will process the P2P calculations on each channel to optain its mean P2P value 
'and then automatically rectify the average to perform MEP and SP areas. Otherwise if chanconf%:=2, P2Ps will be based on 








'(This will save processing time if there are RESTING MUSCLE CHANNELS WHOSE CURSORS YOU ONLY WANT TO SET ONCE, set 
Chanselective%:=1. Advanced: Additionally you can use contraction tags 
'to set conditions to automatically detect active channels. To do this set UseTags% to 1 and edit the conditions in proc 
CheckActive() at the end of the script) 
'2-SPECIFY ACTIVE MUSCLES (CHANNELS) WHOSE CURSORS YOU WANT TO UPDATE FOR EVERY FILE: which channels are active by 



















'Advanced: Please note that if UseTags% is selected, if the conditions that you set in CheckActive()are met 










' Reset Arrays 
'---------------------------------------------------------------- 






















'FrameTag(-1,0); 'untag all frames' 
'***MAGSTIM INTENSITY VALUE 
Frame(1); 
INT$:=FileComment$(); 'if using manually entered file comment 
if Val(INT$)< 1 then 
INT%:= FrameGetRealVar(frnam$); 'multiple states function to obtain magstim intensities 
else INT%:=Val(INT$); 
endif; 
if INT% < 1 then 
INT%:= FrameUserVar(1); 'if using script enterred value 
endif; 
MTag$:=FrameComment$(); 
Hand:= FrameUserVar(5); 'alternatively set it manually here: 
'Hand:=-76.47; 
'----------------------------------------------------- 
'Optional: Get pre-processed data from Frame User Variables: 
'--------------------------------------------------------- 
frmax%:=FrameCount(); 
chmax:=ChanCount(-1); ' count how many channels there are 
for ch%:=chanconf% to chmax step chanconf% do 'select all available rectified channels 'select all available rectified 
channels 
if frmax% >= 2 then 
Frame(2); 
MVCS[ch%]:=FrameUserVar(ch%-UsrVarOf%); 'if MVCs were prerecorded corresponding to channel 
endif; 
if frmax% >= 3 then 
Frame(3); 
MEPS[ch%]:=FrameUserVar(ch%-UsrVarOf%); 'if number of MEPs were prerecorded corresponding to channel 
endif; 
if frmax% >= 4 then 
Frame(4); 
MTh[ch%]:=FrameUserVar(ch%-UsrVarOf%); 'if MTH was prerecorded corresponding to channel 
endif; 
if frmax% >= 5 then 
Frame(5); 
SPTh[ch%]:=FrameUserVar(ch%-UsrVarOf%); 'if SPTH was prerecorded corresponding to channel 
endif; 
view(data%); 
if frmax% >= 6 then 
Frame(6); 










Chanshow(-1,1); 'turn on all channels before removing unrect 
'Set which Channels you do not want to see at the begining (usually just unrectified): 









processframes(1,-1,-1,1,1); 'start processing from right frame and do all frames 
if chanconf%=1 then 
ChanRectify(-1); 
endif; 
'Cursor settings and PrintLog' 




for ch%:=chanconf% to chmax step chanconf% do 'select all available rectified channels 'select all available rectified 
channels 






Chanshow(-1,0); 'turn off all channels before placing cursors 
Chanshow(Ch%-UsrVarOf%,1); 'use this if you also want to see the unrectified counterpart of the above channel 
Optimise(Ch%-UsrVarOf%,0.3); 'optimises view to exclude artefacts 
Chanshow(Ch%,1); 'only show the relevant channel 
YRange(Ch%,-0.1,1); 
Optimise(Ch%,0.3); 'optimises view to exclude artefacts 
CursorSet(0); 
CursorSet(2,mintime(),-0.005); 'defining area for pre-stim meanline calculation 
PreStimMeanmultsd%:=2; 'horizontal cursor placed at 2x SD i.e 95% CI 
PreStimMean:=ChanMean(ch%,cursor(1),cursor(2),meansd); 'redefining mean and SDs before deleting h cursors 
PreStimMeansd1:=PreStimMean-(PreStimMeanmultsd%*meansd); 
PreStimMeansd2:=PreStimMean+(PreStimMeanmultsd%*meansd); 
HCursorDelete(-1); 'getting rid of all horizontal cursors 
HCursorNew(ch%,PreStimMean); 'set new meanline cursor on required channel 
HCursorNew(ch%,PreStimMeansd1); 'first SD line 
HCursorNew(ch%,PreStimMeansd2); 'second SD line 
HCursorLabel(3); 'label both cursor number and position 
HCursorLabelPos(1,75); 
CursorSet(0); 'delete all V cursors (not necessary) 
'Here a Cusum subroutine can be added to automate cursor positions 
CursorSet(3,0.035,0.050,0.1); 
'Message("Click OK on this box and then position cursors (or leave at .035, 0.05 & 0.1)to mark MEP Lat & Lat & endpoint 
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of INHIBITION for Signal Channel ",ch%); 
ch$:=Str$(ch%); 





case ChanSelect%=0 then 
Cursor$:="Position Cursors to mark MEP & INHIBITION for Signal Channel no."+ch$+" (or leave at .035, 0.05 & 0.1) and 
click Done"; 
u%:=Interact(Cursor$,1,0,"Done|0x0d","Abort|0x1b"); 
if u%=2 then 
Done(); 
endif; 
case ChanSelect%=1 and ActiveChan$[ch%]="x" then 
Cursor$:="Position Cursors to mark MEP & INHIBITION for Signal Channel no."+ch$+" (or leave at .035, 0.05 & 0.1) and 
click Done"; 
u%:=Interact(Cursor$,1,0,"Done|0x0d","Abort|0x1b"); 
if u%=2 then 
Done(); 
endif; 
case ChanSelect%=1 and ActiveChan$[ch%]<>"x" and cdx%[ch%]<1 then 
Cursor$:="Position Cursors to mark MEP & INHIBITION for Signal Channel no."+ch$+" (or leave at .035, 0.05 & 0.1) and 
click Done"; 
u%:=Interact(Cursor$,1,0,"Done|0x0d","Abort|0x1b"); 










'MEP AREA CALCULATION' 
MEPdur:=(Cursor(2)-Cursor(1))*1000; 
MEPLAT:=Cursor(1)*1000; 
MEPArea:=(ChanMeasure(ch%,1,cursor(1),cursor(2)))*1000; ' **** now using curve area (1) which measures area from the mean 
line for MEP AREA 







InhibCurvArea:=(Abs(ChanMeasure(ch%,1,cursor(2),cursor(3)))*1000); ' **** now using curve area (1) 
InhibArea:=(ChanMeasure(ch%,4,cursor(2),cursor(3))*1000); ' **** area below mean line to x-axis (4) 
if (cursor(3)+0.1) < 0.5 then 
PostStimMean:=ChanMean(ch%,(cursor(3)+0.02),(cursor(3)+0.1),meansd); 'defining post cSP mean emg 
else 
PostStimMean:=ChanMean(ch%,(cursor(3)+0.02),maxtime(),meansd); 'defining post cSP mean emg 
endif; 












'%Threshold if available - if not available can calculate values below threshold (needs checking) 
var pcMEPs; 




if MTh[ch%] > 0 and INT% > 0 then 
pcMTh:=(INT%/MTh[ch%]); 







'Export average file per Channel with cursor positions 
'----------------------------------------------------------------- 
'if ch%:=2 or 4 then; '*****************CHOOSE WHICH CHANNELS TO SAVE AVERAGE FRAME WITH CURSORS AND ALL PARAMETERS 
'if ch%=2 or ch%=4 then; 
View(ave1%); 
var cfloc$, chanst$; 
oldchan%:=ch%; 







nfloc$:=floc$ + avg$; 
FilePathSet(nfloc$,0,1); 
chanst$:=ch$+"-"+Muscle$; 
cfloc$:=nfloc$ + chanst$; 
FilePathSet(cfloc$,0,1); 




HCursorNew(chanconf%,PreStimMean); 'reset Cursors to save 
CursorSet(3,(MEPLAT/1000),(INHIBlat/1000),(INHIBEnd/1000)); 'defining area for pre-stim meanline calculation 
'********************get out of new folder 
Frame(1); 






' Frame 1 User Variables: 
FrameUserVar(1,INT%); ' 1=File intensity 
FrameUserVar(3,chmax); ' No of Channels 
FrameUserVar(5,Hand); ' Handedness 
FrameUserVar(2,MVCS[oldchan%]); ' MVCfor that channel 
FrameUserVar(4,MTh[oldchan%]); ' MTh 
FrameUserVar(6,SPTh[oldchan%]); ' SPTh 
FrameUserVar(7,oldchan%); ' Original Channel No 
FrameUserVar(8,(MEPLAT/1000)); ' cursor 1 (in seconds) 
FrameUserVar(9,(INHIBlat/1000)); ' cursor 2 (in seconds) 
FrameUserVar(10,(INHIBEnd/1000)); ' cursor 3 (in seconds) 
FrameUserVar(11,PreStimMean); ' MEP Latency (in V) 
' user var 12 is reserved fpr P2P 
FrameUserVar(13,MEPS[oldchan%]); ' Original MEPcount for that channel 
FrameUserVar(14,CONT); ' Contraction Strength (%MVC) 
FrameUserVar(15,MinMeans[oldchan%]); ' Quiet Breathing Mean for that channel 
FrameComment$(MTag$); ' Contraction Tag 
FileComment$(INT$); ' intensity again for quick confirmation (sometimes this is a text 








Chanshow(-1,0); 'turn off all channels before placing cursors 
Chanshow((oldchan%-UsrVarOf%),1); 'only show the relevant channel 
Optimise(-2,0.005); 'optimises view to exclude artefacts 








for fr%:= 1 to frmax% do 
Frame(fr%); 
CursorSet(0); 








CursorSet(0); 'remove cursors 






FrameUserVar(12,P2P); ' P2P MEP Amp (in V) 

















PrintLog("%.6f\t %s\t %.2f\t %.0d\t %.6f\t %.6f\t %.0d\t %.0d\t %.2f\t %.2f\t %.2f\t %.0d\t %s", 
P2P,ChanTitle$(ch%-UsrVarOf%),Hand,INT%,MVCS[ch%],CONT,MEPS[ch%],frmax%,(MEPS[ch%]/frmax%),MTh[ch%],SPTh[ch%], 
chmax,""); 
PrintLog("%.2f\t %.4f\t %.4f\t %.2f\t %.6f\t %.6f\t %.6f\t %.6f\t %.6f\t %.6f\n", 
pThresh,SPtoAREA,SPtoP2P,Threshx120,"",P2PRaw,MinMeans[ch%],PostStimMean,nP2P,nMArea); 
'CHECK all is working section: should you have doubts about MVCs meps and thresholds 
'PrintLog("%s,%.6f\n"," MVCs :",MVCS[]); 
'PrintLog("%s,%.6f\n"," MThs so far:",Mth[]); 
'PrintLog("%s,%.6f\n"," MEPS[] so far:",MEPS[]); 




















case MTag$="TU" or MTag$="LtoR" or MTag$="RtoL" and chanconf%=2 and InStr(Chantitle$(chanconf%-UsrVarOf%),"Gas")<>1 





















case MTag$="HU" or MTag$="TF" and chanconf%=2 and InStr(Chantitle$(chanconf%-UsrVarOf%),"brev")<>1 



















case MTag$="BE" or MTag$="TE" or InStr(Chantitle$(chanconf%-UsrVarOf%),"brev")=1 or InStr(Chantitle$(chanconf%-UsrVarOf%), 
"Brev")=1 
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'Step 5: CURSORS 
'Asks for user to position 3 cursors for MEP and csP Offset and calculated and outputs all immaginable Prestim, 
MEP and cSP characteristics, including normalised values (to MVC but can be set to 
'M Wave). P2P Amplitudes are based on non-averaged single stimulus frames whereas MEP areas and cSP are 
calculated from a created average frame. 
'A new Inhibition area calculation is now measured under the mean emg line and returned as a positive value -this 
uses Curve Area 
'This area under the mean line is taken as a % of the total area from mean line to x axis i.e. 100% = no EMG 
during silent period (SP) and 25% means 75% EMG remaining. 
'Yoann Buisson 27/10/2008 
'revised with frame state info 02/02/2010 
'Added P2P function based on non-averaged single stimulus frames 22/10/2010 
var data%, ave1%,frmax%,chAVdata%; 
var q%, oldchan%; 
var P2Ps[40], MEPp2pRaw[18],P2PRaw; 
var MedFreq[40], FrP2Ps[40],FrP2PsRaw[40],MEPp2p[40]; 
var fr%,PreStimRMS,MEPraw,RMSmin,EndMEP,StartMEP,RMSmax,PostStimMean; 
var avg$, Muscle$, pcMTh; 
var f$, Name$, chmax, cursor$, ch$, chanconf%, UsrVarOf%; 




var PreStimMeanmultsd%; 'horizontal cursor placed at x multiples of SD 
var ch%,floc$, nfloc$; 
var frnam$:= "Power A"; 'Frame variable name for Magstim stimulator output: This will be zero if the frame state feature 
is disabled 
'from the config file. 
'Config File settings: States Tab: select Static and Select Magstim 200 
var file, MEPLAT, MEPdur, INHIBlat, INHIBdur, INHIBEnd, MEPArea, InhibCurvArea, InhibArea, PreStimMean, P2P, Hand; 
var CONT,Threshx120,pThresh,SPtoAREA,SPtoP2P,nP2P,nMArea; 
q%:=1; 
PreStimMeanmultsd%:=2; 'horizontal cursor placed at 2x SD i.e 95% CI 
'Print the Guinness Header 
PrintLog("%s\r ","5-CURSORS Script v27/10/2010"); 
PrintLog("%s\t %s \t %s \t %s \t %s \t %s \t %s \t %s \t %s \t %s \t 
%s", 
"CHAN","file","MEP LAT","MEP DUR","MEPA","InLat","InDur","InEnd","SP cA","%In(cA)",""); 
PrintLog("%s\t %s\t %s\t %s\t %s\t %s\t %s\t %s","SP A(X-Ax)","PreStMean","SP(L)","P2P","M","Hand","INT", 
""); 




PrintLog("%s\t %s\t %s\t %s\t %s","P2P(Raw)","Breath","PoStimM","nP2P","nMArea"); 
PrintLog("\n "); 
'Please begin by answering 2 questions about your data: 
'--------------------------------------------------------------------- 
'CHANNEL CONFIGURATION: 
'1-SPECIFY what channel config you have: 
'--------------------------------------------------------------------- 
'if you have rectified even channels then set chanconf%=2 otherwise chanconf%=1. Use chanconf%:=1 for unrectified 
multichannel files: the script will process the P2P calculations on each channel to optain its mean P2P value 
'and then automatically rectify the average to perform MEP and SP areas. Otherwise if chanconf%:=2, P2Ps will be based on 








'(This will save processing time if there are RESTING MUSCLE CHANNELS WHO's CURSORS YOU ONLY WANT TO SET ONCE, set 
Chanselective%:=1. Advanced: Additionally you can use contraction tags 
'to set conditions to automatically detect active channels. To do this set UseTags% to 1 and edit the conditions in proc 
CheckActive() at the end of the script) 
'2-SPECIFY ACTIVE MUSCLES (CHANNELS) WHO'S CURSORS YOU WANT TO UPDATE FOR EVERY FILE: which channels are active by 



















'Advanced: Please note that if UseTags% is selected, if the conditions that you set in CheckActive()are met 










' Reset Arrays 
'---------------------------------------------------------------- 






















'FrameTag(-1,0); 'untag all frames' 
'***MAGSTIM INTENSITY VALUE 
Frame(1); 
INT$:=FileComment$(); 'if using manually entered file comment 
if Val(INT$)< 1 then 
INT%:= FrameGetRealVar(frnam$); 'multiple states function to obtain magstim intensities 
else INT%:=Val(INT$); 
endif; 
if INT% < 1 then 
INT%:= FrameUserVar(1); 'if using script enterred value 
endif; 
MTag$:=FrameComment$(); 
Hand:= FrameUserVar(5); 'alternatively set it manually here: 
'Hand:=-76.47; 
'----------------------------------------------------- 
'Optional: Get pre-processed data from Frame User Variables: 
'--------------------------------------------------------- 
frmax%:=FrameCount(); 
chmax:=ChanCount(-1); ' count how many channels there are 
for ch%:=chanconf% to chmax step chanconf% do 'select all available rectified channels 'select all available rectified 
channels 
if frmax% >= 2 then 
Frame(2); 
MVCS[ch%]:=FrameUserVar(ch%-UsrVarOf%); 'if MVCs were prerecorded corresponding to channel 
endif; 
if frmax% >= 3 then 
Frame(3); 
MEPS[ch%]:=FrameUserVar(ch%-UsrVarOf%); 'if number of MEPs were prerecorded corresponding to channel 
endif; 
if frmax% >= 4 then 
Frame(4); 
MTh[ch%]:=FrameUserVar(ch%-UsrVarOf%); 'if MTH was prerecorded corresponding to channel 
endif; 
if frmax% >= 5 then 
Frame(5); 
SPTh[ch%]:=FrameUserVar(ch%-UsrVarOf%); 'if SPTH was prerecorded corresponding to channel 
endif; 
view(data%); 
if frmax% >= 6 then 
Frame(6); 










Chanshow(-1,1); 'turn on all channels before removing unrect 
'Set which Channels you do not want to see at the begining (usually just unrectified): 









processframes(1,-1,-1,1,1); 'start processing from right frame and do all frames 
if chanconf%=1 then 
ChanRectify(-1); 
endif; 
'Cursor settings and PrintLog' 




for ch%:=chanconf% to chmax step chanconf% do 'select all available rectified channels 'select all available rectified 
channels 






Chanshow(-1,0); 'turn off all channels before placing cursors 
Chanshow(Ch%-UsrVarOf%,1); 'use this if you also want to see the unrectified counterpart of the above channel 
Optimise(Ch%-UsrVarOf%,0.3); 'optimises view to exclude artefacts 
Chanshow(Ch%,1); 'only show the relevant channel 
YRange(Ch%,-0.1,1); 
Optimise(Ch%,0.3); 'optimises view to exclude artefacts 
CursorSet(0); 
CursorSet(2,mintime(),-0.005); 'defining area for pre-stim meanline calculation 
PreStimMeanmultsd%:=2; 'horizontal cursor placed at 2x SD i.e 95% CI 
PreStimMean:=ChanMean(ch%,cursor(1),cursor(2),meansd); 'redefining mean and SDs before deleting h cursors 
PreStimMeansd1:=PreStimMean-(PreStimMeanmultsd%*meansd); 
PreStimMeansd2:=PreStimMean+(PreStimMeanmultsd%*meansd); 
HCursorDelete(-1); 'getting rid of all horizontal cursors 
HCursorNew(ch%,PreStimMean); 'set new meanline cursor on required channel 
HCursorNew(ch%,PreStimMeansd1); 'first SD line 
HCursorNew(ch%,PreStimMeansd2); 'second SD line 
HCursorLabel(3); 'label both cursor number and position 
HCursorLabelPos(1,75); 
CursorSet(0); 'delete all V cursors (not necessary) 
'Here a Cusum subroutine can be added to automate cursor positions 
CursorSet(3,0.035,0.050,0.1); 
'Message("Click OK on this box and then position cursors (or leave at .035, 0.05 & 0.1)to mark MEP Lat & Lat & endpoint 
of INHIBITION for Signal Channel ",ch%); 
ch$:=Str$(ch%); 







case ChanSelect%=0 then 
Cursor$:="Position Cursors to mark MEP & INHIBITION for Signal Channel no."+ch$+" (or leave at .035, 0.05 & 0.1) and 
click Done"; 
u%:=Interact(Cursor$,1,0,"Done|0x0d","Abort|0x1b"); 
if u%=2 then 
Done(); 
endif; 
case ChanSelect%=1 and ActiveChan$[ch%]="x" then 
Cursor$:="Position Cursors to mark MEP & INHIBITION for Signal Channel no."+ch$+" (or leave at .035, 0.05 & 0.1) and 
click Done"; 
u%:=Interact(Cursor$,1,0,"Done|0x0d","Abort|0x1b"); 
if u%=2 then 
Done(); 
endif; 
case ChanSelect%=1 and ActiveChan$[ch%]<>"x" and cdx%[ch%]<1 then 
Cursor$:="Position Cursors to mark MEP & INHIBITION for Signal Channel no."+ch$+" (or leave at .035, 0.05 & 0.1) and 
click Done"; 
u%:=Interact(Cursor$,1,0,"Done|0x0d","Abort|0x1b"); 










'MEP AREA CALCULATION' 
MEPdur:=(Cursor(2)-Cursor(1))*1000; 
MEPLAT:=Cursor(1)*1000; 
MEPArea:=(ChanMeasure(ch%,1,cursor(1),cursor(2)))*1000; ' **** now using curve area (1) which measures area from the mean 
line for MEP AREA 







InhibCurvArea:=(Abs(ChanMeasure(ch%,1,cursor(2),cursor(3)))*1000); ' **** now using curve area (1) 
InhibArea:=(ChanMeasure(ch%,4,cursor(2),cursor(3))*1000); ' **** area below mean line to x-axis (4) 
if (cursor(3)+0.1) < 0.5 then 
PostStimMean:=ChanMean(ch%,(cursor(3)+0.02),(cursor(3)+0.1),meansd); 'defining post cSP mean emg 
else 
PostStimMean:=ChanMean(ch%,(cursor(3)+0.02),maxtime(),meansd); 'defining post cSP mean emg 
endif; 












'%Threshold if available - if not available can calculate values below threshold (needs checking) 
var pcMEPs; 




if MTh[ch%] > 0 and INT% > 0 then 
pcMTh:=(INT%/MTh[ch%]); 







'Export average file per Channel with cursor positions 
'----------------------------------------------------------------- 
'if ch%:=2 or 4 then; '*****************CHOOSE WHICH CHANNELS TO SAVE AVERAGE FRAME WITH CURSORS AND ALL PARAMETERS 
'if ch%=2 or ch%=4 then; 
View(ave1%); 
var cfloc$, chanst$; 
oldchan%:=ch%; 







nfloc$:=floc$ + avg$; 
FilePathSet(nfloc$,0,1); 
chanst$:=ch$+"-"+Muscle$; 
cfloc$:=nfloc$ + chanst$; 
FilePathSet(cfloc$,0,1); 




HCursorNew(chanconf%,PreStimMean); 'reset Cursors to save 
CursorSet(3,(MEPLAT/1000),(INHIBlat/1000),(INHIBEnd/1000)); 'defining area for pre-stim meanline calculation 
'********************get out of new folder 
Frame(1); 




' Frame 1 User Variables: 
FrameUserVar(1,INT%); ' 1=File intensity 
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FrameUserVar(3,chmax); ' No of Channels 
FrameUserVar(5,Hand); ' Handedness 
FrameUserVar(2,MVCS[oldchan%]); ' MVCfor that channel 
FrameUserVar(4,MTh[oldchan%]); ' MTh 
FrameUserVar(6,SPTh[oldchan%]); ' SPTh 
FrameUserVar(7,oldchan%); ' Original Channel No 
FrameUserVar(8,(MEPLAT/1000)); ' cursor 1 (in seconds) 
FrameUserVar(9,(INHIBlat/1000)); ' cursor 2 (in seconds) 
FrameUserVar(10,(INHIBEnd/1000)); ' cursor 3 (in seconds) 
FrameUserVar(11,PreStimMean); ' MEP Latency (in V) 
' user var 12 is reserved fpr P2P 
FrameUserVar(13,MEPS[oldchan%]); ' Original MEPcount for that channel 
FrameUserVar(14,CONT); ' Contraction Strength (%MVC) 
FrameUserVar(15,MinMeans[oldchan%]); ' Quiet Breathing Mean for that channel 
FrameComment$(MTag$); ' Contraction Tag 
FileComment$(INT$); ' intensity again for quick confirmation (sometimes this is a text 








Chanshow(-1,0); 'turn off all channels before placing cursors 
Chanshow((oldchan%-UsrVarOf%),1); 'only show the relevant channel 
Optimise(-2,0.005); 'optimises view to exclude artefacts 








for fr%:= 1 to frmax% do 
Frame(fr%); 
CursorSet(0); 








CursorSet(0); 'remove cursors 






FrameUserVar(12,P2P); ' P2P MEP Amp (in V) 

















PrintLog("%.6f\t %s\t %.2f\t %.0d\t %.6f\t %.6f\t %.0d\t %.0d\t %.2f\t %.2f\t %.2f\t %.0d\t %s", 
P2P,ChanTitle$(ch%-UsrVarOf%),Hand,INT%,MVCS[ch%],CONT,MEPS[ch%],frmax%,(MEPS[ch%]/frmax%),MTh[ch%],SPTh[ch%], 
chmax,""); 
PrintLog("%.2f\t %.4f\t %.4f\t %.2f\t %.6f\t %.6f\t %.6f\t %.6f\t %.6f\t %.6f\n", 
pThresh,SPtoAREA,SPtoP2P,Threshx120,"",P2PRaw,MinMeans[ch%],PostStimMean,nP2P,nMArea); 
'CHECK all is working section: should you have doubts about MVCs meps and thresholds 
'PrintLog("%s,%.6f\n"," MVCs :",MVCS[]); 
'PrintLog("%s,%.6f\n"," MThs so far:",Mth[]); 
'PrintLog("%s,%.6f\n"," MEPS[] so far:",MEPS[]); 




















case MTag$="TU" or MTag$="LtoR" or MTag$="RtoL" and chanconf%=2 and InStr(Chantitle$(chanconf%-UsrVarOf%),"Gas")<>1 





















case MTag$="HU" or MTag$="TF" and chanconf%=2 and InStr(Chantitle$(chanconf%-UsrVarOf%),"brev")<>1 



















case MTag$="BE" or MTag$="TE" or InStr(Chantitle$(chanconf%-UsrVarOf%),"brev")=1 or InStr(Chantitle$(chanconf%-UsrVarOf%), 
"Brev")=1 





















CURSORS	  for	  Paired	  Pulse	  Applications:	  Universal	  Paired	  Pulse	  
Program	  





'Universal Paired Pulse Script 
'Universal Paired Pulse Script for Rest and Active Muscles including MVC processing. Please only use the MVC compenent when these 
corresspond to 
'the files of interest (chanlow-chanhigh). Note: Also valid for configs where even channels are not the rectified replica of odd channels 
'If a serial cable interface BiStim has been used, then you get a bit more output from this script. 
'*****Note- if you say yes to running the MVC subroutine, it will clear the log file (this info will be exported to the MVC report text 
file though 
'so will not be permanently lost). 
'**Automatic Paired Pulse Calculations Require Test Alone state to be state 1 
'Slight change in the definition of LICI (see InhibP) now LICI is the average of LICIs calculated on a frame by frame basis 
'Also PreStim Amplitude added to check when there is no MEP 
'Yoann Buisson 05082010 
var fh%,ch%,chmax,INTA%,INTB%, Interval%, StateTitle$, state%, ch$, MEPA, MEPA2, Cursor$; 
var f$,P2P2, PreStimMean, MVCS[18], chanlow, chanhigh; 
var fcount%,i%, MVC,q%,CONT, st%, rep%,ACTIVE%,LickMe%; 
var P2P, statehigh%, statelow%, chanconfig, repeats%; 





var FacP, SDFacP, FacA, SDFacA,stp%; 
var InP,InA,SDInP,SDInA; 
var SDTAp,SDTAa,PPCalc%; 
var frnamA$:= "Power A"; 'Frame variable name for Magstim stimulator output: This will be zero if the frame state feature is 
'disabled from the config file 
'Config File settings: States Tab: select Static or Dynamic and Select Magstim 200 
var frnamB$:= "Power B"; 
var Interval$:= "Interval"; 
View(LogHandle()); 
'====================================================================================== 
'YOU NEED TO EDIT THESE VARIABLES ONLY 
'ACTIVE OR AT REST: 
ACTIVE%:=1; 'for Rest Paired Pulse change this to Zero 
'CHANNEL RANGE: 




'and step between channel to process (usually 2 if you used a config where even channels are the rectified replica of odd channels 
'but will be 1 if each channel is a seperate muscle) 
st%:=2; 
'No. of STATES: 
'edit statehigh% with the total number of states that you have (or whatever you want to process): 
statelow%:=4; 
statehigh%:=4; 
'and step between states (usually 1 to do all states) 
stp%:=1; 
'CONFIG: 
'Do you have rectified channels? 
'configs where even channels are the rectified replica of odd channels, chanconfig=2 
chanconfig:=2; 
'otherwise if each channel is a different muscle 
'chanconfig:=1; 
'REPEATS: (All of this can be automated in Signal 4) 
'(usually 6 or 8)How many individual SICIs of ICFs etc were carried ou in your protocol? 
repeats%:=6; 
'if this is 6, then the numbers in the brackets becomes 6: 
var P2Pch[6], MEPAch[6], P2P2ch[6], MEPA2ch[6], TApk[6], TAarea[6], InhibP[6], InhibA[6]; 





'OPTIONAL: To speed things along you can also edit the following to define where cursors go for specific muscle names (used in the config 
file); 




















'Auto Paired Pulse Calculations: 
'If you don't want these set PPCalc%:=0 
PPCalc%:=1; 





Chanshow(-1,1); 'turn on all channels 
if ACTIVE% > 0 then 
q%:=query("Do you have an MVC File specifically for the muscles you are processing (if Yes -select it)?", "Yes", "No"); 
endif; 






Chanshow(-1,1); 'turn on all channels 




PrintLog("%s,%s","","Universal Paired Pulse Script v2 (9/07/2010)"); 
fcount%:=framecount(); 
PrintLog("Total number of frames: %0d", fcount%,""); 
PrintLog("Number of frames per state: %0d", repeats%); 
PrintLog("%s\n"," "); 
Printlog("%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s,%s","Chan","State","P2P(mV)","MEP Area(mVms)","StateTitle","Power A","Power B", 
"Interval(ms)","cursor1(ms)","cursor2(ms)","Conditioning(%P2P)","Conditioning(%Area)","file","PreStimAmp",""); 
Printlog("%s,%s,%s,%s,%s,%s,%s,%s,%s\n","cursor3(ms)","cursor4(ms)","MEP 2 P2P (mV)","MEP 2 Area (mVms)","Inhibition(%P2P)", 
360	  
	  
"Inhibition(%Area)","PreStim RMS (mV)","MVC (mV)","Contraction(%MVC)"); 
PrintLog("%s\n"," "); 
PrintLog("%s\n"," "); 
chmax:=ChanCount(-1); ' count how many channels there are 
for ch%:=chanlow to chanhigh step st% do 'select all available rectified channels 'select all available rectified channels 
'OPTIONAL DEFAULT CURSOR PLACEMENT (May save some time when looking at lots of muscles)=================================== 
CursorSet(0); 
docase 
case InStr(ChanTitle$(ch%),Muscle1$,0)=1 then 
Cursorset(4,c5,c6,c7,c8); 'position the cursors 
case InStr(ChanTitle$(ch%),Muscle2$,0)=1 then 
Cursorset(4,c9,c10,c11,c12); 'position the cursors 
case InStr(ChanTitle$(ch%),Muscle3$,0)=1 then 
Cursorset(4,c13,c14,c15,c16); 'position the cursors 
case InStr(ChanTitle$(ch%),Muscle4$,0)=1 then 
Cursorset(4,c17,c18,c19,c20); 'position the cursors 
else 
Cursorset(4,c1,c2,c3,c4); 'position the cursors 
endcase; 
'========================================================================================================================= 
Chanshow(-1,0); 'turn off all channels before placing cursors 
Chanshow(Ch%,1); 'only show the relevant channel 
if ch% < chmax and chanconfig=2 then 
Chanshow(Ch%+1,1); 'use this if you also want to see the unrectified counterpart of the above channel 
endif; 
Optimise(-2,0.265); 'optimises view to exclude artefacts 
'Message("Click OK on this box and then position cursors (or leave at 0.111 and 0.175) to mark MEP onset and offset for Signal Channel 
",ch%); 
ch$:=Str$(ch%); 
Cursor$:="Use PageUP and DOWN & Adjust Cursors to mark MEP onset and offset (TA,SICI,ICF,SICF cursors 1&2 and LICI cursors 3&4) 
for Signal Channel no."+ch$+" ("+ChanTitle$(ch%)+"). Then click OK button --> "; 
Interact(Cursor$,32); 
for state%:=statelow% to statehigh% step stp% do; 'make sure to change to suit total number of states 
Chanshow(-1,1); 'turn on all channels 
for i%:=1 to fcount% do 
frame(i%); 









if InStr(StateTitle$,"TA")>0 or InStr(StateTitle$,"Test")>0 or InStr(StateTitle$,"TEST")>0 or InStr(StateTitle$,"test")> 
0 
















PreStimMp2p:=ChanMeasure(ch%,9,-0.094,-0.010); 'Prestim Mean using amplitude 
PreStimMean:=ChanMeasure(ch%,10,-0.094,-0.010); 'Prestim Mean using RMS 




'Conditioning Calcs (frame by frame MEP suppression or facilitation) :------------------------------- 
docase 





case InStr(StateTitle$,"TA")>0 or InStr(StateTitle$,"Test")>0 or InStr(StateTitle$,"TEST")>0 





case InStr(StateTitle$,"ICF")>0 or InStr(StateTitle$,"icf")>0 or InStr(StateTitle$,"Icf")>0 





















if LickMe%=1 and ACTIVE% = 0 then 
Printlog("%.3f,%.3f,%.3f,%.3f,%.3f,%.3f\n",(cursor(3))*1000,(cursor(4))*1000,P2P2,MEPA2*1000,InhibP[rep%-1],InhibA[rep%-1]); 
endif; 




if LickMe%=0 and ACTIVE% = 0 then 
PrintLog("%s\n"," "); 
endif; 




case InStr(StateTitle$,"TA")>0 or InStr(StateTitle$,"Test")>0 or InStr(StateTitle$,"TEST")>0 







Printlog("%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f\n","Mean Test Alone (P2P):",TAp,"SD:",SDTAp, 











Printlog("%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f\n","Mean Inhibited MEP (P2P):",InP,"SD:",SDInP, 
"SEM:",(SDInP/Sqrt(repeats%)),"Mean Inhibited MEP (Area):",InA*1000,"SD:",SDInA*1000,"SEM:",(SDInA/Sqrt(repeats% 
))*1000); 
PrintLog("%s,%s","" ,""); 
Printlog("%s\n","Definition: SICI = 1 - (Mean Conditioned MEP/ Mean Test Alone MEP)"); 
PrintLog("%s,%s","" ,""); 
Printlog("%s,%.3f,%s,%.3f\n","SICI (%P2P):",SICIp*100,"SICI (%Area):",SICIa*100); 
PrintLog("%s\n"," "); 
ArrConst(P2Pch[],0); 'set arrays back to zero 
ArrConst(P2P2ch[],0); 
rep%:=1; 











Printlog("%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f\n","Mean MEP 1 (P2P):",meanP2P1,"SD:",SDP2P1, 
"SEM:",(SDP2P1/Sqrt(repeats%)),"Mean MEP 1 (Area):",meanMEPA1*1000,"SD:",SDMEPA1*1000,"SEM:",(SDMEPA1/Sqrt( 
repeats%))*1000); 
PrintLog("%s,%s","" ,""); 
Printlog("%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f,%s,%.6f\n","Mean MEP 2 (P2P):",meanP2P2,"SD:",SDP2P2, 
"SEM:",(SDP2P2/Sqrt(repeats%)),"Mean MEP 2 (Area):",meanMEPA2*1000,"SD:",SDMEPA2*1000,"SEM:",(SDMEPA2/Sqrt( 
repeats%))*1000); 
PrintLog("%s,%s","" ,""); 
Printlog("%s\n","Definition: LICI = 1 - (Mean MEP 2/Mean MEP 1)"); 
PrintLog("%s,%s","" ,""); 
Printlog("%s,%.3f,%s,%.3f\n","LICI (%P2P):",LICIp,"LICI (%Area):",LICIa); 
PrintLog("%s,%s","" ,""); 
PrintLog("%s,%.6f\n","Check InhibP[]:", InhibP[]); 
PrintLog("%s,%s","" ,""); 
PrintLog("%s,%.6f\n","Check p2p[]:", P2Pch[]); 
PrintLog("%s,%s","" ,""); 
PrintLog("%s,%.6f\n","Check p2p2[]:", P2P2ch[]); 
LickMe%:=0; 







case InStr(StateTitle$,"ICF")>0 or InStr(StateTitle$,"icf")>0 or InStr(StateTitle$,"Icf")>0 
or InStr(StateTitle$,"10 ")>0 or InStr(StateTitle$,"10ms")>0 







Printlog("%s,%.6f,%s,%.6f,%s,%.6f,%s","Mean Facilitated MEP(P2P):",FacP,"SD:",SDFacP,"SEM:",(SDFacP/Sqrt(repeats%)),""); 
PrintLog("%s,%s","" ,""); 
Printlog("%s,%.6f,%s,%.6f,%s,%.6f\n","Mean Facilitated MEP(Area):",FacA*1000,"SD:",SDFacA*1000,"SEM:",(SDFacA/Sqrt(repeats%))*1000); 
PrintLog("%s,%s","" ,""); 
Printlog("%s\n","Definition: ICF = Mean Conditioned MEP/Mean Test Alone MEP"); 
PrintLog("%s,%s","" ,""); 
Printlog("%s,%.3f,%s,%.3f\n","ICF (%P2P):",ICFp*100,"ICF (%Area):",ICFa*100); 
PrintLog("%s,%s","" ,""); 
ArrConst(P2Pch[],0); 'set arrays back to zero 
ArrConst(P2P2ch[],0); 
rep%:=1; 
case InStr(StateTitle$,"SICF")>0 or InStr(StateTitle$,"Sicf")>0 or InStr(StateTitle$,"Sicf")>0 







Printlog("%s,%.6f,%s,%.6f,%s,%.6f,%s","Mean Facilitated MEP(P2P):",FacP,"SD:",SDFacP,"SEM:",(SDFacP/Sqrt(repeats%)),""); 
PrintLog("%s,%s","" ,""); 
Printlog("%s,%.6f,%s,%.6f,%s,%.6f\n","Mean Facilitated MEP(Area):",FacA*1000,"SD:",SDFacA*1000,"SEM:",(SDFacA/Sqrt(repeats%))*1000); 
PrintLog("%s,%s","" ,""); 
Printlog("%s\n","Definition: SICF = Mean Conditioned MEP/Mean Test Alone MEP"); 
PrintLog("%s,%s","" ,""); 
Printlog("%s,%.3f,%s,%.3f\n","SICF (%P2P):",ICFp*100,"ICF (%Area):",ICFa*100); 
PrintLog("%s\n"," "); 







if rep% > repeats% then 























'This is to integrate the Basic MVC script and record the values in the first frame of each channel 
'FileClose(-1,-1); 
var log%, ch%, Meancalc; 
var data%; 
var f$, name$, chmax, ch$, fr, q%; 
var mean, MVC, MVCTag$; 










'FrameTag(-1,0); 'untag all frames' 
PrintLog("%s\n"," "); 
PrintLog("%s\n"," "); 
PrintLog("%s%s\n","Basic MVC Script (19/03/2009) Filename: ",f$); 
chmax:=ChanCount(-1); ' count how many channels there are 
for ch%:=chanlow to chanhigh step st% do 
PrintLog("%s\n"," "); 




ArrConst(means[], -100000000); ' Initialise Mean Array to very small numbers 




if (MeanCalc > means[0]) then ' if mean is in top 3 biggest then add to "stack" 
means[0] := MeanCalc; 
endif; 






PrintLog("%s\n","TOP Averages from x=0 to 0.5 seconds of each frame (in ascending order) and MVCs (based on top 3 averages) for File:"+ 
f$+"."); 
'InfoMessg$:="%s\n","TOP Averages from x=0 to 0.5 seconds of each frame (in ascending order) and MVCs (based on top 3 averages) for 
File:"+f$+"."); 
PrintLog("%s\n","Check for abnormally large top values for validity of MVC (last value(s) in top 10 list)."); 

















CheckMVCs$:="Check the log file for abnormal MVCs and click OK. If some frames are abnormally high, make a note of frames to delete & 



















Summary	  of	  permission	  for	  third	  party	  copyright	  works	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